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DNA	  within	   eukaryotic	   nuclei	   is	  wrapped	  around	  histone	  proteins	   to	   form	   chromatin.	   	   Recent	  
advances	   have	   greatly	   extended	   our	   understanding	   of	   both	   histone	   lysine	   methylation	   as	   an	  
important	  post-­‐translational	  modification	  that	  affects	  chromatin	  functionality	  and	  the	  enzymes	  
responsible	  for	  placement	  of	  these	  marks.	  	  This	  particular	  modification	  plays	  important	  roles	  in	  
maintenance	   of	   genome	   integrity,	   transcriptional	   regulation,	   and	   epigenetic	  memory.	   	   In	   the	  
budding	  yeast	  Saccharomyces	  cerevisiae,	  histone	  lysine	  methylation	  has	  been	  shown	  thus	  far	  to	  
occur	  on	  lysine	  residues	  4,	  36,	  and	  79	  of	  histone	  H3	  (H3K4,	  H3K36,	  and	  H3K79,	  respectively)	  and	  
is	  coupled	  tightly	  to	  the	  process	  of	  transcription.	   	  Prior	  to	  completion	  of	  the	  studies	  contained	  
herein,	  both	  the	  reversibility	  of	  histone	  lysine	  methylation	  and	  the	  presence	  of	  methyl	  marks	  on	  
other	  lysine	  residues	  remained	  poorly	  understood.	  	  Histone	  methylation	  was	  long	  considered	  to	  
be	  a	  static	  modification.	  	  However,	  identification	  of	  a	  novel	  enzyme	  capable	  of	  removing	  methyl	  
marks	   from	   modified	   lysine	   residues	   challenged	   this	   thought.	   	   Intriguingly,	   the	   identified	  
demethylase	  activity	  was	  solely	  conferred	  by	  the	  enzyme’s	  JumonjiC	  (JmjC)	  domain,	  a	  signature	  
motif	   present	   in	   a	   large	   family	   of	   proteins,	   suggesting	   that	   other	   JmjC-­‐domain-­‐containing	  
proteins	  could	  also	  act	  as	  histone	  demethylases.	  	  In	  budding	  yeast,	  the	  JmjC-­‐domain-­‐containing	  
protein	   Jhd1	   was	   the	   first	   identified	   histone	   demethylase	   with	   specificity	   for	   the	   mono-­‐	   and	  
dimethyl	  states	  of	  H3K36.	  	  To	  extend	  the	  concept	  of	  reversibility	  of	  histone	  methylation	  in	  yeast	  
to	   other	   modified	   residues	   in	   distinct	   methylation	   states,	   here	   the	   budding	   yeast	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JmjC-­‐domain-­‐containing	   proteins	   Rph1	   and	   Jhd2	   are	   characterized	   as	   active	   histone	  
demethylases	   with	   specificity	   for	   di-­‐	   and	   trimethylated	   H3K36	   and	   H3K4,	   respectively.	  	  
Importantly,	   evidence	   is	   provided	   that	   Rph1-­‐mediated	   demethylation	   of	   H3K36	   putatively	  
functions	  in	  transcription	  elongation	  and	  that	  Jhd2	  is	  necessary	  for	  proper	  silencing	  of	  telomeric	  
regions.	   	  Beyond	  demonstrating	  that	  histone	  methylation	  can	  be	  actively	  reversed,	  evidence	   is	  
also	  provided	  that	  additional	  sites	  of	  lysine	  methylation	  exist.	  	  Namely,	  lysine	  37	  of	  histone	  H2B	  
is	   identified	   as	   a	   novel	   site	   of	   histone	   methylation	   in	   budding	   yeast	   with	   evolutionary	  
conservation	   in	   humans.	   	   Altogether,	   the	   work	   described	   in	   this	   dissertation	   supports	   the	  
dynamic	   nature	   of	   histone	   lysine	   methylation	   and	   existence	   of	   additional	   sites	   of	   lysine	  












“My	  father	  gave	  me	  life,	  
My	  mother	  nourished	  me.	  
Were	  it	  not	  for	  them,	  
I	  could	  not	  have	  come	  into	  being.	  
Their	  love	  for	  me	  cannot	  be	  repaid;	  
It	  is	  as	  boundless	  as	  the	  sky.”	  











I	  must	   first	   thank	  my	  parents,	  William	  and	  Maria	  Gardner,	  who	  opened	   their	  hearts	  and	   their	  
home	   to	   me,	   providing	   for	   me	   more	   opportunities	   in	   this	   lifetime	   than	   I	   could	   have	   ever	  
imagined.	  	  Your	  love	  truly	  knows	  no	  bounds,	  and	  your	  unconditional	  support	  of	  all	  my	  endeavors	  
has	  made	  the	  difference	   in	  my	  achievements	  thus	  far.	   	  Thank	  you	  for	  standing	  behind	  me	  and	  
encouraging	  me	  to	  follow	  my	  dreams.	   	   I	  am	  also	   indebted	  to	  my	  sister,	   Jennifer	  Gardner,	  who	  
from	  the	  time	  we	  were	   little	  was	  my	  role	  model	  (as	  evidenced	  by	  all	  of	  our	  childhood	  photos)	  
and	  friend.	  	  Thank	  you	  for	  your	  support,	  for	  keeping	  me	  grounded,	  and	  for	  constantly	  reminding	  
me	  of	  how	  fortunate	  we	  are.	  
	  
I	  sincerely	  thank	  Dr.	  Brian	  Strahl	  and	  all	   the	  members	  of	  his	   lab	  for	  providing	  me	  with	  a	  warm	  
welcome	  and	  easy	   transition	  when	   I	  made	   the	   very	   challenging	  decision	   to	   change	   labs.	   	   You	  
truly	  epitomize	  southern	  hospitality	  to	  me,	  and	  the	  welcome	  and	  friendship	  you	  have	  provided	  
to	  me,	  as	  well	  as	  training	  opportunity,	  are	  sincerely	  appreciated.	  
	  
I	  would	  be	  remiss	  if	  I	  did	  not	  take	  this	  opportunity	  to	  thank	  Dr.	  Yi	  Zhang	  for	  providing	  me	  with	  
the	  opportunity	  to	  train	  in	  his	  lab	  for	  the	  greater	  portion	  of	  my	  graduate	  career.	  	  I	  would	  not	  be	  
where	  I	  am	  today	  scientifically	  without	  the	  training	  I	  received	  under	  his	  direction.	  	  In	  that	  vein,	  I	  
must	   formally	  acknowledge	  Dr.	  Robert	  Klose,	   for	  believing	  enough	   in	  my	  potential	   to	   take	  me	  
under	   his	   wing	   and	   mentor	   me.	   	   Thank	   you	   for	   continuing	   to	   be	   a	   source	   of	   support	   both	  
scientifically	  and	  personally	  in	  my	  life.	  	  
	  vii	  
My	  committee	  has	  been	  one	  of	   the	  most	  outstanding	  facets	  of	  my	  graduate	  career.	   	  Dr.	  Brian	  
Strahl	  has	  provided	  me	  with	  mentorship	  that	   is	  unparalleled	   in	  my	  experience.	   	  Thank	  you	  for	  
continually	  encouraging	  me,	  especially	  in	  my	  quest	  to	  finish	  my	  degree.	  	  From	  the	  very	  first	  day	  
of	  graduate	  school,	  Dr.	  Jean	  Cook	  has	  been	  a	  supportive	  mentor	  and	  someone	  who	  challenges	  
me.	  	  Thank	  you	  for	  providing	  me	  with	  my	  first	  lab	  home	  at	  Chapel	  Hill,	  and	  for	  always	  asking	  me	  
the	   tough	   questions.	   	   Dr.	   Henrik	   Dohlman	   made	   the	   very	   difficult	   decision	   to	   change	   lab	   as	  
straightforward	  and	  simple	  as	  possible.	  	  I	  congratulate	  and	  thank	  him	  for	  his	  successful	  tenure	  as	  
Director	   of	   Graduate	   Studies,	   for	   supporting	   my	   decision	   to	   change	   labs,	   and	   for	   doing	  
everything	  he	  could	  to	  make	  the	  transition	  easier.	   	  For	  reasons	  that	  were	  never	  100%	  clear	  to	  
me,	  Dr.	  Vytas	  Bankaitis	  took	  an	  early	  interest	  in	  my	  success,	  and	  his	  continued	  support	  has	  made	  
quite	  a	  difference	  these	  past	  five	  years.	  	  Thank	  you	  for	  keeping	  your	  office	  door	  open	  for	  me	  to	  
stop	   by	   and	   chat	   –	   those	   talks	   were	   some	   of	   the	   most	   thought-­‐provoking	   and	   confidence	  
building	  sessions	  for	  me	  during	  graduate	  school.	  	  Dr.	  Beverly	  Errede	  has	  been	  both	  an	  amazing	  
mentor	   and	   role	   model,	   and	   truly	   epitomizes	   to	   me	   what	   it	   means	   for	   a	   woman	   to	   have	   a	  
successful	  career	  in	  science.	  	  Thank	  you	  for	  inviting	  me	  to	  join	  you	  at	  Cold	  Spring	  Harbor	  for	  the	  
2010	  Yeast	  Genetics	  and	  Genomics	  Course	  –	  it	  was	  one	  of	  the	  most	  remarkable	  experiences	  of	  
my	  graduate	  career	  by	  far,	  and	  I	  will	  remember	  it	  always.	  
	  
Lastly,	   I	   acknowledge	   Dr.	   Nara	   Lee,	   whom	   I	   first	   admired	   as	   one	   of	   my	   most	   talented	   and	  
outstanding	   colleagues	   in	   the	   Zhang	   Lab.	   	   Thank	   you	   for	   mentoring	   me	   at	   the	   bench,	   for	  
challenging	  me	  when	   I	   became	   complacent,	   for	   teaching	  me	   to	   be	   confident	   and	   strong,	   for	  
being	   a	   constant	   source	   of	   support	   and	   laughter,	   and	   for	   being	   my	   companion	   through	   this	  
journey	  over	  the	  past	  few	  years.	  	  Your	  presence	  has	  enriched	  my	  life.	  
	  viii	  
Table	  of	  Contents	  
	  
List	  of	  Tables .................................................................................................................................xiii	  
List	  of	  Figures ................................................................................................................................xiv	  
List	  of	  Abbreviations.....................................................................................................................xvi	  
Chapter	  One	  |	  Introduction ............................................................................................................ 1	  
Chromatin	  Structure	  and	  Function..................................................................................... 2	  
Histone	  Post-­‐translational	  Modifications	  and	  the	  Histone	  Code ....................................... 3	  
Histone	  Lysine	  Methylation	  in	  Saccharomyces	  cerevisiae.................................................. 5	  
Histone	  H3	  Lysine	  4	  (H3K4)	  Methylation............................................................... 6	  
Histone	  H3	  Lysine	  36	  (H3K36)	  Methylation........................................................... 9	  
Histone	  H3	  Lysine	  79	  (H3K79)	  Methylation......................................................... 11	  
Dynamic	  Nature	  of	  Histone	  Methylation ......................................................................... 13	  
Histone	  Demethylation	  by	  JumonjiC	  (JmjC)-­‐domain-­‐containing	  Proteins ....................... 14	  
Histone	  Lysine	  Demethylation	  in	  Saccharomyces	  cerevisiae ........................................... 15	  
Additional	  Sites	  of	  Histone	  Lysine	  Methylation................................................................ 17	  
Significance	  of	  Studies	  on	  the	  Dynamic	  Nature	  Histone	  Lysine	  Methylation	  in	  	  
Saccharomyces	  cerevisiae ................................................................................................ 18	  
Synopsis	  of	  Work	  Contained	  within	  this	  Doctoral	  Dissertation........................................ 19	  
Tables ............................................................................................................................... 21	  
Figures .............................................................................................................................. 22	  
Chapter	  Two	  |	  Demethylation	  of	  Histone	  H3K36	  and	  H3K9	  by	  Rph1:	  A	  Vestige	  of	  an	  H3K9	  	  
Methylation	  System	  in	  Saccharomyces	  cerevisiae? ...................................................................... 25	  
	  ix	  
Abstract ............................................................................................................................ 26	  
Introduction ..................................................................................................................... 26	  
Material	  and	  Methods...................................................................................................... 29	  
Yeast	  strains	  and	  media ...................................................................................... 29	  
Plasmid	  constructs............................................................................................... 29	  
Recombinant	  protein	  purification........................................................................ 30	  
Histone	  demethylation	  assays ............................................................................. 30	  
Size	  exclusion	  chromatography	  and	  sucrose	  gradient	  analysis ........................... 32	  
Native	  molecular	  weight	  and	  frictional	  coefficient	  calculations.......................... 33	  
Transfection	  and	  immunofluorescence	  microscopy ............................................ 34	  
Results .............................................................................................................................. 34	  
Rph1	  is	  an	  H3K36me3	  demethylase .................................................................... 34	  
Rph1	  requires	  both	  the	  JmjN	  and	  JmjC	  domains	  to	  catalyze	  histone	  	  
demethylation ..................................................................................................... 36	  
Deletion	  of	  RPH1	  causes	  no	  overt	  cellular	  phenotype ......................................... 37	  
Rph1	  can	  demethylate	  H3K36	  in	  vivo.................................................................. 38	  
Rph1	  is	  not	  stably	  associated	  with	  other	  proteins	  in	  vivo ................................... 39	  
Rph1	  demethylates	  H3K9	  despite	  the	  absence	  of	  this	  modification	  in	  	  
budding	  yeast ...................................................................................................... 41	  
Discussion	   ........................................................................................................................ 43	  
Acknowledgements .......................................................................................................... 47	  
Tables ............................................................................................................................... 48	  
Figures .............................................................................................................................. 50	  
Chapter	  Three	  |	  Identification	  of	  Lysine	  37	  of	  Histone	  H2B	  as	  a	  Novel	  Site	  of	  Methylation........ 59	  
Abstract ............................................................................................................................ 60	  
x	  
Introduction ..................................................................................................................... 60	  
Materials	  and	  Methods .................................................................................................... 64	  
Yeast	  strains	  and	  DNA	  constructs........................................................................ 64	  
Histone	  acid	  extraction........................................................................................ 64	  
Reverse-­‐phase	  HPLC	  purification	  of	  histone	  proteins .......................................... 65	  
µESI-­‐FTICR-­‐MS	  analysis........................................................................................ 66	  
α-­‐H2BK37me2	  antibody	  production	  and	  antibody	  affinity	  purification .............. 67	  
Western	  blot	  analysis	  and	  peptide	  competition	  assay ........................................ 68	  
RNA	  isolation,	  microarray	  and	  RT-­‐qPCR	  mRNA	  analyses .................................... 69	  
Microarray	  data .................................................................................................. 70	  
Phenotypic	  spotting	  assays ................................................................................. 70	  
Results .............................................................................................................................. 70	  
H2B	  is	  dimethylated	  at	  lysine	  37 ......................................................................... 70	  
Elucidating	  the	  enzymes	  that	  place	  and	  remove	  H2BK37	  methylation ............... 74	  
Mutation	  of	  H2BK37	  leads	  to	  no	  overt	  cellular	  phenotype ................................. 76	  
Methylation	  of	  H2BK37	  is	  conserved	  in	  higher	  eukaryotes ................................. 80	  
Discussion......................................................................................................................... 81	  
Acknowledgements .......................................................................................................... 83	  
Tables ............................................................................................................................... 85	  
Figures .............................................................................................................................. 94	  
Chapter	  Four	  |	  OPERating	  ON	  chromatin,	  a	  Colorful	  Language	  where	  Context	  Matters ........... 102	  
Abstract .......................................................................................................................... 103	  
The	  “histone	  code	  hypothesis”:	  the	  first	  ten	  years ......................................................... 106	  
Transcribing	  the	  “histone	  code”:	  chicken	  or	  egg? .......................................................... 110	  
xi	  
Tinkering	  the	  “histone	  code	  hypothesis”	  in	  years	  to	  come ............................................. 114	  
Strict	  code	  versus	  rich	  language:	  exciting	  either	  way..................................................... 118	  
Acknowledgements ........................................................................................................ 120	  
Tables ............................................................................................................................. 121	  
Figures ............................................................................................................................ 122	  
Chapter	  Five|	  Perspectives ......................................................................................................... 124	  
Identification	  and	  Characterization	  of	  Histone	  Lysine	  Demethylases	  in	  	  
Saccharomyces	  cerevisiae .............................................................................................. 126	  
Identification	  and	  Characterization	  of	  Novel	  Sites	  of	  Histone	  Lysine	  Methylation........ 135	  
Closing	  Thoughts ............................................................................................................ 138	  
Figures ............................................................................................................................ 140	  
Appendices ................................................................................................................................. 142	  
Appendix	  One	  |	  Yeast	  Jhd2p	  is	  a	  Histone	  H3	  Lys4	  Trimethyl	  Demethylase .................. 143	  
Abstract ............................................................................................................. 144	  
Introduction,	  Results,	  and	  Discussion ............................................................... 144	  
Materials	  and	  Methods ..................................................................................... 148	  
Yeast	  strains ......................................................................................... 148	  
Recombinant	  protein,	  histone	  demethylase	  assay,	  and	  	  
plasmid	  constructs................................................................................ 149	  
Antibodies............................................................................................. 149	  
Size	  exclusion	  chromatography	  and	  sucrose	  gradient	  analysis ............ 150	  
Acknowledgements ........................................................................................... 150	  
Tables ................................................................................................................ 151	  
Figures ............................................................................................................... 152	  
Appendix	  Two	  |	  Histone	  H2BK123	  Monoubiquitination	  is	  the	  Critical	  
Determinant	  for	  H3K4	  and	  H3K79	  Trimethylation	  by	  COMPASS	  and	  Dot1.................... 156	  
xii	  
Abstract ............................................................................................................. 157	  
Introduction....................................................................................................... 157	  
Materials	  and	  Methods ..................................................................................... 159	  
Generation	  of	  histone	  mutants............................................................. 159	  
Western	  blot	  analyses .......................................................................... 160	  
Generation	  of	  H2A/H2B	  histone	  mutant	  library ................................... 160	  
Results	  and	  Discussion ...................................................................................... 161	  
Acknowledgements ........................................................................................... 165	  
Tables ................................................................................................................ 166	  
Figures ............................................................................................................... 170	  
References .................................................................................................................................. 178	  
xiii	  
List	  of	  Tables	  
	  
TABLE	  	   PAGE	  
1.1	  |	  JmjC-­‐domain-­‐containing	  histone	  lysine	  demethylases	  and	  their	  substrate	  specificity ........ 21	  
2.1	  |	  Yeast	  strains	  table................................................................................................................. 48	  
2.2	  |	  Phenotype	  analysis	  of	  the	  rph1Δ	  strain................................................................................ 49	  
3.1	  |	  Yeast	  strains.......................................................................................................................... 85	  
3.2	  |	  Yeast	  histone	  H2B	  patterns	  of	  PTMs .................................................................................... 88	  
3.3	  |	  Candidates	  screened	  for	  putative	  H2BK37me2	  histone	  methyltransferase	  activity ............ 89	  
3.4	  |	  Genes	  that	  are	  upregulated	  at	  least	  two-­‐fold	  in	  H2B	  K37A	  mutant	  cells ............................. 91	  
3.5	  |	  Genes	  that	  are	  downregulated	  at	  least	  two-­‐fold	  in	  H2B	  K37A	  mutant	  cells ........................ 92	  
4.1	  |	  Histone	  modification	  types	  and	  the	  interacting	  domains	  that	  “read”	  them...................... 121	  
A1.1	  |	  Phenotype	  analysis	  of	  the	  jhd2Δ	  strain............................................................................ 151	  
A2.1	  |	  Strains	  used	  in	  this	  study.................................................................................................. 166	  
A2.2	  |	  Key	  for	  the	  histone	  H2A	  (HTA1)	  library	  in	  FY406	  background.......................................... 168	  
A2.3	  |	  Key	  for	  the	  histone	  H2B	  (HTB1)	  library	  in	  FY406	  background.......................................... 169	  
	  
xiv	  
List	  of	  Figures	  
	  
FIGURE	  	   PAGE	  
1.1	  |	  Histone	  lysine	  methylation	  in	  Saccharomyces	  cerevisiae ..................................................... 22	  
1.2	  |	  Reaction	  mechanisms	  used	  by	  histone	  demethylases	  (HDMTs) .......................................... 23	  
1.3	  |	  JmjC-­‐domain-­‐containing	  proteins	  in	  Saccharomyces	  cerevisiae .......................................... 24	  
2.1	  |	  Rph1	  is	  an	  H3K36	  demethylase	  capable	  of	  removing	  trimethyl	  lysine................................. 50	  
2.2	  |	  Rph1	  requires	  the	  JmjN/JmjC	  domain	  but	  not	  the	  ZF	  domain	  for	  demethylase	  activity...... 52	  
2.3	  |	  Deletion	  of	  RPH1	  causes	  no	  overt	  phenotype ...................................................................... 53	  
2.4	  |	  Rph1	  demethylates	  H3K36	  in	  vivo ........................................................................................ 54	  
2.5	  |	  Rph1	  is	  not	  stably	  associated	  with	  other	  proteins	  in	  yeast	  extracts .................................... 56	  
2.6	  |	  Rph1	  removes	  H3K9	  methylation	  both	  in	  vitro	  and	  in	  vivo .................................................. 57	  
3.1	  |	  Top-­‐down	  mass	  spectrometry	  (MS)	  analysis	  reveals	  histone	  H2B	  is	  	  
dimethylated	  at	  lysine	  37 .............................................................................................................. 94	  
3.2	  |	  α-­‐H2BK37me2	  antibody	  is	  specific	  for	  dimethylated	  lysine	  37	  on	  histone	  H2B .................. 96	  
3.3	  |	  Candidate	  approach	  by	  Western	  blot	  analysis	  does	  not	  reveal	  the	  methyltransferase	  
and	  demethylase	  responsible	  for	  H2B	  lysine	  37	  methylation....................................................... 97	  
3.4	  |	  Phenotypic	  analysis	  of	  strains	  harboring	  H2B	  K37R/A	  mutations ........................................ 99	  
3.5	  |	  RT-­‐qPCR	  analysis	  recapitulates	  microarray	  results	  of	  gene	  expression	  	  
changes	  upon	  mutation	  of	  H2B	  lysine	  37.................................................................................... 100	  
3.6	  |	  Methylation	  of	  lysine	  37	  of	  histone	  H2B	  is	  conserved ....................................................... 101	  
4.1	  |	  Toolkit	  for	  modifying	  the	  chromatin	  template ................................................................... 122	  
4.2	  |	  Mechanisms	  of	  histone-­‐recognition	  modules	  binding	  their	  target	  modification............... 123	  
5.1	  |	  Current	  atlas	  of	  histone	  lysine	  methylation	  in	  Saccharomyces	  cerevisiae ......................... 140	  
5.2	  |	  Deletion	  of	  RPH1	  results	  in	  phenotypes	  supportive	  of	  a	  role	  in	  transcription	  elongation .141	  
A1.1	  |	  Budding	  yeast	  Yjr119Cp	  (renamed	  Jhd2p)	  is	  an	  H3-­‐K4	  demethylase............................... 152	  
A1.2	  |	  Jhd2p	  antagonizes	  H3-­‐K4me3	  methylation	  and	  regulates	  telomeric	  silencing................ 154	  
xv	  
A2.1	  |	  Generation	  of	  antibodies	  specific	  to	  K123-­‐monoubiquitinated	  H2B ............................... 170	  
A2.2	  |	  Di-­‐	  and	  trimethylation	  of	  histone	  H3K4	  and	  trimethylation	  of	  H3K79	  are	  	  
dependent	  solely	  on	  monoubiquitination	  of	  H2BK123............................................................... 171	  
A2.3	  |	  The	  H2A/H2B	  shuffle	  strain	  Y131	  contains	  a	  galactose-­‐regulated	  copy	  of	  	  
HTA2-­‐	  HTB2	  genes	  on	  chromosome	  II......................................................................................... 173	  
A2.4	  |	  In	  the	  Y131	  strain,	  the	  GAL1/10	  promoter	  is	  inserted	  between	  HTA2	  and	  	  
HTB2	  on	  chromosome	  II .............................................................................................................. 175	  
A2.5	  |	  Generation	  of	  the	  entire	  H2A/H2B	  alanine-­‐scanning	  collection	  in	  an	  FY406	  	  
background.................................................................................................................................. 176	  
xvi	  
List	  of	  Abbreviations	  
	  
3H-­‐SAM S-­‐adenosyl-­‐L-­‐[methyl-­‐3H]methionine 
5-­‐FOA	   5-­‐fluoroorotic	  acid	  
6-­‐AU	   6-­‐azauracil	  
AdoHcy	   S-­‐adenosyl-­‐homocysteine	  
AdoMet	   S-­‐adenosyl-­‐L-­‐methionine	  
ChIP	   chromatin	  immunoprecipitation	  
ChIP-­‐chip	   chromatin	  immunoprecipitation	  coupled	  with	  DNA	  microarrays	  analysis	  
ChIP-­‐seq	   chromatin	  immunoprecipitation	  coupled	  with	  deep-­‐sequencing	  
cpm	   counts	  per	  minute	  
CTD	   carboxy	  terminal	  domain	  
Da	   Dalton	  
DTT	   dithiothreitol	  
EDTA	   ethylenediaminetetraacetic	  acid	  
Fe(II)	   iron2+	  
FTICR	   Fourier	  transform	  ion	  cyclotron	  resonance	  
H2A	   histone	  2A	  
H2B	   histone	  2B	  
H2BK123	   histone	  H2B	  lysine	  123	  
H2BK37	   histone	  H2B	  lysine	  37	  
H3	   histone	  3	  
H3K27	   histone	  H3	  lysine	  27	  
H3K36	   histone	  H3	  lysine	  36	  
H3K4	   histone	  H3	  lysine	  4	  
xvii	  
H3K79	   histone	  H3	  lysine	  79	  
H3K9	   histone	  H3	  lysine	  9	  
H4	   histone	  4	  
H4K20	   histone	  H4	  lysine	  20	  
HAT	   histone	  acetyltransferase	  
HDAC	   histone	  deacetylase	  
HDMT	   histone	  demethylase	  
HMT	   histone	  methyltransferase	  
hr	   hour	  
HU	   hydroxyurea	  
JmjC	   JumonjiC	  
kDa	   kilodalton	  
mCi	   millicurie	  
me1	   monomethyl	  
me2	   dimethyl	  
me3	   trimethyl	  
min	   minute	  
mM	   millimolar	  
MMS	   methyl	  methanesulfonate	  	  
MPA	   mycophenolic	  acid	  
MS	   mass	  spectrometry	  
MS/MS	   tandem	  mass	  spectrometry	  
ORF	   open	  reading	  frame	  
PBS	   phosphate-­‐buffered	  saline	  
xviii	  
PHD	   plant	  homeodomain	  
PMSF	   phenylmethylsulfonyl	  fluoride	  
PTM	   post-­‐translational	  modification	  
qPCR	   quantitative	  PCR	  
RNAPII	   RNA	  polymerase	  II	  
RT-­‐PCR	   reverse	  transcription-­‐PCR	  
SC	   synthetic	  complete	  
SDS-­‐PAGE	   sodium	  dodecyl	  sulfate	  polyacrylamide	  gel	  electrophoresis	  
sec	   second	  
SET	   Su(var)3-­‐9,	  Enhancer	  of	  zeste,	  and	  Trithorax	  
TCA	   trichloroacetic	  acid	  
TFA	   trifluoroacetic	  acid	  
ub	   ubiquitin	  
WCE	   whole	  cell	  extract	  
WT	   wild-­‐type	  
YPD	   yeast	  extract-­‐peptone-­‐dextrose	  
ZF	   zinc	  finger	  
α-­‐KG	   α-­‐ketoglutarate	  
β-­‐ME	   β-­‐mercaptoethanol	  
µL	   microliter	  
µM	   micromolar	  




Chromatin	  Structure	  and	  Function	  |	  The	  rich	  history	  of	  chromatin	  to	  date	  has	  been	  written	  by	  
the	   laudable	  efforts	  of	  numerous	  scientists,	  and	   is	  defined	  by	   landmark	  discoveries	  spurred	  by	  
great	   vision	   and	   even	   some	   serendipitous	   moments.	   	   In	   the	   late	   1800s,	   Walther	   Flemming	  
coined	  the	  term	  “chromatin”	  (stainable	  material,	  which	  was	  in	  reference	  to	  the	  observed	  fibrous	  
scaffold	  in	  the	  nucleus	  that	  could	  be	  easily	  stained)	  to	  avoid	  any	  confusion	  that	  may	  arise	  from	  
the	   more	   general	   term	   “nuclear	   substance”	   (PAWELETZ	   2001).	   	   Despite	   the	   discovery	   of	   the	  
phosphate-­‐rich	  “nuclein”	  (now	  nucleic	  acids)	  by	  Friedrich	  Miescher	  in	  1871	  and	  the	  isolation	  of	  
“histon”	   (now	   histones)	   by	   Albrecht	   Kossel	   in	   1884	   (OLINS	   and	   OLINS	   2003),	   as	   well	   as	   the	  
characterization	   of	   the	   double-­‐helical	   structure	   of	  DNA	  by	   James	  Watson	   and	   Francis	   Crick	   in	  
1953	   (WATSON	   and	   CRICK	   1953),	   it	   was	   not	   until	   1974	   that	   the	   model	   for	   the	   structure	   of	  
chromatin	  was	  proposed	  by	  Roger	  Kornberg,	  who	  posited	  that	  approximately	  200	  base	  pairs	  of	  
DNA	  complexed	  with	  four	  histone	  pairs	  (KORNBERG	  1974).	  	  In	  1975,	  “nucleosomes”	  received	  their	  
formal	  name	  from	  Pierre	  Oudet	  (OUDET	  et	  al.	  1975),	  and	  in	  1997,	  the	  elegant	  crystal	  structure	  of	  
the	  nucleosome	  core	  particle	  was	  determined	  to	  2.8	  Å	  by	  Karolin	  Luger	  (LUGER	  et	  al.	  1997).	  
	   From	   such	   elegant	   studies,	   we	   know	   today	   that	   in	   eukaryotes,	   DNA	   is	   assembled	   on	  
histones	  to	   form	  chromatin.	   	  The	  basic	  unit	  of	  chromatin	   is	   the	  nucleosome,	  which	  consists	  of	  
approximately	   147	   base	   pairs	   of	   DNA	  wrapped	   in	   1.75	   superhelical	   turns	   around	   an	   octamer	  
containing	  two	  copies	  of	  each	  of	  the	  four	  core	  histones	  H2A,	  H2B,	  H3	  and	  H4	  (LUGER	  et	  al.	  1997).	  	  
Nucleosomes	   are	   packaged	   into	   progressively	   higher	   order	   structures,	   such	   as	   “beads-­‐on-­‐a-­‐
string”	   and	   the	   30	   nm	   chromatin	   fiber,	   to	   ultimately	   form	  metaphase	   chromosomes	   (ALBERTS	  
and	  MANIS	   2002).	   	   For	  mitotic	   chromosomes,	   such	   packaging	   results	   in	   a	   compaction	   ratio	   of	  
nearly	  10,000-­‐fold	  (ALBERTS	  and	  MANIS	  2002).	  
	   In	  broad	  terms,	  chromatin	  structure	   influences	  transcriptional	  regulation,	  maintenance	  
of	   genomic	   integrity,	   and	   epigenetic	   inheritance.	   	   Because	   chromatin	   structure	   affects	   DNA-­‐
3	  
templated	   processes,	   including	   transcription,	   DNA	   replication,	   recombination	   and	   repair,	   and	  
chromosome	   segregation,	   access	   to	   DNA	   must	   be	   tightly	   controlled	   to	   allow	   factors	   that	  
function	   in	   such	   processes	   to	   make	   appropriate	   contacts	   with	   the	   DNA	   template	   itself.	  	  
Interphase	   chromosomes	   are	   still	   tightly	   packed	   (with	   a	   compaction	   ratio	   of	   approximately	  
1000-­‐fold),	   but	   condense	   and	   decondense	   as	   is	   necessary	   to	   provide	   access	   for	   the	   cellular	  
machinery	  to	  specific	  DNA	  sequences	  appropriate	  for	  a	  particular	  biological	  process	  (ALBERTS	  and	  
MANIS	   2002).	   	   Such	   fluidity	  within	   the	   levels	   of	   chromatin	   compaction	   thereby	   necessitates	   a	  
means	  by	  which	  rapid	  and	  localized	  access	  to	  DNA	  can	  be	  accomplished.	  
	  
Histone	   Post-­‐translational	   Modifications	   and	   the	   Histone	   Code	   |	   One	   means	   by	   which	  
alterations	   to	   chromatin	   structure	   is	   accomplished	   is	   through	   post-­‐translational	  modifications	  
(PTMs)	   of	   the	   histone	   proteins.	   	   Short,	   unstructured	   N-­‐terminal	   tails	   (typically	   less	   than	   40	  
amino	   acids	   long	   and	   rich	   in	   basic	   residues)	   protruding	   from	   the	   globular	   domains	   of	   the	  
nucleosome	   core	   particle	   are	   subject	   to	   numerous	   PTMs	   (CAMPOS	   and	   REINBERG	   2009).	   	   It	   is	  
becoming	   increasingly	   evident	   that	   residues	  within	   the	   globular	   domains	   themselves	   are	   also	  
subject	   to	   being	   post-­‐translationally	  modified	   (CAMPOS	   and	  REINBERG	   2009;	   FREITAS	   et	   al.	   2004;	  
MERSFELDER	  and	  PARTHUN	  2006).	   	  Modifications	   thus	   far	   identified	   to	  occur	  on	  histone	  proteins	  
include	   acetylation,	   methylation,	   phosphorylation,	   ubiquitylation,	   sumoylation,	   ADP-­‐
ribosylation,	  proline	   isomerization,	  citrullination,	  glycosylation,	  butyrylation	  and	  propionylation	  
(CHEN	  et	  al.	  2007;	  KOUZARIDES	  2007;	  SAKABE	  et	  al.	  2010).	  
Distinct	   domains	   exist	   within	   the	   genome,	   where	   condensed	   chromatin	  
(heterochromatin)	   is	   generally	   inaccessible	   and	   open	   chromatin	   (euchromatin)	   is	   more	  
accessible	  to	  cellular	  machinery.	  	  For	  a	  process	  such	  as	  transcription,	  such	  delineation	  between	  
heterochromatin	   and	   euchromatin	   affects	   gene	   expression,	   and	   ultimately	   results	   in	   defined	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transcriptionally	  silenced	  and	  active	  regions,	  respectively	  (CHOSED	  and	  DENT	  2007;	  TAMARU	  2010).	  	  
As	  modifications	  help	  to	  demarcate	  such	  regions,	  modulation	  of	  chromatin	  architecture	  by	  PTMs	  
therefore	   functions	   in	   establishing	   the	   appropriate	   local	   environment	   for	   normal	   cellular	  
processes	   to	   occur.	   	   While	   the	   functional	   significance	   of	   some	   of	   the	   above-­‐mentioned	  
modifications	  remains	  to	  be	  determined,	  other	  modifications	  can	  be	  functionally	  categorized	  as	  
intrinsic,	   extrinsic,	   and/or	   effector-­‐mediated	   (CAMPOS	   and	   REINBERG	   2009).	   	   Where	   intrinsic	  
denotes	   effects	   caused	  by	   PTMs	   that	   directly	   alter	   the	   physical	   properties	   of	   the	   nucleosome	  
(such	   as	   DNA	   contacts	   or	   stability),	   extrinsic	   refer	   to	   those	   PTMs	   that	   directly	   impact	  
internucleosomal	   contacts.	   	   In	  both	   cases,	  modifications	  disturb	   contacts	  between	  histones	   in	  
contiguous	  nucleosomes	  or	  histones	  with	  DNA,	  resulting	  in	  alteration	  of	  higher-­‐order	  chromatin	  
structure.	   	   For	   example,	   acetylation	   of	   lysine	   residues	   on	   histone	   tails	   neutralizes	   the	   basic	  
charge	  of	  the	  residue	  on	  which	  it	  occurs,	  thereby	  disrupting	  histone	  contacts	  with	  other	  histones	  
and/or	  DNA	  and	   in	   turn	   chromatin	   compaction	   (HONG	   et	   al.	   1993;	   SHOGREN-­‐KNAAK	   et	   al.	   2006;	  
WOLFFE	  and	  HAYES	  1999).	  	  Alterations	  of	  nucleosomes	  by	  PTMs	  of	  histones	  can	  also	  promote	  the	  
association	  of	  non-­‐histone	  chromatin-­‐binding	  proteins,	  and	  are	  thus	  termed	  effector-­‐mediated	  
(CAMPOS	  and	  REINBERG	  2009).	  	  Here,	  recruitment	  of	  non-­‐histone	  effector	  proteins	  is	  facilitated	  by	  
the	  ability	  of	  specialized	  domains	  to	  recognize	  and	  bind	  to	  modifications	  in	  defined	  states.	  	  For	  
example,	  bromodomains	  can	  recognize	  acetylated	  lysine	  residues,	  and	  the	  following	  have	  been	  
identified	  as	  methyl-­‐binding	  domains:	  chromodomain,	  tudor	  domain,	  PHD	  finger,	  MBT,	  Ankyrin	  
repeat,	  PWWP	  domain	  and	  WD40	  repeats	  (COLLINS	  et	  al.	  2008;	  TAVERNA	  et	  al.	  2007a;	  VEZZOLI	  et	  
al.	  2010;	  WANG	  et	  al.	  2009).	  
The	  existence	  of	  numerous	  and	  diverse	  types	  of	  PTMs	  capable	  of	  recruiting	  non-­‐histone	  
effector	   proteins	   prompted	   the	   proposal	   of	   a	   histone	   code,	   which	   posits	   that	   combinatorial	  
patterns	   of	   histone	   modifications	   lead	   to	   defined	   biological	   outcomes	   mediated	   by	   the	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recruitment	  of	  effector	  proteins	  (STRAHL	  and	  ALLIS	  2000).	  For	  instance,	  TAF1	  (the	  largest	  subunit	  
of	   the	   TFIID	   complex	   which	   is	   involved	   in	   initiating	   the	   assembly	   of	   the	   transcriptional	  
machinery)	   preferentially	   binds	   to	   multiply	   acetylated	   histone	   H4	   through	   its	   double	  
bromodomain	   (JACOBSON	   et	   al.	   2000)	   and	   functions	   itself	   as	   a	   histone	   acetylase	   (MIZZEN	   et	   al.	  
1996).	   	   It	   was	   believed	   that	   the	   repercussions	   of	   such	   a	   code	   could	   broadly	   impact	   diverse	  
processes	   such	   as	   gene	   expression,	   epigenetic	   inheritance,	   and	   control	   of	   cellular	   growth,	  
differentiation,	   and	   disease.	   	   Numerous	   elegant	   biochemical	   and	   genetic	   studies,	   as	   well	   as	  
technological	   advancements,	   have	   dramatically	   expanded	   this	   concept	   since	   the	   time	   of	   its	  
inception	  to	  demonstrate	  the	  many	  intricacies	  of	  the	  histone	  code	  (AGALIOTI	  et	  al.	  2002;	  FISCHLE	  
et	  al.	  2005;	  HAKE	  and	  ALLIS	  2006;	  NG	  et	  al.	  2002b;	  SHI	  et	  al.	  2006;	  SUN	  and	  ALLIS	  2002;	  TAVERNA	  et	  
al.	  2006;	  WYSOCKA	  et	  al.	  2006;	  ZIPPO	  et	  al.	  2009).	  
	  
Histone	  Lysine	  Methylation	   in	  Saccharomyces	   cerevisiae	  |	  Lysine	  methyltransferases	   catalyze	  
the	  transfer	  of	  one	  to	  three	  methyl	  groups	  from	  S-­‐adenosyl-­‐L-­‐methionine	  to	  the	   ε-­‐amino	  group	  
of	   the	   target	   lysine	   residue	   (FIGURE	   1.1,	   panel	   A)	   (SHILATIFARD	   2006).	   	   The	   budding	   yeast	  
Saccharomyces	  cerevisiae	  encodes	  three	  known	  histone	  lysine	  methyltransferase	  enzymes,	  Set1,	  
Set2,	  and	  Dot1,	  which	  modify	  histone	  H3	  on	   lysine	  residues	  4,	  36,	  and	  79,	  respectively	   (FIGURE	  
1.1,	  panel	  B)	   (MILLAR	  and	  GRUNSTEIN	  2006).	   	  The	  histone	  methyltransferases	  are	  typically	  highly	  
specific	   for	   their	   targeted	  substrate	  as	  well	  as	   the	  degree	   to	  which	   they	  methylate	  a	  specified	  
lysine	  residue	  (SHILATIFARD	  2006;	  XIAO	  et	  al.	  2003a).	   	  As	  methylation	  of	   lysine	  residues	  does	  not	  
change	  the	  overall	  charge	  of	  the	  histone	  molecule,	  this	  modification	  is	  largely	  believed	  to	  serve	  
as	  a	  binding	  platform	  for	  effector	  proteins	  that	  recognize	  and	  interpret	  these	  marks	  to	  mediate	  
downstream	  effects.	  	  Accordingly,	  beyond	  its	  position	  on	  the	  histone	  tail,	  the	  methylation	  state	  
(mono-­‐,	  di-­‐,	   or	   trimethyl;	  me1,	  me2,	  or	  me3,	   respectively)	  of	   a	  modified	   lysine	   residue	   is	   also	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important,	   as	   placement	   of	   a	   specific	   number	   of	   methyl	   marks	   on	   different	   lysine	   residues	  
establishes	  diverse	  environments	   for	   effector	  proteins	   to	   recognize,	   in	   turn	  producing	  distinct	  
functional	  outputs	  (KOUZARIDES	  2007).	  	  Methylation	  of	  histone	  H3	  on	  lysines	  4,	  36,	  and	  79	  largely	  
correlates	  with	   euchromatic	   regions	   of	   chromatin	   (MARTIN	   and	   ZHANG	   2005),	   and	   accordingly,	  
histone	   lysine	  methylation	   in	   budding	   yeast	   is	   tightly	   coupled	   to	   the	   process	   of	   transcription,	  
where	  the	  deposition	  of	  these	  modifications	  occurs	  during	  the	  initiation	  and	  elongation	  phases	  
of	  RNA	  polymerase	  II-­‐based	  transcription	  (MILLAR	  and	  GRUNSTEIN	  2006).	  
Histone	   H3	   Lysine	   4	   (H3K4)	   Methylation	   |	   The	   SET	   domain	   is	   an	   evolutionarily	  
conserved	   domain	   (named	   after	   the	   Drosophila	   genes	   Su(var)3-­‐9,	   Enhancer	   of	   zeste,	   and	  
Trithorax)	  that	  has	  been	  shown	  to	  be	  involved	  in	  modulation	  of	  gene	  activity	  and	  histone	  lysine	  
methylation	   (JENUWEIN	   et	   al.	   1998;	   SHILATIFARD	   2006;	   ZHANG	   and	   REINBERG	   2001).	   	   There	   are	  
hundreds	   of	   proteins	   harboring	   this	  motif	   in	   species	   ranging	   from	  bacteria	   to	   humans	   (ZHANG	  
and	   REINBERG	   2001),	   and	   12	   proteins	   in	   budding	   yeast	   contain	   a	   SET	   domain	   (PETROSSIAN	   and	  
CLARKE	   2009a).	   	   In	   Saccharomyces	   cerevisiae,	   methylation	   of	   H3K4	   is	   mediated	   by	   the	   SET-­‐
domain-­‐containing	   protein	   Set1	   (BRIGGS	   et	   al.	   2001;	   ROGUEV	   et	   al.	   2001).	   	   Set1	   is	   capable	   of	  
methylating	  H3K4	  in	  all	  three	  states,	  and	  deletion	  of	  SET1	  abolishes	  all	  H3K4	  methylation	  (BRIGGS	  
et	  al.	  2001).	  	  	  
As	  Set1	  mediates	  all	  three	  H3K4	  methylation	  states,	  it	  is	  believed	  that	  targeting	  and/or	  
regulation	   of	   the	   methyltransferase	   activity	   of	   Set1	   is	   necessary	   for	   proper	   spatiotemporal	  
patterns	   of	   H3K4	  methylation	   (MARTIN	   and	   ZHANG	   2005).	   	   In	   budding	   yeast,	   Set1	   is	   part	   of	   a	  
larger	  macromolecular	  complex	  named	  COMPASS	  (complex	  proteins	  associated	  with	  Set1).	  	  The	  
subunits	  of	  COMPASS	  are	   termed	  Cps60	   through	  Cps15	   (according	   to	   their	  molecular	  weight),	  
and	  include:	  Cps60,	  Cps50,	  Cps40,	  Cps35,	  Cps30,	  Cps25,	  and	  Cps15	  (KROGAN	  et	  al.	  2002;	  MILLER	  et	  
al.	  2001).	  	  COMPASS	  complex	  members	  are	  necessary	  for	  regulation	  of	  Set1	  enzymatic	  activity.	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For	  example,	  where	  Set1,	  Cps50	  and	  Cps30	  are	  necessary	  for	  all	  three	  methylation	  states,	  only	  
Set1,	  Cps60,	  Cps40,	  and	  Cps25	  are	  necessary	  for	  formation	  of	  trimethylated	  H3K4	  (SCHNEIDER	  et	  
al.	  2005).	  
Set1	   has	   been	   found	   to	   be	   predominantly	   localized	   to	   the	   coding	   regions	   of	   highly	  
transcribed	  RNA	  polymerase	  II	  (RNAPII)	  genes,	  and	  associates	  with	  the	  carboxy	  terminal	  domain	  
(CTD)	  of	  RNAPII	  in	  a	  manner	  that	  is	  dependent	  upon	  Kin28-­‐mediated	  phosphorylation	  of	  serine	  
5	   of	   the	   CTD	   (NG	   et	   al.	   2003).	   	   Set1	   association	   with	   the	   RNAPII	   CTD	   is	   also	   thought	   to	   be	  
mediated	  in	  part	  by	  the	  Paf1	  complex	  (KROGAN	  et	  al.	  2003a).	  	  The	  development	  of	  modification-­‐
specific	   antibodies	   that	   are	   capable	   of	   recognizing	   modified	   lysine	   residues	   in	   a	   particular	  
methylation	  state	  (me1,	  me2,	  or	  me3)	  has	  allowed	  for	  genome-­‐wide	  mapping	  studies	  of	  histone	  
methylation	   by	   chromatin	   immunoprecipitation	   combined	   with	   whole-­‐genome	   microarrays	  
(ChIP-­‐chip)	  and	  more	  recently,	  coupled	  with	  deep	  sequencing	  (ChIP-­‐seq)	  (MILLAR	  and	  GRUNSTEIN	  
2006).	   	   Genome-­‐wide	   ChIP-­‐chip	   analyses	   has	   revealed	   that	   H3K4	   trimethylation	   is	   localized	  
specifically	  to	  the	  5’	  end	  of	  actively	  transcribed	  genes,	  where	  dimethylation	  is	  more	  enriched	  in	  
the	   middle	   of	   genes,	   and	   monomethylation	   is	   found	   predominantly	   at	   the	   3’	   end	   of	   genes	  
(POKHOLOK	  et	  al.	  2005).	  	  Such	  genome-­‐wide	  patterning	  of	  the	  various	  methylated	  forms	  of	  H3K4	  
in	  general	  correlates	  well	  with	  Set1	  occupancy	  and	  RNAPII	  association.	  
Trans-­‐	   and	   cis-­‐tail	   mechanisms	   also	   exist	   as	   a	   level	   of	   regulation	   for	   Set1-­‐mediated	  
methylation	  of	  H3K4.	  	  Monoubiquitylation	  of	  histone	  H2B	  on	  lysine	  123	  (H2BK123ub)	  catalyzed	  
by	  the	  budding	  yeast	  E2	  ubiquitin-­‐conjugating	  enzyme	  Rad6	  and	  E3	  ubiquitin	  ligase	  Bre1	  (ROBZYK	  
et	  al.	  2000)	  has	  been	  demonstrated	  to	  be	  a	  prerequisite	  modification	  for	  H3K4	  methylation,	  as	  
mutation	  of	  H2BK123	  to	  an	  unmodifiable	  form	  (H2B	  K123R)	  or	  deletion	  of	  RAD6	  or	  BRE1	  results	  
in	   a	   loss	   of	   H3K4me	   (BRIGGS	   et	   al.	   2002;	  DOVER	   et	   al.	   2002;	   SUN	   and	  ALLIS	   2002).	   	   It	   has	   been	  
suggested	   that	   the	   Cps35	   subunit	   of	   the	   COMPASS	   complex	   is	   involved	   in	   regulation	   of	   the	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crosstalk	  between	  H2BK123ub	  and	  methylation	  of	  H3K4,	  as	  Cps35	  interacts	  with	  chromatin	  in	  a	  
monoubiquitin-­‐dependent	   fashion	   (TAKAHASHI	   and	   SHILATIFARD	   2010).	   	   Use	   of	   the	   Scanning	  
Histone	  Mutagenesis	  with	  Alanine	  (SHIMA)	  library	  has	  revealed	  that	  additional	  cis-­‐	  and	  trans-­‐tail	  
regulatory	   mechanisms	   may	   exist	   in	   which	   H3K4	   trimethylation	   is	   influenced	   by	   H3K14	   and	  
residues	  on	  histones	  H2A	  and	  H2B	   (namely	  E65,	  L66,	  N69,	  and	  D73	  of	  histone	  H2B,	  and	  H112	  
and	  R119	  of	  histone	  H2B)	  (NAKANISHI	  et	  al.	  2008).	  	  The	  exact	  mechanism	  by	  which	  these	  residues	  
function	  in	  regulating	  H3K4	  methylation	  is	  unknown,	  but	  it	  is	  possible	  that	  acetylation	  of	  H3K14	  
and	   regulation	   of	   H2BK123ub	   function	   in	   these	   cis-­‐	   and	   trans-­‐tail	   histone	   crosstalk	   events,	  
respectively	  (NAKANISHI	  et	  al.	  2008).	  
Set1,	   a	   member	   of	   the	   yeast	   Trithorax	   group	   of	   proteins	   (a	   large	   family	   of	   proteins	  
whose	  members	  have	  been	  implicated	  in	  transcriptional	  regulation	  (RINGROSE	  and	  PARO	  2004)),	  
was	  originally	  identified	  as	  a	  factor	  necessary	  for	  proper	  regulation	  of	  transcriptional	  silencing	  of	  
telomeres	  and	  the	  silent	  mating-­‐type	  loci	  (NISLOW	  et	  al.	  1997).	  	  SET1	  is	  not	  an	  essential	  gene,	  but	  
its	   deletion	   results	   in	   pleiotropic	   phenotypes,	   namely	   affecting	   growth,	   transcriptional	  
activation,	   repression	   and	   elongation,	   regulation	   of	   telomere	   length,	   rDNA	   silencing,	   meiotic	  
differentiation,	   DNA	   repair,	   and	   chromosome	   segregation	   (DEHE	   and	   GELI	   2006),	   supporting	   a	  
role	  for	  H3K4	  methylation	  in	  these	  processes.	  	  It	  is	  also	  possible	  that	  the	  functional	  consequence	  
of	  H3K4	  methylation	  is	  largely	  dictated	  by	  the	  effector	  proteins	  that	  recognize	  and	  bind	  to	  this	  
mark.	   	   For	  example,	  Yng1,	  a	  member	  of	   the	  NuA3	  histone	  acetyltransferase	   (HAT)	  complex,	   is	  
able	  to	  bind	  to	  H3K4me3	  through	  its	  PHD	  finger,	  thus	  promoting	  acetylation	  of	  H3K14	  (MARTIN	  
et	  al.	  2006a;	  TAVERNA	  et	  al.	  2006).	  	  Additionally,	  Set3,	  the	  defining	  member	  of	  the	  Set3	  complex	  
(Set3C)	  containing	  the	  histone	  deacetylases	  (HDAC)	  Hos2	  and	  Hst1,	  harbors	  a	  PHD	  finger	  that	  is	  
capable	  of	  binding	   to	  H3K4me2,	   thereby	   functioning	   in	   localization	  of	   the	  Set3C	  HDAC	  activity	  
(KIM	  and	  BURATOWSKI	  2009).	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Histone	  H3	  Lysine	  36	  (H3K36)	  Methylation	  |	  Methylation	  of	  H3K36	  is	  mediated	  by	  the	  
budding	   yeast	   SET	   protein	   Set2	   (STRAHL	   et	   al.	   2002).	   	   Set2	   is	   capable	   of	   catalyzing	   H3K36	  
methylation	  in	  all	  three	  states.	  	  SET2	  is	  a	  nonessential	  gene,	  and	  its	  deletion	  results	  in	  the	  loss	  of	  
H3K36	  methylation,	   indicating	   that	   it	   is	   the	  sole	  H3K36	  methyltransferase	   (STRAHL	  et	  al.	  2002).	  	  
Further	  SET2	   deletion	   analysis	   has	   revealed	  phenotypes	   that	   are	   consistent	  with	   transcription	  
elongation	   defects,	   including	   resistance	   to	   6-­‐azauracil	   (a	   compound	   that	   reduces	   intracellular	  
levels	  of	  GTP,	  which	  itself	  is	  not	  lethal	  to	  yeast,	  but	  can	  be	  lethal	  when	  combined	  with	  mutations	  
that	  affect	  transcription	  (EXINGER	  and	  LACROUTE	  1992;	  HAMPSEY	  1997;	  RILES	  et	  al.	  2004))	  (KIZER	  et	  
al.	  2005)	  and	  synthetic	  growth	  defects	  when	  combined	  with	  deletions	  of	  elongation	  factors	  such	  
as	  the	  subunits	  of	  the	  Paf	  complex	  (KROGAN	  et	  al.	  2003b).	  	  Consistent	  with	  a	  role	  in	  transcription	  
elongation,	  many	  groups	  have	  shown	   that	  Set2	  physically	   interacts	  with	  RNAPII	   (KROGAN	   et	  al.	  
2003b;	   LI	   et	  al.	   2003;	   LI	   et	  al.	   2002;	   SCHAFT	   et	  al.	   2003;	  XIAO	   et	  al.	   2003b).	   	   Collectively,	   these	  
studies	  demonstrated	  that	  Set2	  interacts	  with	  RNAPII	  in	  a	  manner	  that	  is	  dependent	  upon	  Ctk1-­‐
mediated	   phosphorylation	   of	   serine	   2	   of	   the	   CTD.	   	   Within	   the	   C-­‐terminal	   domain	   of	   Set2,	   a	  
recently	   identified	   domain	   termed	   the	   SRI	   (Set2-­‐Rpb1	   Interacting)	   mediates	   interaction	   with	  
RNAPII	  and	  binds	   to	  RNAPII	  CTD	  repeats	   that	  are	  doubly	  modified	  by	  phosphorylation	  of	  both	  
serines	   2	   and	   5	   (KIZER	   et	   al.	   2005).	   	   Association	  with	   the	   CTD	   of	   RNAPII	   is	   necessary	   for	   Set2	  
catalyzed	  methylation	  of	  H3K36	  (XIAO	  et	  al.	  2003b),	  as	  deletion	  of	  the	  SRI	  results	  in	  a	  loss	  of	  all	  
H3K36	  methylation	  (KIZER	  et	  al.	  2005).	  	  Consistent	  with	  an	  association	  of	  Set2	  with	  RNAPII	  in	  the	  
body	  of	  actively	  transcribed	  genes	  (KROGAN	  et	  al.	  2003b),	  genome-­‐wide	  ChIP-­‐chip	  analyses	  have	  
revealed	  that	  both	  di-­‐	  and	  trimethylation	  mediated	  by	  Set2	  are	  enriched	  at	  the	  3’	  end	  of	  open	  
reading	  frames	  (ORFs),	  and	  that	  H3K36me3	  positively	  correlates	  with	  transcription	  rates	  (LI	  et	  al.	  
2007a;	  POKHOLOK	   et	   al.	   2005;	  RAO	   et	   al.	   2005).	   	   These	  data	   raise	   the	   intriguing	  possibility	   that	  
different	  states	  of	  H3K36	  methylation	  have	  different	  biological	  roles	  in	  gene	  regulation.	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Given	   that	   deletion	   of	   SET2	   causes	   no	   overt	   cellular	   phenotype,	   it	   is	   difficult	   to	  
extrapolate	   the	   functional	   significance	   of	   H3K36	   methylation	   in	   distinct	   cellular	   events	   from	  
deletion	  analysis	  alone.	  	  Thus,	  to	  date,	  the	  role	  of	  H3K36	  methylation	  is	  best	  characterized	  in	  the	  
context	   of	   transcription	   elongation.	   	   Eaf3,	   a	   subunit	   of	   the	   Rpd3S	   HDAC	   complex,	   has	   been	  
shown	  to	  bind	  to	  di-­‐	  and	  trimethylated	  H3K36	  through	  its	  chromodomain	  (CARROZZA	  et	  al.	  2005;	  
JOSHI	  and	  STRUHL	  2005;	  KEOGH	  et	  al.	  2005).	   	  Recruitment	  of	  the	  Rpd3S	  HDAC	  complex	  to	  H3K36	  
that	   has	   been	  methylated	   cotranscriptionally	   results	   in	   a	   hypoacetylated	   environment	   within	  
ORFs.	  	  Such	  deacetylation	  ultimately	  functions	  in	  preventing	  transcription	  initiation	  from	  cryptic	  
promoter-­‐like	  sequences	  within	  the	  gene	  bodies,	  as	  evidenced	  by	  the	  fact	  that	  disruption	  of	  the	  
Set2-­‐Rpd3S	   pathway	   leads	   to	   hyperacetylation	   within	   an	   ORF	   thereby	   enabling	   spurious	  
initiation	  events	   that	   result	   in	   the	   formation	  of	   cryptic	   transcripts	   (CARROZZA	   et	   al.	   2005;	   JOSHI	  
and	  STRUHL	  2005).	  	  The	  Eaf3	  subunit	  of	  the	  Rpd3S	  HDAC	  complex	  is	  also	  a	  member	  of	  the	  NuA4	  
HAT	  complex.	  	  While	  a	  role	  for	  H3K36me-­‐binding	  by	  Eaf3	  in	  recruitment	  of	  the	  NuA4	  complex	  to	  
date	  remains	  to	  be	  shown,	  its	  paradoxical	  role	  as	  a	  subunit	  of	  both	  an	  HAT	  and	  HDAC	  complex	  
suggests	   that	   H3K36	  methylation	   could	   putatively	   function	   in	   localization	   of	   acetyltransferase	  
activity	  in	  addition	  to	  deacetylation.	  	  Alternatively,	  it	  has	  been	  shown	  that	  Eaf3	  can	  also	  bind	  to	  
trimethylated	  H3K4	  (XU	  et	  al.	  2008),	  thereby	  providing	  an	  alternative	  mechanism	  by	  which	  one	  
protein	  can	  function	  as	  a	  toggle	  for	  two	  complexes	  with	  opposing	  roles.	   	   In	   line	  with	  a	  general	  
role	  of	  methylated	  H3K36	   in	   recruitment	  of	   acetyltransferase	  activity,	   the	  NuA3	  HAT	   complex	  
subunit	  Nto1	  has	  been	  shown	  to	  preferentially	  bind	  to	  H3K36me3	  through	  its	  PHD	  finger	  (SHI	  et	  
al.	   2007).	   	   While	   the	   functional	   consequence	   of	   this	   binding	   remains	   to	   formally	   be	  
demonstrated,	   it	   has	   been	   suggested	   that	   the	   interaction	   of	   NuA3	   with	   chromatin	   and	  
subsequent	  HAT	  activity	  of	  this	  complex	  is	  dependent	  upon	  the	  methyltransferase	  Set2	  and	  its	  
substrate	  H3K36	  (MARTIN	  et	  al.	  2006b).	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A	   role	   for	   Set2-­‐mediated	   H3K36	   methylation	   has	   also	   been	   shown	   by	   mutational	  
analysis	  in	  combination	  with	  mutations	  in	  other	  transcriptional	  elongation	  factors.	  	  For	  example,	  
the	  Bur1/2	  cyclin-­‐dependent	  kinase	  complex	  promotes	  transcription	  elongation	  by	  RNAPII	  (CHU	  
et	  al.	  2006;	  KEOGH	  et	  al.	  2003).	  	  While	  BUR2	  is	  a	  non-­‐essential	  gene,	  deletion	  of	  BUR2	  renders	  a	  
slow	  growth	  phenotype	  in	  yeast	  (YAO	  et	  al.	  2000).	  	  Deletion	  of	  SET2	  can	  bypass	  this	  slow	  growth	  
phenotype	   (KEOGH	   et	   al.	   2005).	   	   Similarly,	   mutation	   of	   H3K36	   to	   a	   non-­‐modifiable	   form	   (H3	  
K36A)	   can	   support	   cellular	   viability	   in	   the	   absence	   of	   the	   essential	   gene	   BUR1	   (KEOGH	   et	   al.	  
2005).	  	  Another	  example	  of	  crosstalk	  between	  H3K36	  methylation	  and	  transcription	  elongation	  
is	   provided	   by	   the	   FACT	   histone	   chaperone	   complex,	   composed	   of	   Spt16,	   Pob3	   and	   Nhp6	  
(BELOTSERKOVSKAYA	   et	   al.	   2003;	   FORMOSA	   et	   al.	   2001;	  MASON	   and	   STRUHL	   2003;	   SAUNDERS	   et	   al.	  
2003;	   SCHWABISH	   and	   STRUHL	   2004).	   	   Loss	   of	   the	   FACT	   subunit	   SPT16	   results	   in	   a	   slow	   growth	  
phenotype,	  which	  can	  be	  bypassed	  by	  both	  deletion	  of	  SET2	  and	  mutation	  of	  H3K36	  (BISWAS	  et	  
al.	  2006).	   	  Together,	   these	   findings	   support	  an	  antagonistic	   function	   for	  Set2-­‐mediated	  H3K36	  
methylation	  and	  the	  BUR	  and	  FACT	  complexes.	  
Histone	  H3	  Lysine	  79	  (H3K79)	  Methylation	  |	  Unlike	  lysine	  residues	  4	  and	  36	  that	  reside	  
on	   the	   unstructured	   N-­‐terminal	   tail	   of	   histone	   H3,	   lysine	   79	   is	   located	   within	   the	   globular	  
domain	  of	  histone	  H3	  on	  the	  accessible	  surface	  of	  the	  outside	  of	  the	  nucleosome	  core	  (LUGER	  et	  
al.	  1997).	   	  Methylation	  of	  H3K79	  is	  mediated	  by	  the	  non-­‐SET-­‐domain-­‐containing	  budding	  yeast	  
protein	  Dot1	  (disruptor	  of	  telomeric	  silencing	  1)	  (NG	  et	  al.	  2002a;	  VAN	  LEEUWEN	  et	  al.	  2002).	  	  The	  
majority	  of	  H3	  in	  chromatin	  (estimated	  to	  be	  90%)	  is	  methylated	  at	  H3K79	  (SHILATIFARD	  2006;	  VAN	  
LEEUWEN	  et	  al.	  2002).	   	  Dot1	  catalyzes	  all	   three	  methylation	  states	  of	  H3K79,	  but	   in	  contrast	   to	  
other	   protein	   lysine	   methyltransferases,	   does	   so	   in	   a	   nonprocessive	   fashion	   (FREDERIKS	   et	   al.	  
2008).	   	  Unlike	   Set1	   and	   Set2,	   there	   is	   no	  evidence	   that	  Dot1	  physically	   interacts	  with	   actively	  
transcribing	  RNAPII,	  but	  genome-­‐wide	  ChIP-­‐chip	  studies	  have	  revealed	  that	  trimethylated	  H3K79	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is	   enriched	   within	   the	   transcribed	   regions	   of	   genes,	   although	   such	   enrichment	   is	   not	   clearly	  
correlated	   with	   levels	   of	   transcriptional	   activity	   (POKHOLOK	   et	   al.	   2005;	   SCHULZE	   et	   al.	   2009).	  	  
Arguing	  that	  the	  overall	  level	  of	  H3K79	  methylation	  is	  more	  important	  for	  downstream	  function	  
than	   a	   methylation	   state	   in	   particular,	   previous	   work	   has	   suggested	   that	   Dot1-­‐dependent	  
methylation	   states	   of	   H3K79	   are	   functionally	   redundant	   (FREDERIKS	   et	   al.	   2008).	   	   However,	   a	  
subsequent	   study	   has	   counterargued	   that	   di-­‐	   and	   trimethylated	   H3K79	   are	   differentially	  
associated	  with	  promoters	  and	  ORFs,	  and	  that	  these	  marks	  are	  associated	  with	  distinct	  genomic	  
regions	  thereby	  supporting	  a	  separation	  of	  function	  for	  the	  di-­‐	  and	  trimethyl	  state	  (SCHULZE	  et	  al.	  
2009).	   	   In	   agreement	   with	   previous	   studies,	   H3K79me3	   was	   uniformly	   enriched	   in	   the	  
transcribed	   regions.	   	   However,	   unlike	  H3K79me3,	  H3K79me2	  was	   found	   in	   both	   the	  ORF	   and	  
promoter	  region	  of	  genes	  (particularly	  those	  expressed	  specifically	  in	  the	  M/G1	  phase	  of	  the	  cell	  
cycle)	  (SCHULZE	  et	  al.	  2009).	  
Methylation	  of	  H3K79	  by	  Dot1	  has	  been	  shown	  to	  be	  regulated	  by	  at	  least	  two	  trans-­‐tail	  
pathways.	   	   Like	  methylation	   of	   H3K4	   catalyzed	   by	   Set1,	   monoubiquitylation	   of	   lysine	   123	   on	  
histone	   H2B	   is	   a	   prerequisite	   for	   efficient	   trimethylation	   of	   H3K79	   by	   Dot1	   (NG	   et	   al.	   2002b;	  
SHAHBAZIAN	   et	   al.	   2005).	   	   In	   accordance	   with	   this	   trans-­‐tail	   regulatory	   mechanism,	   ChIP-­‐chip	  
studies	  have	  also	  demonstrated	  that	  genome-­‐wide	  localization	  patterns	  of	  H3K79me3	  (but	  not	  
H3K79me2)	   generally	   correlate	  with	  H2BK123ub,	   supporting	   the	   view	   that	  monoubiquitylated	  
H2B	  functions	  as	  a	  major	  determinant	  for	  H3K79me3	  (SCHULZE	  et	  al.	  2009).	  	  Additionally,	  the	  N-­‐
terminal	  tail	  of	  histone	  H4	  is	  necessary	  for	  methylation	  of	  H3K79	  (ALTAF	  et	  al.	  2007;	  FINGERMAN	  et	  
al.	  2007).	  	  A	  patch	  of	  basic	  residues	  (R17/H18/R19)	  within	  the	  H4	  N-­‐terminal	  tail	  is	  necessary	  for	  
H3K79	  methylation,	  and	   it	  has	  been	  shown	   that	  Dot1	  can	   interact	  with	   the	  H4	  N-­‐terminal	   tail	  
through	  this	  basic	  patch	  (FINGERMAN	  et	  al.	  2007),	  thus	  providing	  a	  putative	  means	  by	  which	  Dot1	  
can	  be	  targeted	  to	  the	  chromatin	  template	  to	  modify	  nucleosomal	  H3K79.	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Unlike	   methylated	   H3K4	   and	   H3K36,	   there	   are	   no	   proteins	   identified	   to	   date	   that	  
definitely	   bind	   to	   a	   specifically	  methylated	   state	   of	   H3K79	   (FREDERIKS	   et	   al.	   2008).	   	   Functional	  
insight	   into	   the	   role	   of	   H3K79	   has	   largely	   come	   from	   DOT1	   deletion	   and	   overexpression	  
analyses.	  	  As	  its	  name	  suggests,	  Dot1	  was	  originally	  identified	  in	  a	  screen	  for	  factors	  that	  affect	  
telomeric	   silencing	   (SINGER	   et	  al.	   1998).	   	   It	  was	   subsequently	   shown	   that	  both	   functional	  Dot1	  
methyltransferase	  activity	  and	  intact	  lysine	  79	  on	  histone	  H3	  are	  required	  for	  proper	  telomeric	  
silencing	   (NG	  et	  al.	  2002a;	  VAN	  LEEUWEN	  et	  al.	  2002).	   	  Dot1	  has	  also	  been	  shown	  to	   function	   in	  
meiotic	   checkpoint	   control	   (SAN-­‐SEGUNDO	   and	   ROEDER	   2000).	   	   Additionally,	   Dot1-­‐mediated	  
methylation	  of	  H3K79	  has	  been	  shown	  to	  function	  in	  DNA	  repair	  pathways	  and	  G1	  and	  S-­‐phase	  
DNA	  damage	  checkpoint	  signaling	  (CONDE	  et	  al.	  2009;	  WYSOCKI	  et	  al.	  2005).	  
	  
Dynamic	   Nature	   of	   Histone	   Methylation	   |	   Unlike	   other	   histone	   modifications,	   the	   dynamic	  
nature	  of	  histone	  methylation	  was	  long	  unclear,	  as	  previous	  studies	  indicated	  that	  methyl	  group	  
turnover	   occurred	   at	   a	   rate	   similar	   to	   histone	   turnover,	   and	   the	   stability	   of	   the	   C-­‐N	   bond	  
between	   the	   methyl	   and	   ε-­‐amino	   groups	   argued	   against	   active	   demethylation	   (AGGER	   et	   al.	  
2008;	  BORUN	   et	  al.	   1972;	  BYVOET	   et	  al.	   1972;	  KLOSE	  and	  ZHANG	  2007).	   	  Alternative	  mechanisms	  
proposed	   in	   lieu	  of	  active	   removal	  of	  methyl	   groups	   from	  histones	   included	  histone	  exchange	  
with	  an	  unmodified	  histone	  or	  proteolytic	  cleavage	  of	  the	  modified	  histone	  tail	   (BANNISTER	  and	  
KOUZARIDES	  2005;	  BANNISTER	  et	  al.	  2002;	  SANTOS-­‐ROSA	  et	  al.	  2009).	  	  Uncertainty	  about	  the	  dynamic	  
nature	  of	  histone	  methylation	  was	  dissipated	  in	  2004,	  when	  Yang	  Shi	  and	  colleagues	  identified	  
Lysine	   Specific	   Demethylase	   1	   (LSD1)	   as	   the	   first	   active	   histone	   demethylase	   and	   showed	  
specificity	  for	  H3K4me2/1	  (SHI	  et	  al.	  2004).	  	  LSD1	  is	  an	  amine	  oxidase	  that	  uses	  a	  FAD-­‐dependent	  
oxidation	  reaction	  to	  remove	  methyl	  groups,	  producing	  hydrogen	  peroxide	  and	  formaldehyde	  as	  
byproducts	   (FIGURE	   1.2,	   top)	   (SHI	   et	   al.	   2004).	   	  When	   associated	  with	   the	   androgen	   receptor,	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LSD1	  can	  change	  its	  substrate	  specificity	  from	  H3K4me2/1	  to	  H3K9me2/1	  (METZGER	  et	  al.	  2005),	  
supporting	   the	   notion	   that	   protein-­‐protein	   interactions	   play	   a	   fundamental	   role	   in	   dictating	  
substrate	  specificity	  for	  the	  histone	  demethylases.	   	  LSD1	  is	   limited	  to	  mono-­‐	  and	  dimethylated	  
substrates	  only,	  as	  amine	  oxidation	  requires	  a	  protonated	  nitrogen	  to	  initiate	  the	  demethylation	  
reaction.	   	  However,	  other	   lysine	   resides	  on	  histone	   tails	  are	  modified	  by	  methylation,	  and	   the	  
trimethylated	   state	   is	   a	   common	   modification,	   supporting	   the	   existence	   of	   other	   enzymes	  
capable	  of	  histone	  lysine	  demethylation.	  
	  
Histone	   Demethylation	   by	   JumonjiC	   (JmjC)-­‐domain-­‐containing	   Proteins	   |	   Using	   an	   unbiased	  
biochemical	  purification	  and	  an	  activity-­‐based	  assay,	  Yi	  Zhang	  and	  colleagues	  demonstrated	  that	  
JHDM1A	   (formerly	   FBXL11,	   an	  uncharacterized	  protein	  originally	   identified	   in	   a	   bioinformatics	  
search	   for	   F-­‐box-­‐containing	   proteins	   (CENCIARELLI	   et	   al.	   1999;	  WINSTON	   et	   al.	   1999))	   possesses	  
histone	   demethylase	   activity	  with	   substrate	   specificity	   for	  H3K36me2/1	   (TSUKADA	   et	   al.	   2006).	  	  
JHDM1A	  was	  shown	  to	  use	  an	  iron	  (Fe(II))-­‐	  and	  α-­‐ketoglutarate	  (α-­‐KG)-­‐dependent	  hydroxylation	  
reaction	  in	  which	  the	  methylamine	  group	  of	  the	  targeted	  lysine	  residue	  is	  hydroxylated,	  thereby	  
creating	  a	  highly	  unstable	  intermediate	  hydroxymethyl	  group	  that	  is	  spontaneously	  released	  as	  
formaldehyde,	  thus	  resulting	  in	  the	  loss	  of	  a	  methyl	  group	  (FIGURE	  1.2,	  bottom)	  (KLOSE	  and	  ZHANG	  
2007;	  TSUKADA	  et	  al.	  2006).	  	  JHDM1A	  contains	  five	  curated	  domains	  (namely	  JmjC,	  FBOX,	  CXXC-­‐
ZF,	   PHD,	   and	   LRR),	   of	   which	   only	   the	   JmjC	   domain	   is	   absolutely	   necessary	   for	   demethylase	  
activity	   (TSUKADA	   et	   al.	   2006).	   	  Within	   the	   JmjC	   domain	   are	   five	   cofactor	   binding	   site	   –	   three	  
amino	  acids	  that	  coordinate	  Fe(II)	  and	  two	  that	  bind	  to	  α-­‐KG	  (KLOSE	  et	  al.	  2006a).	  
	   Phylogenetic	  analysis	  of	  a	  non-­‐redundant	  set	  of	  98	  JmjC-­‐domain-­‐containing	  proteins	   in	  
six	  organisms	  spanning	  from	  yeast	  to	  humans	  revealed	  that	  these	  enzymes	  can	  be	  divided	  into	  
seven	  subfamilies	  on	  the	  basis	  of	  conservation	   in	  the	  JmjC	  domain	  and	  overall	  protein	  domain	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architecture	   (KLOSE	   et	  al.	   2006a).	   	   The	   five	  predicted	  cofactor-­‐binding	   sites	  are	  well	   conserved	  
among	   many	   of	   the	   JmjC-­‐domain-­‐containing	   proteins,	   indicating	   that	   other	   members	   of	   this	  
family	   of	   enzymes	   could	   also	   serve	   as	   histone	   demethylases.	   	   Additionally,	   JmjC-­‐domain-­‐
containing	   proteins	   often	   contain	   other	   DNA-­‐	   and/or	   chromatin-­‐binding	   domains,	   suggesting	  
that	   proteins	   that	   contain	   this	   domain	   could	   function	   in	   regulation	   of	   chromatin	   structure	  
(BALCIUNAS	  and	  RONNE	  2000;	  CLISSOLD	  and	  PONTING	  2001;	  TAKEUCHI	  et	  al.	  1995).	  	  Moreover,	  unlike	  
the	   amine	   oxidation	   mechanism	   employed	   by	   LSD1,	   the	   Fe(II)-­‐	   and	   α-­‐KG-­‐dependent	  
hydroxylation	   reaction	   used	   for	   demethylation	   does	   not	   require	   a	   protonated	   nitrogen	   to	  
initiate	   the	   reaction,	   and	   therefore	   has	   the	   capacity	   to	   target	   not	   only	  mono-­‐	   	   and	   dimethyl	  
marks,	   but	   also	   the	   trimethyl	   state.	   	   Given	   that	   JmjC-­‐domain-­‐containing	   proteins	   have	   a	  
predicted	   role	   in	  modulating	   chromatin	   structure,	   it	   remained	   largely	   possible	   that	   the	   other	  
JmjC-­‐domain-­‐containing	  proteins	  were	   responsible	   for	   demethylation	  of	   other	  modified	   lysine	  
residues	  in	  varying	  methylation	  states.	  	  Indeed,	  following	  the	  initial	  identification	  of	  JHDM1A	  as	  
an	  active	  histone	  demethylase,	  a	   flurry	  of	  publications	  was	   released	  demonstrating	   that	   JmjC-­‐
domain-­‐containing	  proteins	  from	  the	  other	  subfamilies	  also	  function	  as	  evolutionarily	  conserved	  
histone	   demethylases	  with	   particular	   substrate	   specificities	   (see	   TABLE	   1.1,	   and	   (PEDERSEN	   and	  
HELIN	  2010)).	  
	  
Histone	   Lysine	   Demethylation	   in	   Saccharomyces	   cerevisiae	   |	   Budding	   yeast	   has	   no	   LSD1	  
homologue.	   	   However,	   the	   identification	   of	   the	   JmjC-­‐domain-­‐containing	   protein	   Jhd1,	   the	  
budding	   yeast	   orthologue	   of	   mammalian	   JHDM1A,	   as	   an	   H3K36me2/1	   demethylase	  
demonstrated	   the	   dynamic	   nature	   of	   histone	  methylation	   in	   this	   organism	   (FANG	   et	   al.	   2007;	  
TSUKADA	   et	  al.	  2006).	   	  There	  are	   four	  other	   JmjC-­‐domain-­‐containing	  proteins	   in	  budding	  yeast:	  
Rph1,	  Gis1,	  Yjr119c,	  and	  Ecm5	  (FIGURE	  1.3,	  panel	  A)	  (KLOSE	  et	  al.	  2006a;	  KLOSE	  and	  ZHANG	  2007).	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Due	   to	  a	  high	   level	  of	   conservation	  within	   the	   JmjC	  domain,	   it	   is	   possible	   that	  other	  enzymes	  
capable	   of	   histone	   demethylation	   exist	   within	   this	   group.	   	   Namely,	   the	   putative	   histone	  
demethylase	  activity	  of	  the	  remaining	  four	  JmjC-­‐domain-­‐containing	  proteins	  can	  be	  predicted	  by	  
looking	   at	   conservation	   of	   cofactor	   binding	   sites	   (FIGURE	   1.3,	   panel	   B).	   	   Rph1	   and	   Gis1	   were	  
originally	   identified	   as	   repressors	   of	   PHR1,	   a	   DNA	   repair	   gene	   encoding	   a	   photolyase	   that	  
catalyzes	   the	   repair	   of	   pyrimidine	   dimers	   (JANG	   et	   al.	   1999).	   	   Rph1	   and	   Gis1	   are	   the	   yeast	  
homologues	   of	   the	   mammalian	   JHDM3/JMJD2	   proteins	   (TABLE	   1.1),	   which	   possess	   histone	  
demethylase	  activity	  with	  dual-­‐substrate	  specificity	  for	  H3K9me3/2	  and	  H3K36me3/2	  (CLOOS	  et	  
al.	  2006;	  KLOSE	  et	  al.	  2006b;	  WHETSTINE	  et	  al.	  2006).	  	  Whereas	  Rph1	  maintains	  conservation	  of	  all	  
five	   cofactor	   binding	   sites	   and	   is	   a	   likely	   candidate	   for	   histone	   demethylation,	   Gis1	   has	   a	  
mutation	  in	  one	  of	  the	  Fe(II)-­‐binding	  sites	  that	  likely	  abrogates	  any	  activity	  (KLOSE	  et	  al.	  2006a;	  
KLOSE	   and	  ZHANG	  2007).	   	   The	  mammalian	  H3K4me3/2	  demethylases	   from	   the	   JARID	   subfamily	  
(JARID1A-­‐D)	  have	  two	  yeast	  orthologues:	  Yjr119c	  and	  Ecm5	  (TABLE	  1.1)	  (KLOSE	  et	  al.	  2006a;	  KLOSE	  
and	  ZHANG	  2007).	  	  YJR119C	  is	  an	  uncharacterized	  ORF.	  	  Ecm5	  was	  originally	  identified	  in	  a	  screen	  
for	   genes	   involved	   in	   cell	   surface	   assembly,	   but	   its	   function	   remains	   unknown	   (LUSSIER	   et	   al.	  
1997).	  	  Like	  Gis1,	  mutations	  in	  Ecm5	  cofactor	  binding	  sites	  likely	  abrogate	  any	  activity.	  	  Yjr119c,	  
however,	  maintains	   conservation	   at	   all	   cofactor	   binding	   sites,	   thus	  making	   it	   probable	   that	   it	  
functions	  as	  a	  H3K4me3/2	  demethylase	  like	  its	  orthologues	  in	  higher	  eukaryotes	  (EISSENBERG	  et	  
al.	  2007;	  IWASE	  et	  al.	  2007;	  KLOSE	  et	  al.	  2006a;	  KLOSE	  et	  al.	  2007b;	  KLOSE	  and	  ZHANG	  2007;	  LEE	  et	  al.	  
2007;	  SECOMBE	  et	  al.	  2007;	  SEWARD	  et	  al.	  2007;	  YAMANE	  et	  al.	  2007).	  	  On	  the	  basis	  of	  conservation	  
of	   residues	   necessary	   for	   cofactor	   binding,	   it	   remains	   highly	   likely	   that	   the	   JmjC-­‐domain-­‐
containing	  proteins	  Rph1	  and	  Yjr119c	  function	  as	  histone	  demethylases	   in	  budding	  yeast,	   thus	  
expanding	  upon	  the	  dynamic	  nature	  of	  histone	  methylation	  in	  budding	  yeast.	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Additional	   Sites	   of	   Histone	   Lysine	   Methylation	   |	   The	   histone	   code	   hypothesis	   posits	   that	  
combinatorial	  patterns	  of	  post-­‐translational	  modifications	  of	  histone	  proteins	  act	   in	  concert	  to	  
dictate	  downstream	  biological	  outcomes	  (STRAHL	  and	  ALLIS	  2000).	   	   If	  the	  true	  breadth	  of	  such	  a	  
code	  is	  ever	  to	  be	  completely	  understood,	  it	  is	  essential	  that	  the	  totality	  of	  all	  modifications	  that	  
putatively	  contribute	  to	  it	  are	  identified.	  	  To	  date,	  only	  lysine	  residues	  4,	  36,	  and	  79	  of	  histone	  
H3	   have	   been	   characterized	   as	   sites	   of	   histone	   methylation	   in	   budding	   yeast	   (MILLAR	   and	  
GRUNSTEIN	  2006).	  	  In	  higher	  eukaryotes,	  methylation	  also	  occurs	  on	  lysines	  residues	  9	  and	  27	  of	  
histone	  H3	  and	   lysine	  20	  of	  histone	  H4	   (MARTIN	  and	  ZHANG	  2005).	   	  Sophisticated	  technological	  
advancements,	  particularly	  in	  mass	  spectrometry	  (MS),	  have	  significantly	  moved	  forward	  efforts	  
to	  identify	  novel	  histone	  modifications.	  	  For	  example,	  a	  recent	  comprehensive	  study	  designed	  to	  
identify	   patterns	   of	   histone	   PTMs	   associated	   with	   each	   phase	   of	   the	   yeast	   cell	   cycle	   using	  
tandem	  MS	  (MS/MS)	  revealed	  that	  lysine	  111	  of	  histone	  H2B	  (H2BK111),	  lysine	  37	  of	  histone	  H3	  
(H3K37),	   and	   lysine	   31	   of	   histone	   H4	   (H4K31)	   are	   each	  monomethylated	   (UNNIKRISHNAN	   et	   al.	  
2010),	  in	  agreement	  with	  a	  previously	  published	  study	  also	  reporting	  methylation	  of	  H3K37	  and	  
H2BK111	   in	  yeast	   (ZHANG	  et	  al.	  2009).	  The	   latter	  study	   found	  monomethylation	  of	   lysine	  22	  of	  
histone	  H2B	  as	  well.	   	  Another	  study	   looking	  at	  organismal	  differences	   in	  histone	  modifications	  
reported	  that	  monomethylation	  of	  lysine	  residues	  18	  and	  23	  of	  histone	  H3	  was	  conserved	  from	  
yeast	  to	  humans	  (GARCIA	  et	  al.	  2007a).	  	  Additional	  sites	  of	  histone	  lysine	  methylation	  have	  been	  
reported	   in	   higher	   eukaryotes	   (namely,	   trimethylation	   of	   lysine	   64	   and	   monomethylation	   of	  
lysine	  122	  of	  histone	  H3	   in	  mice	  and	  monomethylation	  of	   lysine	  5	  on	  histone	  H2B	   in	  humans	  
(BARSKI	  et	  al.	  2007;	  COCKLIN	  and	  WANG	  2003;	  DAUJAT	  et	  al.	  2009;	  WANG	  et	  al.	  2008)).	   	   It	   is	   likely	  
that	  additional	  sites	  of	  histone	  lysine	  methylation	  remain	  to	  be	  identified,	  thereby	  necessitating	  
additional	   investigations	   aimed	   at	   elucidating	   a	   complete	   atlas	   of	   histone	   PTMs,	   as	   much	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remains	  to	  be	  discovered	  with	  regard	  to	  the	  intricacies	  of	  lysine	  methylation	  and	  how	  exactly	  it	  
contributes	  to	  the	  histone	  code	  and	  cellular	  function.	  
	  
Significance	  of	  Studies	  on	  the	  Dynamic	  Nature	  Histone	  Lysine	  Methylation	   in	  Saccharomyces	  
cerevisiae	   |	   Across	   evolution,	   histone	   methylation	   has	   pleiotropic	   cellular	   roles	   regulating	  
processes	   including	   transcriptional	   regulation,	   X-­‐chromosome	   inactivation,	   heterochromatin	  
formation,	  and	  homeotic-­‐gene	   regulation	   (MARTIN	  and	  ZHANG	  2005).	   	  Both	  enzymes	   that	  place	  
and	   remove	  histone	  methyl	  marks	   are	   of	   fundamental	   importance	   to	   such	  processes,	   as	   they	  
maintain	   appropriate	   levels	   of	   methylation	   necessary	   for	   normal	   cellular	   function.	   	   Aberrant	  
regulation	   of	   gene	   expression	   is	   a	   central	   cause	   of	   many	   human	   diseases.	   	   Mutation	   or	  
overexpression	   of	   both	   histone	   methyltransferases	   and	   histone	   demethylases	   resulting	   in	  
misregulation	   of	   gene	   expression	   has	   been	   linked	   to	   human	   diseases	   including	   neurological	  
disorders	  and	  cancer	  (ALBERT	  and	  HELIN	  2010;	  SHI	  2007).	  	  There	  is	  much	  speculation	  in	  the	  field	  as	  
to	  whether	  HMTs	  and	  HDMTs	  could	  be	  potentially	  targeted	  for	  therapeutic	  purposes.	  	  However,	  
such	   advanced	   applications	   necessitate	   a	   basic	   understanding	   of	   the	   underlying	   enzymology,	  
molecular	  mechanism,	  and	  biological	  function	  of	  the	  appropriate	  histone	  modifying	  enzyme.	  	  To	  
that	  end,	  cross-­‐disciplinary	  investigations	  involving	  model	  organism	  studies	  will	  provide	  a	  more	  
complete	  understanding	  of	  the	  workings	  of	  such	  enzymes,	  as	  models	  such	  as	  the	  budding	  yeast	  
Saccharomyces	  cerevisiae	  provide	  an	  elegant	  system	  in	  which	  complementary	  biochemical	  and	  
genetic	  analyses	  can	  be	  completed.	  	  Moreover,	  with	  particular	  regard	  to	  histone	  modifications,	  
point	  mutants	  in	  specifically	  modified	  residues	  can	  be	  made	  straightforwardly	  in	  this	  organism,	  a	  
feat	   not	   readily	   accomplished	   in	   higher	   eukaryotes	   (KOUZARIDES	   2007).	   	   Thus,	   the	   studies	  
completed	   in	   budding	   yeast	   will	   ultimately	   provide	   a	   more	   comprehensive	   picture	   of	   the	  
dynamic	  regulation	  of	  histone	  lysine	  methylation,	  and	  contribute	  significantly	  to	  future	  studies	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on	  how	  such	  regulation	  functions	  in	  more	  complex	  biological	  processes	  such	  as	  cellular	  growth,	  
differentiation,	  and	  disease.	  
	  
Synopsis	  of	  Work	  Contained	  within	  this	  Doctoral	  Dissertation	  |	  All	  the	  studies	  contained	  within	  
the	   subsequent	   chapters	   are	   centered	   around	   the	   theme	   of	   “Dynamic	   regulation	   of	   histone	  
lysine	   methylation	   in	   Saccharomyces	   cerevisiae”.	   	   The	   majority	   of	   this	   work	   is	   aimed	   at	  
demonstrating	   that	   lysine	   methylation	   is	   a	   dynamic	   modification	   in	   S.	   cerevisiae	   and	   is	   thus	  
focused	  on	  the	  identification	  and	  characterization	  of	  histone	  lysine	  demethylases	  in	  this	  model	  
organism.	  	  To	  that	  end,	  in	  Chapter	  Two,	  the	  budding	  yeast	  JmjC-­‐domain-­‐containing	  protein	  Rph1	  
is	  identified	  as	  an	  active	  histone	  demethylase	  with	  specificity	  for	  di-­‐	  and	  trimethylated	  lysine	  36	  
of	  histone	  H3	   (KLOSE	  et	  al.	  2007a).	   	   In	  continuing	  with	   the	   theme	  of	  histone	  demethylation,	   in	  
Appendix	  One	  the	  protein	  product	  of	  the	  previously	  uncharacterized	  budding	  yeast	  ORF	  YJR119C	  
is	   identified	   as	   a	   histone	   lysine	   demethylase	   with	   specificity	   for	   H3K4me3/2	   (and	   was	  
subsequently	   renamed	   Jhd2	   for	   JmjC-­‐domain-­‐containing	   histone	   demethylase	   2)	   (LIANG	   et	   al.	  
2007).	  	  Beyond	  the	  active	  removal	  of	  histone	  lysine	  methyl	  marks,	  regulation	  of	  their	  placement	  
was	   investigated.	   	   Though	   it	   had	   been	   previously	   established	   that	   a	   trans-­‐tail	   regulatory	  
mechanism	  existed	  for	  placement	  of	  H3K4	  methylation,	  a	  recent	  study	  questioned	  the	  validity	  of	  
this	  histone	  crosstalk	  (FOSTER	  and	  DOWNS	  2009).	  	  Conclusive	  evidence	  that	  monoubiquitylation	  of	  
histone	  H2B	  on	   lysine	  123	   is	   indeed	  a	  prerequisite	  for	  methylation	  of	  both	  H3K4	  and	  H3K79	   is	  
provided	   in	   Appendix	   Two,	   thus	   supporting	   the	   existence	   of	   such	   a	   trans-­‐tail	   regulatory	  
mechanism	  (NAKANISHI	  et	  al.	  2009).	  	  To	  expand	  the	  field	  of	  chromatin	  biology’s	  understanding	  of	  
how	  histone	  methylation	   contributes	   to	   the	  histone	   code	  by	   identifying	   additional	  marks	   that	  
must	  be	  factored	  into	  it,	  in	  Chapter	  Three,	  lysine	  37	  of	  histone	  H2B	  is	  identified	  as	  a	  novel	  site	  of	  
histone	  methylation	   in	   budding	   yeast	   (GARDNER	   et	   al.	   2011b).	   	   Lastly,	   reflections	   on	   how	   the	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histone	   code	   hypothesis	   itself	   has	   evolved	   since	   it	   was	   first	   proposed	   in	   2000	   are	   included	  
Chapter	  Four	  to	  provide	  readers	  with	  a	  current	  synopsis	  of	  how	  landmark	  studies	  in	  chromatin	  
biology	  focused	  on	  placement,	  removal	  and/or	  interpretation	  of	  histone	  modifications	  (including	  
lysine	  methylation)	  have	  influenced	  the	  many	  shapes	  this	  influential	  hypothesis	  has	  taken	  over	  
the	   past	   ten	   years	   (GARDNER	   et	   al.	   2011a).	   	   In	   total,	   this	   work	   endeavors	   to	   expand	   our	  
understanding	   of	   the	   enzymology	   and	   regulation	   of	   histone	   lysine	   methylation	   to	   provide	  




Table	  1.1	  |	  JmjC-­‐domain-­‐containing	  histone	  lysine	  demethylases	  and	  their	  substrate	  specificity	  
	  
Subfamily	   Protein	  Name	   Substrate	  Specificity	   Reference(s)	  
JHDM1	  
JHDM1A	  (Hs)	  







(TSUKADA	  et	  al.	  2006)	  
(HE	  et	  al.	  2008)	  
(LAGAROU	  et	  al.	  2008)	  
(TSUKADA	  et	  al.	  2006)	  
JHDM2	  




(YAMANE	  et	  al.	  2006)	  





















(CLOOS	  et	  al.	  2006;	  KLOSE	  et	  al.	  
2006b;	  WHETSTINE	  et	  al.	  2006)	  
(CLOOS	  et	  al.	  2006;	  FODOR	  et	  al.	  
2006)	  
(CLOOS	  et	  al.	  2006)	  
(WHETSTINE	  et	  al.	  2006)	  
(LIN	  et	  al.	  2008)	  
(LIN	  et	  al.	  2008)	  
(KLOSE	  et	  al.	  2007a)	  
JARID	  
JARID1A/RBP2	  (Mm,	  Hs)	  
	  
























(CHRISTENSEN	  et	  al.	  2007;	  KLOSE	  
et	  al.	  2007b)	  
(YAMANE	  et	  al.	  2007)	  
(IWASE	  et	  al.	  2007)	  
(CHRISTENSEN	  et	  al.	  2007;	  IWASE	  
et	  al.	  2007)	  	  
(CHRISTENSEN	  et	  al.	  2007)	  
(CHRISTENSEN	  et	  al.	  2007;	  
EISSENBERG	  et	  al.	  2007;	  LEE	  et	  
al.	  2007b;	  SECOMBE	  et	  al.	  2007)	  	  
(HUARTE	  et	  al.	  2007)	  
(LI	  et	  al.	  2008)	  
(LIANG	  et	  al.	  2007)	  
UTX/UTY	  
UTX	  (Mm,	  Hs)	  
	  










(AGGER	  et	  al.	  2007;	  LAN	  et	  al.	  
2007;	  LEE	  et	  al.	  2007a)	  
(AGGER	  et	  al.	  2007;	  DE	  SANTA	  et	  
al.	  2007;	  LAN	  et	  al.	  2007)	  	  
(AGGER	  et	  al.	  2007)	  
(SMITH	  et	  al.	  2008)	  	  
PHF2/PHF8	  














(WEN	  et	  al.	  2010)	  
(KLEINE-­‐KOHLBRECHER	  et	  al.	  
2010;	  QI	  et	  al.	  2010)	  
(TSUKADA	  et	  al.	  2010)	  
(TSUKADA	  et	  al.	  2010)	  
(TSUKADA	  et	  al.	  2010)	  








(SINHA	  et	  al.	  2010)	  
(HSIA	  et	  al.	  2010)	  
Abbreviations:	   Saccharomyces	   cerevisiae	   (Sc),	   Schizosaccharomyces	   pombe	   (Sp),	   Drosophila	  





FIGURE	  1.1	  |	  Histone	  lysine	  methylation	  in	  Saccharomyces	  cerevisiae.	  	  (A)	  Reaction	  mechanism	  
for	  histone	  lysine	  methylation.	  	  Histone	  methyltransferases	  (HMTs)	  catalyze	  the	  transfer	  of	  one,	  
two,	  or	  three	  methyl	  groups	  onto	  the	  ε-­‐amino	  group	  of	  target	  lysine	  residues	  using	  the	  cofactor	  
S-­‐adenosyl-­‐L-­‐methionine	  (AdoMet)	  as	  the	  methyl	  group	  donor,	  thereby	  producing	  mono-­‐,	  di-­‐,	  or	  
trimethylated	  lysine	  residue,	  respectively,	  and	  the	  reaction	  byproduct	  S-­‐adenosyl-­‐homocysteine	  
(AdoHcy).	   	   	   	   (B)	  Known	  sites	  of	  histone	  lysine	  methylation	  in	  the	  budding	  yeast	  Saccharomyces	  
cerevisiae	  and	  the	  HMTs	  that	  catalyze	  placement	  of	  each	  methyl	  group	  (Me;	  depicted	  by	  green	  
hexagons).	  	  In	  budding	  yeast,	  histone	  lysine	  methylation	  on	  histone	  H3	  on	  lysine	  residues	  4,	  36,	  





FIGURE	   1.2	   |	   Reaction	   mechanisms	   used	   by	   histone	   demethylases	   (HDMTs).	   	   The	   reaction	  
scheme	   for	   formation	   of	   monomethyl	   lysine	   by	   histone	   methyltransferases	   (HMT)	   in	   a	   S-­‐
adenosyl-­‐L-­‐methionine	  (AdoMet)-­‐dependent	  reaction	  is	  shown	  (left).	  	  Note	  that	  lysine	  residues	  
can	  also	  be	  di-­‐	   and	   trimethylated.	   	  Histone	  methylation	   can	  be	   reversed	  by	  an	  amine	  oxidase	  
reaction	   catalyzed	   by	   LSD1	   (top)	   or	   by	   a	   hydroxylation	   reaction	   catalyzed	   by	   JmjC-­‐domain-­‐
containing	  HDMTs	   (bottom).	   	   LSD1	   uses	   flavin	   adenine	   dinucleotide	   (FAD)	   as	   a	   cofactor	   in	   an	  
amine	  oxidation	  reaction	  to	  demethylate	  methylated	  lysine	  residues,	  where	  removal	  of	  a	  methyl	  
group	   occurs	   through	   an	   imine	   intermediate,	   which	   is	   hydrolyzed	   to	   form	   the	   reaction	  
byproduct	   formaldehyde	   (HCOH)	   thereby	   resulting	   in	   the	   removal	   of	   a	   methyl	   group.	   	   JmjC-­‐
domain-­‐containing	   HDMTs	   use	   the	   cofactors	   iron	   (Fe(II))	   and	   α-­‐ketoglutarate	   (α-­‐KG)	   in	   an	  
oxidation	   reaction	   that	   produces	   a	   hydroxylated	   intermediate.	   	   The	   hydroxymethyl	   group	   is	  





FIGURE	  1.3	  |	  JmjC-­‐domain-­‐containing	  proteins	   in	  Saccharomyces	  cerevisiae.	   	  (A)	   JmjC-­‐domain-­‐
containing	   proteins	   in	   Saccharomyces	   cerevisiae.	   	   The	   five	   budding	   yeast	   JmjC-­‐domain-­‐
containing	   proteins	   and	   their	   domain	   architecture	   are	   illustrated.	   	   Jhd1	   is	   a	   member	   of	   the	  
JHDM1	   family,	   which	   are	   histone	   demethylases	   with	   specificity	   for	   H3K36me2/1	   (FANG	   et	   al.	  
2007;	   TSUKADA	   et	   al.	   2006).	   Rph1	   and	   Gis1	   belong	   to	   the	   JHDM3/JMJD2	   family,	   whose	  
mammalian	   homologues	   have	   been	   identified	   as	   H3K9/36me3/2	   demethylases	   (CLOOS	   et	   al.	  
2006;	   KLOSE	   et	   al.	   2006b;	  WHETSTINE	   et	   al.	   2006).	   	   Jhd2	   and	   Ecm5	   are	  members	   of	   the	   JARID	  
family,	   whose	   orthologues	   in	   higher	   eukaryotes	   have	   been	   shown	   to	   histone	   demethylases	  
specific	   for	  H3K4me3/2	   (IWASE	   et	  al.	   2007;	  KLOSE	   et	  al.	   2007b;	   LEE	   et	  al.	   2007b;	   SECOMBE	   et	  al.	  
2007;	   SEWARD	   et	   al.	   2007;	   YAMANE	   et	   al.	   2007).	   	   (B)	  Multiple	   sequence	   alignment	   of	   the	   JmjC	  
domain	  of	   the	   five	  Saccharomyces	   cerevisiae	   JmjC	  proteins	   shows	   a	   high	  degree	  of	   homology	  
among	   the	   predicted	   Fe(II)-­‐	   (red)	   and	   α-­‐KG	   (blue)	   binding	   sites	   of	   Rph1	   and	   Yjr119c	   to	   the	  
known	  histone	  demethylase	  Jhd1,	  suggesting	  that	  they	  likely	  function	  as	  histone	  demethylases.	  	  
Substitution	  mutations	  within	   the	   JmjC	   domain	   of	   Gis1	   and	   Ecm5	   likely	   abrogate	   any	   histone	  
demethylase	  activity.	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Histone	   methylation	   is	   an	   important	   posttranslational	   modification	   that	   contributes	   to	  
chromatin-­‐based	   processes	   including	   transcriptional	   regulation,	   DNA	   repair,	   and	   epigenetic	  
inheritance.	  	  In	  the	  budding	  yeast	  Saccharomyces	  cerevisiae,	  histone	  lysine	  methylation	  occurs	  
on	  histone	  H3	  lysines	  4,	  36,	  and	  79,	  and	  its	  deposition	  is	  coupled	  mainly	  to	  transcription.	  	  Until	  
recently,	   histone	   methylation	   was	   considered	   to	   be	   irreversible,	   but	   the	   identification	   of	  
histone	   demethylase	   enzymes	   has	   revealed	   that	   this	   modification	   can	   be	   dynamically	  
regulated.	  	  In	  budding	  yeast,	  there	  are	  five	  proteins	  that	  contain	  the	  JmjC	  domain,	  a	  signature	  
motif	   found	  in	  a	   large	  family	  of	  histone	  demethylases	  spanning	  many	  organisms.	   	  One	  JmjC-­‐
domain-­‐containing	   protein	   in	   budding	   yeast,	   Jhd1,	   has	   recently	   been	   identified	   as	   being	   a	  
histone	  demethylase	  that	  targets	  H3K36	  modified	  in	  the	  di-­‐	  and	  monomethyl	  state.	  	  Here,	  we	  
identify	  a	   second	   JmjC-­‐domain-­‐containing	  histone	  demethylase,	  Rph1,	  which	  can	  specifically	  
demethylate	   H3K36	   tri-­‐	   and	   dimethyl	   modification	   states.	   	   Surprisingly,	   Rph1	   can	   remove	  
H3K9	  methylation,	  a	  histone	  modification	  not	  found	  in	  budding	  yeast	  chromatin.	  	  The	  capacity	  
of	  Rph1	   to	  demethylate	  H3K9	  provides	   the	   first	   indication	   that	  S.	   cerevisiae	  may	  have	  once	  




Posttranslational	   modification	   of	   histone	   molecules	   within	   chromatin	   contributes	   epigenetic	  
information	   to	   the	  underlying	  DNA-­‐based	  genetic	   code	   (KORNBERG	  and	  LORCH	  1999).	   	  Recently,	  
the	  histone	  lysine	  (K)	  methylation	  system	  has	  attracted	  a	  significant	  amount	  of	   interest	  due	  to	  
its	   widespread	   roles	   in	   transcriptional	   regulation,	   DNA	   repair,	   and	   epigenetic	   inheritance	  
(MARTIN	  and	  ZHANG	  2005).	   	   In	  higher	  eukaryotes,	  histone	   lysine	  methylation	  occurs	  on	  histone	  
H3K4,	   K9,	   K27,	   K36,	   and	   K79	   and	   histone	   H4K20.	   	   In	   general,	   histone	   H3K4,	   K36,	   and	   K79	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methylation	   is	   associated	   with	   actively	   transcribed	   genes,	   whereas	   H3K9,	   K27,	   and	   H4K20	  
methylation	  is	  associated	  with	  silenced	  regions	  (MARTIN	  and	  ZHANG	  2005).	  	  Budding	  yeast	  has	  a	  
less	   complex	  histone	  methylation	   system	   that	   encodes	   three	  histone	   lysine	  methyltransferase	  
enzymes,	   Set1,	   Set2,	   and	   Dot1,	   which	   modify	   H3K4,	   K36,	   and	   K79,	   respectively	   (MILLAR	   and	  
GRUNSTEIN	  2006).	  	  Histone	  lysine	  methylation	  in	  budding	  yeast	  is	  tightly	  coupled	  to	  the	  process	  of	  
transcription,	  and	  the	  deposition	  of	  these	  modifications	  occurs	  mainly	  during	  the	  initiation	  and	  
elongation	   phases	   of	   RNA	   polymerase	   II-­‐based	   transcription	   (MILLAR	   and	   GRUNSTEIN	   2006).	   	   In	  
particular,	   H3K36	   methylation	   is	   tightly	   coupled	   to	   the	   process	   of	   active	   transcriptional	  
elongation	  and	  forms	  an	  increasing	  concentration	  gradient	  from	  the	  5’	  to	  the	  3’	  end	  of	  the	  gene.	  	  
H3K36	  profiles	  are	  dictated	  by	  the	  preferential	  association	  of	  Set2	  with	  the	  elongating	  form	  of	  
RNA	  polymerase	  II,	  which	  is	  phosphorylated	  on	  serine	  2	  of	  the	  C-­‐terminal	  domain	  (KROGAN	  et	  al.	  
2003b;	   LI	   et	   al.	   2003;	   LI	   et	   al.	   2002;	   SCHAFT	   et	   al.	   2003;	   XIAO	   et	   al.	   2003b).	   	   The	   functional	  
outcome	   of	   histone	   methylation	   is	   often	   elicited	   through	   effector	   proteins	   that	   specifically	  
recognize	   and	   interpret	   these	   histone	  modifications.	   	   In	   budding	   yeast,	   H3K36	  methylation	   is	  
recognized	   by	   the	   chromodomain	   protein	   Eaf3,	   which	   is	   a	   stable	   component	   of	   the	   Sin3	  
corepressor	   complex.	   	   Eaf3	   acts	   as	   an	   effector	   protein	   by	   recruiting	   the	   Sin3	   corepressor	  
complex	   to	   the	  body	  of	   yeast	   genes,	  where	   it	   inhibits	   intragenic	   transcription	   (CARROZZA	   et	  al.	  
2005;	  JOSHI	  and	  STRUHL	  2005;	  KEOGH	  et	  al.	  2005).	  	  Under	  standard	  laboratory	  growth	  conditions,	  
budding	   yeast	   lacking	   H3K36	   methylation	   shows	   no	   obvious	   cellular	   defects.	   	   However,	   the	  
widespread	   involvement	  of	   this	  modification	   in	   transcriptional	  elongation	  suggests	   that	  H3K36	  
methylation	  may	  have	  important	  roles	  in	  transcriptional	  fidelity	  under	  certain	  environmental	  or	  
growth	  conditions.	  
Until	   recently	  histone	  methylation	  was	  considered	   to	  be	  a	   static	  modification,	  but	   the	  
identification	   of	   histone	   demethylase	   enzymes	   has	   revealed	   that	   this	   modification	   can	   be	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dynamically	  regulated	  (CLOOS	  et	  al.	  2006;	  KLOSE	  et	  al.	  2006a;	  KLOSE	  et	  al.	  2006b;	  SHI	  et	  al.	  2004;	  
TSUKADA	   et	   al.	   2006;	   WHETSTINE	   et	   al.	   2006;	   YAMANE	   et	   al.	   2006).	   	   Thus	   far,	   two	   histone	  
demethylase	   enzyme	   families	   have	   been	   identified:	   the	   LSD1	   family	   and	   the	   JmjC-­‐domain-­‐
containing	   family.	   	   These	  enzymes	   are	  potentially	   important	   chromatin	   regulators,	   given	   their	  
capacity	   to	   modify	   epigenetic	   information	   through	   the	   direct	   removal	   of	   histone	   lysine	  
methylation	  marks.	   	   Functional	   characterization	   of	   existing	   histone	   demethylase	   enzymes	   has	  
revealed	  that	  individual	  enzymes	  recognize	  specific	  lysine	  residues	  and	  can	  distinguish	  between	  
the	   monomethylation	   (me1),	   dimethylation	   (me2),	   and	   trimethylation	   (me3)	   states	   of	   their	  
target	   substrates	   (KLOSE	   et	  al.	   2006b).	   	   The	  budding	  yeast	  genome	   is	  predicted	   to	  encode	   five	  
JmjC-­‐domain-­‐containing	   proteins	   but	   has	   no	   apparent	   LSD1	   homologue.	   	   JmjC-­‐domain-­‐
containing	   proteins	   achieve	   histone	   demethylation	   by	   an	   oxidative	  mechanism	   requiring	   iron	  
(Fe(II))	  and	    α-­‐ketoglutarate	   (α-­‐KG)	  as	  cofactors	  and	  are	  capable	  of	   removing	  all	   three	  histone	  
lysine	  methylation	   states	   (KLOSE	   et	  al.	   2006b).	   	   Jhd1	   is	   the	  only	  active	   JmjC-­‐domain-­‐containing	  
histone	  demethylase	  identified	  in	  budding	  yeast,	  and	  it	  targets	  the	  demethylation	  of	  H3K36me2	  
and	  H3K36me1	  (TSUKADA	  et	  al.	  2006).	  	  Bioinformatic	  analysis	  indicates	  that	  other	  JmjC-­‐domain-­‐
containing	  proteins	  in	  budding	  yeast	  may	  be	  enzymatically	  active	  based	  on	  the	  conservation	  of	  
important	  cofactor	  binding	  residues	  and	  therefore	  may	  constitute	  novel	  histone	  demethylases	  
(KLOSE	  et	  al.	  2006a).	  
Here,	  we	   characterize	   a	   second	   budding	   yeast	   JmjC-­‐domain-­‐containing	   protein,	   Rph1,	  
and	   reveal	   that	   it	   is	   an	   H3K36	   demethylase	   capable	   of	   removing	   the	   trimethyl	   modification	  
state.	  	  Biochemical	  analysis	  of	  Rph1	  demonstrates	  that	  this	  enzyme	  is	  also	  capable	  of	  removing	  
H3K9	  methylation	  despite	   the	   fact	   that	  S.	   cerevisiae	  chromatin	   lacks	   this	  modification.	   	   These	  
observations	   reveal	   that	  H3K36me3	   is	   a	   reversible	  modification	   in	  budding	  yeast,	   and	   suggest	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that	   Rph1-­‐mediated	   demethylation	   of	   H3K9	   may	   be	   a	   functional	   vestige	   of	   an	   extinct	   H3K9	  
methylation	  system	  in	  S.	  cerevisiae.	  
	  
Materials	  and	  Methods	  
Yeast	  strains	  and	  media.	  	  Yeast	  strains	  used	  for	  this	  study	  are	  listed	  in	  TABLE	  2.1.	  	  All	  strains	  are	  
isogenic	   to	   the	   BY4741	   background,	   with	   the	   exception	   of	   those	   used	   for	   telomeric	   silencing	  
assays,	  which	  are	  isogenic	  to	  the	  strain	  YCB647	  (SMITH	  et	  al.	  2000).	  	  Yeast	  transformations	  were	  
performed	  using	  standard	  procedures	  (GIETZ	  and	  SCHIESTL	  2007a;	  GIETZ	  and	  SCHIESTL	  2007b).	  	  The	  
rph1Δ::natMX	  strain	  was	  generated	  by	  homologous	  recombination	  using	  a	  PCR-­‐amplified	  natMX	  
knockout	   cassette	   (GOLDSTEIN	   and	   MCCUSKER	   1999).	   	   Endogenous	   Rph1	   was	   Flag-­‐tagged	   by	  
amplification	  of	  a	  p3Flag-­‐kanMX	  cassette	  (GELBART	  et	  al.	  2001)	  using	  primers	  A	  and	  B	  (sequences	  





All	  yeast	  strains	  were	  maintained	  and	  cultured	  according	  to	  standard	  conditions	  on	  appropriate	  
media	  (BURKE	  et	  al.	  2000).	  
	  
Plasmid	   constructs.	   	   For	   recombinant	  protein	   expression,	  RPH1	  was	  PCR	  amplified	   from	  yeast	  
genomic	  DNA	  isolated	  from	  BY4741	  and	  cloned	  into	  the	  NcoI	  and	  NotI	  sites	  of	  pET28a	  (Novagen)	  
encoding	   a	   C-­‐terminal	   His	   tag.	   The	   H235A	   mutation	   in	   the	   predicted	   Fe(II)	   binding	   site	   was	  
generated	   by	   site-­‐directed	   mutagenesis	   using	   the	   QuikChange	   mutagenesis	   kit	   (Stratagene).	  
Deletion	  constructs	  were	  also	  generated	  by	  PCR	  and	  cloned	  into	  pET28a	  containing	  a	  C-­‐terminal	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His	  tag.	   	  For	  the	  expression	  of	  Rph1	   in	  yeast,	   full-­‐length	  Rph1	  and	  Rph1	  deletions	  were	  cloned	  
into	  pAD4M	  (2	  µm	  AmpR	  LEU2	  ADH1	  promoter/terminator)	  containing	  an	  N-­‐terminal	  Flag	  tag.	  	  In	  
all	  cases,	  the	  sequences	  of	  PCR-­‐amplified	  clones	  were	  confirmed	  by	  sequencing.	  
	  
Recombinant	  protein	  purification.	   	   Recombinant	  protein	  was	  purified	  under	  native	   conditions	  
according	   to	   the	   manufacturer’s	   recommendations	   using	   nickel-­‐nitrilotriacetic	   acid	   (Ni-­‐NTA;	  
QIAGEN)	   affinity	   chromatography.	   	   Briefly,	   recombinant	   Rph1	   protein	  was	   expressed	   in	   BL21-­‐
DE3	  E.	  coli	  by	  induction	  using	  1	  mM	  IPTG	  with	  incubation	  at	  30°C	  for	  3	  hr.	  	  Cells	  were	  harvested	  
and	  resuspended	   in	   lysis	  buffer	   [40	  mM	  HEPES-­‐OH	  (pH	  7.9),	  500	  mM	  KCl,	  10%	  glycerol,	  1	  mM	  
DTT,	   1X	   Complete	   protease	   inhibitor	   (Roche)].	   	   Samples	   were	   sonicated	   six	   times	   at	   40%	  
amplitude	   for	   30	   sec	   (with	   alternating	   on	   and	   off	   pulses	   of	   1	   and	   3	   seconds,	   respectively).	  	  
Cellular	   debris	  was	   pelleted	  using	   an	   SS-­‐34	   rotor	   at	   15000	   rpm	   for	   20	  min	   at	   4°C.	   	   Incubated	  
cleared	  cell	  lysate	  was	  incubated	  with	  pre-­‐equilibrated	  Ni-­‐NTA	  agarose	  beads	  (QIAGEN)	  for	  2	  hr	  
at	   4°C.	   	   Beads	   were	   washed	   in	   wash	   buffer	   [40	   mM	   HEPES-­‐OH	   (pH	   7.9),	   500	   mM	   KCl,	   10%	  
glycerol,	  1	  mM	  DTT,	  1X	  Complete	  protease	  inhibitor	  (Roche),	  10	  mM	  imidazole]	  three	  times	  for	  
10	  min	  with	  rotation.	  	  Protein	  was	  batch	  eluted	  with	  elution	  buffer	  [40	  mM	  HEPES-­‐OH	  (pH	  7.9),	  
500	   mM	   KCl,	   10%	   glycerol,	   1	   mM	   DTT,	   1X	   Complete	   protease	   inhibitor	   (Roche),	   200	   mM	  
imidazole].	   	   Peak	   fractions	   were	   determined	   by	   SDS-­‐PAGE	   analysis	   followed	   by	   Coomassie	  
staining.	   	  Prior	  to	  use	   in	   in	  vitro	  histone	  demethylase	  assays,	  protein	  from	  the	  peak	  fraction(s)	  
were	  pooled	  and	  dialyzed	  against	  BC100	  [40	  mM	  HEPES-­‐OH	  (pH	  7.9),	  100	  mM	  KCl,	  10%	  glycerol,	  
1	  mM	  PMSF].	  
	  
Histone	  demethylation	  assays.	  	  All	  histone	  substrates	  were	  radioactively	  labeled	  by	  performing	  
histone	  methyltransferase	   reactions	  as	  described	  previously	   (KLOSE	   et	  al.	  2006b;	  TSUKADA	   et	  al.	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2006;	  TSUKADA	  and	  ZHANG	  2006).	   	  Briefly,	  histone	  octomers	  or	  oligonucleosomes	  purified	   from	  
HeLa	   cells	   as	   described	   previously	   (FANG	   et	   al.	   2004)	   were	   incubated	   with	   different	   purified	  
recombinant	   histone	  methyltransferases	   (namely,	   GST-­‐Set7,	   CBP-­‐Set2,	   and	   GST-­‐Dot1)	   in	   HMT	  
buffer	  [20	  mM	  Tris-­‐Cl	  (pH	  8.0),	  4	  mM	  EDTA,	  1	  mM	  PMSF,	  0.5	  mM	  DTT,	  0.03	  mCi/mL	  S-­‐adenosyl-­‐
L-­‐[methyl-­‐3H]methionine	   (3H-­‐SAM)	   (Perkin	   Elmer)]	   for	   2	   hr	   at	   30°C.	   	   GST-­‐	   and	   CBP-­‐fusion	  
proteins	   were	   expressed	   in	   BL21-­‐DE3	   E.	   coli	   and	   purified	   on	   glutathione	   sepharose	   beads	  
(Amersham)	   or	   calmodulin	   affinity	   resin	   (Stratagene),	   respectively,	   following	   manufacturer	  
protocols.	   	  Labeled	  substrates	  were	  dialyzed	  against	  histone	  storage	  buffer	   [10	  mM	  HEPES-­‐OH	  
(pH	  7.5),	  10	  mM	  KCl,	  0.2	  mM	  PMSF,	  10%	  glycerol]	  overnight	  at	  4°C	  to	  remove	  unincorporated	  
3H-­‐SAM.	  
Histone	   demethylation,	   mass	   spectrometry	   assays,	   and	   histone	  Western	   blot	   analysis	  
were	  carried	  out	  as	  described	  previously	  (TSUKADA	  et	  al.	  2006).	  	  For	  in	  vitro	  formaldehyde-­‐release	  
histone	   demethylase	   assays,	   labeled	   histone	   substrates	   were	   incubated	   with	   purified	  
recombinant	   proteins	   in	   histone	   demethylation	   buffer	   [50	   mM	   HEPES-­‐OH	   (pH	   8.0),	   70	   µM	  
Fe(NH4)2(SO4)2,	   1	   mM	   α-­‐ketoglutarate,	   2	   mM	   ascorbate]	   at	   37°C	   for	   3	   hr.	   	   Equal	   counts	   of	  
labeled	  substrate	  were	  used	  for	  histone	  demethylation	  reactions.	  	  A	  modified	  NASH	  method	  was	  
used	   for	   detection	   of	   released	   3H-­‐labelled	   formaldehyde	   (KLEEBERG	   and	   KLINGER	   1982),	   where	  
following	  TCA	  precipitation,	  an	  equal	  volume	  of	  NASH	  reagent	  [3.89	  M	  ammonium	  acetate,	  0.1	  
M	  acetic	  acid,	  0.2%	  2,4-­‐pentanedione]	  was	  added	  to	  the	  supernatant	  and	  incubated	  at	  37°C	  for	  
50	   min,	   thereby	   converting	   3H-­‐labelled	   formaldehyde	   to	   radiolabeled	   3,5-­‐diacethyl-­‐1,4-­‐
dihydrolutidine.	   	   Radioactive	   3,5-­‐diacethyl-­‐1,4-­‐dihydrolutidine	   was	   extracted	   with	   an	   equal	  
volume	  of	  1-­‐pentanol,	  and	  was	  measured	  by	  scintillation	  counting.	  	  
For	   mass	   spectrometry	   analysis,	   H3K36	   peptide	   substrates	   used	   encompasses	   amino	  
acids	  28	  to	  45	  containing	  a	  trimethyl	  modification,	  amino	  acids	  32	  to	  42	  containing	  a	  dimethyl	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modification,	   and	   amino	   acids	   21	   to	   45	   containing	   a	   monomethyl	   modification	   (Upstate	  
Biotechnology).	   	   The	   H3K9me3	   peptide	   substrate	   used	   in	   mass	   spectrometry	   analyses	  
encompasses	   amino	   acids	   1	   to	   18	   of	   histone	   H3	   (Upstate	   Biotechnology).	   	   Peptides	   were	  
subjected	  to	  demethylation	  reactions	  in	  the	  presence	  or	  absence	  of	  purified	  recombinant	  Rph1.	  	  
For	   detection	   of	   demethylation	   of	   peptide	   substrates,	   peptides	   in	   the	   reaction	  mixture	   were	  
desalted	   on	   an	   RP	   micro-­‐tip	   and	   MALDI-­‐TOF	   mass	   spectrometry	   analysis	   was	   carried	   out	   as	  
previously	  described	  (TSUKADA	  et	  al.	  2006).	  
For	   Western	   blot	   analysis	   of	   histones	   following	   in	   vitro	   demethylase	   assays,	   histone	  
octomers	   or	   oligonucleosomes	   purified	   from	   HeLa	   cells	   as	   described	   previously	   (FANG	   et	   al.	  
2004)	  were	  incubated	  in	  the	  presence	  or	  absence	  of	  recombinant	  Rph1	  in	  histone	  demethylase	  
buffer	   [50	   mM	   HEPES-­‐OH	   (pH	   8.0),	   70	   µM	   Fe(NH4)2(SO4)2,	   1	   mM	   α-­‐ketoglutarate,	   2	   mM	  
ascorbate]	  at	  37°C	   for	  3	  hr.	   	   Following	   the	  demethylation	   reaction,	  histone	  methylation	   levels	  
were	   analyzed	   by	  Western	   blot	   analysis	   with	   modification	   specific	   antibodies	   using	   standard	  
procedures.	   	   Briefly,	   demethylation	   reactions	   were	   quenched	   by	   addition	   of	   Laemmli	   sample	  
buffer	   [60	   mM	   Tris-­‐Cl	   (pH	   6.8),	   2%	   SDS,	   10%	   glycerol,	   5%	   β-­‐mercaptoethanol,	   0.01%	  
bromophenol	  blue].	   	  After	  heating	   samples	  at	  95°C	   for	  5	  min,	  histones	  were	   resolved	  on	  15%	  
SDS	  polyacrylamide	  gels,	  and	  proteins	  were	  transferred	  onto	  nitrocellulose	  membrane	  (0.2	  µm,	  
BIORAD)	  using	  a	  semi-­‐dry	  transfer	  apparatus	  (HOEFER).	  	  The	  following	  antibodies	  were	  used	  at	  
dilutions	   ranging	   from	   1:200	   to	   1:1,000:	   α-­‐H3K4me3	   (Abcam,	   ab8580),	   α-­‐H3K9me3	   (Abcam,	  
ab8898),	   α-­‐H3K36me3	   (Abcam,	   ab9050),	   α-­‐H3K36me2	   (Zhang	   lab),	   α-­‐H3K36me1	   (Abcam,	  
ab9048),	  and	  α-­‐H3K79me3/2	  (Zhang	  lab).	  
	  
Size	   exclusion	   chromatography	   and	   sucrose	   gradient	   analysis.	   	   Whole-­‐cell	   yeast	   extract	   or	  
recombinant	   Rph1	   (rRph1)	   was	   fractionated	   over	   a	   24	   mL	   Superose	   6	   size	   exclusion	   column	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(Amersham)	  equilibrated	  with	  BC400	  [40	  mM	  HEPES-­‐OH	  (pH	  7.9),	  400	  mM	  KCl,	  0.5	  mM	  DTT,	  10%	  
glycerol,	   0.2	   mM	   PMSF]	   with	   the	   aid	   of	   an	   ÄKTA	   purifier	   (Amersham)	   at	   a	   flow	   rate	   of	   0.2	  
mL/min,	   and	   250	   µL	   fractions	   were	   collected.	   Every	   other	   fraction	  was	   analyzed	   for	   Rph1	   by	  
Western	  blotting	  or	  Coomassie	  staining.	   	  Sucrose	  gradients	  were	  formed	  at	  4°C	  in	  13	  mL	  SW40	  
tubes	  using	  a	  manual	  two-­‐chamber	  gradient	  former.	  	  Chamber	  1	  was	  loaded	  with	  buffer	  A	  [300	  
mM	  KCl,	   20	  mM	  HEPES-­‐OH	   (pH	   7.9),	   10%	   glycerol,	   10	  mM	  β-­‐ME]	   containing	   5%	   sucrose,	   and	  
chamber	   2	   was	   loaded	   with	   buffer	   A	   containing	   20%	   sucrose.	   	   Rph1	   and	   protein	   molecular	  
weight	  markers	  were	  applied	  to	  the	  5	  to	  20%	  sucrose	  gradient	  and	  centrifuged	  at	  40,000	  rpm	  in	  
an	  SW40	  rotor	  for	  19	  hr	  at	  4°C.	  	  Fractions	  (500	  µL)	  were	  manually	  collected	  from	  the	  top	  of	  the	  
gradient	  using	  a	  peristaltic	  pump	  fitted	  with	  a	  capillary	  tube.	  	  Each	  fraction	  was	  TCA	  precipitated	  
and	  analyzed	  by	  SDS-­‐PAGE	  analysis	  with	  Coomassie	  staining.	  
	  
Native	   molecular	   weight	   and	   frictional	   coefficient	   calculations.	   	   To	   determine	   the	   native	  
molecular	  weight	  (Mr)	  and	  frictional
	  coefficient	  (f/f0)	  of	  rRph1,	  the	  values	  obtained	  for	  radius
	  and	  
sedimentation	  in	  FIGURE	  2.5	  were	  applied	  to	  equations	  (1)	  and	  (2)	  (SIEGEL	  and	  MONTY	  1966):	  
	  
(1) Mr	  =	  6πη20,w	  •	  s20,w	  •	  RS	  •	  N/(1	  -­‐	  ρ20,wν)	  
(2) f/f0	  =	  6πη20,w	  •	  RS/6πη20,w	  •	  (3νMr/4πN)1/3	  
	  
where	  RS	  is	  Stoke’s	  radius	  (cm),
	  s20,w	  is	  the	  sedimentation	  velocity	  (S	  x	  10
–13),	  η20,w
	  is	  the	  viscosity	  
of	  water	  at	  20°C	   (0.01002	  g·∙s–1	   cm–1),	  N	   is	  Avogadro’s	  number	   (6.022	  x	  1023·∙mol–1),	  ρ20,w	   is	   the	  
density	  of	  water	  at	  20°C	  (0.9981	  g·∙cm3),	  and	  ν	  is	  the	  partial	  specific	  volume	  (used	  0.725	  cm3/g).	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Transfection	   and	   immunofluorescence	   microscopy.	   	   NIH	   3T3	   cells	   were	   grown	   in	   Dulbecco’s	  
modified	   Eagle’s	  medium	   containing	   10%	   fetal	   bovine	   serum	   and	   penicillin-­‐streptomycin.	   	   For	  
immunofluorescence,	  cells	  grown	  on	  coverslips	  in	  six-­‐well	  plates	  were	  transfected	  with	  2	  to	  6	  µg	  
of	  Flag-­‐Rph1	  expression	  plasmid	  using	  Fugene	  6	  transfection	  reagent	  (Roche).	   	  Cells	  were	  fixed	  
24	  hr	  posttransfection	  for	  20	  min	  in	  4%	  paraformaldehyde,	  washed	  three	  times	  with	  phosphate-­‐
buffered	   saline	   (PBS),	   and	   subsequently	   permeabilized	   for	   20	   min	   in	   0.5%	   Triton	   X-­‐100-­‐PBS.	  	  
Permeabilized	  cells	  were	  washed	  two	  times	  in	  PBS	  and	  blocked	  in	  3%	  bovine	  serum	  albumin-­‐PBS	  
for	  30	  min.	   	  Cells	  were	   incubated	  with	  primary	  antibody	   in	  a	  humidified	  chamber	   for	  1	   to	  3	  h	  
using	   histone	   modification	   antibodies	   at	   a	   dilution	   of	   1:100	   and	   the	   Flag	   monoclonal	   M2	  
antibody	  (Sigma,	  F3165)	  at	  a	  dilution	  of	  1:1000.	   	  After	  primary	  antibody	   incubation,	  cells	  were	  
washed	   three	   times	   and	   incubated	   with	   fluorescein	   isothiocyanate	   or	   rhodamine-­‐conjugated	  
secondary	   antibodies	   (Jackson	   ImmunoResearch	   Laboratories).	   	   Cells	   were	  washed	   twice	  with	  
PBS,	   stained	  with	   4,6-­‐diamidino-­‐2-­‐phenylindole	   dihydrochloride	   (DAPI),	   and	  mounted	   on	   glass	  
slides	   in	   fluorescent	   mounting	   medium	   (DAKO).	   	   Slides	   were	   analyzed	   on	   an	   AxioSkop	  
fluorescent	  microscope	  (Zeiss).	  
	  
Results	  
Rph1	   is	   an	   H3K36me3	   demethylase.	   	   We	   and	   others	   recently	   identified	   and	   characterized	  
mammalian	  JHDM3/JMJD2	  histone	  demethylases	  that	  target	  H3K9/36	  methylation	  (CLOOS	  et	  al.	  
2006;	  FODOR	  et	  al.	  2006;	  KLOSE	  et	  al.	  2006b;	  WHETSTINE	  et	  al.	  2006).	   	  These	  proteins	  contain	  N-­‐
terminal	  JmjN	  and	  JmjC	  domains	  that	  are	  required	  for	  enzymatic	  activity.	  	  Bioinformatic	  analysis	  
has	   identified	   an	   S.	   cerevisiae	   protein,	   Rph1,	   which	   has	   a	   high	   level	   of	   similarity	   to	   the	  
JHDM3/JMJD2	   proteins	  within	   its	   JmjN	   and	   JmjC	   domains.	   	   Residues	   predicted	   to	   function	   as	  
cofactor	   binding	   sites	   are	   completely	   conserved	   between	   the	   JmjC	   domain	   of	   Rph1	   and	   the	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JHDM3/JMJD2	   proteins,	   suggesting	   that	   Rph1	   could	   potentially	   encode	   a	   novel	   yeast	   histone	  
demethylase	  (KLOSE	  et	  al.	  2006a).	  	  Interestingly,	  very	  little	  similarity	  exists	  between	  mammalian	  
JHDM3/JMJD2	  proteins	  and	  Rph1	  outside	  of	  the	  JmjN	  and	  JmjC	  domains,	  suggesting	  that	  Rph1	  
may	  have	  unique	  substrate	  specificity	  and	  function	  in	  yeast.	  
To	  test	  whether	  Rph1	  is	  a	  histone	  demethylase,	  rRph1	  or	  rRph1	  with	  a	  replacement	  in	  a	  
predicted	   iron	   binding	   residue	   (H235A)	   was	   used	   in	   a	   histone	   demethylase	   assay	   containing	  
radioactively	   labeled	  methyl	   groups	   on	   histone	   H3	   at	   positions	   K4,	   K36,	   and	   K79	   (FIGURE	   2.1,	  
panel	  A).	   	  Histone	  demethylase	   activity	  was	  monitored	  by	   the	   release	  of	   the	   labeled	   reaction	  
product	  formaldehyde.	  	  Demethylase	  activity	  was	  observed	  only	  when	  H3K36-­‐labeled	  substrate	  
was	   present	   in	   the	   reaction	   mixture,	   suggesting	   that	   Rph1	   is	   an	   H3K36-­‐specific	   histone	  
demethylase	   (FIGURE	   2.1,	   panel	   A).	   	  Mutation	   of	   a	   predicted	   iron-­‐binding	   residue	  within	   Rph1	  
completely	   abolished	   enzymatic	   activity,	   verifying	   that	   Rph1	   relies	   on	   the	   JmjC	   domain	   for	  
catalysis.	  	  Because	  histone	  lysine	  methylation	  can	  occur	  in	  three	  modification	  states,	  we	  sought	  
to	   identify	  which	  H3K36	  modification	   states	   are	   targeted	   by	   Rph1.	   	   Rph1	  was	   incubated	  with	  
core	   histones	   or	   oligonucleosomes,	   and	   the	   resulting	   methylation	   states	   were	   analyzed	   by	  
Western	   blotting	   using	  modification-­‐specific	   antibodies	   (FIGURE	   2.1,	   panel	   B).	   	   Rph1-­‐mediated	  
demethylation	  culminated	  in	  a	  reduction	  of	  H3K36me3	  and	  an	  accumulation	  of	  H3K36me1	  but	  
did	  not	  affect	  H3K4me3	  or	  H3K79me3	  methylation.	  	  Interestingly,	  this	  property	  of	  Rph1	  differs	  
from	   that	   of	   mammalian	   JHDM3/JMJD2	   proteins,	   which	   are	   incapable	   of	   efficiently	  
demethylating	  oligonucleosomal	  substrates	  (KLOSE	  et	  al.	  2006b).	  
Rph1	  activity	   towards	  purified	  histone	  substrates	  clearly	  demonstrates	  that	  Rph1	   is	  an	  
H3K36	  demethylase.	  	  To	  fully	  define	  Rph1	  substrate	  specificity,	  mass	  spectrometry	  was	  used	  to	  
analyze	  the	  modification	  state	  of	  histone	  H3	  peptides	  containing	  K36me3,	  K36me2,	  and	  K36me1	  
following	  demethylation	  by	  Rph1	  (FIGURE	  2.1,	  panels	  C	  through	  G).	  	  In	  agreement	  with	  the	  Rph1-­‐
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mediate	   demethylation	   of	   H3K36me3	   observed	   by	   histone	   Western	   blotting,	   mass	  
spectrometric	   analysis	   revealed	   that	   Rph1	   efficiently	   demethylates	   H3K36me3,	   leading	   to	   a	  
processive	  reduction	  to	  the	  me2,	  me1,	  and	  me0	  modification	  states	  (FIGURE	  2.1,	  panel	  C).	  	  Rph1	  
is	   also	   capable	   of	   initiating	   demethylation	   on	   H3K36me2	   substrates	   but	   is	   unable	   to	  
demethylate	   the	  H3K36me1	  modification	   state	   (FIGURE	   2.1,	   panels	   D	   and	   E).	   	   Together,	   these	  
data	  reveal	  the	  first	  yeast	  histone	  demethylase	  capable	  of	  removing	  the	  trimethyl	  modification	  
state	  and	  demonstrate	  that	  Rph1	  targets	  the	  demethylation	  of	  H3K36me3	  and	  H3K36me2.	  
	  
Rph1	  requires	  both	  the	  JmjN	  and	  JmjC	  domains	  to	  catalyze	  histone	  demethylation.	   	  The	  Rph1	  
protein	  has	  three	  curated	  protein	  domains	  including	  a	  JmjN	  domain,	  a	  JmjC	  domain,	  and	  a	  zinc	  
finger	   (ZF)	   domain.	   	   Mutation	   of	   a	   predicted	   iron-­‐binding	   site	   within	   the	   Rph1	   JmjC	   domain	  
abrogates	  demethylase	  activity,	  demonstrating	  that	  the	  JmjC	  domain	  is	  the	  catalytic	  core	  of	  the	  
enzyme.	   	   Characterization	   of	   other	   JmjC-­‐domain-­‐containing	   proteins	   has	   revealed	   that	  
additional	  domains	  can	  contribute	  to	  demethylase	  activity	  (FODOR	  et	  al.	  2006;	  KLOSE	  et	  al.	  2006b;	  
TSUKADA	  et	  al.	  2006;	  YAMANE	  et	  al.	  2006).	   	  To	  understand	  which	  Rph1	  domains	  are	  required	  for	  
histone	  demethylation,	  a	   series	  of	  deletion	  proteins	   (FIGURE	  2.2,	  panel	  A)	  were	  generated	  and	  
analyzed	   for	   H3K36	   demethylase	   activity	   using	   the	   formaldehyde	   release	   assay	   (FIGURE	   2.2,	  
panel	  B).	   	  A	  unique	   feature	  of	  Rph1	   is	   its	  C-­‐terminal	   ZF	  DNA	  binding	  domain,	  which	   is	   absent	  
from	   the	   related	   mammalian	   JHDM3/JMJD2	   histone	   demethylases	   (JANG	   et	   al.	   1999).	   	   To	  
determine	  whether	  this	  domain	  contributes	  to	  demethylase	  activity,	  the	  ZF	  was	  deleted,	  and	  the	  
activity	  of	  the	  recombinant	  protein	  was	  analyzed	  by	  formaldehyde	  release	  (FIGURE	  2.2,	  panel	  B).	  	  
Removal	  of	  the	  ZF	  domain	  had	  no	  effect	  on	  enzymatic	  activity,	  suggesting	  that	  this	  domain	  may	  
have	  alternative	   roles	   in	  vivo.	   	   In	  contrast,	  deletion	  of	   the	   JmjN	  domain	  completely	  abrogated	  
H3K36	  demethylase	  activity	  (FIGURE	  2.2,	  panel	  B).	   	  Recently,	  the	  crystal	  structure	  of	  the	  human	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JHDM3A/JMJD2A	   protein	   was	   solved,	   revealing	   that	   the	   JmjN	   domain	   folds	   into	   the	   JmjC	  
domain,	  creating	  a	  single	  structural	  entity	  that	  is	  enzymatically	  active	  (CHEN	  et	  al.	  2006).	  	  Given	  
that	  Rph1	  also	  relies	  on	  its	  JmjN	  domain	  for	  enzymatic	  activity,	  it	  seems	  likely	  that	  this	  domain	  
contributes	   to	   the	   structure	   of	   the	   functional	   yeast	   enzyme.	   	   To	   determine	   whether	   the	  
JmjN/JmjC	   domain	   alone	   is	   enzymatically	   active,	   a	   protein	   encompassing	   only	   these	   domains	  
was	  generated	  and	  used	  in	  a	  histone	  demethylase	  assay.	  	  Although	  this	  protein	  showed	  a	  slight	  
reduction	   in	  H3K36	   demethylase	   activity,	   it	  was	   still	   capable	   of	   removing	  H3K36	  methylation,	  
demonstrating	   that	   the	   JmjN/JmjC	   domain	   is	   sufficient	   for	   demethylase	   activity	   (FIGURE	   2.2,	  
panel	  B).	  	  Together,	  these	  data	  show	  that	  Rph1	  demethylase	  activity	  relies	  on	  the	  function	  of	  the	  
JmjN	   and	   JmjC	   domains	   and	   indicate	   that	   the	   ZF	   domain	   may	   have	   alternate	   roles	   in	   vivo,	  
perhaps	  involving	  protein	  targeting.	  
	  
Deletion	   of	   RPH1	   causes	   no	   overt	   cellular	   phenotype.	   	   To	   analyze	   the	   role	   of	   Rph1	   in	   the	  
regulation	  of	  H3K36	   in	  vivo,	   the	  RPH1	   locus	  was	  disrupted	  by	  homologous	  recombination,	  and	  
the	   absence	  of	   the	  Rph1	   transcript	  was	   verified	  by	   reverse	   transcription	   (RT)-­‐PCR	   (FIGURE	   2.3,	  
panel	   A).	   	   The	   Rph1-­‐deficient	   strain	   was	   morphologically	   wild-­‐type,	   and	   analysis	   of	   H3K36	  
methylation	  by	  Western	   blot	   analysis	  with	  modification-­‐specific	   antibodies	   revealed	  no	   global	  
changes	   in	   H3K36	   methylation	   (data	   not	   shown).	   	   Given	   that	   H3K36	   methylation	   has	   been	  
previously	  linked	  to	  transcriptional	  elongation	  (KIZER	  et	  al.	  2005;	  KROGAN	  et	  al.	  2003b),	  we	  tested	  
whether	   deletion	   of	  RPH1	   causes	   sensitivity	   to	  mycophenolic	   acid	   (MPA),	   a	   drug	   that	   affects	  
transcriptional	  elongation.	   	  Results	   shown	   in	  FIGURE	  2.3	   (panel	  B)	   indicate	   that	   the	  deletion	  of	  
RPH1	  does	  not	  confer	  sensitivity	  to	  MPA,	  nor	  does	  it	  cause	  defects	  in	  telomeric	  silencing	  (FIGURE	  
2.3,	  panel	  C).	  	  In	  addition,	  we	  have	  tested	  a	  number	  of	  conditions	  used	  for	  phenotypic	  analysis	  
TABLE	  2.2	  and	  observed	  no	  apparent	  phenotype.	  	  Yeast	  Jhd1	  is	  also	  an	  H3K36	  demethylase,	  but	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in	  contrast	  to	  Rph1,	   it	  specifically	  demethylates	  H3K36me2/1	  modification	  states.	   	  To	  examine	  
whether	  there	  are	  synthetic	  effects	  in	  yeast	  lacking	  both	  Rph1	  and	  Jhd1,	  a	  double	  mutant	  strain	  
was	  generated	  and	  subjected	  to	  the	  same	  phenotypic	  analysis	  as	  the	  Rph1-­‐deficient	  strain	  TABLE	  
2.2.	  	  The	  double	  mutant	  strain	  failed	  to	  display	  any	  synthetic	  effects	  and	  grew	  normally	  under	  all	  
conditions	   tested.	   	   Together,	   these	  data	   indicate	   that	  Rph1	  and	   Jhd1	  do	  not	  play	  an	  essential	  
global	   role	   in	   regulating	   cellular	   processes	   including	   transcription,	   DNA	   replication,	   and	  
heterochromatin	   function.	   	   This	  does	  not,	  however,	   rule	  out	   the	  possibility	   that	  Rph1	  or	   Jhd1	  
contributes	  to	  these	  functions	  in	  a	  more	  subtle	  manner	  not	  realized	  using	  standard	  phenotypic	  
analyses.	  
	  
Rph1	  can	  demethylate	  H3K36	   in	  vivo.	   	  To	  verify	  that	  Rph1	  can	  target	  H3K36	  demethylation	   in	  
vivo,	   Flag-­‐tagged	   Rph1	   was	   overexpressed	   in	   wild-­‐type	   cells	   (FIGURE	   2.4,	   panels	   A	   and	   B).	  	  
Interestingly,	   the	   overexpression	   of	   Rph1	   resulted	   in	   a	   severe	   inhibition	   of	   cell	   growth,	  
suggesting	   that	  elevated	   levels	  of	  Rph1	  have	  a	  detrimental	   effect	  on	   cell	   function	   (FIGURE	  2.4,	  
panel	   C).	   	   To	   determine	   if	   the	   growth	   defect	   was	   a	   result	   of	   Rph1	   demethylase	   activity,	   a	  
catalytically	   inactive	   Rph1	  was	   overexpressed,	   and	   growth	  was	   analyzed	   (FIGURE	   2.4,	   panels	   A	  
through	  C).	  	  Like	  the	  wild-­‐type	  Rph1	  protein,	  the	  overexpression	  of	  the	  mutant	  protein	  resulted	  
in	   a	   growth	   defect,	   indicating	   that	   the	   effect	   of	   Rph1	   on	   cell	   growth	   is	   independent	   of	  
demethylase	   activity	   (FIGURE	   2.4,	   panel	   C).	   	   Rph1	   has	   previously	   been	   shown	   to	   function	   as	   a	  
transcriptional	   repressor,	  suggesting	  that	   the	  growth	  defect	  may	  be	  related	  to	  the	  silencing	  of	  
genes	   involved	   in	   cell	   division	   or	   other	   growth-­‐related	   pathways.	   	   The	   slow	   growth	   and	   low	  
levels	   of	   protein	   expression	   in	   cells	   expressing	   full-­‐length	   Rph1	   made	   it	   impossible	   to	  
reproducibly	  observe	  changes	  in	  H3K36	  methylation.	  	  To	  try	  to	  separate	  the	  growth	  suppression	  
and	  catalytic	  activities	  of	  Rph1,	  a	  protein	   lacking	  the	  C-­‐terminal	  ZF	  domain	  was	  overexpressed	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(FIGURE	   2.4,	   panels	   A	   and	   B).	   	   Deletion	   of	   the	   ZF	   domain	   completely	   abrogated	   the	   growth	  
defect,	   indicating	   that	   the	   DNA	   binding	   ZF	   is	   important	   for	   growth	   suppression,	   perhaps	  
functioning	  as	  a	   targeting	  mechanism	   for	  Rph1-­‐mediated	   repression	   (JANG	   et	  al.	   1999)	   (FIGURE	  
2.4,	  panel	  C).	  	  Cells	  expressing	  Rph1	  that	  lack	  the	  ZF	  domain	  grew	  normally	  and	  expressed	  high	  
levels	  of	  protein,	  making	  it	  possible	  to	  analyze	  the	  H3K36	  methylation	  levels	  by	  Western	  blotting	  
using	   modification-­‐specific	   antibodies	   (FIGURE	   2.4,	   panel	   D).	   	   Consistent	   with	   the	   observation	  
that	   Rph1	   is	   an	   H3K36me3	   demethylase	   in	   vitro,	   the	   overexpression	   of	   Rph1	   lacking	   the	   ZF	  
caused	  a	  decrease	  in	  H3K36me3	  methylation	  levels	  in	  vivo	  (FIGURE	  2.4,	  panel	  D,	  compare	  lanes	  1	  
and	  2).	   	  Demethylase	  activity	  was	  dependent	  on	  an	  intact	  JmjC	  domain,	  as	  a	  point	  mutation	  in	  
the	   catalytic	   domain	   abrogated	   this	   effect	   (FIGURE	   2.4,	   panel	   D).	   	   In	   agreement	  with	   domain-­‐
mapping	   studies	   in	   vitro,	   the	  overexpression	  of	   the	   JmjN/JmjC	  domain	  alone	  was	   sufficient	   to	  
catalyze	  H3K36me3	   demethylation,	   and	   this	   function	   relied	   on	   an	   intact	   JmjC	   domain	   (FIGURE	  
2.4,	  panel	  D,	   lanes	  4	  and	  5).	   	   Together,	   these	  data	   reveal	   that	  Rph1	   functions	   to	  demethylate	  
H3K36	   in	  vivo	  and	  that	  elevated	  levels	  of	  Rph1	  lead	  to	  growth	  defects	  that	  are	  independent	  of	  
demethylase	  activity.	  
	  
Rph1	   is	   not	   stably	   associated	  with	   other	   proteins	   in	   vivo.	   	  Many	   chromatin	   remodeling	   and	  
chromatin-­‐modifying	   enzymes	   are	   found	   in	   high-­‐molecular-­‐weight	   complexes	   containing	  
auxiliary	   proteins	   that	   are	   required	   to	   regulate	   enzymatic	   function	   and	   target	   the	   enzyme	   to	  
defined	  genomic	   regions	   (CAIRNS	  2005;	  CAO	   et	  al.	   2002;	  CARROZZA	   et	  al.	   2005;	   JOSHI	  and	  STRUHL	  
2005;	  KEOGH	  et	  al.	  2005;	  KUZMICHEV	  et	  al.	  2002;	  LI	  et	  al.	  2006;	  MULLER	  et	  al.	  2002;	  WANG	  et	  al.	  
2003).	   	   To	   identify	   potential	   Rph1	   functional	   protein	   partners,	   we	   performed	   TAP-­‐tag	  
purification,	  which	   failed	   to	   reveal	  any	   stable	  associated	  proteins	   (data	  not	   shown).	   	   To	  verify	  
that	  Rph1	  is	  not	  a	  component	  of	  a	  high-­‐molecular-­‐weight	  protein	  complex,	  extract	  from	  a	  Flag-­‐
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tagged	   Rph1	   strain	   (FIGURE	   2.5,	   panel	   A)	   was	   fractionated	   by	   size	   exclusion	   chromatography	  
(FIGURE	  2.5,	  panel	  B).	  	  Rph1-­‐containing	  fractions	  were	  identified	  by	  Western	  blot	  analysis	  using	  a	  
Flag-­‐specific	  antibody	  (FIGURE	  2.5,	  panel	  B).	  	  Rph1	  eluted	  from	  the	  size	  exclusion	  column	  with	  an	  
apparent	   native	   molecular	   mass	   of	   greater	   than	   440	   kDa,	   which	   is	   much	   larger	   than	   its	  
theoretical	  molecular	  mass	  of	  90.2	  kDa	  based	  on	  the	  amino	  acid	  composition	  (FIGURE	  2.5,	  panel	  
B).	   	   Rph1	   affinity	   purification	   failed	   to	   reveal	   associated	   proteins,	   but	   size	   exclusion	   analysis	  
suggests	  that	  the	  native	  molecular	  weight	  of	  Rph1	  is	  larger	  than	  that	  expected	  for	  Rph1	  alone.	  	  
To	   determine	   whether	   the	   high	   apparent	   native	   molecular	   weight	   of	   Rph1	   in	   size	   exclusion	  
fractionation	  was	  due	  to	  an	  association	  with	  other	  proteins,	  rRph1	  was	  separated	  over	  the	  same	  
size	  exclusion	  column	  and	  analyzed	  by	  Coomassie	  staining	  (FIGURE	  2.5,	  panel	  C).	  	  Surprisingly,	  the	  
recombinant	  protein	  also	  eluted	  from	  the	  size	  exclusion	  column	  with	  a	  native	  molecular	  mass	  of	  
greater	   than	  440	  kDa	   (FIGURE	  2.5,	  panel	  C).	   	   This	  observation	   indicates	   that	   the	  high	  apparent	  
native	   molecular	   weight	   of	   Rph1	   in	   yeast	   extracts	   is	   not	   due	   to	   additional	   stably	   associated	  
proteins	   but	   instead	   is	   an	   intrinsic	   property	   of	   Rph1	   alone.	   	   Given	   that	   size	   exclusion	  
chromatography	  separates	  proteins	  based	  on	  radius	  and	  not	  molecular	  weight,	  the	  aberrant	  size	  
of	  Rph1	   in	   these	  experiments	  could	  be	  due	  to	  an	  abnormally	  elongated	  Rph1	  molecule	  or	   the	  
result	  of	   a	  homogenous	  multimeric	  Rph1	   complex.	   	  Over	   four	  decades	  ago,	   Siegel	   and	  Monty	  
derived	  a	   series	  of	   formulae	   that	  combine	  biophysical	  properties	  obtained	   from	  size	  exclusion	  
chromatography	   and	   sedimentation	   analysis	   to	   accurately	   determine	   the	   native	   molecular	  
weight	  of	  proteins	  and	  protein	  complexes	  (SIEGEL	  and	  MONTY	  1966).	  	  Using	  those	  formulae,	  the	  
experimentally	  determined	  radius	  and	  sedimentation	  coefficient	  can	  be	  exploited	  to	  determine	  
whether	  a	  given	  protein	  species	  has	  an	  abnormal	  elution	  profile	  due	  to	  a	  highly	  elongated	  shape	  
or	  multimerization.	  	  The	  Stokes	  radius	  of	  rRph1	  calculated	  from	  size	  exclusion	  chromatography	  
was	   ~6.77	   nm	   (FIGURE	   2.5,	   panel	   C).	   	   To	   determine	   the	   sedimentation	   coefficient,	   rRph1	  was	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analyzed	   by	   sucrose	   gradient	   sedimentation.	   	   The	   sedimentation	   coefficient	   (S20,w)	   of	   rRph1	  
calculated	   from	   the	   sucrose	   gradient	   was	   ~12.76	   S	   (FIGURE	   2.5,	   panel	   D).	   	   By	   applying	   values	  
obtained	  from	  the	  size	  exclusion	  and	  sedimentation	  analysis	  to	  the	  Siegel	  and	  Monty	  formulas,	  
the	  derived	  native	  molecular	  mass	  of	  Rph1	  was	  calculated	  to	  be	  355.43	  kDa,	  and	  the	  frictional	  
ratio	  (f/f0)	  was	  1.45.	  	  This	  analysis	  suggests	  that	  Rph1	  is	  not	  an	  elongated	  molecule	  but	  instead	  
consists	  of	   four	  90.2	  kDa	  (theoretical	  mass)	  Rph1	  subunits.	   	   It	   is	  surprising	  that	  Rph1	  does	  not	  
form	   a	   stable	   heterogeneous	   protein	   complex	   in	   budding	   yeast	   given	   that	   many	   other	  
chromatin-­‐modifying	   enzymes	   are	   found	   in	   high-­‐molecular-­‐weight	   complexes	   that	   have	  
accessory	  proteins	   involved	   in	   targeting	   the	  enzymatic	  activity	   to	  chromatin.	   	  One	  explanation	  
for	   the	   apparent	   absence	   of	   a	   stable	   Rph1	   complex	   could	   be	   the	   intrinsic	   ability	   of	   Rph1	   to	  
directly	   bind	   DNA	   through	   its	   C-­‐terminal	   ZF	   domain	   (JANG	   et	   al.	   1999).	   	   The	   DNA	   binding	  
properties	  of	  Rph1	  may	  allow	   it	   to	   function	   independently	  of	  associated	   factors	   in	  recognizing	  
target	  sites	  in	  chromatin	  and	  permit	  more	  transient	  interactions	  with	  additional	  protein	  factors	  
while	  antagonizing	  H3K36	  methylation.	  
	  
Rph1	   demethylates	   H3K9	   despite	   the	   absence	   of	   this	   modification	   in	   budding	   yeast.	   	   In	   S.	  
cerevisiae,	   histone	   lysine	   methylation	   is	   limited	   to	   positions	   4,	   36,	   and	   79	   of	   histone	   H3.	  	  
Interestingly,	  the	  JHDM3/JMJD2	  proteins	  in	  mammals,	  which	  are	  related	  to	  Rph1,	  are	  capable	  of	  
removing	  both	  H3K36	  and	  H3K9	  methylation	  (CLOOS	  et	  al.	  2006;	  FODOR	  et	  al.	  2006;	  KLOSE	  et	  al.	  
2006b;	   WHETSTINE	   et	   al.	   2006).	   	   An	   H3K9	   methylation	   system	   is	   absent	   from	   budding	   yeast,	  
suggesting	   that	   the	  capacity	  of	   the	  mammalian	   JHDM3/JMJD2	  demethylase	  enzymes	  to	   target	  
H3K9	  methylation	  may	  have	  been	  adaptively	  acquired	  during	  the	  evolution	  of	  a	  more	  complex	  
chromatin	   modification	   system.	   	   To	   analyze	   whether	   Rph1	   specifically	   catalyzes	   H3K36	  
demethylation,	   the	   recombinant	   enzyme	  was	   incubated	  with	   histone	   substrates	   radioactively	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labeled	  on	  H3K9,	  and	  demethylase	  activity	  was	  monitored	  by	  formaldehyde	  release	  (FIGURE	  2.6,	  
panel	   A).	   	   Surprisingly,	   Rph1	   efficiently	   demethylated	   the	   H3K9-­‐modified	   substrate	   requiring	  
both	  the	  JmjN/JmjC	  domain	  but	  not	  the	  ZF	  motif	  for	  enzymatic	  activity	  (FIGURE	  2.6,	  panel	  A).	  	  To	  
verify	   the	   Rph1	   H3K9	   demethylase	   activity	   observed	   by	   formaldehyde	   release,	   Rph1	   was	  
incubated	  with	  histone	  substrates,	  and	  H3K9	  methylation	  was	  assessed	  by	  Western	  blot	  analysis	  
using	  modification-­‐specific	   antibodies	   (FIGURE	  2.6,	   panel	  B).	   	   Like	   its	  mammalian	   counterparts,	  
Rph1	   also	   targets	   the	   demethylation	   of	   H3K9me3,	   resulting	   in	   an	   accumulation	   of	   the	  
monomethyl	   state.	   	   In	   contrast	   to	   the	   mammalian	   JHDM3	   enzymes,	   Rph1	   is	   capable	   of	  
demethylating	  both	  core	  histone	  and	  oligonucleosomal	  substrates	  (FIGURE	  2.6,	  panel	  B)	  (KLOSE	  et	  
al.	   2006b).	   	   The	   capacity	   of	   Rph1	   to	   demethylate	   H3K9me3	   was	   also	   demonstrated	   by	  
incubating	  Rph1	  with	   an	  H3K9me3	  peptide	   substrate	   and	   analyzing	   the	   resulting	  modification	  
states	   by	  mass	   spectrometry	   (FIGURE	   2.6,	   panels	   C	   and	  D).	   	   Rph1	   demethylated	   the	  H3K9me3	  
substrate,	   resulting	   in	   the	   accumulation	   of	   di-­‐	   and	  monomethyl	   methyl	   peptides	   (FIGURE	   2.6,	  
panels	  C	  and	  D).	  
The	  surprising	  observation	  that	  Rph1	  demethylates	  both	  H3K9	  and	  H3K36	  methylation	  
indicates	   that	   the	   H3K9	   demethylase	   activity	   of	   mammalian	   JHDM3/JMJD2	   enzymes	   is	   not	  
simply	  a	  feature	  acquired	  through	  adaptation	  but	  is	  likely	  a	  feature	  of	  the	  ancestral	  enzyme.	  	  To	  
determine	   whether	   Rph1	   can	   remove	   H3K36	   and	   H3K9	   methylation	   in	   cellular	   chromatin	  
containing	  both	  of	  these	  modifications,	  an	  expression	  vector	  was	  generated	  to	  overexpress	  Flag-­‐
tagged	  Rph1	  in	  mammalian	  cells.	   	  Consistent	  with	  a	  role	   in	  counteracting	  histone	  methylation,	  
Rph1	  localized	  predominantly	  to	  the	  nucleus	  when	  expressed	  in	  mouse	  NIH	  3T3	  cells	  (FIGURE	  2.6,	  
panels	   E	   and	   F).	   	   In	   cells	   expressing	   Rph1,	   both	   H3K36me3	   methylation	   and	   H3K9me3	  
methylation	   were	   dramatically	   reduced,	   as	   assessed	   by	   immunofluorescence	   analysis	   using	  
modification-­‐specific	   antibodies	   (FIGURE	   2.6,	   panels	   E	   and	   F,	   top).	   	   Demethylation	   by	   Rph1	   in	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mammalian	  cells	  was	  dependent	  on	  an	  intact	  JmjC	  domain,	  as	  mutation	  in	  the	  catalytic	  domain	  
abolished	  demethylase	   activity	   (FIGURE	  2.6,	   panels	   E	   and	   F,	   bottom).	   	   This	   effect	   on	  H3K9me3	  
and	  H3K36me3	  methylation	  was	   specific,	   as	   other	   histone	  methylation	  marks	   associated	  with	  
silencing	  in	  mammals	  (including	  H3K27me3	  and	  H4K20me3)	  were	  unaffected	  (FIGURE	  2.6,	  panel	  
G).	   	   These	   observations	   strongly	   suggest	   that	   the	   bifunctional	   substrate	   specificity	   of	   the	  
mammalian	   JHDM3	   enzymes	   is	   not	   an	   acquired	   feature,	   but	   instead	   is	   inherited	   from	   the	  
ancestral	  form	  of	  the	  protein.	   	  Furthermore,	  this	  suggests	  that	  the	  budding	  yeast	  genome	  may	  
have	  encoded	  an	  H3K9	  methylation	  system	  that	  was	  lost	  at	  some	  point	  during	  evolution	  of	  the	  
current	  budding	  yeast	  chromatin	  modification	  system.	   	  The	   fact	   that	  Rph1	  has	   the	  capacity	   to	  
target	  H3K9	  methylation	  may	  represent	  a	  functional	  vestige	  of	  this	  H3K9	  modification	  system	  in	  
budding	  yeast.	  	  The	  activity	  of	  Rph1	  towards	  H3K9	  methylation	  has	  presumably	  been	  retained	  in	  
the	  absence	  of	   this	  modification	   through	  selective	  pressure	   to	  preserve	   the	  structurally	   linked	  
H3K36	  demethylase	  activity.	  
	  
Discussion	  
The	   identification	   of	   demethylase	   enzymes	   has	   revealed	   that	   histone	   methylation	   can	   be	  
dynamically	  regulated	  in	  a	  manner	  similar	  to	  that	  of	  histone	  acetylation	  and	  phosphorylation.	  	  In	  
S.	   cerevisiae,	   the	   enzymes	   that	   place	   histone	   methylation	   marks	   are	   well-­‐characterized	   and	  
coordinate	  mainly	  the	  addition	  of	  these	  modifications	  during	  the	  process	  of	  active	  transcription	  
(MILLAR	   and	   GRUNSTEIN	   2006).	   	   Previously,	   only	   one	   histone	   demethylase	   enzyme,	   Jhd1,	   was	  
identified	   in	   budding	   yeast.	   	   Jhd1	   is	   a	   JmjC-­‐domain-­‐containing	   protein	   that	   catalyzes	   the	  
demethylation	  of	  H3K36me2	  and	  H3K36me1	  modification	   states	   (TSUKADA	   et	   al.	   2006).	   	  Given	  
that	  Jhd1	  does	  not	  target	  H3K36me3	   in	  yeast,	   it	   remained	  possible	  that	  this	  methylation	  state	  
was	  irreversible.	  
44	  
Here,	  we	   identify	   Rph1	   as	   being	   a	   histone	   demethylase	  with	   activity	   towards	   histone	  
H3K36me3	  and	  H3K36me2	  modification	  states.	  	  Deletion	  of	  RPH1	  does	  not	  affect	  global	  histone	  
H3K36	  methylation	  profiles,	  and	  deletion	  strains	  are	  viable,	  displaying	  no	  obvious	  morphological	  
or	  cellular	  defects.	  	  This	  observation	  is	  not	  surprising	  given	  that	  deletion	  of	  SET2,	  the	  sole	  H3K36	  
methyltransferase	  in	  budding	  yeast,	  causes	  no	  obvious	  cellular	  defects	  and	  has	  subtle	  effects	  on	  
gene	  expression.	  	  The	  overexpression	  of	  Rph1	  leads	  to	  a	  cellular	  growth	  defect,	  but	  this	  property	  
appears	  to	  be	  independent	  of	  H3K36	  demethylase	  activity	  and	  instead	  relies	  on	  the	  C-­‐terminal	  
ZF	  DNA	  binding	  domain.	  	  It	  remains	  possible	  that	  the	  growth	  defect	  in	  Rph1-­‐overexpressing	  cells	  
is	   due	   to	   demethylase-­‐independent	   repression	   of	   growth-­‐related	   genes	   through	   the	   ZF	   DNA	  
binding	   domain.	   	   The	   overexpression	   of	   the	   Rph1	   JmjN/JmjC	   domains	   alone	   is	   sufficient	   to	  
mediate	   the	   demethylation	   of	  H3K36,	   verifying	   that	   this	   portion	   of	   the	   protein	   is	   catalytically	  
competent	   in	   vivo.	   	   In	   contrast	   to	  many	   other	   chromatin-­‐modifying	   enzymes,	   Rph1	   does	   not	  
stably	   associate	  with	   other	   proteins,	   but	   instead	   forms	   a	   homogenous	   complex	   comprised	   of	  
four	  Rph1	  subunits.	  	  Often,	  chromatin	  remodeling	  complexes	  rely	  on	  associated	  protein	  factors	  
for	  enzyme	  targeting,	  but	  the	  fact	  that	  Rph1	  has	  an	  intrinsic	  DNA	  binding	  domain	  may	  alleviate	  
the	  requirement	  for	  genomic	  targeting	  by	  auxiliary	  protein	  factors	  in	  some	  instances.	  	  Removal	  
of	  the	  ZF	  relieves	  growth	  defects	  in	  cells	  overexpressing	  Rph1,	  supporting	  the	  argument	  that	  this	  
domain	   contributes	   to	   protein	   function	   and	   perhaps	   genomic	   targeting	   in	   vivo.	   	   Additional	  
functional	   analyses	   will	   be	   required	   to	   define	   specific	   genomic	   targets	   of	   Rph1	   and	   to	  
understand	   how	   Rph1-­‐mediated	   demethylation	   contributes	   to	   transcriptional	   regulation	   by	  
Rph1.	  
The	   two	   characterized	   budding	   yeast	   histone	   demethylase	   enzymes,	   Jhd1	   and	   Rph1,	  
both	  target	  H3K36	  methylation.	   	  Two	  of	  the	  three	  remaining	  JmjC-­‐domain-­‐containing	  proteins,	  
Gis1	  and	  Ecm5,	  have	  mutations	  in	  cofactor	  binding	  residues	  that	  ablate	  demethylase	  activity	  (Y.	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Tsukada,	  K.	  E.	  Gardner,	  and	  Y.	  Zhang,	  unpublished	  data).	  	  The	  remaining	  protein,	  Yjr119C,	  is	  an	  
H3K4	   demethylase	   that	   catalyzes	   the	   removal	   of	   the	   H3K4me3	   modification	   state	   (our	  
unpublished	  data).	  	  Therefore,	  it	  appears	  that	  JmjC-­‐domain-­‐containing	  proteins	  in	  budding	  yeast	  
target	   the	   removal	   of	   H3K4	   and	   H3K36	   methylation	   but	   not	   H3K79	   methylation.	   	   H3K4	   and	  
H3K36	   methylation	   are	   placed	   by	   SET-­‐domain-­‐containing	   histone	   methyltransferases.	   	   In	  
contrast,	   H3K79	   methylation	   is	   catalyzed	   by	   Dot1,	   which	   does	   not	   have	   a	   SET	   domain.	   	   The	  
inability	   of	   JmjC-­‐domain-­‐containing	   proteins	   to	   remove	   H3K79	  methylation	   strikingly	   parallels	  
the	   fact	   that	   a	   unique	   enzyme	   is	   required	   to	   place	   this	   modification.	   	   Perhaps	   H3K79	  
methylation	   is	   also	   removed	  by	   a	  novel	   class	  of	  demethylase	  enzymes	  with	  unique	  enzymatic	  
properties.	   	   Further	   biochemical	   and	   genetic	   analyses	   of	  H3K79	  methylation	   in	   budding	   yeast	  
will	   be	   instrumental	   in	   determining	   whether	   this	   modification	   is	   dynamically	   regulated	   and	  
provide	  insight	  into	  potentially	  novel	  enzymes	  involved	  in	  metabolizing	  this	  modification.	  
The	  JmjC-­‐domain-­‐containing	  histone	  demethylase	  enzymes	  characterized	  thus	  far	  have	  
a	  very	  define	  substrate	  specificity	  towards	  the	  lysine	  modification	  site	  and	  state.	   	  The	  catalytic	  
domain	  of	  Rph1	   is	  homologous	   to	   the	  mammalian	   JHDM3/JMJD2	  enzymes,	  which	   target	  both	  
H3K36	   and	   H3K9	   demethylation.	   	   The	   capacity	   of	   mammalian	   enzymes	   to	   target	   H3K9	  
methylation,	   a	   modification	   that	   is	   absent	   from	   budding	   yeast	   chromatin,	   may	   have	   been	  
adaptively	   evolved	   in	   the	   presence	   of	   enzymes	   that	   place	   this	  modification.	   	   Surprisingly,	   the	  
characterization	   of	   Rph1	   substrate	   specificity	   revealed	   that	   Rph1	   is	   also	   capable	   of	  
demethylating	  H3K9	  in	  vitro	  as	  well	  as	  on	  mammalian	  chromatin	  in	  vivo.	  	  This	  property	  of	  Rph1	  
is	  not	   simply	  due	   to	  promiscuous	   substrate	   specificity,	   as	  Rph1	  does	  not	  affect	  other	  yeast	  or	  
mammalian	  histone	  methylation	   sites.	   	  The	  capacity	  of	  Rph1	   to	  demethylate	   this	  modification	  
suggests	  that	  an	  H3K9	  methylation	  system	  may	  have	  once	  existed	  in	  budding	  yeast.	  	  Despite	  the	  
fact	  that	  H3K9	  methylation	  is	  no	  longer	  found	  in	  budding	  yeast	  chromatin,	  the	  enzymatic	  activity	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of	  Rph1	  towards	  this	  modification	  may	  have	  been	  inadvertently	  retained	  due	  to	  its	  bifunctional	  
requirement	  as	  a	  regulator	  of	  H3K36	  methylation.	  	  Other	  components	  of	  the	  H3K9	  methylation	  
system,	   including	   the	   H3K9	   methyltransferase,	   may	   have	   been	   lost	   or	   become	   functionally	  
inactive.	  
No	   SET-­‐domain-­‐containing	   protein	   has	   been	   shown	   to	  modify	   H3K9	   in	   budding	   yeast.	  	  
The	   SET-­‐domain-­‐containing	   protein	   Set3	   is	   a	   structurally	   integral	   component	   of	   a	   high-­‐
molecular-­‐weight	   histone	   deacetylase	   complex	   (PIJNAPPEL	   et	   al.	   2001)	   that,	   much	   like	   Set2,	   is	  
targeted	  to	   the	  body	  of	  active	  genes,	  where	   it	   regulates	  chromatin	  modifications	   (WANG	  et	  al.	  
2002).	   	   Deletion	   of	   SET2	   in	   a	   strain	   lacking	   any	   component	   of	   the	   Set3	   complex	   results	   in	  
synthetic	  growth	  defects,	  suggesting	  that	  these	  factors	  contribute	  to	  similar	  processes	  (KROGAN	  
et	  al.	  2002b).	   	   It	  has	  recently	  been	  demonstrated	  that	   in	  addition	  to	  H3K36	  methylation,	  H3K9	  
methylation	  is	  targeted	  to	  the	  body	  of	  actively	  transcribed	  genes	  in	  mammalian	  cells	  (VAKOC	  et	  
al.	   2005;	   VAKOC	   et	   al.	   2006),	   and	   at	   least	   one	   mammalian	   histone	   deacetylase	   complex	   also	  
contains	  H3K9	  methyltransferase	  activity	  (SHI	  et	  al.	  2003).	  	  No	  histone	  methyltransferase	  activity	  
has	   been	   identified	   for	   the	   budding	   yeast	   Set3	   complex,	   and	   residues	  within	   the	   SET	   domain	  
that	  are	  required	  for	  methyltransferase	  activity	  are	  substituted.	  	  The	  role	  of	  this	  complex	  in	  the	  
transcribed	  regions	  of	  yeast	  genes	  raises	  the	  possibility	  that	  Set3	  may	  have	  once	  played	  a	  role	  
analogous	   to	   that	   of	   the	   methyltransferases	   that	   place	   H3K9	   methylation	   in	   the	   body	   of	  
mammalian	  genes.	   	  During	  the	  evolution	  of	  the	  yeast	  chromatin	  modification	  system,	  a	   loss	  of	  
selective	   pressure	   for	   H3K9	   methylation	   could	   have	   potentially	   allowed	   components	   of	   this	  
system	   to	   functionally	   deteriorate,	   while	   an	   intact	   H3K9	   methylation	   system	   in	   higher	  
eukaryotes	  was	  retained.	  	  Perhaps	  Set3	  remains	  as	  a	  relic	  of	  this	  modification	  system	  due	  to	  its	  
essential	   structural	   role	   in	   the	   assembly	   of	   the	   Set3	   protein	   complex	   and	   its	   role	   in	   histone	  
deacetylation.	   	   It	   will	   be	   interesting	   to	   determine	   whether	   the	   SET	   domain	   of	   Set3	   can	   be	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replaced	   with	   the	   SET	   domain	   from	   an	   active	   H3K9	   methyltransferase	   to	   recapitulate	   H3K9	  
methylation	   profiles	   in	   budding	   yeast	   that	   are	   found	   in	   the	   body	   of	   transcribed	   genes	   in	  
mammals.	   	  The	  revelation	  that	  Rph1	  can	  demethylate	  H3K9	  provides	  the	  first	  evidence	  for	  the	  
possibility	  of	  an	  extinct	  H3K9	  methylation	  system	  in	  budding	  yeast	  and	  suggests	  that	  Rph1	  may	  
represent	  a	  functional	  vestige	  of	  this	  system.	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TABLE	  2.1	  |	  Yeast	  strains	  table	  
	  
Strain	   Genotype	   Reference/Source	  
BY4741	   MATa	  his3Δ1	  leu2Δ0	  met15Δ0	  ura3Δ0	   B.	  Strahl	  
	  
rph1Δ	   MATa	  his3Δ1	  leu2Δ0	  met15Δ0	  ura3Δ0	  rph1Δ::natMX	   This	  study	  
	  
jhd1Δ	   MATa	  his3Δ1	  leu2Δ0	  met15Δ0	  ura3Δ0	  jhd1Δ::kanMX	   Open	  Biosystems	  
	  





set2Δ	   MATa	  his3Δ1	  leu2Δ0	  met15Δ0	  ura3Δ0	  set2Δ::kanMX	   B.	  Strahl	  
	  
spt4Δ	   MATa	  his3Δ1	  leu2Δ0	  met15Δ0	  ura3Δ0	  spt4Δ::kanMX	   B.	  Strahl	  
	  
rtf1Δ	   MATa	  his3Δ1	  leu2Δ0	  met15Δ0	  ura3Δ0	  rtf1Δ::kanMX	   B.	  Strahl	  
	  
snf2Δ	   MATa	  his3Δ1	  leu2Δ0	  met15Δ0	  ura3Δ0	  snf2Δ::kanMX	   B.	  Strahl	  
	  
spt7Δ	   MATa	  his3Δ1	  leu2Δ0	  met15Δ0	  ura3Δ0	  spt7Δ::kanMX	   B.	  Strahl	  
	  
htz1Δ	   MATa	  his3Δ1	  leu2Δ0	  met15Δ0	  ura3Δ0	  htz1Δ::kanMX	   B.	  Strahl	  
	  
sir2Δ	   MATa	  his3Δ1	  leu2Δ0	  met15Δ0	  ura3Δ0	  sir2Δ::kanMX	   B.	  Strahl	  
	  
GY73	   MATa	  his3Δ1	  leu2Δ0	  met15Δ0	  ura3Δ0	  RPH1-­‐3Flag::kanMX	   This	  study	  
	  
YCB647	   MATα	  his3Δ200	  leu2Δ1::TRP1	  lys2Δ202	  trp1Δ63	  ura3-­‐52	  
ADH4::TEL::URA3	  
	  
(SMITH	  et	  al.	  2000)	  
	  












TABLE	  2.2	  |Phenotype	  analysis	  of	  the	  rph1Δ 	  strain	  
	  
Phenotype	   Functional	  implication	  (HAMPSEY	  1997)	   Control	  (Reference)	  




Heat	  sensitivity	   General	  protein	  defects	  indicating	  important	  
genes	  
	  
spt4Δ	  (BASRAI	  et	  al.	  
1996)	  





rtf1Δ	  	  (DESMOUCELLES	  et	  
al.	  2002)	  
Galactose	  fermentation	   Transcriptional	  activation	  
	  
	  
snf2Δ	  	  (NEIGEBORN	  and	  
CARLSON	  1984)	  
Raffinose	  fermentation	   Transcriptional	  derepression	  
	  
	  
snf2Δ	  	  (NEIGEBORN	  and	  
CARLSON	  1984)	  
Inositol	  auxotrophy	   Inositol	  biosynthesis;	  transcriptional	  activation	  
	  
spt7Δ	  	  (PATTON-­‐VOGT	  
and	  HENRY	  1998)	  
	  
Hydroxyurea	  sensitivity	   DNA	  replication	  
	  
	  
htz1Δ	  	  (MIZUGUCHI	  et	  
al.	  2004)	  
Caffeine	  sensitivity	   Mitogen-­‐activated	  protein	  (MAP)	  kinase	  
pathway;	  chromatin	  remodeling	  
	  
htz1Δ	  	  (MIZUGUCHI	  et	  
al.	  2004)	  	  
Telomeric	  silencing	  defect	   Heterochromatin	  silencing	  
	  
	  







FIGURE	  2.1	  |	  Rph1	  is	  an	  H3K36	  demethylase	  capable	  of	  removing	  trimethyl	  lysine.	  	  (A)	  Labeled	  
histone	   substrates	   corresponding	   to	   known	   histone	   methylation	   sites	   in	   budding	   yeast	   were	  
incubated	   with	   wild-­‐type	   rRph1	   or	   rRph1	   H235A.	   	   Set7,	   Set2,	   and	   Dot1	   methyltransferase	  
enzymes	   were	   used	   to	   label	   histone	   substrates	   on	   histone	   H3	   lysine	   residues	   4,	   36,	   and	   79,	  
respectively.	   Histone	   demethylase	   activity	   was	   monitored	   by	   the	   release	   of	   labeled	  
formaldehyde.	   	   Wild-­‐type	   Rph1,	   but	   not	   the	   mutant	   Rph1	   H235A,	   specifically	   demethylates	  
H3K36-­‐labeled	   substrate.	   	   CPM,	   counts	   per	   minute.	   	   (B)	   Core	   histones	   (Core)	   and	  
oligonucleosomes	   (Oligo)	   were	   incubated	   with	   Rph1,	   and	   histone	   methylation	   levels	   were	  
analyzed	   by	  Western	   blotting	   using	  H3K36,	   H3K4,	   and	  H3K79	  methylation-­‐specific	   antibodies.	  	  
Rph1	  demethylates	  H3K36me3	  and	  H3K36me2,	  resulting	   in	  an	  accumulation	  of	  H3K36me1.	   	   (C	  
to	   E)	   H3K36me3,	   H3K36me2,	   and	   H3K36me1	   peptides	   were	   incubated	   with	   Rph1	   in	  
demethylase	  assays	  followed	  by	  mass	  spectrometry	  analysis.	  	  Rph1	  specifically	  demethylates	  the	  
H3K36me3	  and	  H3K36me2	  modification	  states.	   	   (F	  and	  G)	  Bar	  graphs	  representing	  the	   level	  of	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each	  modification	  state	   following	  Rph1-­‐mediated	  demethylation	  of	  H3K36me3	  and	  H3K36me2	  





FIGURE	   2.2	   |	   Rph1	   requires	   the	   JmjN/JmjC	   domain	   but	   not	   the	   ZF	   domain	   for	   demethylase	  
activity.	   	   (A)	   Schematic	   representation	   of	   Rph1	   indicating	   the	   three	   curated	   domains	   within	  
Rph1.	   	   The	   JmjN,	   JmjC,	   and	   ZF	   domains	  were	   individually	   deleted	  or	  mutated	   to	   examine	   the	  
domain	  requirements	  and	  to	  map	  the	  smallest	  catalytically	  active	  fragment	  of	  Rph1.	  	  WT,	  wild-­‐
type;	   aa,	   amino	   acids.	   	   (B)	   The	  mutant	   Rph1	   proteins	   displayed	   in	  A	   were	   used	   in	   a	   histone	  
demethylase	   assay	   containing	  H3K36-­‐labeled	   substrate,	   and	   histone	   demethylase	   activity	  was	  
monitored	   by	   formaldehyde	   release.	   	   The	   JmjN	   and	   JmjC	   domains	   of	   Rph1	   are	   sufficient	   for	  





FIGURE	  2.3	  |	  Deletion	  of	  RPH1	  causes	  no	  overt	  phenotype.	  	  (A)	  The	  RPH1	  gene	  was	  disrupted	  by	  
homologous	  recombination,	  and	  loss	  of	  the	  transcript	  was	  verified	  by	  RT-­‐PCR.	  	  Shown	  are	  RPH1	  
(top)	   and	   actin	   (ACT1,	   bottom)	   RT-­‐PCR	   products.	   	   (B)	   Wild-­‐type	   (WT),	   rph1Δ,	   jhd1Δ,	   rph1Δ	  
jhd1Δ,	   and	   rtf1Δ	   strains	   were	   spotted	   onto	   yeast	   extract-­‐peptone-­‐dextrose	   (YPD)	   and	   a	   YPD	  
plate	  containing	  50	  µg/mL	  mycophenolic	  acid	  (MPA)	  plates	  in	  five-­‐fold	  serial	  dilutions.	  	  Growth	  
was	  analyzed	   following	   incubation	  at	  30°C	  for	  2	  days.	   	   (C)	  Wild-­‐type	   (WT)	  sir2Δ,	  rph1Δ,	  rph1Δ	  
jhd1Δ,	   and	   jhd1Δ	   strains	   were	   spotted	   onto	   synthetic	   complete	   (SC)	   and	   SC	   containing	   50	  
mg/mL	   5-­‐fluoroorotic	   acid	   (FOA)	   plates	   in	   five-­‐fold	   serial	   dilutions.	   	   Growth	   was	   analyzed	  





FIGURE	   2.4	   |	   Rph1	   demethylates	  H3K36	   in	   vivo.	   	   (A)	   Schematic	   representation	   of	   Flag-­‐tagged	  
Rph1	   and	   Rph1	   H235A	   yeast	   overexpression	   constructs.	   	   (B)	   Western	   blot	   analysis	   of	   yeast	  
whole	   cell	   extract	   (WCE)	   expressing	   Flag-­‐Rph1	   proteins.	   	   The	   asterisk	   (*)	   denotes	   a	   cross-­‐
reactive	  and	  in	  the	  yeast	  WCE,	  and	  the	  arrows	  indicate	  overexpressed	  Rph1	  proteins.	  	  (C)	  Yeast	  
strains	   overexpressing	   Rph1	   and	   Rph1	   H235A	   constructs	   displayed	   in	   A	   were	   analyzed	   for	  
growth	   (right).	   	   The	   left	  panel	   indicates	   the	   identity	  of	  each	  strain.	   	   Full-­‐length	  Rph1	  causes	  a	  
severe	  defect	  in	  growth	  that	  is	  not	  alleviated	  by	  mutation	  of	  the	  catalytic	  domain.	  	  Deletion	  of	  
the	  ZF	  domain	  rescues	  the	  growth	  defect,	  but	  in	  all	  cases,	  mutation	  of	  the	  catalytic	  domain	  has	  
no	  effect	  on	   cell	   growth.	   	   (D)	  H3K36	  methylation	   levels	  were	   analyzed	   in	   cells	   overexpressing	  
Rph1	    ΔZF	   and	   Rph1	   JmjN/JmjC	   proteins	   (schematic	   representation	   on	   the	   left)	   using	   H3K36	  
modification-­‐specific	   antibodies	   (arrow	   indicates	   that	   H3K36	  modification-­‐specific	   band).	   	   The	  
overexpression	  of	  both	  proteins	  causes	  a	  reduction	  in	  the	  level	  of	  H3K36me3	  and	  an	  increase	  in	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the	  levels	  of	  H3K36me2	  and	  H3K36me1.	  	  Mutation	  of	  the	  catalytic	  domain	  abolishes	  this	  effect,	  
verifying	   that	   demethylation	   was	   a	   direct	   consequence	   of	   Rph1	   catalytic	   function.	   	   The	  
specificity	   of	   the	  H3K36	   signal	  was	   verified	  by	  Western	  blot	   analysis	   using	   a	   set2Δ	   strain	   that	  





FIGURE	   2.5	   |	   Rph1	   is	   not	   stably	   associated	   with	   other	   proteins	   in	   yeast	   extracts.	   	   (A)	  
Endogenous	  Rph1	  was	  Flag-­‐tagged,	  and	  the	  wild-­‐type	  (WT)	  and	  Flag-­‐tagged	  Rph1	  strains	  were	  
analyzed	  by	  Western	  blot	  analysis	  using	  a	  Flag-­‐specific	  antibody.	  	  A	  signal	  corresponding	  to	  Flag-­‐
Rph1	   was	   evident	   only	   in	   the	   tagged	   strain.	   	   The	   asterisk	   (*)	   indicates	   a	   cross-­‐reactive	   band	  
observed	  in	  budding	  yeast	  whole	  cell	  extract	  (WCE).	  	  (B)	  Flag-­‐Rph1	  yeast	  WCE	  was	  fractionated	  
by	   size	   exclusion	   chromatography,	   and	   the	   Rph1-­‐containing	   fractions	   were	   identified	   by	  
Western	  blotting	  using	  a	  Flag-­‐antibody.	  	  The	  asterisk	  (*)	  indicates	  a	  cross-­‐reacting	  band	  found	  in	  
yeast	  WCE.	   	   Size	   exclusion	   chromatography	  molecular	  mass	  markers	   are	   indicated	   above	   the	  
panel.	  	  Rph1	  elutes	  from	  the	  size	  exclusion	  column	  with	  an	  apparent	  molecular	  mass	  of	  greater	  
than	  440	   kDa.	   	   (C)	   Recombinant	  Rph1	   (rRph1)	  was	   fractionated	  using	   the	   same	   size	   exclusion	  
chromatography	  conditions	  as	  those	  employed	  for	  the	  Flag-­‐Rph1	  WCE,	  and	  the	  Rph1-­‐containing	  
fractions	  were	  identified	  by	  Coomassie	  staining.	  	  Size	  exclusion	  chromatography	  molecular	  mass	  
markers	  are	  indicated	  above	  the	  panel,	  and	  the	  calculated	  radius	  of	  Rph1	  is	  given	  above	  in	  nm.	  	  
rRph1	   elutes	   from	   the	   size	   exclusion	   column	   at	   the	   same	   position	   as	   endogenous	   Rph1.	   	   (D)	  
rRph1	  was	  fractionated	  over	  a	  5-­‐20%	  sucrose	  gradient,	  and	  the	  Rph1-­‐containing	  fractions	  were	  
identified	  by	  Coomassie	  staining.	  	  Molecular	  mass	  standards	  are	  indicated	  above	  the	  panel,	  and	  





FIGURE	  2.6	  |	  Rph1	  removes	  H3K9	  methylation	  both	  in	  vitro	  and	  in	  vivo.	  	  (A)	  Histone	  substrates	  
were	  radioactively	  labeled	  on	  H3K36	  and	  H3K9	  and	  incubated	  with	  the	  Rph1	  proteins	  detailed	  in	  
Figure	   2.2	   (panel	   A).	   	   Demethylase	   activity	   was	   monitored	   by	   the	   release	   of	   radioactive	  
formaldehyde.	   	   Rph1	   efficiently	   demethylates	   both	   H3K36	   and	   H3K9	   substrates	   requiring	   an	  
intact	   JmjN/JmjC	   domain	   for	   enzymatic	   activity.	   	   CPM,	   counts	   per	  minute.	   	   (B)	   Core	   histones	  
(Core)	  and	  oligonucleosomes	  (Oligo)	  were	  incubated	  with	  Rph1,	  and	  histone	  methylation	  levels	  
were	   analyzed	   by	   Western	   blotting	   with	   H3K9	   modification-­‐specific	   antibodies.	   	   Rph1	  
demethylates	  H3K9me3,	   resulting	   in	   an	   accumulation	   of	   H3K9me1.	   	   (C)	   An	  H3K9me3	   peptide	  
was	   incubated	   with	   Rph1,	   and	   the	   resulting	   modification	   state	   was	   analyzed	   by	   mass	  
spectrometry.	   	  Rph1	  can	  demethylate	  H3K9me3,	   leading	   to	  an	  accumulation	  of	  H3K9me2	  and	  
H3K9me1	  modification	  states.	  	  (D)	  Bar	  graph	  representing	  the	  percentage	  of	  each	  modification	  
58	  
state	  after	  Rph1-­‐mediated	  demethylation	  of	  the	  H3K9me3	  peptide.	  	  (E	  and	  F)	  Flag-­‐tagged	  Rph1	  
and	  Rph1	  H235A	  were	  expressed	  in	  NIH	  3T3	  cells,	  and	  the	  levels	  of	  H3K36me3	  (E)	  and	  H3K9me3	  
(F)	   were	   analyzed	   by	   indirect	   immunofluorescence	   using	   histone	   methylation-­‐specific	  
antibodies.	  	  Rph1	  localizes	  to	  the	  nucleus	  and	  demethylates	  both	  H3K36me3	  and	  H3K9me3	  (top	  
panels).	   	   Demethylase	   activity	   requires	   an	   intact	   JmjC	   domain,	   as	   a	  mutation	   of	   the	   catalytic	  
domain	  abrogated	   this	  effect	   (bottom	  panels).	   	   (G)	  Expression	  of	  Flag-­‐tagged	  Rph1	   in	  NIH	  3T3	  
cells	   does	   not	   cause	   demethylation	   of	   other	   repressive	   histone	  methylation	  marks,	   including	  
H3K27me3	   (top)	   or	   H4K20	   (bottom),	   as	   assessed	   by	   indirect	   immunofluorescence	   with	  
methylation-­‐specific	  antibodies.	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Recent	  technological	  advancements	  have	  allowed	  for	  highly-­‐sophisticated	  mass	  spectrometry-­‐
based	   studies	   of	   the	   histone	   code,	   which	   predicts	   that	   combinations	   of	   post-­‐translational	  
modifications	   (PTMs)	  on	  histone	  proteins	   result	   in	  defined	  biological	  outcomes	  mediated	  by	  
effector	  proteins	  that	  recognize	  such	  marks.	  	  While	  significant	  progress	  has	  been	  made	  in	  the	  
identification	  and	   characterization	  of	   histone	  PTMs,	   a	   full	   appreciation	  of	   the	   complexity	  of	  
the	  histone	  code	  will	  require	  a	  complete	  understanding	  of	  all	  the	  modifications	  that	  putatively	  
contribute	  to	  it.	  	  Here,	  using	  the	  top-­‐down	  mass	  spectrometry	  approach	  for	  identifying	  PTMs	  
on	  full-­‐length	  histones,	  we	  report	  that	  lysine	  37	  of	  histone	  H2B	  is	  dimethylated	  in	  the	  budding	  
yeast	   Saccharomyces	   cerevisiae.	   	   By	   generating	   a	   modification-­‐specific	   antibody	   and	   yeast	  
strains	   that	  harbor	  mutations	   in	   the	  putative	   site	  of	  methylation,	  we	  provide	  evidence	   that	  
this	   mark	   exist	   in	   vivo.	   	   Importantly,	   we	   show	   that	   this	   lysine	   residue	   is	   highly	   conserved	  
through	   evolution,	   and	   provide	   evidence	   that	   this	   methylation	   event	   also	   occurs	   in	   higher	  
eukaryotes.	  	  By	  identifying	  a	  novel	  site	  of	  histone	  methylation,	  this	  study	  adds	  to	  our	  overall	  




In	  eukaryotic	  cells,	  DNA	  is	  packaged	  in	  the	  form	  of	  chromatin.	  	  Approximately	  147	  base	  pairs	  of	  
DNA	  wrap	  around	  an	  octomer	   composed	  of	   two	  H2A-­‐H2B	  dimers	  and	  one	  H3-­‐H4	   tetramer	   to	  
form	   nucleosomes,	   the	   fundamental	   repeating	   unit	   of	   chromatin	   (KORNBERG	   and	   LORCH	   1999;	  
LUGER	   et	   al.	   1997).	   	   Because	   nucleosomes	   are	   organized	   into	   progressively	   higher-­‐ordered	  
structures,	   significant	   chromatin	   remodeling	   is	   necessary	   for	   the	   numerous	   DNA-­‐templated	  
processes	   that	  must	  occur	   for	  normal	   cellular	   function,	   such	  as	   transcription,	  DNA	  replication,	  
DNA	  repair,	  and	  chromosome	  segregation.	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One	  means	  by	  which	  alterations	  to	  chromatin	  structure	  is	  accomplished	  is	  through	  post-­‐
translational	   modifications	   (PTMs)	   of	   the	   histone	   proteins.	   	   The	   core	   histones	   are	   largely	  
globular,	  with	  the	  exception	  of	  unstructured	  N-­‐terminal	  tails	  that	  protrude	  from	  the	  surface	  of	  
the	  core	  particle.	  	  Although	  numerous	  PTMs	  have	  been	  shown	  to	  occur	  on	  residues	  located	  on	  
the	  histone	  tails	  (KOUZARIDES	  2007),	   it	   is	  becoming	  increasingly	  evident	  that	  residues	  within	  the	  
globular	   domain	   are	   also	   subject	   to	   modifications	   (CAMPOS	   and	   REINBERG	   2009;	   FREITAS	   et	   al.	  
2004;	   MERSFELDER	   and	   PARTHUN	   2006).	   	   The	   type	   of	   PTMs	   demonstrated	   to	   occur	   on	   histone	  
proteins	   include	   acetylation,	   methylation,	   phosphorylation,	   ubiquitylation,	   sumoylation,	   ADP	  
ribosylation,	  proline	   isomerization,	  citrullination,	  butyrylation,	  propionylation	  and	  glycosylation	  
(CHEN	   et	   al.	   2007;	   KOUZARIDES	   2007;	   SAKABE	   et	   al.	   2010).	   	  While	   the	   functional	   significance	   of	  
some	  of	  the	  aforementioned	  modifications	  remains	  to	  be	  elucidated,	   it	   is	  well	  established	  that	  
some	  of	  the	  histone	  PTMs	  function	  by	  at	  least	  one	  of	  the	  following	  mechanisms:	  (1)	  disruption	  
of	   nucleosomal	   contacts	   between	   histones	   and	   their	   associated	   DNA	   or	   between	   histones	   in	  
contiguous	  nucleosomes,	  or	  (2)	  recruitment	  of	  non-­‐histone	  proteins	  (CAMPOS	  and	  REINBERG	  2009;	  
KOUZARIDES	  2007).	  	  Acetylation	  of	  lysine	  residues	  is	  the	  best-­‐characterized	  modification	  shown	  to	  
affect	   higher-­‐order	   chromatin	   structure,	   where	   this	   mark	   neutralizes	   the	   basic	   charge	   of	   the	  
residue	   on	  which	   it	   occurs,	   thereby	   inhibiting	   histone-­‐histone	   or	   histone-­‐DNA	   interaction	   and	  
thus	   chromatin	   compaction	   (HONG	   et	   al.	   1993;	   SHOGREN-­‐KNAAK	   et	   al.	   2006;	  WOLFFE	   and	   HAYES	  
1999).	  	  With	  regard	  to	  the	  other	  means	  by	  which	  histone	  PTMs	  can	  function,	  the	  recruitment	  of	  
non-­‐histone	  proteins	  is	  facilitated	  by	  the	  ability	  of	  specialized	  domains	  to	  recognize	  and	  bind	  to	  
defined	  marks	  (TAVERNA	  et	  al.	  2007a).	   	  For	  example,	  methylation	  of	  specific	  lysine	  residues	  in	  a	  
defined	   state	   (mono-­‐,	   di-­‐,	   or	   trimethyl)	   can	   serve	   as	   a	   binding	   platform	   for	   effector	   proteins	  
containing	   one	   of	   the	   following	   types	   of	   methyl-­‐binding	   domains:	   chromodomain,	   tudor	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domain,	   PHD	   finger,	   MBT,	   Ankyrin	   repeat,	   PWWP	   domain	   and	   WD40	   repeats	   (COLLINS	   et	   al.	  
2008;	  TAVERNA	  et	  al.	  2007a;	  VEZZOLI	  et	  al.	  2010).	  
The	  complexity	  of	  the	  number	  and	  diverse	  types	  of	  PTMs	  has	  led	  to	  the	  hypothesis	  of	  a	  
“histone	  code”	  (JENUWEIN	  and	  ALLIS	  2001;	  STRAHL	  and	  ALLIS	  2000),	  which	  posits	  that	  combinatorial	  
patterns	  of	  histone	  PTMs	  lead	  to	  defined	  biological	  outcomes	  brought	  about	  by	  the	  recruitment	  
of	  effector	  proteins	  necessary	  for	  function	  in	  DNA-­‐templated	  processes.	  	  For	  example,	  TAF1	  (the	  
largest	   subunit	   of	   the	   TFIID	   complex	   which	   is	   involved	   in	   initiating	   the	   assembly	   of	  
transcriptional	  machinery)	  contains	  a	  double	  bromodomain	  that	  preferentially	  binds	  to	  multiply	  
acetylated	   histone	   H4	   (JACOBSON	   et	   al.	   2000),	   and	   itself	   can	   function	   as	   a	   histone	  
acetyltransferase	   (MIZZEN	   et	   al.	   1996).	   	   There	   are	   numerous	   other	   examples	   of	   how	   defined	  
combinations	   of	   histone	   modifications	   positively	   or	   negatively	   affect	   recruitment	   of	   specific	  
proteins	  (AGALIOTI	  et	  al.	  2002;	  FISCHLE	  et	  al.	  2005;	  SHI	  et	  al.	  2006;	  TAVERNA	  et	  al.	  2006;	  WYSOCKA	  et	  
al.	  2006;	  ZIPPO	  et	  al.	  2009).	   	  Despite	  the	   identification	  of	  numerous	  histone	  PTMs	  to	  date,	   it	   is	  
likely	   that	   other	   modifications	   still	   await	   discovery.	   	   Thus,	   of	   immediate	   importance	   in	  
deciphering	   the	   histone	   code	   is	   the	   need	   for	   identifying	   all	   the	   PTMs	   that	   are	   present	   on	  
histones,	  so	  that	  subsequent	  studies	  can	  be	  completed	  to	  determine	  the	  combinatorial	  patterns	  
in	  which	  such	  modifications	  exist	  on	  physiological	  substrates	  and	  what	  the	  functional	  outcomes	  
of	  such	  combinations	  are.	  
In	  recent	  history,	  mass	  spectrometry	  (MS)	  has	  widely	  been	  used	  as	  the	  primary	  method	  
to	   identify	   histone	   PTMs.	   	  MS	   studies	   have	   commonly	   employed	   the	   bottom-­‐up	   approach,	   in	  
which	   short	   peptides	   derived	   from	   proteolytic	   cleavage	   of	   reverse-­‐phase	   HPLC	   (RP-­‐HPLC)-­‐
purified	  histones	  are	  analyzed	  by	  MS	  with	  peptide	  mass	  fingerprinting	  (PMF)	  or	  a	  combination	  
of	   liquid	   chromatography	   (LC)	   and	   tandem	   MS	   (MS/MS)	   using	   electron	   transfer	   or	   collision-­‐
induced	   dissociation	   methods	   (ETD	   and	   CID,	   respectively)	   (GARCIA	   et	   al.	   2007d).	   	   While	   this	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technique	  is	  a	  highly	  effective	  means	  by	  which	  to	  determine	  the	  molecular	  mass	  (by	  MS-­‐PMF)	  or	  
the	  sequence	  of	  a	  protein	  (by	  LC-­‐MS/MS),	  it	  is	  limited	  in	  that	  incomplete	  sequence	  coverage	  of	  
the	   protein	   of	   interest	   often	   occurs,	   and	   proteins	   with	   multiple	   cleavage	   sites	   (including	   the	  
histone	  core	  proteins,	  which	  are	  rich	  in	  lysine	  and	  arginine	  residues)	  result	  in	  peptide	  segments	  
that	  are	   too	  small	   for	  effective	   retention	  and/or	  detection	   (BORCHERS	   et	  al.	   2006;	  GARCIA	   et	  al.	  
2007b;	   HAN	   and	   BORCHERS	   2010;	   PESAVENTO	   et	   al.	   2008;	   ZHANG	   et	   al.	   2002).	   	   More	   recently,	  
advances	   in	  MS	  have	   led	   to	   the	  development	  of	   the	   top-­‐down	  approach	  as	   a	   complementary	  
method	  to	  bottom-­‐up	  analysis	  as	  a	  highly	  useful	  means	  by	  which	  to	   identify	  PTMs	  on	  histones	  
(BOYNE	  et	  al.	  2006;	  KELLEHER	  2004;	  PESAVENTO	  et	  al.	  2004;	  SIUTI	  et	  al.	  2006;	  TAVERNA	  et	  al.	  2007b;	  
THOMAS	  et	  al.	  2006;	  ZUBAREV	  et	  al.	  1998).	  	  Full-­‐length	  proteins	  are	  analyzed	  with	  top-­‐down	  MS,	  as	  
samples	   are	   infused	   into	   the	  mass	   spectrometer	   by	   electrospray	   ionization	   (ESI),	   allowing	   for	  
MS/MS	  fragmentation	  via	  ETD	  or	  electron	  capture	  dissociation	  (ECD)	  of	   intact	  proteins	  (GARCIA	  
et	   al.	   2007c).	   	   A	   major	   advantage	   of	   top-­‐down	   MS	   is	   that	   combinatorial	   patterns	   of	  
modifications	  that	  exist	  on	  a	  single	  histone	  molecule	  can	  be	  identified	  (UEBERHEIDE	  and	  MOLLAH	  
2007),	   which	   is	   particularly	   valuable	   in	   outlining	   the	   global	   landscape	   of	   PTMs	   on	   histone	  
proteins.	  
In	  this	  study,	  we	  sought	  to	  use	  top-­‐down	  MS	  to	  analyze	  the	  global	  landscape	  of	  PTMs	  on	  
histone	  H2B.	  	  From	  this	  analysis,	  we	  identified	  lysine	  37	  of	  histone	  H2B	  (H2BK37)	  as	  a	  novel	  site	  
of	  methylation	  in	  the	  budding	  yeast	  Saccharomyces	  cerevisiae,	  and	  that	  this	  modification	  exists	  
in	   the	   dimethyl	   state.	   	   We	   generated	   an	   antibody	   specific	   for	   dimethylated	   H2BK37	  
(H2BK37me2),	  with	  which	  we	  were	   able	   to	   confirm	   that	   this	  mark	   does	   in	   fact	   occur	   in	   vivo.	  	  
Though	   our	   candidate	   approach	   to	   identify	   the	  methyltransferase	   responsible	   for	   placing	   this	  
mark	  and	  phenotypic	  analysis	  to	  reveal	  a	  biological	  function	  did	  not	  offer	  conclusive	  results,	  we	  
provide	   evidence	   that	   this	   modification	   is	   evolutionarily	   conserved	   supporting	   its	   overall	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importance	   as	   a	   novel	   histone	   modification.	   	   Furthermore,	   these	   results	   demonstrate	   that	  
despite	   the	   numerous	   rounds	   of	   previous	   MS	   analysis,	   additional	   series	   of	   MS	   analyses	  
employing	   recent	   technological	   advancements	   are	   necessary	   for	   continued	   identification	   of	  
novel	   sites	   of	  modifications	   to	   generate	   a	  more	   complete	   atlas	   of	   the	   factors	   that	   putatively	  
function	  in	  the	  context	  of	  the	  histone	  code.	  
	  
Materials	  and	  Methods	  
Yeast	  strains	  and	  DNA	  constructs.	  	  A	  list	  of	  yeast	  strains	  used	  for	  these	  studies	  can	  be	  found	  in	  
TABLE	  3.1.	  	  Plasmids	  harboring	  wild-­‐type	  or	  mutant	  histone	  H2B	  were	  introduced	  into	  yeast	  H2A-­‐
H2B	  shuffle	  strains	  using	  standard	  transformation	  (GIETZ	  and	  SCHIESTL	  2007b)	  and	  shuffling	  (BOEKE	  
et	  al.	  1987)	  protocols.	  
	   The	  plasmids	  pZS145	   (HTA1-­‐Flag-­‐HTB1	  CEN	  HIS3)	  and	  pZS146	   (HTA1-­‐Flag-­‐htb1	   (K123R)	  
CEN	  HIS3)	  were	  isolated	  from	  the	  strains	  YZS276	  and	  YZS277,	  respectively,	  obtained	  from	  Z.W.	  
Sun	   (SUN	   and	   ALLIS	   2002).	   	   The	   plasmids	   pKG1	   (HTA1-­‐Flag-­‐htb1	   (K37R)	   CEN	   HIS3)	   and	   pKG2	  
(HTA1-­‐Flag-­‐htb1	  (K37A)	  CEN	  HIS3)	  were	  derived	  from	  site-­‐directed	  mutagenesis	  of	  pZS145	  (SUN	  
and	   ALLIS	   2002)	   using	   the	   QuikChange	   II	   Site-­‐Directed	   Mutagenesis	   kit	   (Stratagene).	   	   The	  
accuracy	  of	  all	  constructs	  was	  verified	  by	  DNA	  sequencing.	  
	  
Histone	   acid	   extraction.	   	   Histones	   were	   extracted	   from	   yeast	   nuclei	   using	   a	   standard	   acid	  
extraction	  method	  (EDMONDSON	  et	  al.	  1996).	  	  Briefly,	  250	  mL	  cultures	  were	  grown	  at	  30˚C	  to	  an	  
OD600	   approximately	   equal	   to	   1.5.	   	   Cells	   were	   collected	   by	   centrifugation	   at	   2700	   x	   g	   for	   5	  
minutes,	   washed	   once	   with	   sterile	   water,	   and	   collected	   again	   by	   centrifugation.	   	   Cells	   were	  
resuspended	  in	  7.5	  mL	  Solution	  1	  [0.1	  mM	  Tris-­‐Cl	  (pH	  9.4),	  10	  mM	  DTT],	  and	  then	  incubated	  at	  
30°C	  for	  15	  minutes	  with	  shaking	  at	  100	  rpm.	  	  Cells	  were	  collected	  by	  centrifugation	  at	  2700	  x	  g	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for	   5	  minutes,	   washed	   in	   15	  mL	   Solution	   2	   [1.2	  M	   sorbitol,	   20	  mM	  HEPES-­‐OH	   (pH	   7.4)],	   and	  
pelleted	  again.	  	  Cells	  were	  resuspended	  in	  15	  mL	  Solution	  2	  containing	  Zymolyase	  20T	  at	  a	  final	  
concentration	   of	   0.2	  mg/mL,	   and	  were	   then	   incubated	   at	   30°C	  with	   shaking	   at	   100	   rpm	  until	  
spheroplasting	  was	  greater	  than	  90%	  (as	  determined	  by	  measuring	  the	  OD600	  of	  10	  μL	  sample	  in	  
1	  mL	  1%	  SDS;	  typically	  45-­‐50	  minutes),	  at	  which	  point	  15	  mL	  ice-­‐cold	  Solution	  3	  [1.2	  M	  sorbitol,	  
20	  mM	  PIPES-­‐OH	  (pH	  6.8),	  1	  mM	  MgCl2]	  was	  added.	  	  Cells	  were	  pelleted	  again	  at	  1300	  x	  g	  for	  5	  
minutes	  4°C.	  	  Pellets	  were	  resuspended	  in	  7.5	  mL	  ice-­‐cold	  Solution	  4	  [250	  mM	  sucrose,	  60	  mM	  
KCl,	  14	  mM	  NaCl,	  5	  mM	  MgCl2,	  1	  mM	  CaCl2,	  15	  mM	  MES	  (pH	  6.6),	  1	  mM	  PMSF,	  0.8%	  TritonX-­‐
100],	   incubated	   on	   ice	   for	   20	   minutes,	   and	   spun	   at	   1700	   x	   g	   for	   5	   minutes	   at	   4°C.	   	   Nuclei	  
isolation	  in	  Solution	  4	  was	  carried	  out	  a	  total	  of	  three	  times.	  	  Nuclei	  were	  washed	  three	  times	  in	  
12.5	  mL	  Wash	  1	  [10	  mM	  Tris-­‐Cl	  (pH	  8.0),	  0.5%	  NP-­‐40,	  75	  mM	  NaCl,	  1	  mM	  PMSF]	  for	  15	  minutes	  
on	  ice	  for	  the	  first	  two	  washes,	  and	  5	  minutes	  on	  ice	  for	  the	  third	  wash,	  followed	  by	  two	  washes	  
in	  12.5	  mL	  Wash	  2	  [10	  mM	  Tris-­‐Cl	  (pH	  8.0),	  400	  mM	  NaCl,	  1	  mM	  PMSF]	  for	  10	  minutes	  on	  ice	  for	  
the	  first	  wash,	  and	  centrifuged	  immediately	  following	  the	  second	  resuspension.	  	  Histones	  were	  
extracted	  in	  1.5	  mL	  0.4	  N	  H2SO4	  with	  incubation	  on	  ice	  for	  30	  minutes,	  with	  occasional	  vortexing.	  	  
Debris	  was	  pelleted	  by	   centrifugation	  at	  10,000	  x	  g.	   	  Histone	  proteins	  were	  precipitated	   from	  
the	  supernatant	  by	  addition	  of	  100%	  TCA	  to	  a	  final	  concentration	  of	  20%	  with	  incubation	  on	  ice	  
for	  30	  minutes.	   	  Histone	  proteins	  were	  pelleted	  at	  15,000	  x	  g.	   	  Pellets	  were	  washed	  once	  with	  
acetone	  containing	  1%	  HCl,	  and	  once	  with	  acetone.	  	  After	  being	  air-­‐dried,	  histone	  proteins	  were	  
resuspended	  in	  300	  μL	  10	  mM	  Tris-­‐Cl	  (pH	  8.0).	  
	  
Reverse-­‐phase	   HPLC	   purification	   of	   histone	   proteins.	   	   Following	   sulfuric	   acid	   extraction,	  
histones	   derived	   from	   the	   strain	   YMP001	   were	   subject	   to	   RP-­‐HPLC	   isolation.	   	   Gradient	  
conditions	  used	  for	  histone	  isolation	  were	  adapted	  from	  conditions	  previously	  described	  (STRAHL	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et	   al.	   1999).	   	   Briefly,	   proteins	   from	   sulfuric	   acid	   extracts	   were	   injected	   onto	   a	   Zorbex	   C-­‐18	  
column	  with	  a	  pore	   size	  of	   3.5	  µm	  using	  an	  Agilent	  1100	   series	  RP-­‐HPLC	   (Agilent,	   Santa	  Clara	  
CA).	   	   The	   column	   was	   washed	   and	   prepared	   using	   the	   following	  method:	   5-­‐35%	   Acetonitrile	  
(CH3CN)	  with	  0.1%	  Trifluoroacetic	  acid	  (TFA)	  for	  5	  minutes	  followed	  by	  35%	  CH3CN/0.1%	  TFA	  for	  
10	  minutes.	   	  Histones	  were	   separated	  using	   the	   following	   gradient:	   35%-­‐60%	  CH3CN/0.1%TFA	  
for	  30	  minutes	  (WATERBORG	  2000).	  Protein	  elution	  was	  monitored	  by	  UV	  absorption	  at	  220	  nm.	  	  
Fractions	   containing	   histone	   H2B	   were	   determined	   by	  Western	   blot	   analysis	   using	   an	  α-­‐H2B	  
antibody	  (Active	  Motif,	  Cat.	  No.	  39237).	  
	  
µESI-­‐FTICR-­‐MS	  analysis	  	  
MS	   Conditions.	   	   Acquisition	   of	   MS	   spectra	   was	   performed	   using	   a	   hybrid	   Qe-­‐Fourier	  
Transform	   Ion	  Cyclotron	  Resonance	   -­‐	  Mass	   Spectrometer,	   equipped	  with	  a	  12.0	  Tesla	   actively	  
shielded	  magnet	   (Apex	  Qe-­‐FTICR-­‐MS,	   12.0	   T	   AS,	   Bruker	  Daltonics,	   Billerica,	  MA,	  USA),	   and	   an	  
Apollo	   II	   microelectrospray	   (µESI)	   source.	   	   The	   voltages	   on	   µESI	   spray	   capillary,	   spray	   shield,	  
capillary	  exit,	  deflector,	   ion	   funnel	  and	  skimmer	  were	  set	  at	  +4.2	  kV,	  +3.6	  kV,	  +340	  V,	  +310	  V,	  
+185	  V	  and	  +25	  V,	  respectively.	  	  The	  temperature	  of	  the	  µESI	  source	  was	  maintained	  at	  120˚C.	  	  
Desolvation	  was	  carried	  out	  using	  a	  nebulization	  gas	  flow	  (2.0	  bar)	  and	  a	  countercurrent	  drying	  
gas	   flow	   (4.0	   L/s).	   	   Histone	  H2B	   samples	  were	   prepared	   by	   resuspending	   lyophilized	   RP-­‐HPLC	  
fractions	  containing	  H2B	  in	  a	  mixture	  of	  acetonitrile/water/acetic	  acid	  (49.0:49.0:2.0	  v/v/v)	  at	  a	  
concentration	   of	   0.1-­‐0.2	   µg/µL,	   directly	   infused	   with	   a	   syringe	   pump	   (Harvard	   Apparatus,	  
Holliston,	  MA,	  USA)	  and	  a	  100-­‐µL	  syringe	  (Hamilton,	  Reno,	  NV,	  USA),	  and	  electrosprayed	  at	  an	  
infusion	   flow	   rate	   of	   90	   µL/hr.	   	   Before	   transfer,	   ion	   packets	   were	   accumulated	   inside	   the	  
collision	  cell	  for	  a	  duration	  of	  0.5-­‐1.0	  seconds.	  100	  MS	  scans	  per	  spectrum	  were	  acquired	  in	  the	  
ICR	  cell	  with	  a	  resolution	  of	  580,000	  at	  m/z	  400	  Da.	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MS/MS	  Conditions.	  	  FTICR-­‐ECD	  MS/MS	  method	  was	  employed	  to	  fragment	  histone	  H2B.	  	  
Precursor	   ions	   were	   isolated	   with	   a	   quadrupole	   (Q1)	   and	   subjected	   to	   ICR	   cell	   directly.	   	   The	  
isolation	  window	  width	  was	  2.0	  Da.	  	  Low	  energy	  electrons	  were	  generated	  by	  the	  heated	  hollow	  
dispenser	   cathode	   with	   a	   bias	   voltage	   of	   -­‐2.5	   V.	   	   ECD	   lens	   voltage	   was	   set	   at	   +15.0	   V.	   	   The	  
electrons,	  produced	  by	  the	  hollow	  dispenser	  cathode	  (operated	  at	  1.7	  A),	  were	  pulsed	  into	  the	  
ICR	   cell	   with	   a	   length	   of	   3.0	   ms,	   which	   led	   to	   fragmentation	   of	   the	   ions	   that	   were	   already	  
trapped	  in	  the	  ICR	  cell.	  	  To	  maximize	  the	  ion	  population	  before	  irradiation,	  the	  ICR	  cell	  was	  filled	  
with	   1-­‐5	   iterations	  of	   ion	   accumulation	   from	   the	   external	   collision	   cell	   (BORCHERS	   et	   al.	   2006).	  	  
100	  MS/MS	  scans	  per	  spectrum	  were	  acquired	  with	  a	  resolution	  of	  580,000	  at	  m/z	  400	  Da.	  
	  
α -­‐H2BK37me2	   antibody	   production	   and	   antibody	   affinity	   purification.	   	   A	   synthetic	   peptide	  
containing	  H2B	  sequence	  from	  33	  to	  41,	  in	  which	  lysine	  37	  was	  dimethylated,	  was	  conjugated	  to	  
keyhole	  limpet	  hemocyanin	  via	  a	  C-­‐terminal	  cysteine	  in	  the	  peptide	  and	  was	  used	  to	  immunize	  
rabbits	   (Pocono	   Rabbit	   Farm	   and	   Laboratory	   Inc.).	   	   The	  α-­‐H2BK37me2	   antibody	   was	   affinity	  
purified	   from	  serum.	   	  Briefly,	  equilibrated	  Affigel-­‐10	   (BIORAD)	  was	   incubated	  with	  the	  peptide	  
SKARKme2ETYS-­‐C	  (where	  me2	  is	  dimethyl	   lysine)	  in	  PBS	  for	  2	  hr	  at	  4˚C.	   	  Unbound	  peptide	  was	  
removed,	  and	  the	  peptide-­‐bound	  resin	  was	  blocked	  with	  0.2	  M	  ethanolamine	  (pH	  8.0)	  for	  2	  hr	  at	  
4˚C.	  	  After	  washing	  with	  1	  M	  NaCl	  and	  PBS,	  the	  blocked	  peptide-­‐bound	  resin	  was	  incubated	  with	  
serum	   for	   3	   hr	   at	   room	   temperature	  with	   rotation.	   	   The	   flow-­‐through	  was	   collected,	   and	   the	  
resin	  was	  washed	  with	  0.5	  M	  NaCl	  followed	  by	  PBS.	  	  Antibody	  was	  eluted	  with	  0.1	  M	  glycine	  (pH	  
3.0)	   at	   one-­‐half	   column	   volume/fraction,	   and	   1/10	   (v/v)	   1	   M	   Tris-­‐Cl	   (pH	   8.0)	   was	   added	   to	  
neutralize	  the	  pH.	   	  Purity	  of	  antibody	  fractions	  were	  analyzed	  on	  12%	  SDS-­‐polyacrylamide	  gels	  
followed	  by	  Coomassie-­‐staining,	  allowing	  for	  pooling	  of	  peak	  antibody	  fractions.	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IgG	  was	  purified	  from	  pre-­‐immune	  serum.	  	  Briefly,	  Protein	  A	  beads	  (GE	  Healthcare)	  pre-­‐
equilibrated	  with	  Tris-­‐salt	  buffer	  [100	  mM	  Tris-­‐Cl	  (pH	  7.95),	  135	  mM	  NaCl]	  were	  incubated	  with	  
pre-­‐immune	   serum	   for	   2	   hr	   at	   room	   temperature	   with	   rotation.	   	   The	   flow-­‐through	   was	  
collected,	  and	  the	  column	  was	  washed	  with	  Tris-­‐salt	  buffer,	  followed	  by	  10	  mM	  Tris-­‐Cl	  (pH	  7.95).	  	  
IgG	  was	  eluted	  with	  0.1	  M	  glycine	  (pH	  3.0)	  at	  one-­‐half	  column	  volume/fraction,	  and	  1/10	  (v/v)	  1	  
M	  Tris-­‐Cl	  (pH	  8.0)	  was	  added	  to	  neutralize	  the	  pH.	  	  Purity	  of	  IgG	  fractions	  were	  analyzed	  on	  12%	  
SDS-­‐polyacrylamide	   gels	   followed	   by	   Coomassie-­‐staining,	   allowing	   for	   pooling	   of	   peak	   IgG	  
fractions.	  
	  
Western	  blot	  analysis	  and	  peptide	  competition	  assay.	  	  Histone	  samples	  were	  run	  on	  15%	  SDS-­‐
polyacrylamide	   gels,	   which	   were	   transferred	   to	   PVDF	   membranes	   (Pall	   Corporation)	   using	   a	  
semi-­‐dry	   apparatus	   (Hoefer)	   and	   Towbin	   buffer.	   	   Membranes	   were	   blotted	   using	   standard	  
techniques,	  and	  probed	  with	  the	  antibodies	  at	  the	  following	  dilutions:	  	  α-­‐H3	  (Active	  Motif,	  Cat.	  
No.	  39163;	  1:5000),	  α-­‐H2BK37me2	  (PRF&L,	  generated	  in	  this	  study;	  1:2000),	  α-­‐H3K4me3	  (Active	  
Motif,	  Cat.	  No.	  39159;	  1:10,000),	  α-­‐H3K36me3	  (Abcam,	  Cat.	  No.	  ab9050;	  1:2000),	  α-­‐H3K79me3	  
(Abcam,	  Cat.	  No.	  ab2621;	  1:2000),	  or	  α-­‐H2B	  (Active	  Motif,	  Cat.	  No.	  39237;	  1:10,000).	  
	   For	  peptide	  competition	  assays	  to	  demonstrate	  the	  specificity	  of	  purified	  α-­‐H2BK37me2	  
antibody	   for	   H2BK37me2,	   purified	   IgG	   or	  α-­‐H2BK37me2	   antibody	  was	   pre-­‐incubated	  with	   no	  
peptide,	  a	  H2K37	  peptide	  (SKARKETYS-­‐C)	  or	  a	  H2K37me2	  peptide	  (SKARKme2ETYS-­‐C,	  where	  me2	  
is	  dimethyl	  lysine)	  at	  a	  final	  peptide	  concentration	  of	  0.1	  µg/mL	  for	  1.5	  hr	  at	  room	  temperature	  




RNA	  isolation,	  microarray	  and	  RT-­‐qPCR	  mRNA	  analyses.	  	  Yeast	  cultures	  were	  grown	  at	  30˚C	  in	  
YPD	  simultaneously	  in	  triplicate	  to	  an	  OD600	  of	  approximately	  1.0.	  	  Ten	  OD600	  units	  of	  cells	  were	  
collected,	  washed	  once	  with	  water,	  and	  pellets	  were	  flash	  frozen	  in	  liquid	  nitrogen.	  	  Total	  RNA	  
was	   isolated	   using	   the	   hot	   acidic	   phenol-­‐chloroform	   method	   (COLLART	   and	   OLIVIERO	   2001).	  	  
Briefly,	   cell	   pellets	  were	   resuspended	   in	   400	  µL	   TES	   solution	   [10	  mM	  Tris-­‐Cl	   (pH	  7.5),	   10	  mM	  
EDTA,	  0.5%	  SDS],	  to	  which	  400	  µL	  acidic	  phenol-­‐chloroform	  (Ambion)	  was	  added.	  	  Samples	  were	  
vortexed	  vigorously,	  incubated	  at	  65˚C	  for	  1	  hour	  with	  occasional	  vortexing,	  and	  then	  placed	  on	  
ice	   for	  5	  min.	   	   The	  aqueous	   layer	  was	  back-­‐extracted	  once	  with	  acidic	  phenol-­‐chloroform	  and	  
once	  with	  chloroform.	  	  Following	  back-­‐extraction	  with	  chloroform,	  RNA	  was	  precipitated	  using	  a	  
standard	   ethanol	   precipitation	   protocol,	   and	   resuspended	   in	   RNase-­‐free	   water.	   	   RNA	   was	  
cleaned	   up	   using	   an	   RNeasy	   Mini	   Kit	   (QIAGEN),	   and	   RNA	   quality	   was	   determined	   using	   an	  
Agilent	  Bioanalyzer.	  
Biotinylated-­‐cRNA	   was	   generated	   using	   the	   MessageAmp™II-­‐Biotin	   Enhanced	   Kit	  
(Ambion)	  and	  was	  hybridized	  to	  Yeast	  Genome	  2.0	  arrays	  (Affymetrix),	  following	  manufacturer’s	  
protocol.	   	   Briefly,	   hybridizations	   were	   completed	   for	   16	   hr	   at	   45˚C	   at	   60	   rpm	   in	   a	   GeneChip	  
Hybridization	  Oven	  640.	   	  Arrays	  were	  washed	  and	  stained	  using	   the	  GeneChip	  Fluidics	  Station	  
450,	   and	   were	   scanned	   with	   the	   GeneChip	   Scanner	   3000	   7G	   Plus	   Scanner	   with	   Autoloader.	  	  
Microarray	   hybridization	   and	   analysis	   was	   completed	   at	   the	   University	   of	   North	   Carolina	   at	  
Chapel	  Hill	  Functional	  Genomics	  Core	  Facility.	  
For	  real-­‐time	  quantitative	  PCR	  (qPCR)	  gene	  expression	  analysis,	   following	  treatment	  of	  
isolated	   RNA	  with	   DNA-­‐free	   (Ambion)	   and	   RNA	   clean-­‐up	   using	   an	   RNeasy	  Mini	   Kit	   (QIAGEN),	  
first-­‐strand	   cDNA	   was	   generated	   from	   total	   RNA	   using	   the	   Improm-­‐II	   Reverse	   Transcription	  
System	  (Promega).	   	  PCR	  reactions	  using	  1/20	  of	  total	  cDNA	  as	  template	  were	  completed	  using	  
primers	   specific	   to	   the	   indicated	   genes.	   	   Primers	   used	   are	   as	   follows:	   ACT1	   Forward:	  
70	  
GAGGTTGCTGCTTTGGTTATTGA,	   Reverse:	   ACCGGCTTTACACATACCAGAAC.	   	   AQR1	   5’	   Forward:	  
GCTTTGAGGCAGTTGGAAAA,	   	   5’	   Reverse:	   CACCGCTAACTGTGGGAGAT;	   AQR1	   3’	   Forward:	  
TGGGTTCCTTCTTCACAGGT,	   3’	   Reverse:	   CTCTGCGTCTTGTGGAATCA.	   	   FMP43	   5’	   Forward:	  
ATTAGCGACGGCACTGATTT,	   5’	   Reverse:	   	   CAGTGCAACCCAGGAAAAA;	   FMP43	   3’	   Forward:	  	  
GGATACGGAACGGTGATTCT,	   3’	   Reverse:	   TCATCGATGTGGATGCAGTT.	   	   PCR	   reactions	   were	  
carried	  out	  in	  triplicate	  for	  qPCR	  analysis	  using	  SYBR	  GreenER	  qPCR	  master	  mix	  (Invitrogen)	  and	  
the	  Applied	  Biosystems	  7900HT	  Fast	  Real-­‐Time	  PCR	  system.	  
	  
Microarray	   data.	   	   All	  microarray	   data	   is	  MIAME	   compliant.	   	   Raw	   data	   generated	   from	   these	  
studies	   have	   been	   deposited	   into	   the	  MIAME	   compliant	   database	   Gene	   Expression	   Omnibus	  
(NCBI,	   http://www.ncbi.nlm.nih.gov/geo/)	   and	   are	   accessible	   through	   GEO	   series	   accession	  
number	  GSE24380.	  
	  
Phenotypic	  spotting	  assays.	   	  To	  assay	  for	  growth	  in	  phenotypic	  spotting	  assays,	  five-­‐fold	  serial	  
dilutions	  of	  saturated	  overnight	  yeast	  cultures	  grown	  in	  YPD	  medium,	  or	  in	  synthetic	  complete	  
medium	   supplemented	   as	   appropriate	   for	   plasmid	   selection,	   were	   plated	   onto	   appropriate	  
media	  at	  a	  starting	  OD600	  of	  0.5.	   	  Growth	  on	  plates	  was	  imaged	  after	  2-­‐4	  days	  of	   incubation	  at	  
30˚C,	  unless	  temperature	  is	  otherwise	  indicated.	  
	  
Results	  
H2B	   is	   dimethylated	   at	   lysine	   37.	   	   To	   date,	   only	   three	   lysine	   residues	   have	   been	   well-­‐
characterized	  as	  sites	  of	  methylation	   in	  budding	  yeast	  (namely	   lysines	  4,	  36,	  and	  79	  of	  histone	  
H3)	  (MILLAR	  and	  GRUNSTEIN	  2006).	   	   In	  higher	  eukaryotes,	  methylation	  is	  known	  to	  also	  occur	  on	  
histone	  H3	  at	  lysine	  residues	  9	  and	  27	  and	  histone	  H4	  at	  lysine	  20	  (MARTIN	  and	  ZHANG	  2005).	  	  To	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begin	  to	  address	  whether	  histone	  methylation	  occurs	  on	  other	  sites	  in	  budding	  yeast,	  as	  well	  as	  
to	   acquire	   a	   more	   comprehensive	   atlas	   of	   histone	   PTMs,	   we	   sought	   to	   use	   MS	   analysis	   to	  
identify	  novel	   histone	  modifications.	   	  Given	   recent	   advancements	   in	  MS	   technology,	   it	   is	   now	  
possible	  to	  use	  the	  top-­‐down	  MS	  approach	  to	  analyze	  intact	  histone	  proteins,	  thereby	  allowing	  
for	   more	   precise	   delineation	   and	   quantification	   of	   the	   complex	  modified	   forms	   in	   which	   the	  
histones	  exist	  (GARCIA	  et	  al.	  2007c).	  	  We	  initially	  performed	  our	  top-­‐down	  MS	  studies	  on	  histone	  
H2B,	  as	  this	  histone	  has	  more	  recently	  been	  shown	  to	  be	  monomethylated	  at	  lysine	  5	  in	  humans	  
(BARSKI	   et	   al.	   2007;	  WANG	   et	   al.	   2008),	   and	   we	   were	   interested	   in	   determining	   whether	   this	  
modification	  is	  conserved	  or	  if	  alternative	  sites	  of	  methylation	  exist	  in	  budding	  yeast.	  
	   According	   to	   its	   amino	   acid	   sequence,	   the	   theoretical	  monoisotopic	  mass	   ([M+H]+)	   of	  
yeast	   histone	   H2B	   is	   14113.6056	   Da.	   	   Using	   a	   12	   Tesla	   Bruker	   Daltonics	   μESI-­‐FTICR-­‐MS	   with	  
ultrahigh	  mass	  accuracy	  and	  resolution,	  exact	  mass	  measurement	  of	  the	  protein	  was	  performed	  
to	  validate	  sample	  preparation	  of	  histone	  H2B	  following	  isolation	  from	  yeast	  nuclei	  and	  RP-­‐HPLC	  
purification.	   	   The	  experimental	  monoisotopic	  mass	  of	  one	  of	   the	  major	  peaks	   (peak	  2)	  was	  at	  
14113.6028	  Da,	  extremely	  close	  to	  the	  theoretical	  value	  (mass	  error	  <	  1	  ppm)	  (FIGURE	  3.1,	  panel	  
A).	  	  Patterns	  of	  PTMs	  of	  yeast	  histone	  H2B	  were	  also	  mapped	  by	  exact	  mass	  measurement.	  	  The	  
PTM	  site(s)	  on	  each	   form	  was	   further	   identified	  and	  characterized	  based	  on	  exact	  masses	  and	  
sequence	   information	   from	   MS	   and	   MS/MS	   experiments.	   	   Relative	   abundances	   of	   modified	  
forms	  were	   obtained	   by	   integrating	   the	   four	  most	   abundant	   isotopic	   peaks	   in	   three	   different	  
charge	  states	  of	  MS	  spectra	  and	  taking	  their	  sum	  (TABLE	  3.2).	  
	   With	  a	  mass	  of	  14141.6352	  Da,	  the	  second	  strongest	  peak	  (peak	  4)	  exactly	  matched	  the	  
theoretical	   monoisotopic	  mass	   of	   yeast	   histone	   H2B	   with	   two	  methyl	   marks	   (mass	   error	   <	   1	  
ppm).	   	   To	   identify	   the	   modification	   site(s),	   the	   precursor	   ion	   corresponding	   to	   the	   modified	  
protein	   (m/z	  1415.9	  Da,	   10+	   charge	   state)	  was	   isolated	   for	   top-­‐down	  experiments	  using	  μESI-­‐
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FTICR-­‐MS	  with	  ECD	  (FIGURE	  3.1,	  panel	  B,	  upper).	  	  Inspection	  of	  the	  c	  and	  z	  fragment	  ions	  derived	  
from	   the	   ECD	  MS/MS	   spectrum	   revealed	   +28	  Da	  mass	   shifts	   of	   c37	   to	   c49	   ions,	   indicating	   that	  
lysine	   37	   is	   dimethylated	   (FIGURE	   3.1,	   panel	   B,	   lower).	   	   As	   indicated	   in	   TABLE	   3.2,	   the	   relative	  
abundance	  of	  dimethylated	  lysine	  37	  on	  histone	  H2B	  is	  over	  25.7%	  in	  all	  yeast	  protein	  isoforms.	  	  
Other	  PTMs	  (e.g.,	  sites	  of	  acetylation	  and	  methylation)	  could	  be	  identified	  based	  on	  ECD	  MS/MS	  
experiments.	   	   However,	   with	   the	   exception	   of	   N-­‐terminal	   acetylation	   at	   serine	   1	   (data	   not	  
shown),	  which	  has	  previously	  been	  identified	  (DELANGE	  et	  al.	  1969;	  PESAVENTO	  et	  al.	  2004;	  SONG	  
et	  al.	  2003),	  additional	  PTMs	  could	  not	  be	  conclusively	  assigned.	  
	   The	  finding	  that	  lysine	  37	  of	  histone	  H2B	  is	  dimethylated	  is	  in	  agreement	  with	  recently	  
published	  MS	  results	  from	  a	  study	  surveying	  for	  sites	  of	   lysine	  propionylation	  and	  butylyration	  
(Zhang	  et	  al.	  2009).	  	  However,	  very	  little	  is	  known	  about	  this	  lysine	  residue.	  	  Physically,	  lysine	  37	  
of	  histone	  H2B	  is	  located	  between	  the	  DNA	  gyres	  of	  the	  nucleosome	  structure	  (FIGURE	  3.1,	  panel	  
C).	  	  A	  previous	  study	  surveying	  the	  role	  of	  the	  N-­‐terminal	  domain	  of	  histone	  H2B	  in	  transcription	  
on	   a	   genome-­‐wide	   level	   demonstrated	   that	   residues	   30-­‐37	   of	   histone	  H2B	   are	   necessary	   and	  
sufficient	   for	   the	   repression	   of	   a	   subset	   of	   genes	   in	   the	   budding	   yeast	   genome,	   and	  
subsequently	   termed	   this	   region	   the	   H2B	   repression	   (HBR)	   domain	   (PARRA	   et	   al.	   2006).	   	   This	  
study	  posited	  a	  model	  by	  which	  the	  changes	  in	  gene	  expression	  that	  are	  observed	  upon	  deletion	  
of	  the	  HBR	  could	  be	  due	  to	  elimination	  of	  yet	  to	  be	  identified	  PTMs	  that	  function	  in	  repression,	  
and	  specifically	  suggest	  lysine	  37	  as	  a	  potential	  site	  of	  methylation	  (PARRA	  et	  al.	  2006).	  	  	  
To	  validate	  the	  finding	  that	  H2B	  is	  dimethylated	  on	  lysine	  37	  in	  budding	  yeast,	  we	  first	  
raised	   an	   antibody	   specific	   for	   this	   modified	   state	   in	   rabbit.	   	   Western	   blot	   analysis	   of	   acid-­‐
extracted	  wild-­‐type	  histones	  using	  crude	  serum	  compared	  to	  pre-­‐immune	  serum	  demonstrated	  
that	   this	   mark	   exists	   in	   vivo	   (data	   not	   shown).	   	   To	   further	   corroborate	   this	   finding	   and	  
characterize	   this	   novel	   mark,	  α-­‐H2BK37me2	   antibody	   was	   affinity	   purified	   from	   crude	   serum	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and	  peptide	  competition	  analysis	  was	  completed	  using	  acid-­‐extracted	  wild-­‐type	  H2B,	  H2B	  K37A,	  
and	  H2B	  K123R	  mutant	  histone	  samples.	  	  Where	  affinity	  purified	  α-­‐H2BK37me2	  antibody	  shows	  
a	   clear	   signal	   in	   histone	   samples	   containing	   wild-­‐type	   H2B,	   mutation	   of	   lysine	   37	   to	   a	   non-­‐
modifiable	   alanine	   (K37A)	   abrogates	   this	   signal	   (FIGURE	   3.2,	   panel	   A,	   No	   peptide	   controls:	   left	  
column,	   upper	   panels).	   	   Mutant	   H2B	   harboring	   a	   K123R	   mutation	   was	   used	   as	   a	   control	   to	  
demonstrate	   specificity	   of	   this	   antibody	   for	   lysine	   37.	   	   As	   a	   further	   measure	   of	   control,	   we	  
showed	   that	  H2BK37me2	  was	  not	  detectable	   in	  Western	  blot	   analysis	  using	   IgG	  purified	   from	  
pre-­‐immune	   serum	   (FIGURE	   3.2,	   panel	   A,	   lower).	   	   The	   affinity	   purified	   antibody	   is	   specific	   for	  
dimethylation	  of	  lysine	  37,	  as	  pre-­‐incubation	  of	  the	  α-­‐H2BK37me2	  antibody	  with	  a	  dimethylated	  
H2BK37	  peptide	  resulted	  in	  a	  loss	  of	  signal	  in	  all	  three	  histone	  samples,	  but	  preincubation	  with	  
an	   unmodified	   H2BK37	   peptide	   did	   not	   alter	   reactivity	   (FIGURE	   3.2,	   panel	   A,	  middle	   and	   right	  
columns,	  upper	  panels).	  	  Altogether,	  these	  data	  support	  the	  in	  vivo	  existence	  of	  dimethylation	  of	  
histone	   H2B	   on	   lysine	   37	   and	   the	   generation	   of	   an	   antibody	   that	   is	   capable	   of	   specifically	  
recognizing	  this	  modification.	  
Given	   that	   mutation	   of	   lysine	   123	   of	   histone	   H2B	   results	   in	   a	   loss	   of	   H2B	  
monoubiquitylation	  at	  this	  site	  as	  well	  as	  a	  loss	  of	  methylation	  of	  histone	  H3	  on	  lysines	  4	  and	  79	  
(BRIGGS	  et	  al.	  2002;	  DOVER	  et	  al.	  2002;	  NAKANISHI	  et	  al.	  2009;	  NG	  et	  al.	  2002b;	  SUN	  and	  ALLIS	  2002),	  
we	  sought	  to	  determine	  whether	  crosstalk	  existed	  between	  histone	  H2B	  lysine	  37	  methylation	  
and	   other	   known	   sites	   of	   histone	  methylation	   in	   budding	   yeast.	  Western	   blot	   analysis,	   using	  
acid-­‐extracted	  histones	  from	  wild-­‐type	  H2B	  and	  H2B	  K37A	  mutant	  strains,	  showed	  that	  the	  loss	  
of	  H3K37	  methylation	  did	  not	  disrupt	  H3K4,	  H3K36	  or	  H3K79	  methylation	  (FIGURE	  3.2,	  panel	  B).	  	  
In	  contrast,	  and	  as	  a	  control,	  the	  H2B	  K123R	  mutant	  resulted	  in	  a	  loss	  of	  both	  H3K4	  and	  H3K79	  
methylation,	  in	  agreement	  with	  previously	  published	  results	  (FIGURE	  3.2,	  panel	  B,	  and	  (NAKANISHI	  
et	  al.	  2009)).	  	  Finally,	  the	  H2B	  K123R	  mutation	  does	  not	  disrupt	  H2BK37	  methylation	  (FIGURE	  3.2,	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panel	  B).	   	  Together,	   these	   results	   suggest	   that	  dimethylation	  of	  H2BK37	   is	  neither	  affected	  by	  
H2B	  K123	  ubiquitylation	  nor	  affects	  the	  ability	  of	  additional	  lysine	  residues	  to	  be	  methylated.	  
	  
Elucidating	   the	   enzymes	   that	   place	   and	   remove	   H2BK37	   methylation.	   	  We	   next	   sought	   to	  
identify	  the	  putative	  histone	  methyltransferase	  responsible	  for	  placing	  this	  mark.	  	  To	  this	  end,	  a	  
candidate	   screen	   in	   which	   acid-­‐extracted	   histones	   from	   individual	   deletion	   strains	   from	   the	  
Yeast	  Knockout	  Collection	  (Open	  Biosystems)	  were	  analyzed	  by	  Western	  blot	  analysis	  using	  our	  
α-­‐H2BK37me2	   antibody	   (FIGURE	   3.3,	   panel	   A).	   	   Included	   in	   the	   list	   of	   candidates	   were:	   the	  
budding	   yeast	   SET-­‐domain	   containing	   proteins;	   the	   histone	   lysine	   methyltransferase	   Dot1;	  
known	  non-­‐histone	  lysine	  methyltransferases;	  known	  yeast	  arginine	  methyltransferases	  (specific	  
for	  both	  histone	  and	  non-­‐histone	  substrates);	  and	  putative	  methyltransferases	  (TABLE	  3.3).	  	  The	  
SET	  domain	   is	   the	   catalytic	   domain	  of	   all	   identified	  histone	   lysine	  methyltransferases	   to	  date,	  
with	  the	  exception	  of	  Dot1	  (DILLON	  et	  al.	  2005).	  	  To	  date,	  there	  are	  12	  proteins	  in	  budding	  yeast	  
that	   harbor	   a	   SET	   domain	   (including	   Set1	   through	   Set7,	   Rkm1	   through	   Rkm3,	   and	   Ctm1)	  
(PETROSSIAN	  and	  CLARKE	  2009a).	  	  Of	  these	  proteins,	  only	  Set1	  and	  Set2	  have	  been	  demonstrated	  
to	  function	  as	  histone	  lysine	  methyltransferases,	  and	  are	  specific	  for	  histone	  H3	  lysine	  residues	  4	  
and	  36,	  respectively	   (BRIGGS	  et	  al.	  2001;	  JENUWEIN	  et	  al.	  1998;	  ROGUEV	  et	  al.	  2001;	  STRAHL	  et	  al.	  
2002).	   	   Methylation	   of	   histone	   H3	   at	   lysine	   79	   is	   catalyzed	   by	   Dot1,	   which	   is	   structurally	  
unrelated	  to	  the	  other	  identified	  methyltransferases,	  as	  it	  lacks	  a	  SET	  domain	  altogether	  (NG	  et	  
al.	  2002a;	  SAWADA	  et	  al.	  2004).	  	  In	  addition	  to	  histone	  lysine	  methyltransferases,	  budding	  yeast	  
enzymes	  from	  the	  SET	  domain	  family	  that	  are	  capable	  of	  methylating	  non-­‐histone	  substrates	  on	  
lysine	  residues	  (namely,	  Ctm1,	  Rkm1,	  Rkm2,	  and	  Rkm3;	  (POLEVODA	  et	  al.	  2000;	  PORRAS-­‐YAKUSHI	  et	  
al.	   2006;	   PORRAS-­‐YAKUSHI	   et	   al.	   2005;	  WEBB	   et	   al.	   2008))	   were	   also	   tested	   in	   this	   screen.	   	   As	  
arginine	   methylation	   is	   also	   known	   to	   occur	   in	   budding	   yeast,	   it	   is	   possible	   that	   enzymes	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responsible	  for	  such	  modification	  on	  arginine	  residues	  could	  demonstrate	  substrate	  promiscuity,	  
and	  thus	  the	  known	  arginine	  methyltransferases	  Hmt1,	  Rmt2,	  and	  Hsl7	  (GARY	  et	  al.	  1996;	  LEE	  et	  
al.	  2000;	  NIEWMIERZYCKA	  and	  CLARKE	  1999)	  were	  also	  included	  in	  this	  screen.	  Finally,	  a	  number	  of	  
annotated	   proteins	   (of	   both	   known	   and	   unknown	   function)	   predicted	   to	   function	   as	  
methyltransferases	   based	   on	   structural	   predictions	   were	   also	   screened	   for	   activity	   toward	  
histone	  H2B	  lysine	  37,	  including	  the	  following:	  Trm12,	  Mtq1,	  Ylr137w,	  Ynl092w,	  Mni1,	  Ybr271w,	  
Tae1,	  Ymr209c,	  Ylr063w,	  Ybr141c,	  Crg1,	  Yjr129c,	  and	  See1	  (KALHOR	  et	  al.	  2005;	  KATZ	  et	  al.	  2003;	  
NIEWMIERZYCKA	  and	  CLARKE	  1999;	  PETROSSIAN	  and	  CLARKE	  2009b;	  POLEVODA	  et	  al.	  2006;	  WEBB	  et	  al.	  
2010).	  
We	  predicted	  that	  deletion	  of	  the	  responsible	  histone	  methyltransferase	  would	  result	  in	  
a	   loss	  of	   signal	   in	  Western	  blot	  analysis	  using	   the	  α-­‐H2BK37me2	  antibody,	  as	   is	  observed	   in	  a	  
parallel	  manner	  with	  Western	  blot	  analysis	  of	  samples	  derived	  from	  strains	  harboring	  individual	  
deletions	   of	   the	  other	   known	  histone	  methyltransferases	   and	   the	   antibodies	   specific	   for	   their	  
respective	   substrates.	   	  Unfortunately,	   all	   candidates	   screened	   to	   date	   (TABLE	   3.3)	   did	   not	   give	  
insight	   into	   the	   identity	  of	   the	   responsible	  methyltransferase.	   	  A	   loss	  of	  H2BK37me2	  signal	  by	  
Western	   blot	   analysis	   was	   not	   detected	   upon	   deletion	   of	   the	   individual	   candidates,	   as	   was	  
observed	   for	   the	   control	   H2B	   K37R	   and	  H2B	   K37A	  mutants	   compared	   to	   their	   isogenic	   strain	  
expressing	   wild-­‐type	   H2B	   (FIGURE	   3.3,	   panel	   A,	   bottom).	   	   This	   could	   be	   due	   functional	  
redundancy	   amongst	   methyltransferases,	   which	   would	   be	   masked	   by	   single	   gene	   deletions.	  	  
This,	   however,	   seems	   unlikely,	   as	   histone	   methyltransferases	   are	   typically	   highly	   specific	   for	  
both	  the	  lysine	  residue	  that	  they	  target	  as	  well	  as	  the	  degree	  to	  which	  they	  can	  methylate	  their	  
respective	  substrate	  (SHILATIFARD	  2006;	  XIAO	  et	  al.	  2003a).	  	  Alternatively,	  another	  class	  of	  yet	  to	  
be	   identified	   histone	   methyltransferases	   or	   a	   methyltransferase	   that	   is	   essential	   for	   viability	  
could	  facilitate	  placement	  of	  this	  mark,	  in	  which	  case	  a	  candidate	  screen	  of	  non-­‐essential	  ORFs	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would	  fail	  to	  reveal	  the	  responsible	  enzyme	  and	  rather	  an	  unbiased	  approach	  would	  have	  to	  be	  
employed	  to	  identify	  the	  catalytic	  enzyme.	  
	   Recently,	   the	   JmjC	   domain	   has	   been	   identified	   as	   the	   catalytic	   domain	   of	   a	   family	   of	  
histone	   demethylases	   (KLOSE	   et	   al.	   2006a;	   TSUKADA	   et	   al.	   2006).	   	   There	   are	   five	   JmjC-­‐domain-­‐
containing	   proteins	   in	   budding	   yeast:	   Jhd1,	   Rph1,	   Gis1,	   Jhd2,	   and	   Ecm5	   (KLOSE	   et	   al.	   2007a).	  	  
Jhd1,	  Rph1,	  and	  Jhd2	  have	  all	  been	  demonstrated	  to	  possess	  histone	  demethylase	  activity,	  with	  
specificity	   for	  H3K36me2/1,	  H3K36me3/2,	  and	  H3K4me3/2,	   respectively	   (FANG	  et	  al.	  2007;	  KIM	  
and	  BURATOWSKI	  2007;	  KLOSE	   et	  al.	  2007a;	   LIANG	   et	  al.	  2007;	  SEWARD	   et	  al.	  2007;	  TSUKADA	   et	  al.	  
2006).	   	   We	   also	   tried	   a	   candidate	   approach	   using	   deletion	   analysis	   of	   the	   five	   JmjC-­‐domain-­‐
containing	   proteins	   to	   identify	   a	   putative	   demethylase	   for	   this	   mark.	   	   Again,	   acid-­‐extracted	  
histones	  were	  analyzed	  by	  Western	  blot	  analysis	  using	   the	  α-­‐H2BK37me2	  antibody,	  with	  wild-­‐
type	   H2B	   and	   H2B	   K37A	   mutant	   histones	   serving	   as	   controls	   (FIGURE	   3.3,	   panel	   B).	   	   We	  
anticipated	   that	   deletion	  of	   the	  putative	  demethylase	  would	   result	   in	   an	   increase	   in	   the	   total	  
H2BK37me2,	  but	  deletion	  of	  the	  individual	  JmjC-­‐domain-­‐containing	  proteins	  did	  not	  show	  global	  
changes	   in	   the	   level	  of	  H2BK37me2.	   	  This	  was	  not	  entirely	   surprising,	  as	   individual	  deletion	  of	  
demethylases	   such	   as	   Jhd1	   or	   Rph1	   fails	   to	   show	   global	   changes	   in	   the	   levels	   of	   their	   target	  
substrates	   (FANG	  et	  al.	  2007;	  KLOSE	  et	  al.	  2007a).	   	  Collectively,	  both	  the	  methyltransferase	  and	  
demethylase	   enzymes	   specifically	   responsible	   for	   placing	   and	   removing	   dimethyl	   marks	   on	  
H2BK37	  remain	  to	  be	  identified.	  
	  
Mutation	  of	  H2BK37	   leads	   to	  no	  overt	   cellular	  phenotype.	   	   In	  parallel	   to	   identifying	  enzymes	  
that	   catalyze	   the	   placement	   and	   removal	   of	   this	  methylation	   event,	   we	   sought	   to	   define	   the	  
biological	   function	  of	   this	  mark.	   	  To	   this	  end,	  a	  number	  of	  phenotypic	  assays	  were	  completed	  
using	  a	  series	  of	   strains	  harboring	  wild-­‐type	  H2B,	  H2B	  K37A,	  H2B	  K37R,	  or	  H2B	  K123R	  mutant	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histones	   (in	   most	   cases,	   except	   where	   specifically	   noted,	   the	   H2B	   K123R	   mutant	   strain	   was	  
included	  as	  a	  positive	  control).	  	  General	  growth	  at	  various	  temperatures	  and	  on	  various	  types	  of	  
complete	  media	   was	   assessed,	   but	   both	   the	   H2B	   K37R	   and	   H2B	   K37A	   strains	   failed	   to	   show	  
differential	  growth	  as	  compared	  to	  the	  isogenic	  wild-­‐type	  strain.	  	  This	  was	  in	  contrast	  to	  the	  H2B	  
K123R	  strain,	  which	  exhibited	  a	  slow	  growth	  phenotype	  at	  all	  of	  the	  temperatures	  and	  various	  
medias	  assessed	  (data	  not	  shown).	  	  Examination	  of	  growth	  under	  anaerobic	  conditions,	  as	  well	  
as	   following	   release	   from	   stationary	   phase,	   also	   failed	   to	   show	  a	   difference	   between	   the	   K37	  
mutant	  and	  wild-­‐type	  histone	  strains	  (data	  not	  shown).	  	  Mutation	  of	  lysine	  37	  to	  either	  arginine	  
or	  alanine	  also	  did	  not	  affect	  the	  ability	  of	  yeast	  cells	  to	  properly	  sporulate	  as	  compared	  to	  an	  
isogenic	   strain	  expressing	  wild-­‐type	  H2B	   (data	  not	   shown).	   	  We	  next	  posited	   that	  H2BK37me2	  
might	   be	   cell-­‐cycle	   regulated,	   and	   therefore	   synchronized	   wild-­‐type	   cells	   in	   G2/M	   with	  
nocodazole	   and	   harvested	   cells	   at	   defined	   points	   along	   the	   cell	   cycle	   following	   nocodazole	  
release.	  	  Western	  blot	  analysis	  of	  these	  cells	  at	  various	  stages	  of	  the	  cell	  cycle	  failed	  to	  reveal	  an	  
enrichment	   and/or	   depletion	   of	   H2BK37me2	   at	   any	   defined	   cell	   cycle	   stage	   (as	   compared	   to	  
known	   cell-­‐cycle	   regulated	   marks	   such	   as	   phosphorylation	   of	   histone	   H3	   on	   serine	   10	   and	  
threonine	  45,	  which	  occur	  during	  mitosis	  and	  S-­‐phase,	  respectively	  (BAKER	  et	  al.	  2010;	  HSU	  et	  al.	  
2000))	  (data	  not	  shown).	  
	   We	   also	   performed	   assays	   to	   screen	   for	   phenotypes	   related	   to	   DNA	   replication	   and	  
repair.	   	   To	   that	   end,	   wild-­‐type	   H2B	   and	   the	   H2B	   K37	  mutant	   strains	   were	   spotted	   on	  media	  
containing	  the	  agents	  hydroxyurea	  (HU,	  an	  agent	  which	  blocks	  replication	  leading	  to	  replication	  
fork	  collapse)	  or	  methyl	  methanesulfonate	   (MMS,	  an	  alkylating	  agent	   that	  causes	  DNA	   lesions	  
and	  ultimately	  DNA	  strand	  breaks).	   	  However	   lysine	  37	  mutations	   in	  histone	  H2B	  did	  not	  alter	  
cellular	   growth	   compared	   to	   an	   isogenic	   wild-­‐type	   parent	   on	   media	   containing	   0.05%	   MMS	  
(data	   not	   shown)	   or	   100	   mM	   HU	   (FIGURE	   3.4,	   panel	   A),	   where	   cells	   bearing	   a	   H2B	   K123R	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mutation	  were	  sensitive	  to	  both.	  	  Moreover,	  to	  assess	  the	  ability	  of	  lysine	  37	  mutant	  strains	  to	  
carry	  out	  replication,	  plasmid	  maintenance	  assays	  were	  completed,	  where	  the	  ability	  of	  a	  cell	  to	  
replicate	  a	  reporter	  plasmid	  containing	  a	  single	  origin	  of	  replication	  and	  a	  selectable	  marker	   is	  
measured	  (HOGAN	  and	  KOSHLAND	  1992).	  	  Mutation	  of	  lysine	  37	  on	  histone	  H2B	  to	  either	  arginine	  
or	  alanine	  did	  not	  affect	  the	  ability	  of	  yeast	  strains	  to	  faithfully	  replicate	  the	  reporter	  plasmid	  as	  
compared	  to	  isogenic	  wild-­‐type	  cells	  (data	  not	  shown).	   	  Taken	  together,	  the	  results	  from	  these	  
screening	   assays	   suggest	   that	   histone	   H2B	   lysine	   37	   does	   not	   have	   a	   significant	   role	   in	   DNA	  
replication	  or	  repair.	  
	   As	   methylation	   of	   both	   lysine	   4	   and	   79	   of	   histone	   H3	   have	   been	   previously	  
demonstrated	   to	   be	   necessary	   for	   proper	   telomeric	   silencing	   (KROGAN	   et	   al.	   2002;	   NG	   et	   al.	  
2002a;	  NG	  et	  al.	  2002b;	  SUN	  and	  ALLIS	  2002),	  we	  next	  sought	  to	  determine	  if	  mutation	  of	  lysine	  
37	   would	   also	   result	   in	   loss	   of	   telomeric	   silencing.	   	   To	   that	   end,	   H2B	   K37R	   and	   H2B	   K37A	  
mutations	   were	   introduced	   into	   a	   histone	   H2A-­‐H2B	   shuffle	   strain	   engineered	   to	   assay	   for	  
defects	   in	   telomeric	   silencing,	  where	   expression	   of	  URA3,	   located	   at	   the	   left-­‐end	   telomere	   of	  
chromosome	  VII	   (URA3-­‐TEL),	   is	  used	  as	  a	  readout	   for	  proper	  silencing	  (SUN	  and	  ALLIS	  2002).	   	   If	  
telomeric	  silencing	  properly	  occurs,	  the	  URA3	  gene	  is	  silenced,	  and	  cells	  grow	  normally	  on	  media	  
containing	   5-­‐fluoroortic	   (5-­‐FOA),	   an	   agent	   that	   is	   toxic	   only	   to	   cells	   that	   express	   URA3.	  	  
Introduction	  of	  H2B	  K37R	  and	  H2B	  K37A	  mutations	   in	  URA3-­‐TEL	   strains	   results	   in	   comparable	  
growth	   on	   5-­‐FOA-­‐containing	  media	   to	   the	   isogenic	  URA3-­‐TEL	   strain	   expressing	  wild-­‐type	   H2B	  
(FIGURE	  3.4,	  panel	  B).	  	  This	  is	  in	  direct	  contrast	  to	  cells	  expressing	  H2B	  K123R	  or	  cells	  deleted	  of	  
SIR2,	  which	  both	  fail	  to	  grow	  on	  media	  containing	  5-­‐FOA	  due	  to	  improper	  silencing	  of	  the	  URA3	  
gene	  (FIGURE	  3.4,	  panel	  B),	  in	  agreement	  with	  previously	  published	  results	  (SUN	  and	  ALLIS	  2002).	  	  
Together,	  these	  data	  suggest	  that	  lysine	  37	  of	  histone	  H2B	  is	  not	  essential	  for	  gene	  silencing	  in	  
yeast.	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   Several	  assays	   to	   test	   for	   transcriptional	  defects	  were	  also	  employed.	   	   Spotting	  assays	  
on	   media	   containing	   6-­‐azauracil	   (6-­‐AU)	   or	   mycophenolic	   acid	   (MPA),	   which	   both	   deplete	  
intracellular	   levels	   of	   nucleotides	   leading	   to	   altered	   cellular	   viability	   when	   combined	   with	  
mutations	   that	   affect	   transcriptional	   elongation,	  were	   completed.	   	   In	   both	   cases,	   strains	  with	  
mutant	  H2B	  K37R	  or	  K37A	  grew	  comparably	  to	  cells	  with	  wild-­‐type	  H2B,	  where	  an	  H2B	  K123R	  
mutation	  resulted	   in	  a	  slow	  growth	  phenotype	   (data	  not	  shown).	   	  Transcription	   induction	  was	  
also	  assessed	  by	  measuring	  the	   induction	  of	  GAL1	  and	  GAL10	   transcripts	   in	  wild-­‐type	  H2B	  and	  
H2B	   K37	   mutant	   strains.	   	   However,	   gene	   expression	   analysis	   by	   reverse-­‐transcription	  
quantitative	  PCR	   (RT-­‐qPCR)	   revealed	   that	  mutation	  of	   lysine	  37	  on	  histone	  H2B	  does	  not	  alter	  
induction	  of	  either	  GAL1	  or	  GAL10,	  as	  compared	  to	  wild-­‐type	  cells,	  supporting	  that	  this	  residue	  
does	  not	   significantly	   contribute	   to	   transcriptional	   induction	  of	   these	  genes.	   	   Finally,	  we	  were	  
curious	   to	   see	  how	  mutation	   in	  H2B	  K37	  would	  behave	   in	   combination	  with	  mutant	  SPT16,	   a	  
member	   of	   the	   FACT	   histone	   chaperone	   complex	   that	   promotes	   transcription	   elongation	  
(BELOTSERKOVSKAYA	  et	  al.	  2003;	  BISWAS	  et	  al.	  2006;	  MASON	  and	  STRUHL	  2003;	  SAUNDERS	  et	  al.	  2003).	  	  
Previous	  results	  have	  shown	  that	  the	  growth	  phenotype	  observed	  upon	  inactivation	  of	  SPT16	  is	  
enhanced	  and	  suppressed	  by	  mutations	  in	  lysine	  residues	  4	  and	  36	  of	  histone	  H3,	  respectively,	  
suggesting	   that	  FACT	   function	   is	  dependent	  upon	  H3K4	  methylation	  and	   is	  opposed	  by	  H3K36	  
methylation	   (BISWAS	   et	  al.	  2006).	   	  We	   therefore	   introduced	   lysine	  37	  mutations	   into	  a	  histone	  
H2A-­‐H2B	   shuffle-­‐strain	   containing	   a	   temperature-­‐sensitive	   allele	   of	   SPT16	   (spt16-­‐197),	   and	  
cellular	  growth	  was	  assessed	  at	  range	  of	  temperatures.	  	  However,	  this	  analysis	  failed	  to	  reveal	  a	  
combinatorial	  effect	  between	  mutation	  of	  lysine	  37	  on	  histone	  H2B	  and	  inactivation	  of	  SPT16,	  as	  
H2B	  K37R/A	  spt16-­‐197	  double	  mutant	  strains	  grew	  comparably	  to	  isogenic	  spt16-­‐197	  containing	  
wild-­‐type	  H2B	  (FIGURE	  3.4,	  panel	  C).	  	  This	  is	  in	  direct	  opposition	  to	  a	  H2B	  K123R	  spt16-­‐197	  double	  
mutant	   strain,	   which	   demonstrated	   a	   synthetic	   effect	   upon	   inactivation	   of	   the	   FACT	   allele.	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These	  data	  together	  substantiate	  that	  methylation	  of	  lysine	  37	  does	  not	  appear	  to	  play	  a	  major	  
role	   in	   transcription,	   as	  mutation	   of	   this	   histone	   residue	   results	   in	   no	   overt	   phenotype	   in	   all	  
transcription-­‐based	  assays	  completed	  to	  date.	  
	   Finally,	   given	   that	   Parra	   et	   al	   presented	   a	   model	   by	   which	   gene	   expression	   changes	  
observed	  upon	  deletion	  of	   the	  HBR	  domain	  could	  be	  a	  consequence	  of	  eliminating	  a	  modified	  
form	  of	  this	  domain	  (PARRA	  et	  al.	  2006),	  we	  sought	  to	  address	  whether	  methylation	  lysine	  37	  of	  
H2B	   in	  particular	   functions	   in	   transcriptional	   regulation	  on	  a	  genomic	   level.	   	  To	   this	  end,	  gene	  
expression	   changes	   upon	   mutation	   of	   lysine	   37	   were	   assessed	   by	   microarray	   analysis.	  	  
Comparison	   of	   gene	   expression	   changes	   in	   cells	   expressing	  wild-­‐type	  H2B	   versus	   a	   H2B	   K37A	  
mutant	   revealed	   that	   lysine	   37	   does	   not	   appear	   to	   function	   significantly	   in	   genome-­‐wide	  
transcription	  regulation,	  as	  only	  20	  genes	  showed	  differential	  gene	  expression	  using	  a	  cutoff	  of	  a	  
two-­‐fold	  difference	  in	  expression	  (where	  two	  genes	  were	  upregulated	  (TABLE	  3.4)	  and	  18	  genes	  
were	  downregulated	  (TABLE	  3.5)	  in	  a	  H2B	  K37A	  mutant	  relative	  to	  the	  isogenic	  wild-­‐type	  strain).	  	  
RT-­‐qPCR	  analysis	  was	  able	   to	   recapitulate	   the	  microarray	   results	  of	   genes	   shown	   to	  be	  up-­‐	  or	  
downregulated	  in	  a	  H2B	  K37A	  mutant	  strain	  relative	  to	  the	  isogenic	  parent	  strain	  (FIGURE	  3.5	  and	  
data	   not	   shown),	   thus	   validating	   the	   microarray	   results.	   	   However,	   the	   lack	   of	   a	   significant	  
number	   of	   genes	   showing	   differential	   expression	   between	   wild-­‐type	   and	   H2B	   K37A	   mutant	  
strains	   indicates	   overall	   that	   H2BK37me2	   alone	   does	   not	   play	   a	   major	   role	   in	   regulation	   of	  
transcription	  on	  a	  genome-­‐wide	  level	  in	  budding	  yeast.	  
	  
Methylation	  of	  H2BK37	  is	  conserved	  in	  higher	  eukaryotes.	  	  Sequence	  alignment	  of	  histone	  H2B	  
from	  Saccharomyces	  cerevisiae	  against	  multiple	  species	  reveals	  that	  lysine	  37	  is	  conserved	  along	  
evolution,	   despite	   lower	   sequence	   similarity	   of	   surrounding	   amino	   acid	   residues	   (FIGURE	   3.6,	  
panel	   A).	   	   To	   determine	   if	   we	   could	   detect	   the	   presence	   of	   methylated	   lysine	   37	   in	   higher	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eukaryotes,	   we	   performed	   Western	   blot	   analysis	   comparing	   oligonucleosomes	   isolated	   from	  
chicken	  erythrocyte	  nuclei	  and	  core	  histones	  from	  HeLa	  cell	  nuclei	  to	  yeast	  histones.	   	  Western	  
blot	  analysis	  using	   the	  α-­‐H2BK37me2	  antibody	   revealed	   that	   this	  mark	   is	   indeed	  conserved	   in	  
higher	  eukaryotes	  (Figure	  3.6,	  panel	  B),	  as	  a	  comparable	  species	  is	  observed	  in	  both	  the	  chicken	  
and	  human	  histone	  samples	  as	  to	  histones	  extracted	  from	  yeast	  harboring	  wild-­‐type,	  but	  not	  the	  
K37A	   mutant,	   H2B.	   	   The	   presence	   of	   a	   discernable	   signal	   in	   samples	   derived	   from	   higher	  
eukaryotic	   species	  suggests	   that,	  despite	   the	   lack	  of	  an	  obvious	  cellular	  phenotype	   in	  yeast	   to	  
date,	  this	  mark	  is	  likely	  to	  be	  biologically	  important	  since	  it	  was	  retained	  during	  evolution.	  
	  
Discussion	  
To	   date,	   only	   six	   lysines	   residues	   have	   been	   identified	   and	   characterized	   as	   sites	   of	   histone	  
methylation	   (namely,	   lysines	   4,	   9,	   27,	   36	   and	   79	   of	   histone	   H3,	   and	   lysine	   20	   of	   histone	   H4)	  
(MARTIN	  and	  ZHANG	  2005).	  	  Recently,	  a	  comprehensive	  study	  employing	  LC-­‐ESI	  MS/MS	  to	  identify	  
PTMs	  of	  histones	  associated	  with	  each	  phase	  of	  the	  yeast	  cell	  cycle	  revealed	  that	  lysine	  111	  of	  
histone	  H2B	  is	  also	  a	  site	  of	  histone	  methylation	  (UNNIKRISHNAN	  et	  al.	  2010),	   in	  agreement	  with	  
additional	  previously	  publishes	  results	   (ZHANG	  et	  al.	  2009).	   	  Phenotypic	  analyses	  have	  revealed	  
that	  mutation	   of	   this	   lysine	   residue	   confers	   sensitivity	   to	   the	   DNA-­‐damaging	   agent	  MMS	   and	  
renders	   telomeric	   silencing	   defective	   (KYRISS	   et	   al.	   2010),	   supporting	   the	   importance	   of	   this	  
lysine	  residue	  and	  its	  methylation	  in	  chromatin	  function.	  	  Trimethylation	  of	  lysine	  64	  on	  histone	  
H3	  has	  been	  shown	  to	  be	  enriched	  at	  pericentric	  heterochromatin	  in	  human	  and	  mice	  samples,	  
and	   is	   dynamically	   regulated	   during	   early	   development,	   supporting	   a	   function	   for	   this	  
modification	   in	   the	   reprogramming	   process	   involved	   in	   germ	   cell	   development	   (DAUJAT	   et	   al.	  
2009).	  	  Additionally,	  methylation	  of	  histone	  H3	  at	  lysine	  122	  has	  recently	  been	  reported	  in	  mice	  
(COCKLIN	  and	  WANG	  2003),	  and	  genome-­‐wide	  localization	  patterns	  of	  methylation	  of	  lysine	  5	  on	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histone	  H2B	  have	  been	  reported	  in	  humans	  (BARSKI	  et	  al.	  2007;	  WANG	  et	  al.	  2008).	  	  However,	  the	  
latter	   two	   sites	  of	  histone	  methylation	  are	   largely	  uncharacterized	  at	  present.	   	   It	   is	   likely	   that	  
additional	  sites	  of	  histone	  lysine	  methylation	  remain	  to	  be	  identified,	  and	  that	  much	  remains	  to	  
be	   discovered	   with	   regard	   to	   the	   complexity	   of	   histone	   methylation	   and	   how	   this	   PTM	   in	  
particular	   contributes	   to	   the	   histone	   code	   and	   cellular	   function.	   	   That	   additional	   sites	   of	  
modifications	   critical	   for	  normal	   cellular	   function	   remain	   to	  be	   identified	   thereby	  necessitates	  
further	  investigations	  directed	  toward	  elucidating	  a	  complete	  atlas	  of	  histone	  PTMs.	  
	   In	  this	  manuscript,	  we	  reveal	  the	  utility	  of	  top-­‐down	  MS	  analysis	  in	  the	  identification	  of	  
novel	  histone	  PTMs,	  and	  report	  that	  lysine	  37	  of	  histone	  H2B	  is	  dimethylated	  in	  budding	  yeast.	  	  
We	  also	  provide	  evidence	  that	  this	  modification	   is	  evolutionarily	  conserved.	   	  Much	  remains	  to	  
be	  determined	  with	  respect	  to	  the	  placement	  and	  removal,	  regulation	  and	  biological	  function(s)	  
of	  this	  mark.	  	  For	  example,	  a	  candidate	  screen	  employing	  all	  known	  lysine	  methyltransferases	  in	  
budding	   yeast	   (both	   specific	   for	   histone	   and	   non-­‐histone	   substrates)	   has	   revealed	   that	   the	  
methyltransferase	  responsible	  for	  placement	  of	  this	  mark	  does	  not	  fall	  into	  the	  category	  of	  one	  
of	   the	   previously	   identified	   methyltransferases.	   	   This	   suggests	   that	   either	   multiple	  
methyltransferases	   function	   redundantly	   to	   methylate	   H2BK37,	   or	   that	   a	   novel	   class	   of	  
methyltransferases	   capable	  of	  placing	   this	  mark	  exists.	   	  Using	  a	   similar	   candidate	  approach	   to	  
screen	   known	   histone	   demethylases	   for	   specificity	   for	   this	   mark	   also	   failed	   to	   expose	   a	  
demethylase	   specific	   for	   this	   mark.	   	   Given	   that	   deletion	   of	   known	   JmjC-­‐domain-­‐containing	  
demethylases	  does	  not	  result	   in	  global	  changes	  in	  the	  levels	  of	  histone	  modifications	  that	  they	  
have	  been	  shown	  to	  target	  (FANG	  et	  al.	  2007;	  KLOSE	  et	  al.	  2007a),	  it	  is	  likely	  that	  identification	  of	  
the	   demethylase	   responsible	   for	   removal	   of	   lysine	   37	   methylation	   cannot	   be	   revealed	   by	  
deletion	  analysis.	   	  Alternatively,	  multiple	  demethylases	  could	  be	   functionally	   redundant	   in	   the	  
removal	  of	   this	  mark,	   thus	  making	  deletion	  analysis	   a	   less	   ideal	   assay	   for	   identification	  of	   the	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enzyme	   responsible	   for	   erasing	   methylation	   at	   H2BK37.	   	   It	   is	   also	   possible	   that	   a	   family	   of	  
enzymes	  other	  than	  JmjC-­‐domain-­‐containing	  histone	  demethylases	  exists	  that	  is	  responsible	  for	  
removal	  of	  this	  mark,	  as	  well	  as	  others	  (for	  example,	  a	  demethylase	  specific	  for	  H3K79	  remains	  
to	  be	  identified),	  or	  that	  there	  simply	  is	  not	  a	  demethylase	  for	  this	  mark.	  	  	  
Saccharomyces	   cerevisiae	   provides	   an	   advantageous	   genetic	   system	   for	   studying	   the	  
functional	   consequence	  of	   loss	   of	   a	   specific	   amino	   acid	   residue	   (a	   feat	   that	   cannot	  be	   readily	  
accomplished	   in	   higher	   eukaryotes	   (KOUZARIDES	   2007)),	   thus	   prompting	   us	   to	   carry	   out	  
phenotypic	  analysis	  in	  budding	  yeast.	  As	  MS	  analysis	  has	  revealed	  that	  H2BK37	  dimethylation	  is	  
a	   relatively	  abundant	  modification,	  we	  reasoned	  that	  mutation	  of	   lysine	  37	  would	   likely	  cause	  
pleiotropic	   effects.	   	   However,	   all	   assays	   screened	   to	   date	   have	   failed	   to	   reveal	   a	   functional	  
phenotype	   when	   lysine	   37	   is	   changed	   to	   either	   arginine	   or	   alanine.	   	   It	   is	   possible	   that	   this	  
modification	   could	   function	   redundantly	   with	   another	   histone	   modification,	   in	   which	   case	  
combinatorial	   mutations	   would	   be	   necessary	   to	   reveal	   the	   functional	   significance	   of	   these	  
marks.	  	  Thus,	  further	  studies	  will	  have	  to	  be	  completed	  to	  determine	  the	  biological	  significance	  
of	  this	  mark	  in	  chromatin.	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  TABLE	  3.1	  |	  Yeast	  strains	  
	  
Strain	   Genotype	   Reference/Source	  
FY406	   MATa	  (hta1-­‐htb1)Δ::LEU2	  (hta2-­‐htb2)Δ::TRP1	  leu2Δ1	  ura3-­‐52	  
lys2Δ1	  lys2-­‐128δ	  his3Δ200	  trp1Δ63	  [pSAB6	  (HTA1-­‐HTB1,	  URA3)]	  
	  
(HIRSCHHORN	  et	  al.	  
1995)	  
YKG001	   MATa	  (hta1-­‐htb1)Δ::LEU2	  (hta2-­‐htb2)Δ::TRP1	  leu2Δ1	  ura3-­‐52	  
lys2Δ1	  lys2-­‐128δ	  his3Δ200	  trp1Δ63	  [pZS145	  (HTA1-­‐Flag-­‐HTB1	  CEN	  
HIS3)]	  
	  
(NAKANISHI	  et	  al.	  
2009)	  
YKG002	   MATa	  (hta1-­‐htb1)Δ::LEU2	  (hta2-­‐htb2)Δ::TRP1	  leu2Δ1	  ura3-­‐52	  
lys2Δ1	  lys2-­‐128δ	  his3Δ200	  trp1Δ63	  [pZS146	  (HTA1-­‐Flag-­‐htb1	  
(K123R)	  CEN	  HIS3)]	  
	  
(NAKANISHI	  et	  al.	  
2009)	  
YKG006	   MATa	  (hta1-­‐htb1)Δ::LEU2	  (hta2-­‐htb2)Δ::TRP1	  leu2Δ1	  ura3-­‐52	  




YKG007	   MATa	  (hta1-­‐htb1)Δ::LEU2	  (hta2-­‐htb2)Δ::TRP1	  leu2Δ1	  ura3-­‐52	  
lys2Δ1	  lys2-­‐128δ	  his3Δ200	  trp1Δ63	  [pKG2	  (HTA1-­‐Flag-­‐htb1	  (K37A)	  
CEN	  HIS3)]	  
	  
This	  study	  	  
YZS272	   MATa	  ura3-­‐1	  leu2-­‐3,112	  ade2-­‐1	  trp1-­‐1	  his3-­‐11,15	  can1-­‐100	  (hta1-­‐
htb1)Δ::LEU2	  (hta2-­‐htb2)Δ	  [pZS144	  (HTA1-­‐Flag-­‐HTB1	  CEN	  TRP1)]	  
URA3-­‐TEL	  
	  
(SUN	  and	  ALLIS	  2002)	  
YKG027	   MATa	  ura3-­‐1	  leu2-­‐3,112	  ade2-­‐1	  trp1-­‐1	  his3-­‐11,15	  can1-­‐100	  (hta1-­‐




YKG028	   MATa	  ura3-­‐1	  leu2-­‐3,112	  ade2-­‐1	  trp1-­‐1	  his3-­‐11,15	  can1-­‐100	  (hta1-­‐




YKG029	   MATa	  ura3-­‐1	  leu2-­‐3,112	  ade2-­‐1	  trp1-­‐1	  his3-­‐11,15	  can1-­‐100	  (hta1-­‐




YZS274	   MATa	  ura3-­‐1	  leu2-­‐3,112	  ade2-­‐1	  trp1-­‐1	  his3-­‐11,15	  can1-­‐100	  (hta1-­‐
htb1)Δ::LEU2	  (hta2-­‐htb2)Δ	  [pZS146	  (HTA1-­‐Flag-­‐htb1	  (K123R)	  CEN	  
HIS3)]	  URA3-­‐TEL	  
	  
(SUN	  and	  ALLIS	  2002)	  
YZS275	   MATa	  ura3-­‐1	  leu2-­‐3,112	  ade2-­‐1	  trp1-­‐1	  his3-­‐11,15	  can1-­‐100	  (hta1-­‐
htb1)Δ::LEU2	  (hta2-­‐htb2)Δ	  [pZS145	  (HTA1-­‐Flag-­‐HTB1	  CEN	  HIS3)]	  
URA3-­‐TEL	  sir2Δ::TRP1	  
	  
(SUN	  and	  ALLIS	  2002)	  
YZS276	   MATa	  (hta1-­‐htb1)Δ::LEU2	  (hta2-­‐htb2)Δ	  leu2-­‐3,112	  his3-­‐11,15	  trp1-­‐1	  
ura3-­‐1	  ade2-­‐1	  can	  1-­‐100	  [pZS145	  (HTA1-­‐Flag-­‐HTB1	  CEN	  HIS3)]	  
	  
(SUN	  and	  ALLIS	  2002)	  
YZS277	   MATa	  (hta1-­‐htb1)Δ::LEU2	  (hta2-­‐htb2)Δ	  leu2-­‐3,112	  his3-­‐11,15	  trp1-­‐1	  
ura3-­‐1	  ade2-­‐1	  can	  1-­‐100	  [pZS146	  (HTA1-­‐Flag-­‐htb1	  (K123R)	  CEN	  
HIS3)]	  
(SUN	  and	  ALLIS	  2002)	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Y131	   MATa	  (hta1-­‐htb1)Δ::LEU2	  (hta2-­‐htb2)Δ	  leu2-­‐3,112	  trp1-­‐1	  ura3-­‐1	  
ade2-­‐1	  can1-­‐100	  his3-­‐11,15	  [pRS426	  (HTA1-­‐HTB1	  URA3	  2	  µm)]	  
	  
(ROBZYK	  et	  al.	  2000)	  
YCH278	   MATa	  (hta1-­‐htb1)Δ::LEU2	  (hta2-­‐htb2)Δ	  leu2-­‐3,112	  trp1-­‐1	  ura3-­‐1	  
ade2-­‐1	  can1-­‐100	  his3-­‐11,15	  spt16:kanMX	  [pRS426	  (HTA-­‐HTB	  URA3	  
2	  µm)]	  [pBM46-­‐spt16-­‐197]	  
	  
(FLEMING	  et	  al.	  2008)	  
YKG031	   MATa	  (hta1-­‐htb1)Δ::LEU2	  (hta2-­‐htb2)Δ	  leu2-­‐3,112	  trp1-­‐1	  ura3-­‐1	  
ade2-­‐1	  can1-­‐100	  his3-­‐11,15	  spt16:kanMX	  [pZS145	  (HTA1-­‐Flag-­‐HTB1	  
CEN	  HIS3)]	  [pBM46-­‐spt16-­‐197]	  
	  
This	  study	  
YKG032	   MATa	  (hta1-­‐htb1)Δ::LEU2	  (hta2-­‐htb2)Δ	  leu2-­‐3,112	  trp1-­‐1	  ura3-­‐1	  
ade2-­‐1	  can1-­‐100	  his3-­‐11,15	  spt16:kanMX	  [pZS146	  (HTA1-­‐Flag-­‐htb1	  
(K123R)	  CEN	  HIS3)]	  [pBM46-­‐spt16-­‐197]	  
	  
This	  study	  
YKG033	   MATa	  (hta1-­‐htb1)Δ::LEU2	  (hta2-­‐htb2)Δ	  leu2-­‐3,112	  trp1-­‐1	  ura3-­‐1	  
ade2-­‐1	  can1-­‐100	  his3-­‐11,15	  spt16:kanMX	  [pKG1	  (HTA1-­‐Flag-­‐htb1	  
(K37R)	  CEN	  HIS3)]	  [pBM46-­‐spt16-­‐197]	  
	  
This	  study	  
YKG034	   MATa	  (hta1-­‐htb1)Δ::LEU2	  (hta2-­‐htb2)Δ	  leu2-­‐3,112	  trp1-­‐1	  ura3-­‐1	  
ade2-­‐1	  can1-­‐100	  his3-­‐11,15	  spt16:kanMX	  [pKG2	  (HTA1-­‐Flag-­‐htb1	  
(K37A)	  CEN	  HIS3)]	  [pBM46-­‐spt16-­‐197]	  
	  
This	  study	  
















MATα	  ade2	  can1	  his3	  leu2	  lys2	  trp1	  ura3	  	  
	  
	  
(WATSON	  et	  al.	  2000)	  
YAR005	   MATα	  ade2	  can1	  his3	  leu2	  lys2	  trp1	  ura3	  rph1Δ::kanMX	  
	  
This	  study	  
YAR007	   MATα	  ade2	  can1	  his3	  leu2	  lys2	  trp1	  ura3	  jhd1Δ::kanMX	  
	  
This	  study	  
YAR009	   MATα	  ade2	  can1	  his3	  leu2	  lys2	  trp1	  ura3	  gis1Δ::kanMX	  
	  
This	  study	  
YAR011	   MATα	  ade2	  can1	  his3	  leu2	  lys2	  trp1	  ura3	  jhd2Δ::kanMX	  
	  
This	  study	  
YAR013	   MATα	  ade2	  can1	  his3	  leu2	  lys2	  trp1	  ura3	  ecm5Δ::kanMX	  
	  
This	  study	  
YNL037	   MATα	  ade2	  can1	  his3	  leu2	  lys2	  trp1	  ura3	  dot1Δ::kanMX	  
	  
This	  study	  
BY4741	   MATa	  his3Δ1	  leu2Δ0	  met15Δ0	  ura3Δ0	  
	  
Open	  Biosystems	  





The	   following	   deletion	   strains	   used	   for	   candidate	   screening	   are	   from	   the	   Yeast	   Knockout	  
Collection	   in	   the	   BY4741	   background	   (Open	   Biosystems):	   crg1Δ::kanMX,	   ctm1Δ::kanMX,	  
htm1Δ::kanMX,	  mni1Δ::kanMX,	  mtq1Δ::kanMX,	  rkm1Δ::kanMX,	  rkm2Δ::kanMX,	  rkm3Δ::kanMX,	  
rmt2Δ::kanMX,	   see1Δ::kanMX,	   set2Δ::kanMX,	   set3Δ::kanMX,	   set4Δ::kanMX,	   set5Δ::kanMX,	  
set6Δ::kanMX,	   set7Δ::kanMX,	   tae1Δ::kanMX,	   trm12Δ::kanMX,	   ybr141cΔ::kanMX,	  
ybr271wΔ::kanMX,	   yjr129cΔ::kanMX,	   ylr063wΔ::kanMX,	   ylr137wΔ::kanMX,	   ymr209cΔ::kanMX,	  
ynl092wΔ::kanMX.	  	  The	  following	  deletion	  strain	  used	  for	  candidate	  screening	  is	  from	  the	  Yeast	  
Knockout	  Collection	  in	  the	  BY4742	  background	  (Open	  Biosystems):	  hsl7Δ::kanMX.	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TABLE	  3.2	  |	  Yeast	  histone	  H2B	  patterns	  of	  PTMs	  
	  




























*	  RSD	  =	  ±	  1.0%.	  
**	  PTM	  sites	  cannot	  be	  assigned.	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TABLE	  3.3	  |	  Candidates	  screened	  for	  putative	  H2BK37me2	  histone	  methyltransferase	  activity	  	  
	  
Candidate	   Annotated	  SGD	  description(s)	  
CRG1	   Putative	   S-­‐adenosylmethionine-­‐dependent	   methyltransferase;	   mediates	   cantharidin	  
resistance	  
	  
CTM1	   Cytochrome	   c	   lysine	  methyltransferase;	   trimethylates	   residue	   72	   of	   apo-­‐cytochrome	   c	  
(Cyc1p)	  in	  the	  cytosol;	  not	  required	  for	  normal	  respiratory	  growth	  
	  
DOT1	   Nucleosomal	   histone	   H3-­‐Lys79	   methylase;	   methylation	   is	   required	   for	   telomeric	  
silencing,	  meiotic	  checkpoint	  control,	  and	  DNA	  damage	  response	  
	  
HMT1	   Nuclear	   SAM-­‐dependent	   mono-­‐	   and	   asymmetric	   arginine	   dimethylating	  
methyltransferase	   that	   modifies	   hnRNPs,	   including	   Npl3p	   and	   Hrp1p,	   affecting	   their	  
activity	  and	  nuclear	  export;	  methylates	  U1	  snRNP	  protein	  Snp1p	  and	  ribosomal	  protein	  
Rps2p	  
	  
HSL7	   Protein	  arginine	  N-­‐methyltransferase	  that	  exhibits	  septin	  and	  Hsl1p-­‐dependent	  bud	  neck	  
localization	   and	   periodic	   Hsl1p-­‐dependent	   phosphorylation;	   required	   along	   with	   Hsl1p	  
for	  bud	  neck	  recruitment,	  phosphorylation,	  and	  degradation	  of	  Swe1p	  
	  
MNI1	   AdoMet-­‐dependent	  methyltransferase	  involved	  in	  a	  novel	  3-­‐methylhistidine	  modification	  
of	   ribosomal	   protein	   Rpl3p;	   seven	   beta-­‐strand	   MTase	   family	   member;	   null	   mutant	  
exhibits	  a	  weak	  vacuolar	  protein	  sorting	  defect	  and	  caspofungin	  resistance	  
	  
MTQ1	   S-­‐adenosylmethionine-­‐dependent	   methyltransferase;	   methylates	   translational	   release	  
factor	  Mrf1p	  
	  
RKM1	   SET-­‐domain	   lysine-­‐N-­‐methyltransferase,	   catalyzes	   the	   formation	   of	   dimethyllysine	  
residues	  on	  the	  large	  ribosomal	  subunit	  protein	  L23a	  (RPL23A	  and	  RPL23B)	  
	  
RKM2	   Ribosomal	  protein	   lysine	  methyltransferase,	   responsible	   for	   trimethylation	  of	   the	   lysine	  
residue	  at	  position	  3	  of	  Rpl12Ap	  and	  Rpl12Bp	  
	  
RKM3	   Ribosomal	   lysine	   methyltransferase	   specific	   for	   monomethylation	   of	   Rpl42ap	   and	  
Rpl42bp	  (lysine	  40);	  nuclear	  SET	  domain	  containing	  protein	  
	  
RMT2	   Arginine	  N5	  methyltransferase;	  methylates	  ribosomal	  protein	  Rpl12	  (L12)	  on	  Arg67	  
SEE1	   Probable	  lysine	  methyltransferase	  involved	  in	  the	  dimethylation	  of	  eEF1A	  (Tef1p/Tef2p);	  
sequence	  similarity	  to	  S-­‐adenosylmethionine-­‐dependent	  methyltransferases	  of	  the	  seven	  
beta-­‐strand	  family;	  role	  in	  vesicular	  transport	  
	  
SET1	   Histone	  methyltransferase,	  subunit	  of	   the	  COMPASS	   (Set1C)	  complex	  which	  methylates	  
histone	  H3	   on	   lysine	   4;	   required	   in	   transcriptional	   silencing	   near	   telomeres	   and	   at	   the	  
silent	  mating	  type	  loci;	  contains	  a	  SET	  domain	  
	  
SET2	   Histone	  methyltransferase	  with	  a	   role	   in	   transcriptional	  elongation,	  methylates	  a	   lysine	  
residue	   of	   histone	   H3;	   associates	   with	   the	   C-­‐terminal	   domain	   of	   Rpo21p;	   histone	  
methylation	  activity	  is	  regulated	  by	  phosphorylation	  status	  of	  Rpo21p	  
	  
SET3	   Defining	  member	   of	   the	   SET3	   histone	   deacetylase	   complex	   which	   is	   a	  meiosis-­‐specific	  
repressor	   of	   sporulation	   genes;	   necessary	   for	   efficient	   transcription	   by	   RNAPII;	   one	   of	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two	  yeast	  proteins	  that	  contains	  both	  SET	  and	  PHD	  domains	  
	  
SET4	   Protein	  of	  unknown	  function,	  contains	  a	  SET	  domain	  
	  
SET5	   Zinc-­‐finger	  protein	  of	  unknown	  function,	  contains	  one	  canonical	  and	  two	  unusual	  fingers	  
in	  unusual	  arrangements;	  deletion	  enhances	  replication	  of	  positive-­‐strand	  RNA	  virus	  
	  
SET6	   SET	   domain	   protein	   of	   unknown	   function;	   deletion	   heterozygote	   is	   sensitive	   to	  
compounds	  that	  target	  ergosterol	  biosynthesis,	  may	  be	  involved	  in	  compound	  availability	  
	  
SET7/RKM4	   Ribosomal	   lysine	   methyltransferase	   specific	   for	   monomethylation	   of	   Rpl42ap	   and	  
Rpl42bp	  (lysine	  55);	  nuclear	  SET-­‐domain	  containing	  protein	  
	  
TAE1	   AdoMet-­‐dependent	  proline	  methyltransferase;	  catalyzes	  the	  dimethylation	  of	  ribosomal	  
proteins	  Rpl12	  and	  Rps25	  at	  N-­‐terminal	  proline	  residues;	  has	  a	  role	  in	  protein	  synthesis;	  
fusion	  protein	  localizes	  to	  the	  cytoplasm	  
	  
TRM12	   S-­‐adenosylmethionine-­‐dependent	   methyltransferase	   of	   the	   seven	   beta-­‐strand	   family;	  
required	  for	  wybutosine	  formation	  in	  phenylalanine-­‐accepting	  tRNA	  
	  
YBR141C	   Putative	   S-­‐adenosylmethionine-­‐dependent	   methyltransferase;	   GFP-­‐fusion	   protein	  
localizes	  to	  the	  nucleolus	  
	  
YBR271W	   Putative	   S-­‐adenosylmethionine-­‐dependent	   methyltransferase	   of	   the	   seven	   beta-­‐strand	  
family;	   GFP-­‐fusion	   protein	   localizes	   to	   the	   cytoplasm;	   predicted	   to	   be	   involved	   in	  
ribosome	  biogenesis	  
	  
YJR129C	   Putative	   protein	   of	   unknown	   function;	   predicted	   S-­‐adenosylmethionine-­‐dependent	  
methyltransferase	   of	   the	   seven	   beta-­‐strand	   family;	   GFP-­‐fusion	   protein	   localizes	   to	   the	  
cytoplasm	  
	  
YLR063W	   Putative	   S-­‐adenosylmethionine-­‐dependent	   methyltransferase;	   GFP-­‐fusion	   protein	  
localizes	  to	  the	  cytoplasm	  
	  
YLR137W	   Putative	  S-­‐adenosylmethionine-­‐dependent	  methyltransferase	  
	  
YMR209C	   Putative	  S-­‐adenosylmethionine-­‐dependent	  methyltransferase	  
	  





	  TABLE	  3.4	  |	  Genes	  that	  are	  upregulated	  at	  least	  two-­‐fold	  in	  H2B	  K37A	  mutant	  cells	  
	  
Candidate	   Name	   Fold	  
Change*	  
Annotated	  SGD	  description(s)	  
YNL065W	   AQR1	   2.50	   Plasma	   membrane	   multidrug	   transporter	   of	   the	   major	  
facilitator	   superfamily,	   confers	   resistance	   to	   short-­‐chain	  
monocarboxylic	  acids	  and	  quinidine;	   involved	   in	   the	  excretion	  
of	  excess	  amino	  acids	  
	  





TABLE	  3.5	  |	  Genes	  that	  are	  downregulated	  at	  least	  two-­‐fold	  in	  H2B	  K37A	  mutant	  cells	  
	  
Candidate	   Name	   Fold	  
Change*	  
Annotated	  SGD	  description(s)	  
YHR209W	   CRG1	   0.49	   Putative	   S-­‐adenosylmethionine-­‐dependent	   methyltransferase;	  
mediates	  cantharidin	  resistance	  
	  
YKL163W	   PIR3	   0.49	   O-­‐glycosylated	   covalently-­‐bound	   cell	  wall	   protein	   required	   for	  
cell	  wall	   stability;	  expression	   is	  cell	   cycle	   regulated,	  peaking	   in	  
M/G1	   and	   also	   subject	   to	   regulation	   by	   the	   cell	   integrity	  
pathway	  
	  
YEL011W	   GLC3	   0.48	   Glycogen	   branching	   enzyme,	   involved	   in	   glycogen	  
accumulation;	  GFP-­‐fusion	  protein	   localizes	  to	  the	  cytoplasm	  in	  
a	  punctate	  pattern	  
	  
YOR028C	   CIN5	   0.48	   Basic	   leucine	   zipper	   (bZIP)	   transcription	   factor	   of	   the	   yAP-­‐1	  
family,	  mediates	  pleiotropic	  drug	  resistance	  and	  salt	  tolerance;	  
nuclearly	   localized	   under	   oxidative	   stress	   and	   sequestered	   in	  
the	  cytoplasm	  by	  Lot6p	  under	  reducing	  conditions	  
	  
YHR184W	   SSP1	   0.48	   Protein	   involved	   in	   the	  control	  of	  meiotic	  nuclear	  division	  and	  
coordination	   of	  meiosis	  with	   spore	   formation;	   transcription	   is	  
induced	  midway	  through	  meiosis	  
	  
YMR101C	   SRT1	   0.48	   Cis-­‐prenyltransferase	   involved	   in	   synthesis	   of	   long-­‐chain	  
dolichols	   (19-­‐22	   isoprene	   units;	   as	   opposed	   to	   Rer2p	   which	  
synthesizes	   shorter-­‐chain	   dolichols);	   localizes	   to	   lipid	   bodies;	  
transcription	  is	  induced	  during	  stationary	  phase	  
	  
YBR147W	   RTC2	   0.47	   Protein	  of	  unknown	  function;	  identified	  in	  a	  screen	  for	  mutants	  
with	  decreased	  levels	  of	  rDNA	  transcription;	  detected	  in	  highly	  
purified	  mitochondria;	  null	  mutant	  suppresses	  cdc13-­‐1;	  similar	  
to	  a	  G-­‐protein	  coupled	  receptor	  from	  S.	  pombe	  
	  
YDL169C	   UGX2	   0.47	   Protein	   of	   unknown	   function,	   transcript	   accumulates	   in	  
response	  to	  any	  combination	  of	  stress	  conditions	  
	  
YDL079C	   MRK1	   0.47	   Glycogen	  synthase	  kinase	  3	  (GSK-­‐3)	  homolog;	  one	  of	  four	  GSK-­‐3	  
homologs	   in	   S.	   cerevisiae	   that	   function	   to	   activate	   Msn2p-­‐
dependent	   transcription	   of	   stress	   responsive	   genes	   and	   that	  
function	  in	  protein	  degradation	  
	  
YMR206W	   -­‐-­‐-­‐	   0.46	   Putative	   protein	   of	   unknown	   function;	   YMR206W	   is	   not	   an	  
essential	  gene	  
	  
YGL158W	   RCK1	   0.45	   Protein	   kinase	   involved	   in	   the	   response	   to	   oxidative	   stress;	  
identified	   as	   suppressor	   of	   S.	   pombe	   cell	   cycle	   checkpoint	  
mutations	  
	  
YOR178C	   GAC1	   0.45	   Regulatory	  subunit	  for	  Glc7p	  type-­‐1	  protein	  phosphatase	  (PP1),	  
tethers	   Glc7p	   to	   Gsy2p	   glycogen	   synthase,	   binds	   Hsf1p	   heat	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shock	  transcription	  factor,	  required	  for	  induction	  of	  some	  HSF-­‐
regulated	  genes	  under	  heat	  shock	  
	  
YFL052W	   ROP1	   0.44	   Putative	   zinc	   cluster	   protein	   that	   contains	   a	   DNA	   binding	  
domain;	   null	   mutant	   sensitive	   to	   calcofluor	   white,	   low	  
osmolarity	  and	  heat,	  suggesting	  a	  role	  for	  YFL052Wp	  in	  cell	  wall	  
integrity	  
	  
YDR277C	   MTH1	   0.44	   Negative	   regulator	   of	   the	   glucose-­‐sensing	   signal	   transduction	  
pathway,	   required	   for	   repression	   of	   transcription	   by	   Rgt1p;	  
interacts	  with	  Rgt1p	  and	  the	  Snf3p	  and	  Rgt2p	  glucose	  sensors;	  
phosphorylated	  by	  Yck1p,	  triggering	  Mth1p	  degradation	  
	  
YGR243W	   FMP43	   0.43	   Putative	  protein	  of	  unknown	  function;	  expression	  regulated	  by	  
osmotic	   and	   alkaline	   stresses;	   the	   authentic,	   non-­‐tagged	  
protein	   is	   detected	   in	   highly	   purified	   mitochondria	   in	   high-­‐
throughput	  studies	  
	  
YBR299W	   MAL32	   0.43	   Maltase	   (alpha-­‐D-­‐glucosidase),	   inducible	   protein	   involved	   in	  
maltose	   catabolism;	   encoded	   in	   the	   MAL3	   complex	   locus;	  
functional	   in	   genomic	   reference	   strain	   S288C;	   hydrolyzes	   the	  
disaccharides	  maltose,	  turanose,	  maltotriose,	  and	  sucrose	  
	  
YMR280C	   CAT8	   0.42	   Zinc	  cluster	  transcriptional	  activator	  necessary	  for	  derepression	  
of	   a	   variety	   of	   genes	   under	   non-­‐fermentative	   growth	  
conditions,	   active	   after	   diauxic	   shift,	   binds	   carbon	   source	  
responsive	  elements	  
	  
YIL057C	   RGI2	   0.37	   Putative	   protein	   of	   unknown	   function;	   expression	   induced	  








FIGURE	  3.1	  |	  Top-­‐down	  mass	  spectrometry	  (MS)	  analysis	  reveals	  histone	  H2B	  is	  dimethylated	  
at	   lysine	   37.	   	   (A)	   Top-­‐down	   µESI-­‐FTICR-­‐MS	   analysis	   of	   yeast	   histone	   H2B.	   	   Shown	   is	   a	   mass	  
spectrum	   of	   H2B	   revealing	   multiply	   modified	   forms	   of	   this	   histone,	   as	   indicated	   by	   peaks	  
numbered	   1-­‐9.	   	   Each	   peak	   was	   analyzed	   by	   top-­‐down	   µESI-­‐FTICR-­‐MS/MS	   analysis	   and	  
modifications	   identified	   are	   denoted	   in	   the	   legend.	   	   Asterisks	   indicate	   PTMs	   that	   were	   not	  
assigned.	  	  100	  scans	  per	  spectrum	  were	  acquired	  in	  the	  ICR	  cell	  with	  a	  resolution	  of	  580,000	  at	  
m/z	   400	   Da.	   	   (B)	   Top-­‐down	   µESI-­‐FTICR-­‐MS/MS	   analysis	   of	   peak	   4.	   	   ECD	  MS/MS	   spectrum	   of	  
histone	  H2B	  with	  two	  methyl	  marks	  (precursor:	  m/z	  1415.9	  Da,	  10+	  charge	  state)	  reveals	  lysine	  
37	  is	  dimethylated.	   	  N-­‐terminal	  (c	   ions)	  and	  C-­‐terminal	  (z	   ions)	  fragment	   ions	  are	  assigned	  and	  
shown	  in	  the	  upper	  panel.	  	  Lower	  panel	  denotes	  the	  ions	  in	  the	  sequence.	  	  Unassigned	  ions	  are	  
either	  internal	  fragment	  ions	  or	  electronic	  noise.	  	  100	  scans	  per	  spectrum	  were	  acquired	  in	  the	  
ICR	  cell	  with	  a	  resolution	  of	  580,000	  at	  m/z	  400	  Da.	   	  (C)	  Lysine	  37	  of	  H2B	  is	   located	  within	  the	  
DNA	   gyres	   in	   the	   nucleosomal	   structure.	   	   Histones	   H2A,	   H2B,	   H3	   and	   H4	   are	   shaded	   green,	  
yellow,	  red,	  and	  blue,	  respectively.	  	  The	  DNA	  backbone	  is	  colored	  gray.	  	  The	  yellow	  arrow	  points	  
to	   the	   location	   of	   lysine	   37	   of	   histone	   H2B.	   	   The	   nucleosomal	   representation	   was	   generated	  
using	   open-­‐source	   PyMOL	   software	   (PyMOL	   0.99rev10,	   DeLan	   Scientific	   LCC)	   with	   structural	  




FIGURE	  3.2	  |	   α -­‐H2BK37me2	  antibody	  is	  specific	  for	  dimethylated	  lysine	  37	  on	  histone	  H2B.	  	  (A)	  
A	   polyclonal	   antibody	   was	   purified	   from	   antiserum	   raised	   by	   immunizing	   rabbits	   with	   the	  
peptide	   SKARKme2ETYS-­‐C,	   where	   me2	   is	   dimethyl	   lysine.	   	   Peptide	   competition	   assay	  
demonstrates	   specificity	   of	   purified	  α-­‐H2BK37me2	   antibody	   for	   dimethyl	   lysine	   37	   of	   histone	  
H2B.	  	  Western	  blot	  analysis	  was	  completed	  using	  acid-­‐extracted	  histones	  from	  strains	  harboring	  
wild-­‐type	   Flag-­‐H2B	   (YKG001),	   Flag-­‐H2B	   K37A	   (YKG007),	   and	   Flag-­‐H2B	   K123R	   (YKG002),	  
demonstrating	  that	  dimethylation	  of	  lysine	  37	  on	  histone	  H2B	  occurs	  in	  vivo,	  as	  the	  antibody	  is	  
able	  to	  recognize	  this	  modification	  in	  wild-­‐type	  and	  H2B	  K123R-­‐derived	  histone	  samples,	  but	  not	  
histones	   extracted	   from	   the	   Flag-­‐H2B	   strain	   harboring	   a	   K37A	  mutation	   (No	  peptide	   controls:	  
left	   column,	   upper	   panels).	   	   Preincubation	   of	   the	   purified	   antibody	   with	   H2K37me2	   peptide	  
resulted	  in	  a	  loss	  of	  the	  ~15	  kDa	  band	  in	  all	  three	  histone	  samples,	  whereas	  preincubation	  with	  
unmodified	   H2BK37	   peptide	   did	   not	   alter	   the	   reactivity	   (middle	   and	   right	   columns,	   upper	  
panels).	  	  H2BK37me2	  signal	  was	  not	  detectable	  in	  Western	  blot	  analysis	  using	  IgG	  purified	  from	  
pre-­‐immune	   serum	   (lower	   panels).	   	   All	   blots	   were	   stripped	   and	   reprobed	   with	   an	   α-­‐H2B	  
antibody	   to	   demonstrate	   equal	   loading.	   	   (B)	  Western	   blot	   analysis	   using	  modification	   specific	  
antibodies	   indicates	   that	  mutation	  of	   lysine	  37	  on	  histone	  H2B	  does	  not	  affect	  methylation	  at	  
other	  known	  sites	  of	  methylation	  in	  budding	  yeast,	  including	  histone	  H3	  lysines	  4,	  36,	  and	  79.	  	  A	  
H2B	  K123R	  mutation	  abrogates	  methylation	  at	  H3K4	  and	  H3K79,	   in	  agreement	  with	  previously	  




FIGURE	   3.3	   |	   Candidate	   approach	   by	   Western	   blot	   analysis	   does	   not	   reveal	   the	  
methyltransferase	  and	  demethylase	  responsible	  for	  H2B	  lysine	  37	  methylation.	  	  (A)	  Following	  
validation	  of	  correct	  deletion	  of	   the	  ORF	  of	   interest	  and	  replacement	  with	  kanMX	  by	  genomic	  
PCR	   (data	  not	  shown),	  histones	  were	  acid-­‐extracted	   from	  candidates	   from	  the	  Yeast	  Knockout	  
Collection	   (Open	   Biosystems),	   and	   putative	   histone	   methyltransferase	   activity	   was	   tested	   by	  
Western	   blot	   analysis	   using	   the	   purified	   α-­‐H2BK37me2	   antibody.	   	   A	   Coomassie-­‐stained	   gel	  
illustrating	  a	  representative	  purification	  of	  histones	  is	  shown	  in	  upper	  panel,	  and	  representative	  
Western	  blots	  results	  from	  the	  candidate	  screen	  are	  shown	  below.	  	  The	  blots	  were	  first	  probed	  
with	   the	   α-­‐H2BK37me2	   antibody	   (upper)	   and	   then	   striped	   and	   reprobed	   with	   an	   α-­‐H2B	  
antibody	   (lower)	   to	  demonstrate	  equal	   loading.	   	  Histones	  derived	   from	  strains	  harboring	  wild-­‐
type	  Flag-­‐H2B	  (YKG001)	  and	  Flag-­‐H2B	  K37R	  (YKG006)	  or	  K37A	  (YKG007)	  were	  loaded	  on	  all	  gels	  
98	  
to	   demonstrate	   loss-­‐of-­‐signal	   upon	   mutation	   of	   lysine	   37,	   thereby	   serving	   as	   a	   control	   for	  
antibody	   specificity.	   	   The	   presence	   of	   a	   Flag-­‐tag	   on	   histone	   H2B	   results	   in	   the	   slight	   shift	   in	  
electrophoretic	  mobility	  observed	  in	  the	  control	  strains,	  as	  compared	  to	  untagged	  H2B	  species	  
in	   the	   candidate	   deletion	   strains.	   	   Deletion	   of	   candidate	   genes	   did	   not	   reveal	   a	   putative	  
H2BK37me2	   histone	   methyltransferase	   by	   Western	   blot	   analysis.	   	   (B)	   Histones	   were	   acid-­‐
extracted	  from	  the	  five	  JmjC-­‐domain-­‐containing	  protein	  deletions	   in	  Saccharomyces	  cerevisiae,	  
and	   putative	   histone	   demethylase	   activity	   was	   analyzed	   by	   Western	   blot	   analysis	   using	   the	  
purified	  α-­‐H2BK37me2	  antibody.	  	  Shown	  are	  Western	  blot	  results	  from	  the	  candidate	  screen,	  in	  
which	  the	  blots	  were	  first	  probed	  with	  the	  α-­‐H2BK37me2	  antibody	  (upper)	  and	  then	  striped	  and	  
reprobed	   with	   an	   α-­‐H2B	   antibody	   (lower)	   to	   demonstrate	   equal	   loading.	   	   Again,	   histones	  
derived	  from	  strains	  harboring	  wild-­‐type	  Flag-­‐H2B	  (YKG001)	  and	  Flag-­‐H2B	  K37A	  (YKG007)	  were	  
used	  as	  a	  control	  for	  antibody	  specificity,	  and	  the	  presence	  of	  a	  Flag-­‐tag	  on	  histone	  H2B	  results	  
in	   the	   slight	   shift	   in	   electrophoretic	  mobility	   observed	   in	   the	   control	   strains,	   as	   compared	   to	  
untagged	  H2B	  species	   in	   the	  candidate	  deletion	  strains.	   	  Deletion	  of	  each	   individual	  candidate	  
did	  not	  result	   in	  an	  enhanced	  signal,	   suggesting	  that	  none	  of	   these	  candidates	   function	  as	   the	  




FIGURE	  3.4	  |	  Phenotypic	  analysis	  of	  strains	  harboring	  H2B	  K37R/A	  mutations.	   	   (A)	  Phenotypic	  
spotting	  assays	   indicate	   that	   cells	  harboring	  mutations	  at	   lysine	  37	   in	  histone	  H2B	   to	  arginine	  
(YKG006)	   or	   alanine	   (YKG007)	   do	   not	   show	   sensitivity	   to	   YPD	   media	   containing	   100	   mM	  
hydroxyurea	  (HU;	  a	  DNA	  damaging	  agent	  that	  leads	  to	  replication	  fork	  collapse),	  as	  is	  observed	  
in	   an	  H2B	   K123R	  mutant	   strain	   (YKG002)	   (DAI	   et	   al.	   2010),	   but	   rather	   grow	   similarly	   to	   yeast	  
containing	  wild-­‐type	  H2B	   (YKG001).	   	   (B)	   Telomeric	   silencing	   assay	  demonstrates	   that	   reporter	  
strains	  harboring	  H2B	  K37R	  and	  H2B	  K37A	  mutations	  (YKG028	  and	  YKG029,	  respectively)	  exhibit	  
normal	  silencing	  like	  that	  observed	  for	  reporter	  strains	  expressing	  wild-­‐type	  H2B	  (YKG027),	  but	  
not	  strains	  that	  express	  an	  H2B	  K123R	  mutation	  (YZS274)	  or	  are	  deleted	  for	  SIR2	  (YZS275),	  which	  
have	  known	  defects	   in	  telomeric	  silencing	  (SUN	  and	  ALLIS	  2002).	   	  Growth	  on	  SC-­‐HIS	  serves	  as	  a	  
plating	   control,	   as	   all	   strains	   express	   H2B-­‐containing	   plasmids	   carrying	   a	   HIS3	   auxotrophic	  
marker.	   	   (C)	   Introduction	   of	  H2B	  K37R	  or	   K37A	  mutations	   (YKG033	   and	   YKG034,	   respectively)	  
into	   strains	   containing	   a	   temperature-­‐sensitive	   allele	   of	   SPT16	   (spt16-­‐197)	   does	   not	   affect	  
cellular	  growth	  at	  the	  semi-­‐	  and	  non-­‐permissive	  temperatures	  (32˚C	  and	  34˚C,	  respectively),	  as	  
cells	  grow	  at	  a	  similar	  rate	  to	  those	  harboring	  wild-­‐type	  H2B	  (YKG031).	  	  Introduction	  of	  an	  H2B	  
K123R	   mutation	   (YKG032)	   exacerbates	   growth	   in	   the	   spt16-­‐197	   background	   at	   the	   semi-­‐
permissive	   temperature,	   in	   agreement	  with	  previously	  published	   results	   (FLEMING	   et	   al.	   2008).	  	  
The	   isogenic	   parental	   strain	   Y131	   expressing	  wild-­‐type	   SPT16	   grows	   phenotypically	   normal	   at	  




FIGURE	   3.5	   |	   RT-­‐qPCR	   analysis	   recapitulates	   microarray	   results	   of	   gene	   expression	   changes	  
upon	  mutation	  of	  H2B	  lysine	  37.	   	  Yeast	  cells	  harboring	  wild-­‐type	  H2B	  (YKG001)	  or	  a	  H2B	  K37A	  
mutation	   (YKG007)	   were	   grown	   to	   mid-­‐log	   phase,	   and	   RNA	   samples	   were	   isolated.	   	   The	  
expression	   of	   genes	   identified	   as	   up-­‐	   or	   downregulated	   upon	   mutation	   of	   lysine	   37	   by	  
microarray	   analysis	   was	   verified	   by	   RT-­‐quantitative	   real	   time	   PCR	   analysis	   (RT-­‐qPCR)	   using	  
primers	  designed	  against	  the	  5’	  or	  3’	  end	  of	  the	  open	  reading	  frame.	   	  Representative	  RT-­‐qPCR	  
analysis	   is	   shown	   for	  AQR1	   and	   FMP43,	   which	   were	   up-­‐	   and	   downregulated,	   respectively,	   in	  
yeast	  cells	  harboring	  the	  H2B	  K37A	  mutation	  relative	  to	  wild-­‐type	  H2B	  according	  to	  microarray	  




FIGURE	   3.6	   |	   Methylation	   of	   lysine	   37	   of	   histone	   H2B	   is	   conserved.	   	   (A)	   Multiple	   sequence	  
alignment	  of	  histone	  H2B	  from	  different	  species	  reveals	  that	  budding	  yeast	  histone	  H2B	   lysine	  
37	   is	   conserved	   from	   yeast	   to	   humans.	   	   Sequence	   alignment	   was	   completed	   using	   ClustalX	  
(LARKIN	   et	   al.	   2007).	   	   NCBI	   accession	   numbers	   are	   as	   follows:	   Saccharomyces	   cerevisiae:	  
NP_010510.1;	   Schizosaccharomyces	   pombe:	   NP_588181.1;	   Drosophila	   melanogaster:	  
NP_724342.1;	   Caenorhabditis	   elegans:	   NP_507031.1;	   Xenopus	   laevis:	   NP_001086753.1;	   Mus	  
musculus:	   NP_783594.1;	   Gallus	   gallus:	   CAA40537.1;	   Bos	   taurus:	   DAA31692.1;	   Homo	   sapiens:	  
NP_733759.1.	  	  Asterisk	  (*)	  denotes	  position	  of	  conserved	  lysine	  residue.	  	  (B)	  Increasing	  amounts	  
of	   oligonucleosomes	   purified	   from	   chicken	   erythrocyte	   nuclei	   and	  mononucleosomes	   isolated	  
from	  HeLa	  cell	  nuclei	  were	  run	  against	  histones	  extracted	  from	  yeast	  strains	  harboring	  wild-­‐type	  
Flag-­‐H2B	  (YKG001),	  Flag-­‐H2B	  K37A	  (YKG007),	  and	  wild-­‐type	  H2B	  (untagged)	  (BY4742),	  as	  shown	  
by	   Coomassie	   brilliant	   blue	   (CBB)	   staining	   of	   histone	   proteins	   electrophoresed	   on	   15%	   SDS-­‐
polyacrylamide	   gels	   (lower	   panel).	   	   An	   equivalent	   loading	   of	   histone	   substrate	   was	   used	   for	  
Western	  blot	  analysis	  using	  purified	  α-­‐H2BK37me2	  antibody	  (upper	  panel).	   	  Similar	  signals	  are	  
detected	   for	   chicken-­‐	   and	   human-­‐derived	   histone	   substrates	   to	   that	   observed	   for	   yeast	  
harboring	  wild-­‐type	  H2B	  (either	  tagged	  or	  untagged),	  but	  not	  yeast	  H2B	  with	  an	  K37A	  mutation,	  
thus	  demonstrating	  that	  dimethylation	  of	  histone	  H2B	  lysine	  37	  is	  conserved	  among	  species.	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Histones,	  the	  fundamental	  packaging	  elements	  of	  eukaryotic	  DNA,	  are	  highly	  decorated	  with	  a	  
diverse	   set	   of	   post-­‐translational	   modifications	   (PTMs)	   that	   are	   recognized	   to	   govern	   the	  
structure	   and	   function	   of	   chromatin.	   	   Ten	   years	   ago,	   we	   put	   forward	   the	   histone	   code	  
hypothesis,	   which	   provided	   a	   model	   to	   explain	   how	   single	   and/or	   combinatorial	   PTMs	   on	  
histones	  regulate	  the	  diverse	  activities	  associated	  with	  chromatin	  (e.g.	  gene	  transcription).	  	  At	  
that	   time,	   there	   was	   a	   limited	   understanding	   of	   both	   the	   number	   of	   PTMs	   that	   occur	   on	  
histones	  as	  well	  as	  the	  proteins	  that	  place,	  remove	  and	  interpret	  them.	  	  Since	  the	  conception	  
of	  this	  hypothesis,	  the	  field	  has	  witnessed	  an	  unprecedented	  advance	  in	  our	  understanding	  of	  
the	   enzymes	   that	   contribute	   to	   the	   establishment	   of	   histone	   PTMs,	   as	   well	   as	   the	   diverse	  
effector	  proteins	  that	  bind	  them.	   	  While	  debate	  continues	  as	  to	  whether	  histone	  PTMs	  truly	  
constitute	   a	   strict	   “code”,	   it	   is	   becoming	   clear	   that	   PTMs	   on	   histone	   proteins	   function	   in	  
elaborate	   combinations	   to	   regulate	   the	  many	   activities	   associated	   with	   chromatin.	   	   In	   this	  
special	  issue,	  we	  celebrate	  the	  50th	  anniversary	  of	  the	  landmark	  publication	  of	  the	  lac	  operon	  
with	   a	   review	   that	   provides	   a	   current	   view	   of	   the	   histone	   code	   hypothesis,	   the	   lessons	  we	  
have	  learned	  over	  the	  last	  decade,	  and	  the	  technologies	  that	  will	  drive	  our	  understanding	  of	  
histone	  PTMs	  forward	  in	  the	  future.	  
	  
“Small	  changes	  modifying	  the	  distribution	  in	  time	  and	  space	  of	  the	  same	  structures	  are	  
sufficient	   to	   affect	   deeply	   the	   form,	   the	   functioning,	   and	   the	   behavior	   of	   the	   final	  
product….	   It	   is	   always	   a	   matter	   of	   using	   the	   same	   elements,	   of	   adjusting	   them,	   of	  
altering	   here	   or	   there,	   of	   arranging	   various	   combinations	   to	   produce	   new	   objects	   of	  
increasing	  complexity.	  	  It	  is	  always	  a	  matter	  of	  tinkering.”	  
–	  François	  Jacob,	  “Evolution	  and	  Tinkering”	  (Science	  1977)	  	  
	  
The	  adult	  animal	  was	   in	  actuality	   the	   final	  product	   that	  François	   Jacob	  was	   referring	   to	   in	   this	  
eloquent	   statement	   taken	   from	   his	   article	   “Evolution	   and	   Tinkering”	   (JACOB	   1977).	   	   Yet,	   as	  
chromatin	  biologists,	  we	  delight	  in	  the	  applicability	  of	  Jacob’s	  quote	  regarding	  the	  plasticity	  of	  a	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single	  template	  to	  the	  chromatin	  landscape.	  	  However,	  François	  Jacob	  is	  not	  best	  known	  for	  his	  
theories	  on	  how	  patterns	  of	  gene	  expression	  affect	  evolution,	  but	   rather	   for	  his	   seminal	  work	  
with	   Jacques	   Monod	   establishing	   the	   basis	   of	   the	   lac	   operon.	   In	   celebration	   of	   the	   50th	  
anniversary	   of	   François	   Jacob	   and	   Jacques	   Monod’s	   landmark	   publication	   on	   the	   lac	   operon	  
(JACOB	  and	  MONOD	  1961),	  we	  are	  honored	  to	  contribute	  this	  piece	   in	  which	  we	  reflect	  on	  how	  
several	   of	   the	   scientific	   themes	   put	   forward	   by	   Jacob	   and	   Monod	   in	   their	   historic	   work	   are	  
widely	  applicable	  to	  topics	  as	  diverse	  as	  chromatin	  biology	  and	  the	  histone	  code	  hypothesis.	  
In	   simplistic	   terms,	   an	   operon	   is	   a	   functional	   genomic	   unit	   comprised	   of	   a	   cluster	   of	  
genes	   that	   is	   controlled	   by	   a	   single	   regulatory	   element	   or	   promoter	   (JACOB	   et	   al.	   1960).	  	  
Complementary	  genetic	  and	  biochemical	  studies	  revealed	  that	  the	  basic	  principle	  underlying	  the	  
lac	  operon	   is	   that	   the	   coordinated	  expression	  of	   the	  genes	  necessary	   to	  metabolize	   lactose	   is	  
under	  the	  control	  of	  the	   lac	  repressor	  protein	  and	  activator	  protein	  CAP,	  which	  negatively	  and	  
positively	  control	   transcription	  of	   the	   lac	  operon,	  respectively	   (JACOB	  and	  MONOD	  1961).	   	  From	  
the	  pioneering	  studies	  on	   the	   lac	  operon	  completed	  by	   Jacob	  and	  Monod,	  we	  now	  know	  that	  
there	  are	   three	  major	   types	  of	   regulatory	  DNA	  sequences	   that	   function	   in	   the	  control	  of	  gene	  
expression	  in	  prokaryotes:	  (1)	  promoter	  sequences	  to	  which	  RNA	  polymerase	  binds;	  (2)	  operator	  
sequences	  to	  which	  transcriptional	  repressors	  bind;	  and	  (3)	  positive	  control	  elements	  to	  which	  
transcriptional	  activator	  proteins	  bind	  (STRUHL	  1999).	  	  While	  the	  lac	  operon	  provides	  a	  simple	  yet	  
elegant	  mechanism	  by	  which	  gene	  expression	  is	  controlled	  in	  prokaryotes,	  it	  is	  unreasonable	  to	  
think	   that	   such	   a	   system	  would	   adequately	   provide	   a	  means	   by	  which	   efficient	   regulation	   of	  
gene	  expression	  could	  occur	  in	  eukaryotes,	  where	  DNA	  must	  be	  highly	  compacted	  to	  fit	  within	  
the	   confines	   of	   the	   nuclear	   space.	   	   The	   need	   for	   differential	   patterns	   of	   gene	   expression	   to	  
specify	  diverse	  types	  of	  tissues	  from	  a	  single	  genome	  in	  multicellular	  organisms	  also	  calls	  for	  the	  
existence	  of	  additional	  regulatory	  mechanisms.	  	  For	  example,	  cellular	  identity	  must	  be	  faithfully	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maintained	  through	  cell	  divisions	   for	  a	   lifetime,	  despite	  differentiation	  occurring	  earlier	  during	  
embryonic	   development.	   	   The	   plasticity	   of	   cellular	   differentiation	   and	   the	   stability	   of	   cellular	  
memory	   are	   thought	   to	   represent	   epigenetic	   phenomena	   wherein	   inherited	   changes	   in	  
phenotype	   occur	   independently	   of	   changes	   in	   the	   underlying	  DNA	   sequence	   and	  without	   the	  
need	  for	  trans-­‐factors	  that	  establish	  the	  initial	  programs	  of	  coordinated	  gene	  regulation.	  	  Hence,	  
while	  the	  historic	  work	  of	  Jacob	  and	  Monod	  reveals	  an	  elegant	  mechanism	  for	  prokaryotic	  gene	  
regulation,	   it	   is	   clear	   that	  more	   sophisticated	  means	  of	   gene	   regulation	   involving	   components	  
that	  do	  more	  than	  engage	  the	  DNA	  template	  alone	  are	  necessary	  for	  processes	  such	  as	  cellular	  
memory	  in	  multicellular	  eukaryotes.	  
Based	   on	   many	   insightful	   studies	   on	   chromosome	   structure,	   we	   know	   that	   in	  
eukaryotes,	   DNA	   is	   assembled	   on	   a	   histone	   scaffold	   to	   form	   chromatin	   (KORNBERG	   and	   LORCH	  
1999).	   	  The	  nucleosome	  core	  particle,	  or	   fundamental	   repeating	  unit	  of	  chromatin,	  consists	  of	  
approximately	  147	  base	  pairs	  of	  DNA	  wrapped	  around	  an	  octamer	  containing	  one	  tetramer	  of	  
histones	   H3	   and	   H4	   (two	   copies	   each)	   and	   two	   histone	   H2A-­‐H2B	   dimers	   (KORNBERG	   1974;	  
KORNBERG	  and	  LORCH	  1999;	  LUGER	  et	  al.	  1997;	  OUDET	  et	  al.	  1975).	  	  Nucleosomes	  are	  packaged	  into	  
progressively	   higher-­‐order	   structures	   to	   ultimately	   form	   chromosomes.	   	   Chromatin	   structure	  
largely	  affects	  DNA-­‐templated	  processes	  such	  as	  transcription,	  thus	  necessitating	  that	  access	  to	  
DNA	  be	  tightly	  controlled	  to	  allow	  factors	  that	  function	  in	  such	  processes	  to	  make	  appropriate	  
contacts	  with	  the	  DNA	  template	  itself	  (KORNBERG	  and	  LORCH	  1999;	  WOLFFE	  and	  HAYES	  1999).	  	  Post-­‐
translational	  modifications	  (PTMs)	  to	  the	  histone	  proteins	  themselves	  can	  significantly	  affect	  the	  
levels	   of	   chromatin	   compaction	   by	   creating	   generally	   condensed	   “heterochromatic”	   or	   more	  
open	  “euchromatic”	  regions,	  and	  therefore	  provide	  a	  means	  by	  which	  rapid	  and	  localized	  access	  
to	  DNA	  can	  be	  accomplished	   (BERGER	  2007;	  KOUZARIDES	  2007).	   	  Additionally,	  other	  well-­‐studied	  
mechanisms,	   such	   as	   ATP-­‐dependent	   chromatin	   remodeling	   and	   the	   exchange	   of	   primary	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sequence	   histone	   variants,	   introduce	   meaningful	   variation	   into	   the	   chromatin	   polymer,	  
“tinkering”	   in	   such	   a	  way	   that	   one	   relatively	   stable	   genome	   can	   give	   rise	   to	   the	   demands	   of	  
multicellular	  development	  (CLAPIER	  and	  CAIRNS	  2009;	  HO	  and	  CRABTREE	  2010;	  TALBERT	  and	  HENIKOFF	  
2010).	  
	  
The	  “histone	  code	  hypothesis”:	  the	  first	  ten	  years.	   	  In	  2000,	  we	  proposed	  what	  has	  commonly	  
come	  to	  be	  referred	  to	  as	  the	  ‘histone	  code	  hypothesis’,	  which,	   in	  its	  original	  form,	  posits	  that	  
“multiple	   histone	   modifications,	   acting	   in	   a	   combinatorial	   or	   sequential	   fashion	   on	   one	   or	  
multiple	  histone	  tails,	  specify	  unique	  downstream	  functions”	  (STRAHL	  and	  ALLIS	  2000).	   	  Parallels	  
to	  François	  Jacob’s	  quote	  from	  “Evolution	  and	  Tinkering”	  are	  readily	  apparent.	  	  The	  same	  fixed	  
set	   of	   amino	   acids	   that	   make	   up	   the	   histone	   proteins	   have	   the	   potential	   of	   being	   post-­‐
translationally	  modified	  within	  the	  chromatin	  template,	  where	  distinct	  spatiotemporal	  patterns	  
of	  modifications	   ultimately	   shape	   functional	   outcome.	   	   One	   of	   the	  more	   striking	   phenomena	  
predicted	   by	   such	   a	   code	   is	   that	   subtle	   variations	   to	   the	   same	   template	   can	   result	   in	   vastly	  
different	  outcomes,	  especially	  in	  the	  context	  of	  regulation	  of	  gene	  expression.	  
At	   the	   time	   that	   we	   proposed	   the	   histone	   code	   hypothesis,	   we	   had	   a	   limited	  
understanding	   of	   the	   true	   breadth	   of	   the	   number	   and	   type	   of	   PTMs	   that	   exist	   on	   histone	  
residues	  either	  on	  the	  unstructured	  N-­‐terminal	  tails	  that	  protrude	  from	  the	  nucleosomal	  surface	  
or	   within	   the	   structured	   globular	   domains.	   	   Acetylation	   and	   phosphorylation	   were	   the	   best-­‐
characterized	   modifications	   at	   that	   time,	   with	   multiple	   sites	   and	   several	   of	   the	   enzymes	  
responsible	  for	  their	  placement	  and	  removal	  having	  been	  identified.	  	  However,	  investigations	  on	  
the	  dynamics	  of	  histone	  methylation	  were	  in	  their	  infancy.	  	  Only	  a	  handful	  of	  sites	  modified	  by	  
methylation	  were	  known,	  and	  the	  function	  of	  histone	  methylation	  was	  largely	  unclear,	  primarily	  
because	  the	  enzyme	  systems	  responsible	  for	  the	  steady-­‐state	  balance	  of	  methyl	  marks	  (histone	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methyltransferases	   and	   demethylases)	   were	   not	   yet	   identified	   and	   the	   intricacies	   associated	  
with	   a	   modification	   that	   could	   exist	   in	   multiple	   states	   (mono-­‐,	   di-­‐,	   or	   trimethyl)	   complicated	  
studies.	   	   Insight	   into	  other	  modifications	  was	  even	  more	  rudimentary.	   	  Today,	  we	  know	  that	  a	  
number	   of	   PTMs	   exist,	   including	   acetylation,	   methylation,	   phosphorylation,	   ubiquitylation,	  
sumoylation,	  ADP-­‐ribosylation,	  proline	  isomerization,	  citrullination,	  butyrylation,	  propionylation,	  
and	  glycosylation	  (TABLE	  4.1)	  (CHEN	  et	  al.	  2007;	  KOUZARIDES	  2007;	  SAKABE	  et	  al.	  2010).	  	  Numerous	  
studies	  using	  both	  biochemical	  and	  genetic	  approaches	  have	  revealed	  many	  of	  the	  enzymes	  that	  
are	  responsible	  for	  placement	  or	  removal	  of	  these	  modifications	  on	  specific	  amino	  acid	  residues	  
on	  histones	  as	  well	  as	  non-­‐histone	  proteins.	  	  While	  the	  functional	  significance	  of	  some	  of	  these	  
modifications	   remains	   to	  be	  determined,	   the	  collective	   field	  of	   chromatin	  biologists	  has	  made	  
great	   strides	   toward	   identifying	   the	   biological	   consequence	   of	   others.	   	   For	   example,	  
modifications	   can	   disturb	   contacts	   between	   histones	   in	   contiguous	   nucleosomes	   or	   histones	  
with	  DNA,	  resulting	  in	  alteration	  of	  higher-­‐order	  chromatin	  structure.	  	  Specifically,	  acetylation	  of	  
lysine	   residues	  on	  histone	   tails	  neutralizes	   the	  basic	   charge	  of	   the	   residue	  on	  which	   it	  occurs,	  
thereby	   disrupting	   histone	   contacts	   with	   other	   histones	   and/or	   DNA	   and	   in	   turn	   chromatin	  
compaction	  (WOLFFE	  and	  HAYES	  1999).	  	  While	  it	  had	  been	  known	  that	  histone	  modifications	  such	  
as	   methylation	   did	   not	   disrupt	   nucleosomal	   contacts	   by	   altering	   the	   charge	   of	   the	   modified	  
residue,	  we	  now	   know	   that	   specialized	   domains	  within	   effector	   proteins	   facilitate	   recognition	  
and	   binding	   to	  methyl	  marks	   in	   a	   defined	   state	   on	   specific	   residues	   to	  mediate	   downstream	  
effects.	   	  Domains	   characterized	   thus	   far	   as	   being	   able	   to	  bind	   to	  methylated	   residues	   include	  
chromodomains,	  tudor	  domains,	  PHD	  fingers,	  MBT	  domains,	  Ankyrin	  repeats,	  PWWP	  domains,	  
HEAT	  domains	  and	  WD40	  repeats	  (TABLE	  4.1)	  (COLLINS	  et	  al.	  2008;	  LIU	  et	  al.	  2010;	  TAVERNA	  et	  al.	  
2007a;	   VEZZOLI	   et	   al.	   2010;	   WANG	   et	   al.	   2009).	   	   Other	   domains	   that	   recognize	   and	   bind	   to	  
specifically	   modified	   histone	   forms	   have	   also	   been	   characterized.	   	   For	   instance,	   where	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bromodomains	  can	  bind	  to	  acetylated	  lysine	  residues,	  14-­‐3-­‐3,	  BRCT,	  and	  BIR	  domains	  can	  bind	  
to	   phosphorylated	   threonine	   and	   serine	   residues	   (TABLE	   4.1)	   (KELLY	   et	   al.	   2010;	   TAVERNA	   et	   al.	  
2007a).	  	  
The	  chromatin-­‐modifying	  enzymes	  that	  facilitate	  alterations	  to	  the	  chromatin	  landscape	  
by	  placing,	  removing,	  or	  interpreting	  modifications	  to	  establish	  variable	  states	  have	  been	  more	  
recently	  come	  to	  be	  generally	   referred	  to	  as	  writers,	  erasers,	  and	  readers,	   respectively,	  of	   the	  
histone	  code	   (FIGURE	  4.1).	   	  Returning	  to	   the	   idea	  of	   tinkering	  with	  chromatin,	  we	  are	  now	   in	  a	  
position	  to	  appreciate	  the	  true	  potential	  of	  a	  “toolkit”	  (LIM	  and	  PAWSON	  2010)	  of	  writers,	  erasers,	  
and	   readers	   of	   the	   histone	   code	   in	   the	   establishment	   of	   proper	   spatiotemporal	   patterns	   of	  
modifications	  necessary	  for	  cellular	  identity	  and	  function.	  	  At	  defined	  points,	  writers	  place	  marks	  
on	   defined	   histone	   residues,	   which	   are	   in	   turn	   interpreted	   by	   readers	   harboring	   specialized	  
domains	   that	   facilitate	   recognition	   and	   binding	   to	   the	   specific	   mark	   of	   interest	   to	   drive	   the	  
progression	   of	   a	   specific	   biological	   phenomenon.	   	   At	   a	   time	  when	   such	   signaling	   needs	   to	   be	  
terminated,	  erasers	  are	  recruited	  to	  their	  defined	  target(s)	  to	  remove	  the	  mark,	  thereby	  ending	  
the	  associated	  functional	  outcome	  of	  the	  previously	  defined	  reader.	  	  Admittedly,	  the	  situation	  is	  
made	  vastly	  more	  complicated	  by	  the	  fact	  that	  particular	  amino	  acid	  residues	  can	  house	  more	  
than	  one	  type	  of	  modification	  (this	  is	  largely	  true	  for	  lysine	  residues,	  which	  can	  be	  methylated,	  
acetylated,	   ubiquitylated,	   or	   sumoylated),	   and	   that	   some	   enzymes	   can	   write,	   erase,	   or	   read	  
more	  than	  one	  modification.	   	  Moreover,	  one	  mark	  can	  often	  recruit	  multiple	  effector	  proteins	  
(RUTHENBURG	  et	  al.	  2007a;	  SIMS	  and	  REINBERG	  2006).	   	  Such	  complications,	  however,	  support	  the	  
general	  notion	  of	  tinkering	  with	  combinatorial	  pattern	  of	  PTMs	  to	  control	  proper	  recruitment	  of	  
effector	  proteins	  or	  complexes	  in	  which	  they	  reside.	  
We	   appreciate	   that	   the	   “histone	   code	   hypothesis”,	   as	   originally	   articulated	   by	   us	   in	  
2000,	   evolved	   into	   an	   influential	   review	   on	   the	   function(s)	   of	   covalent	   histone	  modifications.	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We	  acknowledge	   that	   this	   hypothesis,	   and	   extensions	   of	   it,	   rest	   heavily	   on	   the	   foundation	   of	  
many	  biologists	  and	  biochemists	  who	  were	  dedicated	   to	   the	  general	  view	   that	  chromatin	  was	  
going	  to	  be	  much	  more	  than	  a	  passive	  way	  to	  package	  the	  genome.	   	  However,	  because	  of	  the	  
rapid	   pace	   of	   research	   in	   chromatin	   biology	   and	   the	   complexity	   associated	   with	   chromatin	  
modifications	   such	  as	   those	  mentioned	  above,	  we	  must	   continually	   refine	  how	  we	  define	   the	  
histone	   code.	   	   In	   fact,	   the	   mere	   existence	   of	   a	   code	   in	   the	   first	   place	   has	   been	   a	   point	   of	  
contention	  (SMITH	  and	  SHILATIFARD	  2010).	   	  Beyond	  discussions	  in	  the	  field	  as	  to	  whether	  a	  strict	  
histone	  code	  truly	  exists,	  there	  is	  also	  debate	  over	  whether	  it	  is	  most	  appropriate	  to	  define	  it	  as	  
“code”	   in	   which	   definite	   combinations	   lead	   to	   an	   absolute	   outcome	   (as	   exemplified	   by	   the	  
genetic	   code).	   	   Some	   see	   it	   more	   in	   terms	   of	   a	   “language”,	   where	   complex	   combinatorial	  
patterns	   of	   modifications	   form	   words	   that	   ultimately	   give	   rise	   to	   a	   vocabulary	   of	   histone	  
crosstalk	   (LEE	   et	   al.	   2010).	   	   Others	   yet	   prefer	   to	   think	   of	   it	   more	   specifically	   in	   terms	   of	   an	  
“epigenetic	  code”	  that	  is	  defined	  by	  combinations	  of	  histone	  PTMs	  which	  are	  predictive	  of,	  and	  
necessary	  for,	  expression	  patterns	  of	  differentiation	  and	  developmental-­‐specific	  genes	  (TURNER	  
2007).	   	   On	   the	   other	   hand,	   it	   has	   been	   argued	   that	   histone	   modifications	   are	   not	   truly	  
“epigenetic”,	   as	   the	   nature	   of	   their	   heritability	   (a	   requisite	   condition	   to	   be	   defined	   in	   the	  
classical	   sense	   of	   epigenetic)	   is	   questionable	   (PTASHNE	   2007),	   thereby	   disputing	   the	  
appropriateness	  of	  an	  “epigenetic	  code”.	  	  At	  some	  point,	  the	  question	  of	  how	  exactly	  to	  define	  
the	   histone	   code	   becomes	   somewhat	   rhetorical,	   as	   at	   their	   very	   essence,	   all	   definitions	  
ultimately	  seem	  to	  convey	  the	  same	  fundamental	  principle	  that	  histone	  PTMs	  act	  in	  concert	  to	  
elicit	  downstream	  biological	  outcomes.	   	  Here	  we	  reflect	  on	   the	  many	   forms	   the	   ‘histone	  code	  
hypothesis’	   has	   come	   to	   take	   since	   the	   time	   of	   its	   inception	   a	   decade	   ago,	   and	   suggest	   that	  




Transcribing	  the	  “histone	  code”:	  chicken	  or	  egg?	  	  Although	  applicable	  to	  a	  diverse	  set	  of	  cellular	  
processes,	   the	   histone	   code	   is	   most	   commonly	   considered	   in	   the	   context	   of	   transcription	  
regulation.	   	   Within	   this	   realm,	   there	   has	   been	   much	   debate	   as	   to	   whether	   a	   putative	   code	  
formed	   by	   combinatorial	   modifications	   can	   formally	   regulate	   transcription	   itself	   or	   rather,	   if	  
patterns	  of	  modifications	  are	  generally	  associated	  with	  a	  particular	  transcriptional	  state.	  	  On	  one	  
side	  is	  the	  argument	  that	  genes	  are	  not	  necessarily	  regulated	  by	  chromatin	  modifications	  per	  se,	  
but	  rather	  are	  regulated	  by	  specific	  DNA-­‐binding	  proteins	  that	  recruit	  activating	  and	  repressive	  
complexes	   to	   genomic	   loci	   to	   modulate	   transcriptional	   activity.	   	   According	   to	   this	   line	   of	  
reasoning,	   the	  histone-­‐modifying	  machinery	   is	   recruited	  by	  canonical	   transcriptional	  activators	  
and	   repressors	   (as	   would	   be	   defined	   in	   the	   classical	   sense	   by	   Jacob	   and	   Monod),	   and	   the	  
placement	   of	  modifications	   by	   these	   enzymes	   then	   contributes	   to	   transcription	   by	   creating	   a	  
more	   or	   less	   permissive	   chromatin	   environment	   for	   the	   further	   recruitment	   of	   downstream	  
factors	  that	  regulate	  transcription.	  In	  support	  of	  this	  idea,	  it	  has	  long	  been	  known	  that	  histone	  
acetylation	   is	  associated	  with	  active	  genes	   (ALLFREY	   et	  al.	  1964),	  and	   functions	   to	   facilitate	   the	  
disruption	  of	  higher-­‐order	  chromatin	  structure	  prior	  to	  gene	  activation	  (WOLFFE	  and	  HAYES	  1999).	  	  
Thus,	   one	   would	   argue	   that	   it	   is	   the	   action	   of	   the	   activators	   that	   directly	   determine	  
transcriptional	  output,	  and	  that	  the	  targeting	  of	  acetylation	  to	  histones	  via	  activators	  that	  bind	  
to	  specific	  upstream	  activating	  sequences	  functions	  to	  make	  the	  chromatin	  environment	  more	  
permissive	  for	  transcriptional	  regulation	  (STRUHL	  1998;	  WOLFFE	  and	  HAYES	  1999).	  	  In	  an	  analogous	  
fashion,	   binding	   of	   transcriptional	   repressors	   to	   upstream	   repressive	   sequences	   facilitates	  
recruitment	  of	  histone	  deacetylase	  (HDAC)	  enzymes	  to	  chromatin,	  which	  in	  turn	  remove	  acetyl	  
marks	   to	   contribute	   to	   transcriptional	   repression	   through	   chromatin	   compaction	   (KATAN-­‐
KHAYKOVICH	   and	   STRUHL	   2002;	   PAZIN	   and	   KADONAGA	   1997;	   STRUHL	   1998).	   	   By	   this	   argument,	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modifications	   are	   thereby	   associated	   with	   gene	   activation	   and/or	   silencing	   (much	   like	   RNA	  
polymerase	   II	   (RNAPII)	   is	   associated	   with	   active	   genes),	   but	   do	   not	   formally	   regulate	  
transcription	   itself.	   	   An	   extension	   of	   this	   position	   would	   be	   that	   chromatin	   modifications	  
themselves	  do	  not	  intrinsically	  regulate	  gene	  expression	  alone	  because	  an	  element	  of	  targeting	  
or	   recruitment	   is	   necessary	   (in	   other	   words,	   how	   do	   the	   enzymes	   know	   where	   to	   place	   the	  
marks?).	   	   Once	   set,	   PTMs	   putatively	   function	   in	   transcriptional	   regulation	   by	   promoting	   or	  
excluding	   the	   binding	   of	   elements	   that	   directly	   function	   in	   regulation	   (i.e.,	   activators	   and/or	  
repressors)	  to	  such	  regions.	  
One	  counterargument	   that	  could	  be	  made	   in	   response	   to	   the	  aforementioned	  view	  of	  
the	   histone	   code	   whereby	   chromatin-­‐modifying	   machinery	   is	   recruited	   by	   transcriptional	  
activators	  or	  repressors	  would	  be	  that	  histone	  modifications	  are	  a	  prerequisite	  for	  recruitment	  
of	   certain	  elements	  of	   the	   transcriptional	  machinery.	   	   For	  example,	   two	  TBP-­‐associated	   factor	  
(TAF)	   subunits	   of	   the	   transcription	   factor	   complex	   TFIID	   have	   been	   shown	   to	   bind	   directly	   to	  
histone	   PTMs,	   which	   would	   suggest	   that	   modification	   of	   histone	   proteins	   is	   necessary	   for	  
binding	  of	  the	  transcriptional	  machinery.	  	  The	  double	  bromodomain	  of	  Taf1,	  the	  largest	  subunit	  
of	  TFIID,	  binds	  preferentially	  to	  diacetylated	  histone	  H4	  (JACOBSON	  et	  al.	  2000).	   	  Taf3	  harbors	  a	  
PHD	  finger	  that	  is	  selective	  for	  binding	  to	  trimethylated	  lysine	  4	  of	  histone	  H3	  (H3K4me3),	  and	  
loss	  of	  this	  chromatin	  mark	  results	  in	  reduced	  TFIID	  association	  with	  and	  transcriptional	  activity	  
from	  certain	  promoters	  (VERMEULEN	  et	  al.	  2007),	  providing	  support	  for	  the	  role	  of	  histone	  PTMs	  
as	  a	  requisite	  component	  in	  the	  recruitment	  of	  transcription	  factors.	  
Despite	   the	   seemingly	   opposite	   lines	   of	   reasoning	   regarding	   the	   role	   of	   histone	  
modifications	  in	  transcriptional	  regulation,	  we	  maintain	  that	  the	  nature	  of	  the	  histone	  code	  may	  
not	   necessarily	   be	   as	   clear-­‐cut	   as	   histone	   PTMs	   functioning	   solely	   as	   a	   consequence	   of	   or	  
prerequisite	   for	   recruitment	   of	   the	   canonical	   transcriptional	  machinery.	   	   It	   is	   likely	   that	   both	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arguments	   hold	   true	   in	   their	   own	   rights	   with	   respect	   to	   transcription	   (as	   well	   as	   other	   DNA-­‐
templated	  processes),	  and	  that	  possibly	  no	  absolute	  rule	  exists	  favoring	  either	  position	  over	  the	  
other,	  thereby	  necessitating	  examination	  of	  such	  codes	  on	  an	  individual	  basis.	   	   It	   is,	  therefore,	  
perhaps	  more	   judicious	   to	   focus	   our	   discussion	   on	   the	   histone	   code	   in	   the	   context	   of	   how	   it	  
more	   generally	   contributes	   to	   the	   physical	   organization	   of	   eukaryotic	   genomes.	   	   Three	  major	  
principles	  have	  developed	  during	  the	  evolution	  of	  the	  histone	  code	  hypothesis	  over	  the	  past	  ten	  
years:	  (1)	  interactions	  between	  histone	  modifications	  are	  not	  limited	  to	  a	  single	  tail;	  (2)	  a	  single	  
mark	   can	   recruit	  more	   than	   one	   protein;	   and	   (3)	   proteins	   acting	   alone	   or	   in	   the	   context	   of	   a	  
macromolecular	  complex	  can	  contain	  multiple	  domains	  to	  facilitate	  binding	  to	  chromatin	  (FIGURE	  
4.2).	  	  At	  the	  time	  when	  the	  histone	  code	  hypothesis	  was	  put	  forward,	  we	  had	  a	  relatively	  limited	  
scope	  of	  the	  existent	  histone	  PTMs,	  the	  combinations	  in	  which	  they	  exist,	  and	  how	  they	  affect	  
downstream	   functionality.	   	   That	  marks	   located	   in	   close	   proximity	   to	   one	   another	   often	   times	  
exhibit	  functional	  interplay	  was	  demonstrated	  by	  examples	  such	  as	  phosphorylation	  of	  serine	  10	  
of	  histone	  H3	  (H3S10ph)	  reducing	  the	  affinity	  of	  the	  chromodomain	  of	  heterochromatin	  protein	  
1	   (HP1)	   for	   di-­‐	   and	   trimethylated	   lysine	   9	   of	   histone	   H3	   (FISCHLE	   et	   al.	   2005).	   At	   present,	   the	  
chromatin	   field	   continually	   refines	   our	   understanding	   of	   how	   individual	   modifications	   affect	  
placement	  of	  another,	  especially	  in	  the	  context	  of	  how	  modifications	  on	  one	  histone	  tail	  affects	  
placement	  of	  marks	  and	  recruitment	  of	  effector	  proteins	  on	  other	  tails.	  	  A	  clear	  example	  of	  this	  
idea	   is	   provided	   by	   studies	   that	   have	   demonstrated	   that	   a	   signal	   cascade	   in	   which	   14-­‐3-­‐3	   is	  
recruited	  to	  the	  enhancer	  of	  FOSL1	  by	  binding	  to	  H3S10ph	  and	  itself	  subsequently	  recruits	  the	  
histone	  acetyltransferase	  MOF,	  which	  acetylates	  histone	  H4	  on	  lysine	  16	  (H4K16ac)	  to	  create	  a	  
doubly-­‐modified	  H3S10ph/H4K16ac	  nucleosome	  (ZIPPO	  et	  al.	  2009).	   	  These	  PTMs	  then	  function	  
as	  a	  platform	  for	  the	  bromodomain-­‐containing	  protein	  BRD4	  (which	  in	  turn	  recruits	  the	  positive	  
transcription	   factor	   b	   (P-­‐TEFb))	   to	   activate	   transcription	   elongation,	   thus	   providing	   an	   elegant	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example	   of	   the	   numerous	   intricacies	   associated	   with	   interactions	   between	   multiple	   histone	  
PTMs	  across	  multiple	  tails	  (ZIPPO	  et	  al.	  2009).	  	  It	  is	  becoming	  increasingly	  clear	  that	  modifications	  
that	  work	  together	  to	  form	  a	  putative	  code	  are	  not	  limited	  to	  a	  single	  histone	  tail,	  but	  are	  likely	  
to	  span	  multiple	  tails	  within	  one	  nucleosome,	  between	  adjacent	  nucleosomes,	  or	  between	  non-­‐
adjacent	   nucleosomes	   that	   are	   physically	   located	   in	   close	   proximity	   to	   one	   another	   due	   to	  
higher-­‐order	  chromatin	  structure.	  	  Examples	  of	  histone	  crosstalk	  continue	  to	  evolve,	  and	  many	  
more	  are	  likely	  to	  surface	  from	  future	  work,	  thereby	  shedding	  light	  on	  the	  growing	  complexity	  
associated	  with	  the	  many	  permutations	  of	  a	  histone	  code.	  
As	   alluded	   to	   above,	  modifications	   of	   histone	   residues	   in	   defined	   states	   can	   serve	   as	  
platforms	   for	   binding	   of	   more	   than	   one	   effector	   protein.	   	   For	   example,	   multiple	   proteins	  
(including	  JMJD2A,	  Rag2,	  BPTF,	  Ing2	  and	  Taf3)	  have	  all	  been	  demonstrated	  to	  bind	  to	  H3K4me3	  
(HUANG	   et	   al.	   2006;	   LI	   et	   al.	   2006;	   MATTHEWS	   et	   al.	   2007;	   PENA	   et	   al.	   2006;	   SHI	   et	   al.	   2006;	  
VERMEULEN	  et	  al.	  2007;	  WYSOCKA	  et	  al.	  2006).	   	  Such	  promiscuity	  by	  a	  defined	  mark	  for	  multiple	  
readers	  indicates	  that	  secondary	  levels	  of	  specification	  must	  exist.	   	  One	  possible	  explanation	  is	  
that	   one	   protein	   can	   harbor	   multiple	   domains	   that	   cooperatively	   facilitate	   recognition	   and	  
binding	   to	   chromatin	   (RUTHENBURG	   et	  al.	   2007b).	   	   For	  example,	  Tsai	  et	  al	  have	   recently	   shown	  
that	   the	   tandem	   PHD	   finger	   and	   bromodomain	   of	   the	   protein	   TRIM24,	   a	   co-­‐activator	   of	  
oestrogen	  receptor	  α	  (ERα),	  bind	  combinatorially	  to	  unmodified	  H3K4	  and	  acetylated	  H3K23	  to	  
facilitate	  chromatin	  recognition	  and	  contribute	  to	  ERα-­‐mediated	  transcription	  activation	  (TSAI	  et	  
al.	  2010).	  	  Alternatively,	  more	  than	  one	  histone	  PTM	  (or	  the	  recognition	  of	  unmodified	  histone	  
residues	  with	  modified	   ones)	   can	   function	   in	   concert	   to	   form	   a	   recognition	   code	   for	   a	   single	  
protein	   with	   multiple	   chromatin-­‐binding	   domains	   or	   multiple	   proteins	   within	   a	   chromatin-­‐
associated	   complex	   (OLIVER	   and	   DENU	   2010).	   	   One	   example	   of	   this	   type	   of	   nucleosomal	  
interaction	   is	  provided	  by	   the	  Rpd3S	  histone	  deacetylase	  complex,	  which	  stably	   interacts	  with	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H3K36	  methylated	  nucleosomes	   via	   recognition	  of	  H3K36	  methylation	  by	   the	   chromodomain-­‐
containing	  subunit	  Eaf3	  and	  H3	  recognition	  by	  a	  PHD	  finger	  within	  in	  Rco1	  subunit	  of	  this	  same	  
complex	  (LI	  et	  al.	  2007b).	  	  Thus,	  it	  is	  becoming	  increasingly	  clear	  that	  the	  one	  mark:one	  reader	  
(or	  writer	  or	  eraser	  in	  certain	  instances)	  ratio	  does	  not	  allow	  for	  generation	  of	  enough	  physically	  
distinct	   relationships	   to	   sufficiently	   impart	   the	   degree	   of	   information	   necessary	   to	   mediate	  
diverse	   outcomes,	   supporting	   the	   existence	   of	   numerous	   levels	   of	   complexity	   built	   into	   the	  
histone	   code.	   	   Such	   complexity	  would	  allow	  multiple	  ways	   to	   tinker	  with	   the	   same	  chromatin	  
landscape	  to	  promote	  diverse	  biological	  outcomes.	  
	  
Tinkering	  the	  “histone	  code	  hypothesis”	  in	  years	  to	  come.	  	  The	  key	  question	  that	  remains	  then,	  
is	  perhaps	  not	  one	  of	  mulling	  over	  how	  to	  best	  define	  the	  histone	  code,	  but	  rather,	  what	  form	  
will	  the	  histone	  code	  hypothesis	  take	  over	  the	  years	  to	  come?	  	  Given	  the	  rapidity	  of	  chromatin-­‐
based	   research	   and	   the	   prominent	   role	   of	   chromatin	   in	   numerous	   DNA-­‐based	   processes,	  
research	  in	  the	  years	  to	  come	  is	  likely	  to	  continue	  along	  the	  same	  fruitful	  path	  of	  discovery	  that	  
it	  has	  witnessed	   in	   the	  past	   ten	  years,	  demonstrating	  additional	   levels	  of	  complexity	  by	  which	  
intrinsic	   cellular	   machines	   tinker	   with	   the	   chromatin	   template.	   	   While	   studies	   aimed	   at	  
identifying	  additional	  writers	  and	  erasers	  of	  the	  histone	  code	  as	  well	  as	  novel	  marks	  remain	  ever	  
important,	  investigations	  elucidating	  how	  chromatin	  marks	  act	  in	  concert	  to	  recruit	  readers	  are	  
of	   equal	   significance.	   	   Technological	   advancements	   and	   new	  methodologies	   have	   significantly	  
progressed	  our	  efforts	   in	  both	  areas	  of	  study,	  and	  are	  expected	  to	  continue	  to	  do	  so	  well	   into	  
the	  future	  (VOIGT	  and	  REINBERG	  2010;	  YOUNG	  et	  al.	  2010).	  	  Histone	  PTMs	  have	  traditionally	  been	  
identified	   by	  metabolic	   labeling,	  microsequencing,	   the	   generation	   of	   immunological	   reagents,	  
and	   more	   recently,	   mass	   spectrometry	   (MS)	   (GARCIA	   et	   al.	   2007c).	   	   Advancements	   in	   MS	  
technology	   include	   the	   recently	   developed	   top-­‐down	   methodology,	   which	   analyzes	   intact	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proteins	   samples	   (as	  opposed	   to	   the	  more	   canonical	   bottom-­‐up	  approach	  where	  proteins	   are	  
fragmented	  prior	  to	  analysis).	  	  Because	  proteins	  are	  analyzed	  at	  the	  whole-­‐molecule	  level,	  top-­‐
down	  MS	  allows	   for	   identification	  of	   combinatorial	   patterns	  of	  modifications	   that	   exist	  within	  
one	  histone	  protein	  (SIUTI	  and	  KELLEHER	  2007).	  	  For	  example,	  top-­‐down	  MS	  analysis	  has	  now	  been	  
completed	   on	   all	   three	   human	   histone	  H3	   variants	   (H3.1,	   H3.2,	   and	  H3.3),	   revealing	   complex	  
patterns	  of	  modified	  H3	  forms	  (GARCIA	  et	  al.	  2007b;	  THOMAS	  et	  al.	  2006).	  	  Additionally,	  analysis	  of	  
asynchronously	  grown	  HeLa	  cells	  treated	  with	  the	  HDAC	  inhibitor	  sodium	  butyrate	  has	  revealed	  
a	   surprising	   and	   complex	  number	  of	   combinatorially-­‐modified	   species	   of	   histone	  H3.2	   and	  H4	  
(GARCIA	  et	  al.	  2007b;	  YOUNG	  et	  al.	  2009).	   	  Though	  still	   in	   its	   infancy,	  studies	  such	  as	  these	  have	  
made	  it	  readily	  apparent	  that	  top-­‐down	  MS	  analysis	  will	  be	  a	  highly	  utilized	  technique	  in	  future	  
studies	   to	   decipher	   how	   combinatorial	   patterns	   of	   histone	   modifications	   contribute	   to	   the	  
regulation	  of	  diverse	  biological	  processes	  (YOUNG	  et	  al.	  2010).	  
Identification	  of	  the	  histone	  marks	  themselves	  and	  the	  combinatorial	  patterns	  in	  which	  
they	   exist	   is	   not	   enough	   to	   understand	   functional	   consequences	   of	   their	   placement.	   	   The	  
availability	   of	   modification-­‐specific	   antibodies	   has	   allowed	   for	   immunoprecipitation	   of	   DNA	  
fragments	  associated	  with	  a	  particular	  mark	  by	  chromatin	  immunoprecipitation	  (ChIP).	  	  It	  should	  
be	   formally	   noted	   that	   one	   major	   limitation	   to	   be	   kept	   in	   mind	   when	   designing	   and/or	  
interpreting	  experiments	  involving	  ChIP	  is	  the	  requirement	  for	  a	  high-­‐quality	  antibody	  that	  can	  
specifically	   recognize	   a	   defined	  modification	   state	   (e.g.,	   a	   dimethylated	   but	   not	   trimethylated	  
lysine	   residue).	   	   Moreover,	   as	   neighboring	   modifications	   may	   unpredictably	   impact	   antibody	  
specificity,	   it	   is	   becoming	   increasingly	   clear	   that	   rigorous	   validation	   of	   antibody	   quality	   is	  
essential	   for	   any	   ChIP-­‐based	   analysis	   to	   effectively	   provide	   insight	   into	   the	   location	   of	   a	  
particular	  modification	   in	  a	  defined	  state	   (BOCK	   et	  al.	  2011;	  EGELHOFER	   et	  al.	  2011;	  FUCHS	   et	  al.	  
2011).	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Early	  approaches	  for	  studying	  chromatin-­‐modifications	  on	  a	  genome-­‐wide	  level	  utilized	  
ChIP	   combined	   with	   DNA	  microarray	   analysis	   (ChIP-­‐chip).	   	   More	   recently,	   ChIP	   coupled	   with	  
next-­‐generation	   sequencing	   technology	   (ChIP-­‐seq)	   has	   provided	   considerable	   insight	   into	   the	  
function	   of	   histone	   PTMs,	   allowing	   for	   the	   identification	   of	   genome-­‐wide	   patterns	   of	   specific	  
modifications	  as	  well	  as	   transcription	   factors	  and	  the	  machinery	  responsible	   for	  modifying	  the	  
chromatin	  landscape	  under	  defined	  biological	  conditions	  (SCHONES	  and	  ZHAO	  2008).	   	  Early	  ChIP-­‐
seq	  analyses	  mapping	  histone	  modifications	  in	  CD4+	  T	  cells	  or	  mouse	  embryonic	  stem	  (mES)	  cells	  
revealed	  a	  number	  of	  findings	  (BARSKI	  et	  al.	  2007;	  MIKKELSEN	  et	  al.	  2007;	  WANG	  et	  al.	  2008).	  	  For	  
instance,	  a	  comparative	  ChIP-­‐seq	  analysis	  of	  mES,	  neural	  progenitor	  and	  embryonic	  fibroblasts	  
confirmed	   the	  existence	  of	  bivalent	  domains	   characterized	  by	   the	   co-­‐localization	  of	  H3K4	  and	  
H3K27	   trimethylation	   that	   function	   in	   cellular	   plasticity	   and	   commitment	   to	   a	   defined	   lineage	  
(BERNSTEIN	  et	  al.	  2006;	  MIKKELSEN	  et	  al.	  2007).	  	  However,	  how	  widespread	  bivalent	  domains	  occur	  
in	  various	  developmental	  contexts	  remains	  unclear	  and	  is	  under	  active	  investigation.	  	  Genome-­‐
wide	  association	   studies	  derived	   from	  ChIP-­‐seq	  analyses	   completed	   to	  date	  have	   led	  many	   to	  
see	  the	  histone	  code	  less	  in	  terms	  of	  as	  sets	  of	  definite	  combinations	  that	  produce	  an	  absolute	  
outcome,	  but	  rather,	  more	  as	  patterns	  of	  modifications	  that	  when	  in	  combination	  tend	  to	  favor	  
a	  specified	  outcome.	   	   In	   that	  vein,	   the	  ramifications	  of	   the	  histone	  code	  are	  correlative	  rather	  
than	   causal	   in	   that	   combinatorial	   patterns	   provide	   a	   bias	   for	   a	   specific	   outcome	   rather	   than	  
serve	  as	  an	  absolute	  mark	  of	  one.	  	  ChIP-­‐seq	  analyses	  has,	  for	  example,	  revealed	  that	  in	  general,	  
higher	  levels	  of	  H3K9me1	  and	  H2BK5me1	  in	  the	  5’	  end,	  H3K27me1	  distributed	  throughout,	  and	  
H3K36me3	  in	  the	  3’	  end	  of	  a	  transcribed	  region	  mark	  actively	  transcribed	  regions	  (BARSKI	  et	  al.	  
2007).	   	  Furthermore,	  another	  study	  found	  that	  there	  is	  a	  combinatorial	  pattern	  of	  methylation	  
and	  acetylation	  events	  on	  histone	   tails	   that	  are	  co-­‐associated	  with	  each	  other	  on	  a	   significant	  
fraction	  of	  genes	  within	  the	  human	  genome	  (WANG	  et	  al.	  2008).	  	  Such	  studies	  provide	  important	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insight,	   in	   that	   they	   demonstrate	   that	   actively	   transcribed	   regions	   of	   the	   genome,	   as	   well	   as	  
functional	   elements	   in	   general,	   bear	   distinct	   histone	   PTM	   signatures	   (ZHOU	   et	   al.	   2011).	  	  
Additional	  studies	  will	  surely	  expand	  upon	  whether	  the	  histone	  code	  is	  characterized	  by	  a	  fixed	  
set	  of	  combinatorial	  patterns	  that	  establish	  defined	  chromatin	  states	  (also	  referred	  to	  frequently	  
as	  chromatin	  ‘signatures’)	  or	  rather,	  if	  certain	  combinations	  tend	  to	  tip	  the	  balance	  in	  favor	  of	  a	  
certain	  state.	  	  For	  example,	  recent	  work	  published	  by	  the	  modENCODE	  Consortium	  has	  provided	  
great	   insight	   into	   the	   genome-­‐wide	   chromatin	   organization	   in	   the	   model	   organisms	  
Caenorhabditis	  elegans	  and	  Drosophila	  melanogaster,	  which	  together	  have	  vastly	  advanced	  our	  
understanding	  how	  various	  histone	  PTMs	  are	  associated	  with	   genomic	   regulatory	  elements	   in	  
defined	   developmental	   states	   (GERSTEIN	   et	   al.	   2010;	   KHARCHENKO	   et	   al.	   2010;	   ROY	   et	   al.	   2010).	  	  
Newcomers	  to	  this	  field	  should	  refer	  to	  these	  studies	  to	  become	  oriented	  not	  only	  to	  some	  of	  
the	   principal	   PTMs	   that	   mark	   chromatin	   domains,	   but	   also	   to	   the	   staggering	   complexities	  
underlying	   the	   combinatorial	   nature	   with	   which	   gene	   bodies	   and	   regulatory	   elements	   are	  
specified	   and	   defined	   in	   a	   chromatin	   context.	   	   Indeed	   the	   language	   is	   colorful	   and	   must	   be	  
interpreted	  in	  context,	  especially	  in	  a	  developmental	  setting.	  
Novel	   methods	   are	   also	   being	   developed	   to	   characterize	   combinatorial	   patterns	   that	  
facilitate	  binding	  of	  effector	  proteins	  as	  well	  as	  identify	  novel	  proteins	  that	  can	  bind	  to	  modified	  
histone	   tails.	   	  Use	  of	  combinatorial	  peptide	   libraries	  based	  on	   the	  N-­‐terminal	  histone	   tails	  has	  
become	  a	  widely	  used	  practice	   to	   identify	  how	   the	  presence	  of	   additional	  marks	  enhances	  or	  
weakens	  the	  affinity	  of	  an	  effector	  protein	  for	  its	  target	  binding	  module.	  	  Peptide	  libraries	  have	  
been	   synthesized	  as	  various	   types	  of	  platforms,	   including	   resin-­‐bound	  PTM-­‐containing	  histone	  
tail	   libraries	   and	   custom	   peptide	  microarrays	   (BOCK	   et	   al.	   2011;	   BUA	   et	   al.	   2009;	   FUCHS	   et	   al.	  
2011;	  GARSKE	  et	  al.	  2010).	  	  Such	  platforms	  have	  recently	  begun	  to	  be	  used	  to	  identify	  synergistic	  
and	   antagonistic	   combinations	   of	   histone	   modifications	   that	   ultimately	   affect	   the	   binding	   of	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effectors.	   	   For	   example,	   the	   H3K9me2	   demethylase	   PHF8	   binds	   to	   H3K4me3/2,	   and	  
hybridization	   of	   a	   recombinant	   GST-­‐PHD(PHF8)	   fusion	   protein	   to	   a	   synthetic	   peptide	   array	  
containing	  combinatorial	  modifications	  patterns	   revealed	  that	  binding	   to	  H3K4me3/2	  was	  also	  
achieved	  when	  peptides	  were	   acetylated	   at	   the	  H3K9/K14	  positions	   (KLEINE-­‐KOHLBRECHER	   et	   al.	  
2010).	  	  While	  peptide	  libraries	  are	  advantageous	  at	  looking	  at	  how	  effector	  proteins	  respond	  to	  
various	   combinatorial	   patterns	   of	  modifications,	   alternative	   functional	   technologies	   are	   being	  
employed	  to	  screen	  for	  proteins	  that	  bind	  to	  a	  particular	  modification	   in	  an	  unbiased	  manner.	  	  
Recently,	   a	   histone	   peptide	   pulldown	   approach	   paired	  with	   SILAC	   proteomics	   technology	  was	  
used	  to	  define	  a	   large-­‐scale	  methyl	   lysine	   interactome	  (VERMEULEN	  et	  al.	  2010).	   	  Extending	  this	  
concept	  further,	  designer	  synthetic	  nucleosomes	  in	  which	  nucleosomes	  are	  reconstituted	  using	  
recombinant	   histones	   harboring	   specific	   modifications	   states	   have	   allowed	   for	   unbiased	  
identification	  of	   cellular	  proteins	   that	  bind	   to	  a	   specific	   state	  on	  a	  nucleosomal	   substrate	   in	  a	  
technique	  called	  SNAP	  (SILAC	  nucleosome	  affinity	  purification)	  (BARTKE	  et	  al.	  2010).	  	  Because	  the	  
DNA	  sequence	  and	  modifications	  of	   interest	  are	  user-­‐defined,	  one	  could	  theoretically	  begin	  to	  
make	   oligonucleosomes	   in	   which	   crosstalk	   both	   within	   and	   across	   nucleosomes	   can	   be	  
addressed.	   	   This	   latter	   technology	   holds	   great	   potential	   for	   future	   studies	   in	   which	   peptides	  
harboring	  several	  modifications	  are	  fused	  to	  multiple	  histone	  tails	  via	  native	  chemical	  ligation	  to	  
reconstitute	   multiply-­‐modified	   nucleosomes	   to	   give	   a	   more	   complete	   picture	   of	   how	  
combinatorial	  patterns	  affect	  binding	  by	  chromatin	  readers	  in	  the	  more-­‐physiologically	  relevant	  
nucleosomal	  context.	  
	  
Strict	   code	   versus	   rich	   language:	   exciting	   either	   way.	   	  At	   the	   time	   of	   inception,	   it	   is	   always	  
difficult	  to	  discern	  how	  influential	  a	  hypothesis	  will	  truly	  be.	  	  We	  have	  been	  privileged	  to	  witness	  
that	  François	  Jacob	  and	  Jacques	  Monod’s	  report	  on	  the	   lac	  operon	  in	  the	  Journal	  of	  Molecular	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Biology	  in	  1961	  has	  revolutionized	  our	  understanding	  of	  the	  basic	  mechanisms	  underlying	  gene	  
regulation.	   	  We	  are	  also	  beginning	  to	  understand	  the	  richness	  of	   the	  histone	  code	  hypothesis.	  	  
When	   we	   posited	   this	   hypothesis,	   now	   ten	   years	   ago,	   we	   had	   what	   in	   retrospect	   would	   be	  
described	  as	  a	  quite	  limited	  scope	  of	  histone	  post-­‐translational	  modifications.	  	  One	  decade	  later,	  
we	   stand	   in	   awe	   at	   how	   the	   chromatin	   field,	   and	   scientific	   research	   community	   at	   large,	   has	  
come	  together	   to	  expand	  this	  code	  to	  a	  scope	  beyond	  what	  was	   imaginable	  at	   the	   time	  of	   its	  
conception.	   	  For	  example,	  never	   in	  our	  wildest	  dreams	  had	  we	  envisioned	  a	  Keystone	  meeting	  
being	  dedicated	  to	  the	  singular	  topic	  of	  the	  ‘Histone	  Code’:	  Fact	  or	  Fiction	  (January	  10-­‐15,	  2011	  
in	  Midway,	  Utah).	  	  However,	  it	  is	  with	  a	  sense	  of	  realism	  that	  we	  recognize	  that	  many	  obstacles	  
remain	  to	  be	  overcome	  before	  we	  can	  officially	  declare	  that	  this	  code	  has	  been	  deciphered	  to	  its	  
fullest	  potential.	   	  For	  example,	   it	  will	  be	  difficult	   to	  discern	  when	  saturation	  has	  been	  reached	  
and	   all	   modifications	   have	   been	   identified,	   a	   reality	   complicated	   by	   the	   fact	   that	   organismal	  
differences	  exist	  within	   the	   chromatin	   landscape.	   	   The	   staggering	   complexity	  of	   this	  proposed	  
‘epigenetic	  code’	  promises	  to	  keep	  many	  talented	  scientists	  busy	  for	  the	  next	  decade	  with	  many	  
more	  welcomed	  surprises	  along	  the	  way.	  	  Moreover,	  we	  are	  coming	  to	  realize	  that	  such	  a	  code	  
may	   not	   pertain	   specifically	   to	   histones,	   but	   could	   potentially	   be	   extended	   to	   proteins	   in	  
general.	  	  That	  proteins	  are	  modified	  post-­‐translationally	  is	  by	  no	  means	  a	  novel	  concept,	  but	  the	  
idea	   that	   modifications	   working	   in	   concert	   are	   predictive	   of	   defined	   downstream	   biological	  
events	  has	  received	  more	  thought	  recently.	  	  The	  tumor	  suppressor	  p53	  is	  highly	  regarded	  as	  the	  
model	  for	  the	  existence	  of	  a	  more	  general	  protein	  code,	  as	  this	  protein	  is	  subject	  to	  a	  number	  of	  
PTMs,	   including	   methylation,	   acetylation,	   phosphorylation,	   and	   ubiquitylation	   (SIMS	   and	  
REINBERG	   2008).	   The	   observation	   that	   modifications,	   such	   as	   acetylation,	   correlate	   with	  
stabilization	   and	   activation	   of	   p53	   (BODE	   and	   DONG	   2004)	   in	   concert	   with	   the	   idea	   that	   one	  
modification	   can	   enhance	   or	   preclude	   the	   placement	   of	   another	   supports	   a	   more	   general	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mechanism	  in	  which	  modifications	  are	  tightly	  linked	  to	  p53	  function	  in	  an	  analogous	  fashion	  as	  
to	  how	  histone	  PTMs	  work	   together	   to	   form	  a	   functional	   code.	   	  Also	  worthy	  of	  noting	   is	   that	  
many	   of	   the	   enzymes	   responsible	   for	   writing,	   erasing,	   and	   reading	   histone	   methylation	   and	  
acetylation	   on	   histone	   proteins	   are	   also	   responsible	   for	  modifying	   the	   C-­‐terminus	   of	   p53	   and	  
certainly	   other	   non-­‐histone	   proteins	   (GLOZAK	   et	   al.	   2005;	   HUANG	   and	   BERGER	   2008),	   echoing	  
Jacob’s	  visionary	  sentiment	   that	   the	  same	  elements	  are	  often	  used	   to	  create	  new	  products	  of	  
increasing	  complexity.	  	  	  
Our	   piece	   in	   2000	  was	   framed	   as	   a	   hypothesis	  with	   the	   hope	   that	   it	  would	   stimulate	  
discussion	  and	  lead	  to	  subsequent	  tests	  of	   its	  central	  tenets.	   	  Much	  of	  this	  has	  happened,	  and	  
we	  look	  forward	  to	  much	  more	  along	  these	  lines.	  	  While	  contention	  over	  use	  of	  the	  word	  “code”	  
may	  eventually	  lead	  to	  an	  alternative	  designation	  in	  future	  years,	  we	  are	  confident	  that	  debates	  
over	   diction	   will	   not	   hinder	   the	   elegant	   work	   that	   the	   chromatin	   community	   has	   collectively	  
produced	  at	  a	  remarkable	  pace.	  	  We	  close	  with	  a	  prediction	  -­‐-­‐	  we	  will	  indeed	  witness	  a	  period	  of	  
further	  enlightenment	  with	   regard	   to	  how	  cellular	  enzymes	   tinker	  with	  both	  histone	  and	  non-­‐
histone	  proteins	  alike	  to	  create	  increasingly	  complex	  patterns	  of	  regulatory	  mechanisms	  in	  the	  
years	   to	   come.	   	   Coloring	   the	   chromatin	   code	  with	   even	  more	   shades	   will	   be	   part	   of	   the	   fun	  
(FILION	  et	  al.	  2010;	  SCHUBELER	  2010).	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TABLE	  4.1	  |	  Histone	  modification	  types	  and	  the	  interacting	  domains	  that	  “read”	  them	  
	  
Modification	  types	   Residue(s)	  modified	   Reader	  domain(s)	  
Unmodified	  lysine	   Lysine	   PHD	  
	  
Acetylation	   Lysine	   Bromo	  
	  
Methylation	   Lysine/Arginine	   Ankyrin,	  Chromo,	  HEAT,	  MBT,	  PHD,	  Tudor,	  PWWP,	  
WD40	  
	  
Phosphorylation	   Serine/Threonine	   14-­‐3-­‐3,	  BIR,	  BRCT	  
	  
Ubiquitylation	   Lysine	   ?	  
	  
Sumoylation	   Lysine	   ?	  
	  
ADP-­‐ribosylation	   Lysine	   ?	  
	  
Citrullination	   Arginine	   ?	  
	  
Butyrylation	   Lysine	   ?	  
	  
Propionylation	   Lysine	   ?	  
	  






FIGURE	  4.1	  |	  Toolkit	  for	  modifying	  the	  chromatin	  template.	   	  Schematic	  illustrating	  the	  concept	  
that	   writers	   place	   post-­‐translational	   modifications	   on	   histone	   proteins	   (left),	   erasers	   remove	  
such	   modifications	   from	   histone	   proteins	   (middle),	   and	   readers	   function	   to	   interpret	   these	  





FIGURE	   4.2	   |	   Mechanisms	   of	   histone-­‐recognition	   modules	   binding	   their	   target	   modification.	  	  
Binding	   of	   specialized	   domains	   to	   histone	   post-­‐translational	   modifications	   can	   occur	   in	   cis,	  
where	   contact	   is	  made	   to	   a	   series	   of	  modifications	   on	   the	   same	   histone	   tail	   (A),	   or	   in	   trans,	  
where	   contacts	   are	   made	   to	   distinct	   modifications	   across	   histone	   tails	   (B).	   	   Often,	   a	   single	  
modification	  can	  serve	  as	  a	  docking	  site	  for	  more	  than	  one	  protein,	   in	  which	  secondary	  signals	  
(e.g.	   other	   PTMs)	   may	   serve	   to	   dictate	   which	   protein	   is	   recruited	   to	   the	   specific	   mark	   (C).	  	  
Proteins	   acting	   alone	   (A-­‐B),	   or	   in	   the	   context	   of	   a	   macromolecular	   complex	   (D)	   can	   harbor	  
multiple	   domains	   capable	   of	   facilitating	   chromatin	   recognition	   and	   binding.	   	   For	   clarity,	   no	  
attempts	   have	   been	   made	   to	   depict	   histone	   recogntion	   between	   nucleosomes	   in	   either	   the	  
same	  or	  distinct	  polynucleosome	  fibers,	  but	  these	  modes	  of	  binding	  recognition	  are	  also	   likely	  
(reviewed	  in	  (RUTHENBURG	  et	  al.	  2007b)).	  
	  




The	  unifying	  theme	  of	  the	  work	  contained	  within	  this	  dissertation	  is	  that	  of	  dynamic	  regulation	  
of	   histone	   lysine	   methylation	   in	   the	   budding	   yeast	   Saccharomyces	   cerevisiae.	   	   Prior	   to	   the	  
commencement	  of	  these	  studies,	  it	  had	  been	  well	  established	  that	  lysines	  residues	  4,	  36,	  and	  79	  
of	   histone	   H3	   were	   methylated	   in	   budding	   yeast	   by	   the	   enzymes	   Set1,	   Set2,	   and	   Dot1,	  
respectively	  (MILLAR	  and	  GRUNSTEIN	  2006).	   	  However,	  two	  prominent	  questions	  remained	  to	  be	  
answered.	   	   The	   first	  was	  whether	   histone	   lysine	  methylation	   could	   be	   actively	   removed	   in	   S.	  
cerevisiae.	  	  LSD1	  had	  been	  shown	  to	  be	  an	  active	  histone	  demethylase	  in	  higher	  eukaryotes	  (SHI	  
et	  al.	  2004),	  but	  budding	  yeast	  lack	  a	  LSD1	  homologue	  (KLOSE	  and	  ZHANG	  2007).	  	  Thus,	  it	  was	  of	  
general	   interest	   to	   determine	   whether	   methylation	   is	   indeed	   a	   dynamic	   mark	   in	   this	   model	  
organism	  and	  if	  another	  class	  of	  enzymes	  existed	  that	  is	  capable	  of	  removing	  methyl	  marks.	  	  The	  
second	  question	  was	  whether	   lysine	  residues	  other	  than	  4,	  36,	  and	  79	  on	  histone	  H3	  could	  be	  
methylated.	   	   While	   these	   three	   residues	   are	   by	   far	   the	   best-­‐characterized	   sites	   of	   lysine	  
methylation	   in	   budding	   yeast,	   it	   remained	   possible	   that	   other	   yet-­‐to-­‐be-­‐identified	   sites	   could	  
additionally	  be	  modified	  post-­‐translationally	  by	  the	  addition	  methyl	  groups.	  
In	  what	  was	  an	  exciting	  time	  in	  the	  field	  of	  chromatin	  biology,	  JmjC-­‐domain-­‐containing	  
proteins	  were	   identified	  as	  histone	   lysine	  demethylases,	  thus	  supporting	  the	  active	  removal	  of	  
methyl	  marks	   from	  modified	   residues	   (KLOSE	   et	   al.	   2006a;	   TSUKADA	   et	   al.	   2006).	   	   The	   budding	  
yeast	   protein	   Jhd1	   was	   the	   first	   JmjC-­‐domain-­‐containing	   protein	   demonstrated	   to	   possess	  
histone	  demethylase	  activity	  and	  shows	  specificity	  for	  mono-­‐	  and	  dimethylated	  H3K36	  (TSUKADA	  
et	  al.	  2006).	  	  Among	  the	  works	  described	  within	  these	  chapters	  is	  evidence	  that	  the	  yeast	  JmjC-­‐
domain-­‐containing	   proteins	   Rph1	   and	   Jhd2	   also	   function	   as	   histone	   lysine	   demethylases	  with	  
specificity	   for	  di-­‐	  and	  trimethylated	  H3K36	  and	  H3K4,	  respectively	   (KLOSE	  et	  al.	  2007a;	  LIANG	  et	  
al.	  2007)	  (FIGURE	  5.1).	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In	  support	  of	  the	  notion	  that	  lysine	  resides	  other	  than	  4,	  36,	  and	  79	  on	  histone	  H3	  can	  
be	   methylated,	   work	   contained	   herein	   identifies	   lysine	   37	   of	   histone	   H2B	   as	   a	   novel	   site	   of	  
histone	  methylation	   in	   budding	   yeast,	   and	   that	   this	   modification	   exists	   in	   the	   dimethyl	   state	  
(GARDNER	  et	  al.	  2011b)	  (FIGURE	  5.1).	   	  Concurrent	  with	  the	  studies	  presented	  here,	   lysine	  111	  of	  
histone	  H2B	  was	   also	   shown	   to	   be	   a	   site	   of	   histone	  methylation	   in	   S.	   cerevisiae	   (KYRISS	   et	   al.	  
2010).	   	   Comprehensive	   in-­‐depth	   histone	   modification	   MS	   analysis	   has	   suggested	   that	  
methylation	   also	  occurs	  on:	   	  H2BK22,	  H3K18,	  H3K23,	  H3K37,	   and	  H4K31	   (GARCIA	   et	   al.	   2007a;	  
UNNIKRISHNAN	  et	  al.	  2010;	  ZHANG	  et	  al.	  2009)	  (FIGURE	  5.1).	  Together	  these	  data	  corroborate	  that	  
lysine	   methylation	   is	   not	   limited	   to	   the	   three	   previously	   characterized	   sites,	   but	   rather	   that	  
additional	  sites	  of	  methylation	  likely	  await	  discovery.	  
Many	   questions	   regarding	   active	   demethylation	   of	   histones	   and	   identification	   and	  
characterization	  of	  novel	   sites	  of	  histone	   lysine	  methylation	   remain.	   	   Topics	   to	  be	  explored	   in	  
future	  studies	  regarding	  each	  area	  are	  discussed	  below.	  
	  
Identification	   and	   Characterization	   of	   Histone	   Lysine	   Demethylases	   in	   Saccharomyces	  
cerevisiae	  |	  The	  recent	  discovery	  of	  a	  number	  of	  histone	  lysine	  demethylases	  has	  demonstrated	  
the	  dynamic	  nature	  of	  histone	  methylation.	   	  Three	  members	  from	  the	  JmjC-­‐domain-­‐containing	  
family	   of	   proteins	   that	   have	   been	   demonstrated	   to	   function	   as	   active	   histone	   lysine	  
demethylases	  in	  the	  budding	  yeast	  Saccharomyces	  cerevisiae:	  Jhd1,	  Rph1,	  and	  Jhd2	  (KLOSE	  et	  al.	  
2007a;	   LIANG	   et	   al.	   2007;	   TSUKADA	   et	   al.	   2006).	   	   Beyond	   identification	   of	   enzymes	   capable	   of	  
reversing	   histone	  methylation,	   in	   broad	   terms,	   the	  primary	   questions	   remaining	   point	   toward	  
elucidating	   the	  mechanism	  by	  which	   the	  demethylases	   are	   regulated	   and	   targeted,	   as	  well	   as	  
the	   functional	   consequence	   of	   the	   removal	   of	   histone	   methyl	   marks.	   	   Jhd1	   is	   a	   mono-­‐	   and	  
dimethyl	   H3K36	   demethylase,	   whose	   characterization	   to	   date	   has	   largely	   been	   discussed	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elsewhere	  (FANG	  et	  al.	  2007;	  KIM	  and	  BURATOWSKI	  2007;	  TSUKADA	  et	  al.	  2006).	  	  In	  addition	  to	  the	  
work	  contained	  within	  this	  dissertation	  identifying	  Rph1	  as	  a	  demethylase	  with	  specificity	  for	  di-­‐	  
and	  trimethyl	  lysine	  36	  of	  histone	  H3	  (KLOSE	  et	  al.	  2007a),	  preliminary	  studies	  were	  completed	  to	  
explore	   the	  biological	   consequence	  of	  H3K36	  demethylation	  during	   transcriptional	  elongation.	  	  
Given	   the	   established	   role	   of	   H3K36	   methylation	   in	   transcription	   elongation	   in	   promoting	  
recruitment	  of	   the	  Rpd3S	  histone	  deacetylase	  complex	   (CARROZZA	  et	  al.	  2005;	   JOSHI	  and	  STRUHL	  
2005;	   KEOGH	   et	   al.	   2005),	   I	   sought	   to	   identify	   a	   role	   for	   removal	   of	   methyl	   marks	   from	   this	  
residue	   during	   this	   process.	   	   Deletion	   of	   the	   H3K36	   demethylases	   alone	   leads	   to	   no	   obvious	  
cellular	  phenotypes	  or	   impaired	  cellular	  growth	  (FIGURE	  5.2,	  panel	  A	  and	  see	  (FANG	  et	  al.	  2007;	  
KLOSE	   et	   al.	   2007a)).	   	  However,	   recent	   studies	  have	   shows	   that	   the	  overexpression	  of	   Jhd1	  or	  
Rph1	   can	   remove	   H3K36	   methylation	   and	   promote	   transcription	   elongation	   (KIM	   and	  
BURATOWSKI	   2007).	   	   The	   lack	   of	   an	   overt	   cellular	   phenotype	   in	   the	   individual	   deletion	   strains	  
alone	  thus	  prompted	  more	  specific	  analysis	  of	  the	  role	  of	  these	  enzymes	  in	  the	  context	  of	  H3K36	  
function	  during	  transcription	  elongation.	  
Previous	   studies	   revealed	   that	   the	   loss	   of	   H3K36me	   by	   either	   deletion	   of	   SET2	   or	  
mutation	   of	   lysine	   36	   to	   a	   non-­‐modifiable	   amino	   acid	   residue	   can	   bypass	   anomalous	   growth	  
phenotypes	   of	   strains	   harboring	   mutations	   in	   factors	   necessary	   for	   proper	   transcription	  
elongation,	   such	   as	  members	   of	   the	   FACT	   chaperone	   and	   the	   Bur1/2	   kinase	   complexes.	   	   For	  
example,	  the	  slow-­‐growth	  phenotype	  of	  strains	  harboring	  a	  temperature	  sensitive	  mutant	  allele	  
of	   SPT16	   (spt16-­‐11),	   a	   member	   of	   the	   FACT	   histone	   chaperone	   complex	   that	   promotes	  
transcription	   elongation	   (BELOTSERKOVSKAYA	   et	   al.	   2003;	   BISWAS	   et	   al.	   2006;	   FORMOSA	   2003;	  
FORMOSA	  et	  al.	  2001;	  MASON	  and	  STRUHL	  2003;	  SAUNDERS	  et	  al.	  2003;	  SCHWABISH	  and	  STRUHL	  2004),	  
grown	  at	   the	  non-­‐permissive	   temperature	   is	   suppressed	  by	  a	   loss	  of	  SET2	  or	   introduction	  of	  a	  
histone	  H3	  mutant	  containing	  an	  lysine-­‐to-­‐arginine	  substitution	  mutation	  at	  amino	  acid	  residue	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36	  (K36R)	  (FIGURE	  5.2,	  panel	  A,	  and	  (BISWAS	  et	  al.	  2006)).	  	  Likewise,	  deletion	  of	  SET2	  can	  improve	  
the	  weak	  growth	  phenotype	  of	   strains	  deleted	  of	  BUR2,	  which	  encodes	   for	   a	   kinase	   linked	   to	  
transcriptional	   regulation	   through	   its	   activity	   for	   phosphorylation	   of	   the	   CTD	   of	   the	   largest	  
subunit	   of	   RNAPII	   (FIGURE	   5.2,	   panel	   B,	   and	   (KEOGH	   et	   al.	   2005;	   YAO	   et	   al.	   2000)).	   	   Preliminary	  
deletion	   analyses	   have	   revealed	   that	   loss	   the	   H3K36me3/2	   demethylase	   Rph1	   shows	  
phenotypes	   supportive	   of	   a	   role	   in	   promoting	   transcription	   elongation.	   	   Genes	   encoding	   the	  
knows	  H3K36	  demethylases	   Jhd1	  and	  Rph1	   (as	  well	   as	   the	  putative	  H3K36	  demethylase	  Gis1)	  
were	  individually	  deleted	  in	  wild-­‐type	  or	  spt16-­‐11	  strains,	  and	  strains	  were	  assayed	  for	  growth	  
at	  either	  the	  permissive	  (30°C)	  or	  semi-­‐permissive	  (34°C)	  temperature.	   	  As	  shown	  in	  FIGURE	  5.2	  
(panel	  A),	  deletion	  of	  the	  individual	  H3K36	  demethylase	  genes	  in	  either	  the	  wild-­‐type	  or	  spt16-­‐
11	  strains	  does	  not	  affect	  cellular	  growth	  at	  the	  permissive	  temperature.	  	  However,	  deletion	  of	  
RPH1	   in	   the	   spt16-­‐11	   strain	   shows	   in	   a	   synthetic	   effect	   at	   the	   semi-­‐permissive	   temperature	  
(FIGURE	  5.2,	  panel	  A).	  	  Similarly,	  where	  a	  bur2∆	  strain	  is	  viable,	  but	  slow	  growing,	  introduction	  of	  
a	  secondary	  mutation	  in	  which	  RPH1	  is	  deleted	  results	  in	  a	  loss	  of	  cell	  viability	  (FIGURE	  5.2,	  panel	  
B).	   	   Collectively,	   these	   results	   suggest	   that	   Rph1	   could	   function	   to	   promote	   transcription	  
elongation	  by	  operating	   in	   pathways	   that	   overlap	  with	   the	   specific	   functions	  of	   the	   FACT	   and	  
BUR	   complexes.	   	   It	   is	   possible	   that	   precise	  modulation	  of	   the	   levels	   of	  H3K36	  methylation	   by	  
Set2	  and	  the	  H3K36	  histone	  demethylase(s),	  such	  as	  Rph1,	  is	  necessary	  for	  proper	  transcription	  
elongation.	  	  
That	  Rph1	  definitely	   functions	   in	  the	  process	  of	  transcription	  elongation	  as	  well	  as	  the	  
exact	  mechanism	   of	   action	   by	   which	   Rph1-­‐mediated	   demethylation	   of	   H3K36	   could	   promote	  
faithful	   elongation	   remain	   to	   be	   conclusively	   demonstrated.	   	   The	   putative	   genetic	   interaction	  
between	   RPH1	   and	   SPT16	   or	   BUR2	   was	   identified	   using	   genetic	   analysis.	   	   As	   alteration	   of	  
chromatin-­‐modifying	  machinery	  could	  lead	  to	  the	  introduction	  of	  unwanted	  mutations	  that	  are	  
129	  
capable	   of	   suppressing	   and/or	   enhancing	   cellular	   phenotypes,	   it	   is	   crucial	   to	   complete	  
sequential	  rounds	  of	  backcrossing	  to	  an	  isogenic	  wild-­‐type	  strain	  to	  ensure	  that	  the	  genotypes	  
of	   the	  mutant	   strains	   are	   not	   compromised	   in	   an	   undesirable	  manner.	   	   Should	   the	   synthetic	  
growth	   defect	   of	   a	   spt16-­‐11	   rph1Δ	   double	  mutant	   strain	   hold	   true,	   it	   would	   be	   necessary	   to	  
demonstrate	   that	   such	  a	   synthetic	  phenotype	   is	  due	   to	   loss	  of	  Rph1	  demethylase	  activity.	   	  To	  
that	  end,	  a	  rescue	  experiment	   in	  which	  growth	   is	  assessed	  following	   introduction	  of	  a	  plasmid	  
expressing	  either	  wild-­‐type	  or	  catalytically	  inactive	  Rph1	  into	  a	  spt16-­‐11	  rph1Δ	  strain	  should	  be	  
completed	   (and	   likewise	   for	   the	   bur2∆	   rph1∆	   double	   mutant	   strain).	   	   If	   Rph1	   demethylase	  
activity	  does	   in	   fact	  promote	  proper	  FACT	  function	   in	  yeast,	  expression	  of	  wild-­‐type	  Rph1,	  but	  
not	  catalytically	  inactive	  Rph1,	  should	  restore	  growth	  to	  a	  level	  comparable	  to	  that	  of	  the	  spt16-­‐
11	  allele	  alone,	   in	  turn	  supporting	  the	  notion	  that	  Rph1	  demethylase	  activity	   likely	  contributes	  
to	  proper	  transcription	  elongation.	  
One	   possible	   means	   by	   which	   Rph1	   could	   function	   during	   transcription	   elongation	   is	  
through	   the	  proper	   recruitment	  and/or	   function	  of	   the	  Rpd3S	  histone	  deacetylase	  complex	   to	  
chromatin.	  	  H3K36me	  is	  important	  for	  the	  stable	  association	  and	  function	  of	  the	  Rpd3S	  histone	  
deacetylase	  complex	  on	  nucleosomes	  (CARROZZA	  et	  al.	  2005;	  GOVIND	  et	  al.	  2010;	  JOSHI	  and	  STRUHL	  
2005;	  KEOGH	  et	  al.	  2005;	  LI	  et	  al.	  2007b;	  LI	  et	  al.	  2009a;	  YOUDELL	  et	  al.	  2008).	  	  Similar	  to	  deletion	  
of	  SET2,	   loss	  of	  the	  Rpd3S	  complex	  members	  Rco1	  or	  Eaf3	  in	  the	  spt16-­‐11	  mutant	  background	  
results	   in	   suppression	   of	   the	   synthetic	   growth	   defect	   observed	   at	   the	   semi-­‐permissive	  
temperature	   (BISWAS	   et	   al.	   2006;	  BISWAS	   et	   al.	   2008).	   	   It	   could	  be	   that	   the	  observed	   synthetic	  
growth	   defect	   of	   the	   spt16-­‐11	   rph1Δ	   double	   mutant	   exhibited	   in	   FIGURE	   5.2	   (panel	   A)	   is	  
dependent	  on	  the	  Rpd3S	  complex,	  as	   it	   is	  possible	  that	   increased	   levels	  of	  H3K36me	  on	  genes	  
following	  deletion	  of	  Rph1	  could	  lead	  to	  enhanced	  recruitment	  of	  the	  Rpd3S	  HDAC	  complex	  and	  
subsequent	   deacetylation	   of	   nucleosomes	   in	   transcribed	   regions.	   	   If	   this	   model	   is	   correct,	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deletion	  of	  Rpd3S	   complex	  members	  would	   suppress	   the	  observed	   slow	  growth	  defect	  of	   the	  
spt16-­‐11	   rph1Δ	   double	   mutant	   strain.	   	   Thus,	   future	   experiment	   should	   include	   phenotypic	  
growth	   assays	   testing	   how	   introduction	   of	   individual	   deletion	   of	   members	   of	   the	   Rpd3S	  
complex,	  including	  Rco1	  and	  Eaf3,	  affects	  the	  growth	  of	  a	  spt16-­‐11	  rph1Δ	  double	  mutant	  strain.	  
Unlike	   deletion	   of	   SET2,	   which	   leads	   to	   both	   global	   and	   gene-­‐specific	   increases	   in	  
acetylation	  levels	  due	  to	  the	  inability	  to	  recruit	  the	  Rpd3S	  complex,	  preliminary	  western	  blot	  and	  
ChIP	  analyses	   indicate	  that	   loss	  of	  RPH1	  does	  not	  appear	  to	  result	   in	  altered	  acetylation	   levels	  
either	  globally	  or	  on	  a	  subset	  of	  genes	  tested	  (data	  not	  shown).	   	  This	  suggests	  that	  Rph1	  likely	  
acts	  on	  a	  distinct	  group	  of	  genes	  whose	  identity	  remains	  to	  be	  determined.	  	  Thus,	  further	  work	  
that	  remains	  to	  be	  completed	  also	  includes	  positive	  identification	  of	  Rph1	  target	  genes,	  as	  such	  
analyses	   could	   provide	   significant	   insight	   into	   the	   biological	   function	   of	   Rph1-­‐mediated	  
demethylation	  of	  H3K36.	  	  Microarray	  analyses	  of	  wild-­‐type	  versus	  RPH1	  deletion	  strains	  would	  
provide	   insight	   as	   to	   the	   genes	   whose	   expression	   changes	   upon	   loss	   of	   Rph1.	   	   Such	   analysis	  
should	  be	  completed	  bearing	   in	  mind	  that	  Rph1	  and	   its	  homolog	  Gis1	  have	  been	  shown	  to	  be	  
functionally	   redundant	   In	   the	   context	   of	   their	   previously	   identified	   roles	   as	   DNA	   damage-­‐
responsive	  repressors	  (JANG	  et	  al.	  1999).	  	  Although	  it	  has	  been	  suggested	  that	  Gis1	  is	  a	  histone	  
lysine	  demethylase	  (TU	  et	  al.	  2007),	  substitutions	   in	  necessary	  amino	  acids	   in	   its	  catalytic	   JmjC	  
domain	   likely	   abrogate	   its	   enzymatic	   activity	   (KLOSE	   et	   al.	   2007a;	   KLOSE	   and	   ZHANG	   2007).	  	  
Nonetheless,	   consideration	   for	   its	  putatively	   redundant	   function	  as	  a	   transcriptional	   repressor	  
must	   be	   taken	   in	   such	   studies.	   	   As	   microarray	   analysis	   would	   merely	   provide	   information	  
regarding	  categories	  of	  genes	  whose	  expression	  is	  changed	  upon	  loss	  of	  a	  demethylase,	  a	  more	  
ideal	   approach	   to	   identify	  direct	   targets	  would	  be	   to	  perform	  chromatin	   immunoprecipitation	  
coupled	   with	   deep	   sequencing	   (ChIP-­‐seq)	   using	   an	   antibody	   capable	   of	   immunoprecipitating	  
Rph1.	  	  However,	  we	  and	  others	  have	  experienced	  difficulty	  in	  performing	  ChIP	  analysis	  of	  JmjC-­‐
131	  
domain-­‐containing	  demethylases	  in	  yeast	  (INGVARSDOTTIR	  et	  al.	  2007;	  KIM	  and	  BURATOWSKI	  2007),	  
which	  could	  perhaps	  be	  due	  to	  transient	  interactions	  between	  the	  demethylases	  and	  chromatin.	  	  
Such	  limitations	  must	  be	  overcome	  if	  genome-­‐wide	  localization	  of	  the	  demethylases	  by	  ChIP-­‐seq	  
analysis	   is	  to	  be	  completed.	   	  Should	   it	  be	  possible	  to	   identify	  target	  genes,	  subsequent	  studies	  
must	  then	  be	  completed	  to	  determine	  the	  mechanism	  by	  which	  Rph1	  is	  recruited	  to	  such	  genes,	  
as	  well	   as	   how	   the	   different	   states	   of	  H3K36	  methylation	   regulated	   by	   Set2	   and	   Rph1	   at	   this	  
subset	  of	   genes	  ultimately	   control	   the	   recruitment	  and	   function	  of	   the	  Rpd3S	   complex	  during	  
transcription	  elongation.	  
	   Originally	   identified	   as	   a	   transcriptional	   repressor	   of	   PHR1,	   a	   DNA	   repair	   gene	   that	  
encodes	  a	  photolyase	   that	   repairs	  pyrimidine	  dimers,	  Rph1	  does	  have	  one	  known	  target	  gene	  
(JANG	  et	  al.	  1999).	  	  EMSA	  and	  DNase	  I	  footprinting	  have	  suggested	  that	  in	  vitro	  Rph1	  associates	  
through	   its	   C-­‐terminal	   zinc	   fingers	   with	   a	   single	   AG4	   sequence	   in	   the	   upstream	   repressive	  
sequence	  of	  PHR1	  (URSPHR1)	  (JANG	  et	  al.	  1999;	  SANCAR	  et	  al.	  1995).	  	  Upon	  DNA	  damage,	  Rph1	  is	  
released	   from	   the	   URSPHR1,	   thereby	   allowing	   for	   transcription	   of	   PHR1	   and	   enhanced	   cellular	  
DNA	  repair	  (JANG	  et	  al.	  1999).	  	  Of	  interest	  would	  be	  to	  demonstrate	  a	  direct	  association	  of	  Rph1	  
with	   the	  URSPHR1	  by	  ChIP	   analysis.	   	  Given	   the	  difficulties	   in	   immunoprecipitating	   JmjC-­‐domain-­‐
containing	   demethylases	   (as	   described	   above)	   for	   ChIP	   analysis,	   it	  would	   at	   the	   very	   least	   be	  
interesting	  to	  see	  evidence	  of	  demethylase	  activity	  at	  the	  URSPHR1	  by	  assessing	  changes	  in	  H3K36	  
methylation	  states	  in	  the	  presence	  and	  absence	  of	  DNA	  damage	  in	  wild-­‐type	  and	  Rph1	  deletion	  
strains	   using	   H3K36me	   modification-­‐specific	   antibodies	   for	   ChIP	   analysis.	   	   Should	   changes	   in	  
H3K36	   methylation	   be	   detectable	   upon	   DNA	   damage,	   it	   would	   suggest	   action	   by	   Rph1.	  	  
Subsequent	   analysis	   could	   be	   performed	   to	   see	   if	   other	   genomic	   regions	   that	   contain	   a	   AG4	  
consensus	   sequence	   similar	   to	   that	   found	   in	   the	  URSPHR1	   (see	   (JANG	   et	   al.	   1999)	   for	   examples)	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could	  putatively	  provide	  insight	  into	  additional	  targets	  of	  Rph1	  by	  assessing	  H3K36	  methylation	  
levels	  at	  those	  genomic	  loci	  in	  the	  presence	  and	  absence	  of	  Rph1.	  
In	  this	  work,	  Jhd2	  was	  identified	  as	  a	  H3K4	  demethylase	  specific	  for	  the	  di-­‐	  and	  trimethyl	  
state	   (LIANG	   et	   al.	   2007).	   	   At	   present,	   the	   regulation	   and	   functional	   consequence	   of	   Jhd2-­‐
mediated	  demethylation	  is	  better	  characterized	  than	  that	  of	  Jhd1	  or	  Rph1.	   	  Where	  phenotypic	  
analysis	  of	  a	  JHD2	  deletion	  strain	  revealed	  no	  obvious	  function,	  overexpression	  of	  Jhd2	  disrupts	  
silencing	  of	  telomeric	  regions	  (LIANG	  et	  al.	  2007).	  	  This	  finding	  correlates	  well	  with	  the	  previously	  
established	  role	  of	  H3K4	  methylation	   in	  regulation	  of	  telomeric	  silencing	  (KROGAN	  et	  al.	  2002a;	  
NISLOW	  et	  al.	  1997).	   	  Given	  the	  role	  of	  Set1-­‐mediated	  H3K4	  methylation	   in	   regulation	  of	  other	  
biological	  processes	  in	  budding	  yeast	  including	  cellular	  growth,	  transcriptional	  regulation,	  rDNA	  
silencing,	   meiotic	   differentiation,	   DNA	   repair,	   and	   chromosome	   segregation	   (DEHE	   and	   GELI	  
2006),	   and	   that	   Jhd2	   is	   the	   only	   known	   H3K4	   demethylase,	   it	   is	   somewhat	   surprising	   that	  
phenotypic	  analysis	  of	  a	  JHD2	  deletion	  strain	  did	  not	  reveal	  more	  obvious	  cellular	  phenotypes,	  
indicating	  that	  more	  specific	  assays	  are	  likely	  needed	  to	  provide	  greater	  insight	  into	  the	  role	  of	  
H3K4	  demethylation.	  	  For	  example,	  cell	  synchronization	  and	  release	  studies	  have	  revealed	  that	  
Jhd2	   contributes	   to	   cell	   cycle	   dynamics	   of	   H3K4	   methylation	   (RADMAN-­‐LIVAJA	   et	   al.	   2010).	  	  
Additionally,	   Jhd2	   has	   been	   shown	   to	   be	   necessary	   to	   both	   establish	   proper	   levels	   of	   H3K4	  
methylation	   during	   activation	   of	   the	  GAL1	   gene	   and	   remove	   H3K4	   trimethylation	   during	   the	  
attenuation	  phase	  of	  transcription	  (INGVARSDOTTIR	  et	  al.	  2007).	  
Studies	   are	   beginning	   to	   shed	   light	   onto	   the	   regulation	   and	   targeting	   of	   the	   histone	  
demethylases.	   	   For	  example,	   it	  has	  been	  shown	  that	   levels	  of	   the	  H3K4	  demethylase	   Jhd2	  are	  
controlled	   via	  polyubiquitylation	  by	   the	  E3	  ubiquitin	   ligase	  Not4	  and	   subsequent	  proteasome-­‐
mediated	  degradation	  (MERSMAN	  et	  al.	  2009).	  	  Proteasomal	  degradation	  provides	  one	  potential	  
means	  by	  which	  the	  precise	  amount	  of	  Jhd2	  necessary	  to	  maintain	  the	  proper	  balance	  of	  H3K4	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methylation	  for	  normal	  cellular	  activities	  can	  be	  controlled.	   	   It	   is	  possible,	  however,	  that	  other	  
means	   such	   as	   post-­‐translational	   modification	   of	   the	   demethylases	   themselves	   control	  
enzymatic	  activity.	  	  Purification	  of	  native	  demethylases	  followed	  by	  mass	  spectrometric	  analysis	  
could	   provide	   insight	   into	   differentially	   modified	   forms	   of	   the	   demethylases	   that	   exist	   which	  
could	  potentially	  function	   in	  regulation	  of	  enzymatic	  activity.	   	   Investigations	  revealing	  how	  the	  
demethylases	   are	   potentially	   targeted	   to	   their	   respective	   substrates	   have	   also	   recently	   been	  
reported.	   	   One	  means	   by	   which	   targeting	   and	   regulation	   of	   chromatin	  modifying	   enzymes	   is	  
often	  mediated	  is	  through	  association	  with	  other	  proteins	  in	  the	  form	  of	  high	  molecular	  weight	  
complexes	   (CAIRNS	  2005;	  CAO	   et	  al.	  2002;	  KEOGH	   et	  al.	  2005;	  KROGAN	   et	  al.	  2002a;	  MILLER	   et	  al.	  
2001).	   	   However,	   all	   studies	   completed	   thus	   far	   have	   failed	   to	   reveal	   stable	   associations	  
between	  the	  histone	  demethylases	  and	  auxiliary	  proteins	  that	  could	  putatively	  function	  in	  their	  
targeting	   and/or	   regulation	   (FANG	   et	   al.	   2007;	   KLOSE	   et	   al.	   2007a;	   LIANG	   et	   al.	   2007).	  	  
Alternatively,	   domains	   within	   the	   proteins	   could	   likely	   facilitate	   binding	   to	   chromatin.	   	   For	  
example,	  it	  has	  already	  been	  established	  that	  Rph1	  can	  bind	  to	  DNA	  through	  its	  C-­‐terminal	  zinc	  
fingers	  (JANG	  et	  al.	  1999).	  	  The	  ability	  to	  directly	  interact	  with	  DNA	  may	  circumvent	  the	  need	  for	  
auxiliary	  proteins	  in	  recognizing	  target	  sites	  in	  chromatin.	  	  Both	  Jhd1	  and	  Jhd2	  have	  PHD	  fingers,	  
a	  domain	  that	  has	  been	  shown	  to	  be	  able	  to	  bind	  to	  methylated	  lysine	  residues	  (TAVERNA	  et	  al.	  
2007a).	  	  Previous	  studies	  have	  indicated	  that	  Jhd1	  can	  bind	  to	  methylated	  H3K4	  in	  vitro	  (with	  a	  
preference	   for	   the	   trimethyl	   state)	   through	   its	   PHD	   finger	   (SHI	   et	   al.	   2007),	   and	   that	   the	   PHD	  
finger	   of	   Jhd2	   is	   necessary	   for	   chromatin	   association	   in	   vivo	   (HUANG	   et	   al.	   2010).	   	   Such	  
interactions	   likely	   provide	   one	   mechanism	   by	   which	   the	   demethylases	   are	   targeted	   to	  
chromatin,	   thus	   necessitating	   further	   studies	   to	   decipher	   the	   connection	   between	   chromatin	  
association	  and	  subsequent	  histone	  demethylation.	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Although	   JmjC-­‐domain-­‐containing	   histone	   demethylases	   with	   specificity	   for	   H3K4	   and	  
H3K36	   have	   been	   identified,	   an	   active	   demethylase	   with	   specificity	   for	   H3K79	   remains	   to	   be	  
discovered.	   	  Thus,	  a	   lingering	  question	   in	  the	  field	  of	  histone	  demethylation	   is	  whether	  H3K79	  
methylation	   is	  reversible.	   	  Where	  methylation	  of	  H3K4	  and	  H3K36	   is	  catalyzed	  by	  SET-­‐domain-­‐
containing	  methyltransferases,	  methylation	   of	   H3K79	   is	   catalyzed	   by	   Dot1,	   which	   lacks	   a	   SET	  
domain	   altogether.	   	   The	   inability	   of	   JmjC-­‐domain-­‐containing	   proteins	   to	   catalyze	   removal	   of	  
H3K79	  methylation	  parallels	  the	  fact	  that	  a	  unique	  type	  of	  methyltransferase	  is	  responsible	  for	  
its	   placement.	   	   It	   could	   be	   that	   a	   yet-­‐to-­‐be-­‐identified	   class	   of	   novel	   histone	   demethylase	  
enzymes	   with	   unique	   enzymatic	   properties	   facilitates	   the	   removal	   of	   H3K79	   methylation,	  
thereby	  necessitating	  further	  biochemical	  and	  genetic	  analyses	  to	  demonstrate	  that	  this	  mark	  is	  
dynamically	  regulated.	  	  Experiments	  must	  be	  done	  thoughtfully,	  as	  H3K79	  is	  highly	  methylated	  
(estimated	  at	  90%,	  (VAN	  LEEUWEN	  et	  al.	  2002)),	  and	  high	  levels	  of	  methylation	  could	  mask	  slight	  
changes	  arising	   from	  deletion	  of	   the	   responsible	  enzyme.	   	  Alternatively,	   it	   is	  possible	   that	   this	  
modification	  may	  be	  enzymatically	   irreversible,	  and	  thus	  relies	  on	  passive	  mechanisms	  such	  as	  
histone	   turnover	   for	   removal.	   	   Clearly,	   further	   biochemical	   investigations	   are	   necessary	   to	  
delineate	  if	  either	  of	  these	  possibilities	  is	  correct.	  
The	   thermodynamic	   stability	   of	   the	   amino-­‐methyl	   group	   within	   methylated	   histone	  
residues	   led	   many	   to	   believe	   that	   histone	   lysine	   methylation	   was	   irreversible,	   thereby	  
supporting	  a	  function	  in	  long-­‐term	  epigenetic	  memory	  (KUBICEK	  and	  JENUWEIN	  2004).	  	  While	  the	  
existence	   of	   histone	   lysine	   demethylases	   has	   now	   been	   known	   for	   several	   years,	   studies	   on	  
these	  enzymes	  are	  still	  in	  their	  infancy.	  	  The	  studies	  contained	  in	  this	  work	  greatly	  expanded	  our	  
understanding	   of	   the	   dynamic	   nature	   of	   histone	  methylation	   in	   their	   identification	   of	   histone	  
lysine	  demethylases	  in	  budding	  yeast.	  	  However,	  many	  questions	  remain	  thus	  prompting	  future	  
investigations	   related	   to	   the	  enzymology	  and	   regulation	  of	   the	  histone	  demethylases	   that	  will	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ultimately	   increase	   our	   genuine	   appreciation	   for	   the	   complexity	   associated	   with	   this	   highly	  
stable,	  yet	  dynamic,	  modification.	  
	  
Identification	  and	  Characterization	  of	  Novel	  Sites	  of	  Histone	  Lysine	  Methylation	  |	  At	  the	  time	  
of	   inception	  of	  the	  histone	  code	  hypothesis,	  which	  posits	  that	  combinatorial	  and/or	  sequential	  
patterns	   of	   post-­‐translational	   modifications	   (PTMs)	   of	   histone	   tails	   dictate	   downstream	  
biological	   phenomena	   (STRAHL	   and	   ALLIS	   2000),	   we	   had	   quite	   a	   limited	   understanding	   of	   the	  
breadth	   of	   the	   number	   and	   type	   of	   PTMs	   that	   existed	   on	   histone	   residues	   both	   on	   the	  
unstructured	   N-­‐terminal	   tails	   protruding	   from	   the	   nucleosomal	   surface	   and	   on	   the	   globular	  
domain	   of	   the	   nucleosome	   core	   particle.	   	   Acetylation	   and	   phosphorylation	   were	   the	   best	  
characterized	   at	   that	   time,	   as	   multiple	   sites	   and	   the	   enzymes	   responsible	   for	   their	   dynamic	  
placement	   had	   been	   identified.	   	   However,	   investigations	   of	   modification	   of	   histones	   by	  
methylation	  of	   lysine	  residues	  were	   just	  beginning	  to	  take	  off.	   	  While	   just	  a	   few	  sites	  of	   lysine	  
methylation	  were	  known	  at	  the	  time,	  the	  past	  ten	  years	  has	  witnessed	  a	  dramatic	  expansion	  in	  
our	  understanding	  of	  the	  dynamic	  nature	  of	  this	  modification.	  	  Numerous	  enzymes	  responsible	  
for	   both	   the	   placement	   and	   removal	   of	   methylation	   events	   have	   been	   identified,	   and	   the	  
biological	   consequences	   of	   histone	   lysine	   methylation	   are	   becoming	   apparent	   ((CLOOS	   et	   al.	  
2008;	  SHILATIFARD	  2006)	  and	  FIGURE	  5.1).	  	  In	  spite	  of	  this	  new	  knowledge,	  however,	  several	  sites	  
of	   histone	   lysine	   methylation	   in	   budding	   yeast	   have	   been	   identified	   that	   have	   no	   ascribed	  
methyltransferase,	   demethylase,	   and/or	   biological	   function,	   including	   H2BK22,	   H2BK37,	  
H2BK111,	   H3K18,	   H3K23,	   H3K37,	   and	   H4K31	   (GARCIA	   et	   al.	   2007a;	   KYRISS	   et	   al.	   2010;	  
UNNIKRISHNAN	  et	  al.	  2010;	  ZHANG	  et	  al.	  2009),	   thereby	  necessitating	  continued	  biochemical	  and	  
genetic	   analyses	   to	   delineate	   the	   enzymology,	   regulation,	   and	   functional	   consequence(s)	   of	  
placement	  and	  removal	  of	  methyl	  marks	  at	  these	  sites.	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A	   clear	   challenge	   that	   remains	   for	   future	   studies	   is	   to	   identify	   novel	   sites	   of	   histone	  
lysine	  methylation	  (and	  PTMs	   in	  general)	  and	  decipher	  how	  such	  modifications	  function	   in	  the	  
context	  of	  the	  same	  histone,	  within	  the	  same	  nucleosome,	  and	  within	  contiguous	  nucleosomes.	  	  
Technological	  advancements	  have	  significantly	  advanced	  our	  efforts	  to	  both	  identify	  novel	  sites	  
of	   histone	   modifications	   and	   the	   combinations	   in	   which	   they	   exist	   and	   to	   understand	   the	  
biological	  significance	  of	  such	  combinatorial	  patterns.	  	  Histone	  modifications	  have	  typically	  been	  
identified	   using	   mass	   spectrometry	   (MS)	   analysis.	   	   Recent	   advancements	   in	   MS	   technology	  
include	   the	   development	   of	   top-­‐down	   MS	   analysis,	   in	   which	   intact	   proteins	   samples	   are	  
analyzed,	   as	   opposed	   to	   the	   more	   canonical	   bottom-­‐up	   MS	   approach	   where	   proteins	   are	  
fragmented	  prior	  to	  analysis.	   	  Because	  proteins	  are	  analyzed	  at	  the	  whole-­‐molecule	   level,	   top-­‐
down	  MS	  allows	   for	   identification	  of	   combinatorial	   patterns	  of	  modifications	   that	   exist	  within	  
one	  histone	  protein.	  	  Within	  this	  work,	  we	  used	  top-­‐down	  MS	  analysis	  to	  analyze	  novel	  sites	  and	  
combinations	   of	   modification	   on	   histones	   to	   begin	   to	   understand	   the	   totality	   of	   existent	  
modifications	  and	   identified	   lysine	  37	  of	  histone	  H2B	  as	  a	  novel	   site	  of	  histone	  methylation	   in	  
budding	   yeast	   (GARDNER	   et	   al.	   2011b).	   	   This	   is	   likely	   to	   be	   one	   of	   numerous	   sites	   of	   histone	  
methylation	   present	   on	   chromatin,	   thus	   necessitating	   continued	   MS	   studies	   to	   more	   fully	  
catalogue	   modifications	   that	   potentially	   function	   within	   the	   context	   of	   the	   histone	   code.	  	  
Although	   only	   recently	   developed,	   top-­‐down	   MS	   analysis	   has	   already	   proven	   itself	   to	   be	   a	  
powerful	  tool	  that	  will	  likely	  continue	  to	  push	  forward	  our	  understanding	  both	  the	  dynamics	  and	  
combinatorial	  states	  of	  histone	  PTMs	  in	  future	  studies.	  
MS	  approaches	  employed	  to	  examine	  combinatorial	  modifications	  on	  histones	  must	  be	  
complemented	   by	   comprehensive	   genomic	   location	   analysis,	   as	   identification	   of	   the	   histone	  
PTMs	  themselves	  is	  not	  enough	  to	  understand	  functional	  consequences	  of	  their	  placement.	  	  The	  
availability	   of	   modification	   specific	   antibodies	   has	   allowed	   for	   immunoprecipitation	   of	   DNA	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fragments	   associated	   with	   a	   particular	   mark	   by	   chromatin	   immunoprecipitation	   (ChIP).	   	   The	  
relatively	   small	   size	   of	   the	   genome	   has	   made	   hybridization	   of	   immunoprecipitated	   DNA	   to	  
microarrays	   (ChIP-­‐chip)	   a	   successful	   means	   by	   which	   genome-­‐wide	   profiles	   of	   histone	  
methylation	  in	  budding	  yeast	  have	  be	  assessed	  (POKHOLOK	  et	  al.	  2005;	  RAO	  et	  al.	  2005;	  SCHULZE	  et	  
al.	   2009).	   	   Coupled	   with	   ChIP,	   next-­‐generation	   sequencing	   technology	   (ChIP-­‐seq)	   has	  
considerably	  advanced	  comprehensive	  mapping	  of	  genome-­‐wide	  modification	  patterns	  in	  higher	  
eukaryotes	  (BARSKI	  et	  al.	  2007;	  MIKKELSEN	  et	  al.	  2007).	  	  Given	  the	  great	  insight	  that	  ChIP-­‐chip	  and	  
ChIP-­‐seq	   studies	   have	   provided	  with	   respect	   to	   the	   coordinated	   placement	   of	   histone	  marks,	  
these	   techniques	   are	   likely	   to	   be	   readily	   called	   upon	   in	   future	   studies	   to	   map	   genome-­‐wide	  
patterns	   of	   novel	  marks	   as	  well	   as	   patterns	   of	   transcription	   factors	   and	   chromatin	  modifying	  
machinery	  that	  place,	  remove,	  and	  interpret	  modifications.	  
	   The	  rapid	  pace	  of	  research	  in	  chromatin	  biology	  means	  that	  we	  are	  continually	  refining	  
how	  we	   define	   the	   histone	   code.	   	   Recently,	   it	   has	   come	   to	   be	   seen	   less	   as	   a	   set	   of	   definite	  
combinations	   that	   lead	   to	   an	   absolute	   outcome	   (as	   would	   be	   dictated,	   for	   example,	   by	   the	  
genetic	  code),	  and	  more	  as	  patterns	  of	  modifications	  that	  when	  in	  combination	  tend	  to	  tip	  the	  
balance	   toward	   a	   specific	   outcome.	   	   Perhaps,	   then,	   the	   ramifications	   of	   the	   histone	   code	   are	  
correlative	   rather	   than	   causal	   in	   that	   combinatorial	   patterns	   provide	   a	   bias	   for	   a	   specific	  
outcome	  rather	  than	  serve	  as	  an	  absolute	  mark	  of	  one.	  	  Regardless	  of	  how	  the	  code	  is	  defined,	  it	  
is	   certain	   that	   continued	   efforts	   are	   needed	   to	   both	   identify	   and	   characterize	   novel	   histone	  
modifications	   and	   the	   combinatorial	   patterns	   in	   which	   they	   exist	   and	  map	   the	   genome-­‐wide	  
localization	   patterns	   of	   such	   modifications	   so	   that	   we	   can	   continue	   to	   refine	   instead	   our	  




Closing	   Thoughts	   |	   From	   the	   onset	   of	   the	   studies	   included	   within	   this	   body	   of	   work,	   the	  
overarching	   objective	  was	   to	   understand	   how	   dynamic	   changes	   in	   histone	   lysine	  methylation	  
regulate	   chromatin	   structure	   and	   function.	   	   Although	   the	   budding	   yeast	   Saccharomyces	  
cerevisiae	   has	   a	   relatively	   simplistic	   histone	   lysine	   methylation	   system	   compared	   to	   higher	  
eukaryotes,	   elegant	   studies	   can	   be	   conducted	   in	   this	   model	   organism	   that	   are	   simply	   not	  
possible	   in	   higher	   organisms.	   	   For	   example,	  where	   the	   budding	   yeast	   protein	   Set2	   is	   the	   sole	  
methyltransferase	  responsible	  for	  methylation	  of	  H3K36	  (STRAHL	  et	  al.	  2002),	  mammals	  have	  at	  
least	   three	  proteins	   that	  can	  methylate	  H3K36	  (LI	  et	  al.	  2009b;	  RAYASAM	  et	  al.	  2003;	  SUN	  et	  al.	  
2005).	   	  Where	  depletion	  of	  the	  murine	  Setd2	  in	  cultured	  cells	  results	  in	  a	  loss	  of	  trimethylated	  
H3K36,	  mono-­‐	  and	  dimethyl	  H3K36	  remain	  largely	  unaffected,	  supporting	  the	  view	  that	  Setd2	  is	  
a	   trimethyl	   specific	   H3K36	  methyltransferase	   (EDMUNDS	   et	   al.	   2008).	   	   Such	   an	   example	   of	   the	  
complexity	   associated	  with	   the	  histone	   lysine	  methylation	   system	   in	  higher	  eukaryotes	  makes	  
the	   difficulties	   of	   conducting	   functional	   studies	   in	   which	   a	   methylation	   event	   is	   completely	  
abrogated	   immediately	   apparent.	   	   For	   studies	   related	   to	   identification	   of	   novel	   enzymes	   and	  
sites	   of	   modification	   by	   dynamic	   methylation	   as	   were	   conducted	   within	   this	   piece,	   budding	  
yeast	  therefore	  offers	  the	  advantage	  of	  a	  system	  in	  which	  biochemical	  and	  genetic	  studies	  that	  
reveal	  insight	  into	  the	  enzymology	  and	  regulation	  of	  such	  events	  can	  be	  completed	  with	  relative	  
ease	   and	   can	   then	   be	   translated	   to	   higher	   eukaryotes.	   	   Moving	   forward,	   cross-­‐disciplinary	  
investigations	  involving	  exploratory	  studies	  in	  model	  organisms	  followed	  by	  translation	  to	  higher	  
organisms	   seem	  most	   advantageous	   in	   creating	   a	   comprehensive	   picture	   of	   the	   dynamics	   of	  
histone	   methylation,	   and	   future	   studies	   in	   budding	   yeast	   will	   thus	   continue	   to	   contribute	  
significantly	  to	  our	  understanding	  of	  the	  intricacies	  of	  this	  modification.	  
	   As	  our	  understanding	  of	  the	  sites	  on	  which	  histone	  lysine	  methylation	  occur	  as	  well	  as	  
the	  proteins	  that	  place,	   interpret,	  and	  remove	  this	  modification	  increases,	  the	  importance	  of	  a	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histone	   methylation	   system	   in	   the	   regulation	   of	   chromatin-­‐based	   processes	   becomes	   more	  
apparent.	  	  A	  major	  challenge	  in	  chromatin	  biology	  is	  to	  integrate	  how	  the	  addition	  and	  removal	  
of	  specific	  modifications	  such	  as	  lysine	  methylation	  on	  histones	  fits	  into	  the	  fluid	  picture	  of	  the	  
continually	  changing	  chromatin	  template.	  	  Fortunately,	  technological	  advancements	  continue	  to	  
further	  our	  research	  efforts,	  arming	  us	  with	  a	  continually	  polished	  understanding	  of	  methylation	  
patterns.	  	  Although	  the	  scientific	  investigations	  within	  this	  dissertation	  individually	  advance	  our	  
basic	  knowledge	  of	  the	  histone	  methylation	  system	  in	  yeast,	  it	  is	  with	  great	  optimism	  that	  they	  
will	  contribute	  to	  even	  more	  sophisticated	  analysis	  of	  defining	  how	  histone	   lysine	  methylation	  
dictate	  epigenetic	  states	  involved	  in	  more	  complex	  biological	  processes	  such	  as	  human	  disease	  




FIGURE	   5.1	   |	   Current	   atlas	   of	   histone	   lysine	   methylation	   in	   Saccharomyces	   cerevisiae.	  	  
Illustrated	   are	   the	   presently	   known	   sites	   of	   histone	   lysine	   methylation	   in	   the	   budding	   yeast	  
Saccharomyces	   cerevisiae	   along	   with	   the	   known	   histone	   methyltransferases	   and	   histone	  
demethylases	   that	   catalyze	   placement	   and	   removal	   of	  methyl	   groups	   (Me;	   depicted	   by	   green	  
hexagons),	  respectively.	  	  The	  number	  of	  methyl	  groups	  shown	  represents	  the	  maximum	  state	  to	  
which	  the	  modified	  residue	  has	  been	  shown	  to	  methylated.	  	  Work	  contained	  within	  this	  doctoral	  
dissertation	   contributed	   to	   this	   atlas	   by	   demonstrating	   that	   the	   budding	   yeast	   proteins	   Rph1	  
and	   Jhd2	   function	   as	   histone	   lysine	   demethylases	   with	   specificity	   for	   di-­‐	   and	   trimethylated	  
histone	  H3	  lysine	  residues	  36	  and	  4,	  respectively,	  and	  by	  also	  showing	  that	  lysine	  37	  of	  histone	  




FIGURE	   5.2	   |	   Deletion	   of	   RPH1	   results	   in	   phenotypes	   supportive	   of	   a	   role	   in	   transcription	  
elongation.	   	   (A)	   JHD1,	   RPH1,	   GIS1,	   and	   SET2	   were	   individually	   deleted	   in	   isogenic	   wild-­‐type	  
(W303)	  and	  spt16-­‐11	  haploid	  strains,	  which	  were	  subsequently	  backcrossed	  to	  wild-­‐type	  (W303)	  
for	  three	  generations.	  	  Segregants	  from	  individual	  tetrads	  from	  the	  third	  backcross	  were	  assayed	  
for	  growth	  on	  rich	  YPD	  media	  (spotted	  in	  5-­‐fold	  serial	  dilutions)	  at	  either	  the	  permissive	  (30°C)	  
or	  semi-­‐permissive	  (34°C)	  temperature.	  	  Cells	  were	  grown	  on	  selective	  rich	  media	  (YPD	  +	  G418)	  
as	   a	   control	   to	   demonstrate	   appropriate	   kanMX	   deletions.	   	   rph1∆::kanMX,	   jhd1∆::kanMX,	  
gis1∆::kanMX,	  and	  set2∆::kanMX	  single	  mutant	  strains	  grow	  equivalently	  to	  wild-­‐type	  strains.	  	  A	  
spt16-­‐11	   rph1Δ::kanMX	  double	  mutant	  strain	  exhibits	  a	   synthetic	  growth	  defect,	  as	  compared	  
to	  growth	  of	  a	  spt16-­‐11	  strain	  alone.	  	  This	  is	  in	  direct	  contrast	  to	  the	  enhanced	  cellular	  growth	  
observed	  for	  cells	  upon	  loss	  of	  SET2	  in	  combination	  with	  the	  spt16-­‐11	  allele	  grown	  at	  the	  semi-­‐
permissive	  temperature	  (as	  previously	  established	  (BISWAS	  et	  al.	  2006)).	   	   (B)	  RPH1,	  JHD1,	  GIS1,	  
and	  SET2	  were	  individually	  deleted	  in	  a	  bur2∆::TRP1	  strain	  containing	  a	  pRS316-­‐BUR2	  plasmid.	  	  
Shown	   is	   the	   growth	   of	   the	   bur2Δ::TRP1,	   bur2Δ::TRP1	   rph1Δ::kanMX,	   bur2Δ::TRP1	  
jhd1Δ::kanMX,	  bur2Δ::TRP1	  gis1Δ::kanMX,	  and	  bur2Δ::TRP1	  set2Δ::kanMX	  strains	  spotted	  in	  5-­‐
fold	  serial	  dilutions	  on	  SC-­‐URA	  and	  SC-­‐URA	  containing	  5-­‐fluoroorotic	  acid	  (5-­‐FOA)	  plates.	   	  Cells	  
were	  grown	  on	  selective	  rich	  media	   (SC-­‐URA	  +	  G418)	  as	  a	  control	   to	  demonstrate	  appropriate	  
kanMX	  deletions.	   	  Deletion	  of	  RPH1	   is	   lethal	  when	  combined	  with	  loss	  of	  BUR2,	  as	  opposed	  to	  
the	  combined	  loss	  of	  SET2	  and	  BUR2,	  which	  results	  in	  enhanced	  cellular	  growth	  as	  compared	  to	  
the	  bur2∆::TRP1	  strain	  alone	  (in	  agreement	  with	  previously	  published	  data	   (KEOGH	  et	  al.	  2005;	  
YAO	  et	  al.	  2000)).	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Histone	  methylation	  is	  important	  in	  regulating	  chromatin	  structure	  and	  function.	  	  In	  budding	  
yeast,	  methylation	  of	  histone	  H3	  at	  Lys4	  (H3-­‐K4)	  is	  associated	  with	  active	  transcription	  and	  is	  
enriched	  at	  the	  5’	  regions	  of	  transcribed	  genes.	  	  Here	  we	  identify	  a	  novel	  budding	  yeast	  JmjC-­‐
domain-­‐containing	   H3-­‐K4	   demethylase,	   Jhd2p,	   that	   antagonizes	   the	   trimethyl	   modification	  
state	  and	  contributes	  to	  regulation	  of	  telomeric	  silencing.	  	  
	  
Histone	  methylation	  on	  lysine	  residues	  contributes	  to	  transcriptional	  regulation,	  maintenance	  of	  
genome	   integrity,	   and	   epigenetic	   inheritance	   (MARTIN	   and	   ZHANG	   2005).	   	   Characterization	   of	  
individual	   histone	   lysine	  methylation	  marks	   has	   revealed	   that	   specific	  modifications	   can	   have	  
very	  defined	  functional	  effects	  on	  surrounding	  chromatin.	  	  In	  addition,	  each	  modified	  lysine	  can	  
exist	  in	  the	  mono-­‐	  (me1),	  di-­‐	  (me2),	  or	  trimethyl	  (me3)	  state,	  increasing	  the	  potential	  complexity	  
of	   the	   histone	   lysine	   modification	   system.	   	   The	   effects	   of	   histone	   methylation	   are	   mediated	  
largely	   through	   recruitment	   of	   effector	   proteins	   that	   can	   recognize	   regions	   of	   differentially	  
modified	  chromatin	  (BANNISTER	  et	  al.	  2001;	  LACHNER	  et	  al.	  2001;	  MARTIN	  et	  al.	  2006a;	  WYSOCKA	  et	  
al.	   2006).	   	   In	   budding	   yeast	   (Saccharomyces	   cerevisiae),	   histone	   lysine	   methylation	   occurs	  
exclusively	   on	   histone	   H3	   at	   Lys4,	   Lys36,	   and	   Lys79	   (MILLAR	   and	   GRUNSTEIN	   2006).	   	   H3-­‐K4	   is	  
methylated	  by	  the	  Set1p	  methyltransferase	  during	  transcriptional	  initiation,	  through	  association	  
with	   the	   Ser5-­‐phosphorylated	   CTD	   of	   RNA	   polymerase	   II	   (NG	   et	   al.	   2003).	   	   Although	   the	  
dynamics	  of	  H3-­‐K4	  methylation	  in	  budding	  yeast	  are	  poorly	  characterized,	  some	  rapid	  changes	  
in	  H3-­‐K4	  methylation	  have	  been	  reported,	  suggesting	  an	  active	  mechanism	  exists	  to	  counteract	  
this	  modification	  (KATAN-­‐KHAYKOVICH	  and	  STRUHL	  2005;	  ZHANG	  et	  al.	  2005).	  
	  	  
Recently,	  JmjC-­‐domain-­‐containing	  enzymes	  have	  been	  shown	  to	  directly	  remove	  histone	  lysine	  
methylation	   via	   a	   hydroxylation	   reaction	   that	   requires	   iron	   and	  α-­‐ketoglutarate	   as	   co-­‐factors	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(KLOSE	   et	   al.	   2006a;	   TSUKADA	   et	   al.	   2006).	   	   In	   budding	   yeast,	   there	   are	   five	   JmjC-­‐domain-­‐
containing	  proteins:	   Jhd1p,	  Rph1p,	  Gis1p,	   Yjr119Cp,	   and	  Ecm5p	   (FIGURE	  A1.1,	   panel	   a).	   	   Jhd1p	  
has	  previously	  been	  shown	  to	  catalyze	  demethylation	  of	  H3-­‐K36me2	  and	  H3-­‐K36me1	  (TSUKADA	  
et	   al.	   2006),	   but	   the	   potential	   enzymatic	   activity	   of	   other	   JmjC-­‐domain-­‐containing	   proteins	  
remains	   uncharacterized.	   	   Bioinformatic	   analysis	   has	   indicated	   that	   substitution	  mutations	   in	  
important	  catalytic	  residues	  of	  the	  JmjC	  domains	  of	  Gis1p	  and	  Ecm5p	  render	  the	  JmjC	  domain	  
enzymatically	   inactive	   (KLOSE	   et	   al.	   2006a).	   	   We	   have	   recently	   demonstrated	   that	   Rph1p	  
catalyzes	   demethylation	   of	   H3-­‐K36me3	   and	   H3-­‐K36me2	   (KLOSE	   et	   al.	   2007a).	   	   To	   determine	  
whether	  the	  remaining	  JmjC-­‐domain-­‐containing	  protein,	  Yjr119Cp,	  is	  a	  histone	  demethylase,	  we	  
expressed	   recombinant	   Yjr119Cp	   in	   insect	   cells	   using	   a	   baculovirus	   expression	   system	   and	  
purified	   the	   recombinant	   protein	   by	   affinity	   chromatography	   (FIGURE	   A1.1,	   panel	   b).	  	  
Recombinant	   Yjr119Cp	   protein	   was	   incubated	   with	   radioactively	   labeled	   histone	   substrates	  
corresponding	   to	   all	   three	   histone	   lysine	  methylation	   sites	   in	   yeast,	   and	   demethylase	   activity	  
was	   analyzed	  by	   release	  of	   the	   labeled	   reaction	  product	   formaldehyde	   (FIGURE	  A1.1,	   panel	   c).	  	  
Yjr119Cp	  catalyzed	  demethylation	  of	  substrates	  labeled	  by	  Set7p	  Y245A,	  an	  enzyme	  capable	  of	  
producing	  H3-­‐K4me3	  and	  H3-­‐K4me2	  modification	  states	  (XIAO	  et	  al.	  2003a),	  but	  not	  substrates	  
labeled	   in	   the	   H3-­‐K36	   or	   H3-­‐K79	   positions	   (FIGURE	   A1.1,	   panel	   c).	   	   Notably,	   Yjr119Cp	   was	  
catalytically	  inactive	  towards	  substrates	  produced	  by	  wild-­‐type	  Set7p,	  which	  generates	  the	  H3-­‐
K4me1	  modification	  state	   (data	  not	  shown),	   suggesting	  that	  Yjr119Cp	  targets	  H3-­‐K4me2/3	  but	  
not	  H3-­‐K4me1.	   	  To	   reflect	   the	  protein’s	  newly	   identified	  enzymatic	  activity,	  we	  have	   renamed	  
the	  YJR119C	  gene	  as	  JmjC-­‐domain-­‐containing	  histone	  demethylase	  2	  (JHD2).	  
	  
Many	   chromatin-­‐modifying	   proteins	   in	   yeast	   are	   found	   in	   large	   multiprotein	   complexes	   with	  
auxiliary	  proteins	  that	  function	  to	  target,	  and	  in	  some	  cases,	  regulate	  enzymatic	  activity	  (MILLAR	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and	  GRUNSTEIN	   2006;	  MILLER	   et	   al.	   2001).	   	   To	   gain	   insight	   into	   potential	   functional	   partners	   of	  
Jhd2p,	   we	   sought	   to	   analyze	   whether	   Jhd2p	   forms	   a	   high-­‐molecular	   weight	   multiprotein	  
complex.	  	  To	  this	  end,	  extract	  from	  a	  strain	  containing	  Flag-­‐tagged	  Jhd2p	  was	  separated	  by	  size-­‐
exclusion	   chromatography	   and	   Jhd2p-­‐containing	   fractions	   were	   identified	   by	   western	   blot	  
analysis.	   	   The	  molecular	  weight	  of	   Jhd2p,	   as	  determined	  by	   size	  exclusion	   chromatography,	   is	  
between	  80	  and	  100	  kDa,	  which	  corresponds	  to	  the	  predicted	  molecular	  weight	  of	  monomeric	  
Jhd2p	   (85	   kDa)	   (FIGURE	   A1.1,	   panel	   d,	   top).	   	   The	   elution	   profile	   of	   Jhd2p	   from	   yeast	   extracts	  
mirrors	   the	   profile	   of	   recombinant	   protein	   fractionated	   on	   the	   same	   column,	   verifying	   the	  
monomeric	  nature	  of	   this	  enzyme	   (FIGURE	  A1.1,	  panel	  d,	  bottom).	   	   Therefore,	   Jhd2p	   seems	   to	  
function	  as	  an	  H3-­‐K4	  demethylase	  in	  the	  absence	  of	  stably	  associated	  protein	  factors.	  
	  
To	  examine	  whether	  Jhd2	  can	  target	  demethylation	  of	  H3-­‐K4	  in	  vivo,	  wild-­‐type	  (WT)	  Jhd2p	  and	  
Jhd2p	  with	  a	  mutation	  in	  a	  proposed	  iron-­‐binding	  site	  (H427A)	  were	  overexpressed	  in	  budding	  
yeast,	   and	   the	   resulting	   H3-­‐K4	   methylation	   states	   were	   analyzed	   with	   modification-­‐specific	  
antibodies	   (FIGURE	  A1.2,	  panel	  a).	   	  Overexpression	  of	  WT	   Jhd2p	   resulted	   in	  a	   reduction	  of	  H3-­‐
K4me3	  and	  H3-­‐K4me2	  and	  an	  increase	  in	  the	  levels	  of	  H3-­‐K4me1	  (FIGURE	  A1.2,	  panel	  a,	  middle	  
lanes).	   	  Jhd2p	  demethylase	  activity	  was	  specific	  for	  H3-­‐K4,	  as	  the	  levels	  of	  H3-­‐K36me3	  and	  H3-­‐
K79me3	  remained	  unchanged	  (FIGURE	  A1.2,	  panel	  a).	  	  The	  effect	  of	  Jhd2p	  on	  H3-­‐K4	  methylation	  
was	  completely	  dependent	  on	  an	   intact	   JmjC	  domain,	  as	  mutation	  of	  a	  predicted	   iron-­‐binding	  
residue	  abrogated	  demethylase	  activity	   (FIGURE	  A1.2,	  panel	   a,	   right	   lane).	   	  Alteration	  of	  H3-­‐K4	  
methylation	   levels	  by	  deletion	  of	  Set1p	  or	   the	  Cps30p	  component	  of	   the	  Set1	  complex	  causes	  
defects	  in	  telomeric	  silencing	  and	  sensitivity	  to	  agents	  that	  inhibit	  DNA	  replication	  (KROGAN	  et	  al.	  
2002;	  MUELLER	  et	  al.	  2006;	  NAGY	  et	  al.	  2002;	  NISLOW	  et	  al.	  1997;	  SCHLICHTER	  and	  CAIRNS	  2005).	  	  To	  
examine	   whether	   elevated	   levels	   of	   Jhd2p	   result	   in	   similar	   cellular	   defects,	   Jhd2p	   was	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overexpressed	  in	  a	  strain	  containing	  the	  URA3	  telomeric	  reporter	  (SMITH	  et	  al.	  2000)	  or	  treated	  
with	   the	  DNA	  replication-­‐inhibiting	  agent	  hydroxyurea	   (FIGURE	  A1.2,	  panels	  b	  and	  c).	   	  Notably,	  
elevated	  levels	  of	  Jhd2	  and	  demethylation	  of	  H3-­‐K4	  caused	  partial	  reactivation	  of	  the	  telomeric	  
URA3	   reporter	   gene,	   as	   evidenced	  by	   reduced	  growth	  on	  5-­‐fluoroorotic	   acid	   (FOA)-­‐containing	  
media,	  and	  also	  reduced	  growth	  after	  treatment	  with	  hydroxyurea	  (FIGURE	  A1.2,	  panels	  b	  and	  c).	  	  
These	  effects	  were	  completely	  dependent	  on	  the	  enzymatic	  activity	  of	  Jhd2p,	  they	  did	  not	  occur	  
upon	  overexpression	  of	  catalytically	  inactive	  Jhd2p	  H427A	  (FIGURE	  A1.2,	  panels	  b	  and	  c).	  	  These	  
data	   indicate	   that	   Jhd2p	   can	   demethylate	   H3-­‐K4	   in	   vivo	   to	   counteract	   cellular	   functions	  
mediated	   by	   Set1	   methylation.	   	   Furthermore,	   overexpression	   of	   Jhd2p	   resulted	   in	   DNA	  
replication	  defects	  and	  loss	  of	  telomeric	  silencing	  similar	  to	  strains	  with	  perturbed	  Set1	  function	  
(KROGAN	  et	  al.	  2002a;	  MUELLER	  et	  al.	  2006;	  NAGY	  et	  al.	  2002;	  NISLOW	  et	  al.	  1997;	  SCHLICHTER	  and	  
CAIRNS	  2005),	   indicating	  that	  these	  effects	  are	  dependent	  on	  H3-­‐K4	  methylation	  and	  not	  other	  
regulatory	  properties	  of	  the	  Set1	  complex.	  
	  
To	   determine	   whether	   endogenous	   Jhd2p	   contributes	   to	   regulation	   of	   normal	   H3-­‐K4	  
methylation	  levels,	  we	  deleted	  the	  JHD2	  gene	  and	  analyzed	  the	  H3-­‐K4	  methylation	  levels	  using	  
modification-­‐specific	   antibodies	   (FIGURE	  A1.2,	   panel	   d).	   	   In	   strains	   lacking	   Jhd2p,	   there	  was	   an	  
increase	   in	   the	   levels	   of	   H3-­‐K4me3	   (FIGURE	   A1.2,	   panels	   d	   and	   e),	   whereas	   H3-­‐K4me2	   were	  
reduced	  (FIGURE	  A1.2,	  panels	  d	  and	  e),	  indicating	  a	  global	  shift	  from	  H3-­‐K4me2	  to	  the	  H3-­‐K4me3	  
modification	  state,	  while	  H3-­‐K4me1	  levels	  remained	  constant	  (FIGURE	  A1.2,	  panel	  d).	   	  Together	  
these	   data	   indicate	   that	   H3-­‐K4me3	   is	   preferentially	   demethylated	   by	   Jhd2p	   in	   vivo	   and	   that	  
Jhd2p	   contributes	   to	   global	   regulation	   of	   H3-­‐K4me3	   levels.	   	   Despite	   global	   changes	   in	   H3-­‐K4	  
methylation,	  Jhd2p	  deletion	  strains	  are	  viable	  and	  healthy.	  	  To	  try	  to	  uncover	  functional	  defects	  
in	  the	  Jhd2p	  deletion	  strain,	  we	  examined	  the	  strain’s	  phenotypes	  under	  a	  number	  of	  conditions	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(TABLE	  A1.1).	  	  This	  analysis	  revealed	  no	  phenotypic	  defects	  in	  the	  Jhd2p	  deletion	  strain,	  with	  the	  
exception	   of	   a	   subtle	   enhancement	   of	   telomeric	   silencing	   (FIGURE	   A1.2,	   panel	   f).	   	   Therefore,	  
disruption	   of	   Jhd2p	   and	   overexpression	   of	   Jhd2p	   have	   the	   opposite	   effects	   on	   telomeric	  
silencing.	  	  Although	  the	  possibility	  cannot	  be	  ruled	  out	  that	  the	  observed	  phenotypes	  are	  due	  to	  
demethylation	  of	  nonhistone	  substrates,	  these	  observations	  presumably	  demonstrate	  a	  role	  for	  
Jhd2p	  and	  H3-­‐K4	  methylation	  in	  regulation	  of	  telomeric	  chromatin	  function.	  	  	  
	  
The	   identification	   of	   histone	   demethylases	   has	   revealed	   that	   histone	   methylation	   can	   be	  
dynamically	  regulated,	  like	  histone	  acetylation	  or	  phosphorylation	  (KLOSE	  et	  al.	  2006a;	  SHI	  et	  al.	  
2004;	   TSUKADA	   et	   al.	   2006).	   	   Here	   we	   demonstrate	   that	   Jhd2p	   dynamically	   regulations	   H3-­‐K4	  
methylation	   in	   budding	   yeast.	   	   Jhd2p	   preferentially	   demethylates	   the	  H3-­‐K4me3	  modification	  
state	   in	   vivo	   and	   contributes	   to	   regulation	  of	   telomeric	   silencing.	   	  Notably,	   none	  of	   the	   JmjC-­‐
domain-­‐containing	  proteins	   in	  budding	  yeast	   can	   remove	  H3-­‐K79	  methylation,	   suggesting	   that	  
this	   modification	   may	   be	   enzymatically	   irreversible	   or	   that	   an	   uncharacterized	   class	   of	  
demethylase	   enzyme	   with	   unique	   enzymatic	   properties	   remains	   to	   be	   identified.	   	   Further	  
analysis	   of	   the	   dynamics	   of	   H3-­‐K79	   methylation	   in	   budding	   yeast	   will	   be	   important	   in	  
determining	  whether	   this	  modification	   can	   be	   dynamically	   regulated	   and	  will	   help	   to	   identify	  
enzymes	  that	  could	  remove	  this	  histone	  modification.	  	  
	  
Materials	  and	  Methods	  
Yeast	  strains.	  	  All	  strains,	  except	  those	  in	  telomeric	  silencing	  assay,	  were	  derived	  from	  BY4741.	  	  
Strains	   used	   in	   telomeric	   silencing	   assay	  were	   of	   the	   YCB647	   background	   (SMITH	   et	   al.	   2000).	  	  
The	   jhd2Δ	   strains	   were	   generated	   by	   homologous	   recombination	   of	   PCR-­‐amplified	   hphMX	  
(GOLDSTEIN	   and	   MCCUSKER	   1999)	   or	   kanMX	   (BRACHMANN	   et	   al.	   1998)	   knock-­‐out	   cassettes.	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Endogenous	   Jhd2	   was	   C-­‐terminal	   3xFlag-­‐tagged	   by	   amplifying	   the	   p3Flag-­‐KanMX	   cassette	  
(GELBART	  et	  al.	  2001)	  using	  primers	  A	  and	  B	  (sequences	  listed	  below)	  and	  was	  introduced	  into	  the	  
BY4741	  strain	  by	  homologous	  recombination.	  	  
A:	   GAAGGATATTGACTCTTTAATAAAGCAAGTTGGTGTTAAGTTAGATAGAAGGGAACAAAAGCTGGAG	  
B:	  	  GTATTATTCTAAAAAATCATTACGCCATACACAAATATTGAAGACTACTATAGGGCGAATTGGGT	  	  
	  
Recombinant	   protein,	   histone	   demethylase	   assay,	   and	   plasmid	   constructs.	   For	   recombinant	  
protein	  expression,	  JHD2	  was	  PCR	  amplified	  from	  yeast	  genomic	  DNA	  and	  cloned	  into	  a	  modified	  
pFastbacHT	   vector	   (Invitrogen)	   containing	   an	   N-­‐terminal	   Flag-­‐tag.	   	   Recombinant	   Yjr119c/Jhd2	  
baculovirus	   was	   generated	   to	   purify	   recombinant	   protein	   as	   described	   previously	   (CAO	   and	  
ZHANG	  2004).	  	  The	  histone	  demethylase	  assay	  was	  carried	  out	  as	  described	  previously	  (TSUKADA	  
et	  al.	  2006).	  The	  H427A	  substitution	  mutation	  in	  the	  predicted	  iron-­‐binding	  site	  was	  generated	  
by	   site-­‐directed	  mutagenesis	   using	   the	   QuikChange	  mutagenesis	   kit	   (Stratagene).	   	   Full-­‐length	  
Jhd2	  or	  Jhd2-­‐H427A	  was	  cloned	  into	  a	  2	  µm	  LEU2	  plasmid	  under	  ADH1	  promoter	  containing	  an	  
N-­‐terminal	   Flag-­‐tag	   for	   Jhd2	   over-­‐expression	   in	   yeast.	   	   In	   all	   cases	   the	   sequences	   of	   PCR	  
amplified	  clones	  were	  confirmed	  by	  sequencing.	  	  
	  
Antibodies.	   	   For	  western	  blot	  analysis	  of	  yeast	  histones	   the	   following	  antibodies	  were	  used	  at	  
dilutions	   ranging	   from	   1:200	   to	   1:1000:	   α-­‐H3K4me3	   (Abcam,	   ab8580),	   α-­‐H3K4me2	   (Abcam,	  
ab7766),	   α-­‐H3K4me1	   (Abcam,	   abAb8895),	   α-­‐H3K36me3	   (Abcam,	   ab9050),	   and	   α-­‐H3K79me3	  




Size	   exclusion	   chromatography	   and	   sucrose	   gradient	   analysis.	   	  Whole	   cell	   yeast	   extract	   or	  
recombinant	  Jhd2	  were	  fractionated	  over	  a	  24	  mL	  Superose	  6	  size	  exclusion	  column	  (Amersham	  
Biosciences)	  equilibrated	  with	  BC400	   [40	  mM	  HEPES	   (pH	  7.9),	  400	  mM	  KCl,	  0.5	  mM	  DTT,	  10%	  
glycerol,	  0.2mM	  PMSF]	  with	  the	  aid	  of	  an	  ÄKTA	  purifier	  (Amersham	  Biosciences)	  at	  a	  flow	  rate	  of	  
0.2	  ml/min	  and	  250	  µl	  fractions	  were	  collected.	   	  Every	  other	  fraction	  was	  analyzed	  for	  Jhd2	  by	  
western	  blot	  or	  Coomassie	  staining.	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TABLE	  A1.1|	  Phenotype	  analysis	  of	  the	  jhd2Δ 	  strain	  
	  
Phenotype	   Functional	  implication	  (HAMPSEY	  1997)	   Control	  (Reference)	  




Heat	  sensitivity	   General	  protein	  defects	  indicating	  important	  
genes	  
	  
spt4Δ	  (BASRAI	  et	  al.	  
1996)	  





rtf1Δ	  	  (DESMOUCELLES	  et	  
al.	  2002)	  
Galactose	  fermentation	   Transcriptional	  activation	  
	  
	  
snf2Δ	  	  (NEIGEBORN	  and	  
CARLSON	  1984)	  
Raffinose	  fermentation	   Transcriptional	  derepression	  
	  
	  
snf2Δ	  	  (NEIGEBORN	  and	  
CARLSON	  1984)	  
Inositol	  auxotrophy	   Inositol	  biosynthesis;	  transcriptional	  activation	  
	  
spt7Δ	  	  (PATTON-­‐VOGT	  
and	  HENRY	  1998)	  
	  
Hydroxyurea	  sensitivity	   DNA	  replication	  
	  
	  
htz1Δ	  	  (MIZUGUCHI	  et	  
al.	  2004)	  
Caffeine	  sensitivity	   Mitogen-­‐activated	  protein	  (MAP)	  kinase	  
pathway;	  chromatin	  remodeling	  
	  
htz1Δ	  	  (MIZUGUCHI	  et	  
al.	  2004)	  	  
Telomeric	  silencing	  defect	   Heterochromatin	  silencing	  
	  
	  






FIGURE	   A1.1	   |	   Budding	   yeast	   Yjr119Cp	   (renamed	   Jhd2p)	   is	   an	   H3-­‐K4	   demethylase.	   	   (a)	  
Schematic	   illustration	   of	   domain	   architecture	   of	   the	   five	   JmjC-­‐domain-­‐containing	   proteins	   in	  
budding	  yeast.	  	  (b)	  Coomassie-­‐stained	  gel	  showing	  affinity-­‐purified	  recombinant	  Yjr119Cp/Jhd2p	  
produced	  in	   insect	  cells.	   	   (c)	  Histone	  substrates	  were	  labeled	  using	  methyltransferase	  enzymes	  
that	  modify	  known	  histone	  methylation	  sites	  in	  budding	  yeast	  and	  incubated	  with	  recombinant	  
Yjr119Cp/Jhd2p.	   	   Histone	   demethylase	   activity	   was	   monitored	   as	   the	   release	   of	   labeled	  
formaldehyde,	   plotted	   as	   a	   bar	   graph	   (error	   bars	   show	   s.d.).	   	   Yjr119Cp/Jhd2p	   specifically	  
demethylates	   H3-­‐K4me3	   and	   H3-­‐K4me2.	   	   (d)	   Top,	   Flag-­‐Jhd2	   (F-­‐Jhd2p)	   in	   yeast	   extract	   was	  
fractionated	  by	   size-­‐exclusion	   chromatography	  and	   identified	  by	   Flag-­‐specific	  western	  blotting	  
(top	   gel).	   	   Asterisk	   (*)	   indicates	   a	   cross-­‐reacting	   band	   found	   in	   yeast	   extracts.	   	   Size-­‐exclusion	  
chromatography	  molecular	  weight	  markers	  are	  indicated	  above	  the	  panel.	  	  Jhd2p	  eluted	  with	  an	  
apparent	   molecular	   weight	   of	   80-­‐100	   kDa.	   	   Bottom,	   recombinant	   Jhd2p	   was	   fractionated	   by	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size-­‐exclusion	  chromatography	  and	  identified	  by	  Coomassie	  staining.	  	  Recombinant	  Jhd2	  eluted	  
with	   the	   same	   apparent	   molecular	   weight	   as	   endogenous	   Jhd2p,	   suggesting	   Jhd2p	   is	   a	  






FIGURE	  A1.2	  |	  Jhd2p	  antagonizes	  H3-­‐K4me3	  methylation	  and	  regulates	  telomeric	  silencing.	  	  (a)	  
Whole-­‐cell	   extracts	   were	   prepared	   from	   strains	   containing	   either	   empty	   vector	   or	   constructs	  
expressing	  Flag-­‐tagged	  wild-­‐type	  Jhd2p	  or	  the	  H427A	  mutant.	  	  Histone	  methylation	  levels	  were	  
analyzed	   by	   western	   blotting	   using	   modification-­‐specific	   antibodies.	   	   (b)	   WT	   Jhd2p	   or	   Jhd2p	  
H427A	  was	  overexpressed	   in	  a	  strain	  carrying	  a	  silenced	   telomeric	  URA3	  reporter	  gene.	   	  After	  
normalization	   for	   cell	   number,	   each	   strain	   was	   serially	   diluted	   in	   five-­‐fold	   increments	   and	  
spotted	   on	   SC	   medium	   or	   SC	   containing	   100	   μg/μL	   5-­‐fluoroorotic	   acid	   (FOA).	   	   Strains	  
overexpressing	   Jhd2p	  show	  reactivation	  of	   the	  URA3	   gene,	  evident	   from	  growth	  sensitivity	  on	  
plates	   containing	   FOA.	   	   (c)	  WT	   Jhd2p	   or	   Jhd2p	   H427A	  was	   overexpressed	   in	   wild-­‐type	   yeast.	  
Each	   strain	  was	   serially	   diluted	   as	   in	  b	   and	   spotted	   on	   SC	  medium	   or	   SC	   containing	   100	  mM	  
hydroxyurea	  (HU).	  	  Strains	  overexpressing	  Jhd2p	  are	  sensitive	  to	  hydroxyurea,	  as	  is	  evident	  from	  
reduced	  growth.	  	  A	  cps30Δ	  strain,	  which	  has	  compromised	  Set1	  enzymatic	  function,	  was	  used	  as	  
a	  control	  for	  sensitivity	  to	  hydroxyurea.	  	  (d)	  Whole-­‐cell	  extracts	  were	  prepared	  from	  wild-­‐type,	  
jhd2Δ,	   and	  cps30Δ	   strains.	   	  H3-­‐K4	  methylation	   levels	  were	  analyzed	  by	  western	  blotting	  using	  
modification-­‐specific	   antibodies.	   	   The	   jhd2Δ	   strain	   has	   increased	   levels	   of	   H3-­‐K4me3	   and	  
reduced	  levels	  of	  H3-­‐K4me2.	  	  (e)	  Plot	  of	  quantified	  relative	  changes	  in	  d.	  	  (f)	  Cells	  from	  wild-­‐type	  
(WT),	  sir2Δ,	  and	  jhd2Δ	  strains	  were	  normalized	  for	  cell	  density	  and	  spotted	  in	  five-­‐fold	  dilutions	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onto	  SC	  medium	  or	  SC	  medium	  containing	  100	  μg/μL	  FOA.	   	  sir2Δ	   strain	   is	  a	  control	   for	   loss	  of	  
telomeric	  silencing.	  	  Two	  independent	  jhd2Δ	  strains	  show	  enhanced	  telomeric	  silencing,	  evident	  
from	  reduced	  sensitivity	  to	  FOA	  in	  the	  URA3	  reporter	  strain.	  	  
	  
	  Appendix	  Two	  
	  
Histone	  H2BK123	  Monoubiquitination	  is	  the	  Critical	  Determinant	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  H3K4	  and	  H3K79	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Histone	   H2B	   monoubiquitination	   by	   Rad6/Bre1	   is	   required	   for	   the	   trimethylation	   of	   both	  
histone	   H3K4	   and	   H3K79	   by	   COMPASS	   and	   Dot1	   methyltransferases,	   respectively.	   	   The	  
dependency	  of	  methylation	  at	  H3K4	  and	  H3K79	  on	  the	  monoubiquitination	  of	  H2BK123	  was	  
recently	   challenged,	   and	   extragenic	   mutations	   in	   the	   strain	   background	   used	   for	   previous	  
studies	  or	  epitope-­‐tagged	  proteins	  were	  suggested	  to	  be	  the	  sources	  of	   this	  discrepancy.	   	   In	  
this	   study,	   we	   show	   that	   H3K4	   and	   H3K79	   methylation	   is	   solely	   dependent	   on	   H2B	  
monoubiquitination	  regardless	  of	  any	  additional	  alteration	  to	  the	  H2B	  sequence	  or	  genome.	  	  
Furthermore,	  we	   report	   that	  Y131,	  one	  of	   the	  yeast	  histone	  H2A/H2B	   shuffle	   strains	  widely	  
used	  for	  the	  last	  decade	  in	  the	  field	  of	  chromatin	  and	  transcription	  biology,	  carries	  a	  wild-­‐type	  
copy	  of	  HTA2	  and	  HTB2	  genes	  under	  the	  GAL1/10	  promoter	  on	  chromosome	  II.	  	  Therefore,	  we	  
generated	   the	   entire	   histone	   H2A	   and	   H2B	   alanine-­‐scanning	   mutant	   strains	   in	   another	  
background,	  which	  does	  not	  express	  wild-­‐type	  histones.	  
	  
Introduction	  
A	   nucleosome	   contains	   146	   bp	   of	   DNA	  wrapped	   twice	   around	   an	   octamer	   composed	   of	   two	  
copies	   of	   each	   histone	   protein:	   H2A,	   H2B,	   H3,	   and	   H4	   (KORNBERG	   1974;	   KORNBERG	   and	   LORCH	  
1999).	   	   Nucleosomes	   are	   observed	   as	   a	   series	   of	   “beads	   on	   a	   string”	   via	   electron	  microscopy	  
with	   the	  “beads”	  being	   the	   individual	  nucleosomes	  connected	  by	   the	   linker	  DNA,	   the	  “string”.	  	  
Structural	  studies	  have	  demonstrated	  that	  histone	  N-­‐terminal	  tails	  protrude	  outward	  from	  the	  
nucleosome	   and	   can	   be	   posttranslationally	  modified	   by	   different	   enzymes	   (LUGER	   et	   al.	   1997;	  
SHILATIFARD	  2006).	  	  	  Such	  posttranslational	  modifications	  of	  histone	  tails	  include	  phosphorylation,	  
acetylation,	  sumoylation,	  ADP	  ribosylation,	  ubiquitination,	  and	  methylation.	  
The	   first	   H3K4	   (histone	   H3	   lysine	   4)	   methylase,	   Set1/COMPASS,	   was	   isolated	   from	  
Saccharomyces	  cerevisiae	  and	  was	  demonstrated	  to	  be	  capable	  of	  mono-­‐,	  di-­‐,	  and	  trimethylating	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H3K4	   (KROGAN	   et	   al.	   2002a;	   MILLER	   et	   al.	   2001;	   ROGUEV	   et	   al.	   2001).	   	   This	   posttranslational	  
modification	   of	   H3K4	   by	   COMPASS	   requires	   prior	   H2BK123	   (histone	   H2B	   lysine	   123)	  
monoubiquitination	   in	  yeast	  and	  H2BK120	  in	  vertebrates,	  which	   is	  a	  process	  known	  as	  histone	  
cross	  talk	  (DOVER	  et	  al.	  2002;	  SHILATIFARD	  2006;	  SUN	  and	  ALLIS	  2002;	  WOOD	  et	  al.	  2005).	  	  It	  has	  also	  
been	   demonstrated	   that	   histone	   H3K79	   methylation	   by	   Dot1	   also	   requires	   H2BK123	  
monoubiquitination	   (BRIGGS	   et	   al.	   2002;	  WOOD	   et	   al.	   2003b).	   	   Monoubiquitination	   of	   histone	  
H2BK123	   is	  mediated	   by	   the	  macromolecular	   complex	   containing	   the	   E2-­‐conjugating	   enzyme	  
Rad6	  and	  the	  E3	  ligase	  Bre1	  in	  S.	  cerevisiae	  (HWANG	  et	  al.	  2003;	  ROBZYK	  et	  al.	  2000;	  WOOD	  et	  al.	  
2003a).	  	  This	  modification	  has	  been	  linked	  to	  transcriptional	  activation	  and	  elongation	  (HENRY	  et	  
al.	  2003;	  KAO	  et	  al.	  2004;	  KIM	  and	  BURATOWSKI	  2009;	  PAVRI	  et	  al.	  2006;	  SHILATIFARD	  2006;	  TANNY	  et	  
al.	  2007;	  XIAO	  et	  al.	  2005).	  	  Studies	  in	  other	  eukaryotic	  organisms	  also	  have	  confirmed	  that	  this	  
mode	   of	   regulation	   is	   well	   conserved	   from	   yeast	   to	   human	   (PAVRI	   et	   al.	   2006;	   SMITH	   and	  
SHILATIFARD	  2009).	  	  However,	  a	  recent	  study	  performed	  by	  Foster	  and	  Downs	  (2009)	  argued	  that	  
monoubiquitination	   of	   H2BK123	   in	   yeast	   is	   not	   the	   sole	   determinant	   for	   the	   methylation	   of	  
H3K4	  and	  H3K79	  (FOSTER	  and	  DOWNS	  2009).	   	   In	  their	  study,	  Foster	  and	  Downs	  (2009)	  observed	  
the	  presence	  of	   both	  H3K4	   and	  H3K79	   trimethylation	   in	   the	  H2BK123R	  mutant	   strain	  derived	  
from	   an	   FY406	   parental	   strain,	   which	   is	   contradictory	   to	   the	   previous	   findings,	   whereas	   both	  
modifications	  were	  lost	  in	  an	  H2BK123R	  mutant	  derived	  in	  the	  Y131	  background.	  	  Surprisingly,	  a	  
triple	   KSS	   mutant	   (H2BK123R-­‐S125A-­‐S126A)	   in	   the	   FY406	   background	   resulted	   in	   the	   loss	   of	  
trimethylation	  of	  both	  H3K4	  and	  H3K79.	   	  Additionally,	  Foster	  and	  Downs	  (2009)	  demonstrated	  
that	   Flag-­‐tagged	   H2B	   containing	   the	   K123R	   mutation	   (Flag-­‐H2BK123R)	   abolished	   the	  
trimethylation	  of	  H3K4	  and	  H3K79,	  whereas	  untagged	  H2BK123R	  still	  possessed	  normal	  levels	  of	  
trimethylation	  of	  both	  of	   the	   lysine	   residues	   in	   strain	   FY406.	   	   These	  observations	   led	   them	   to	  
conclude	  that	  monoubiquitination	  of	  histone	  H2B	  alone	  is	  not	  required	  for	  the	  trimethylation	  of	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either	  H3K4	  or	  H3K79,	  but	   that	  an	  additional	  “unknown”	  alteration	   to	  H2B	  or	   the	  mutation	   in	  
the	  genome	  in	  combination	  with	  the	  K123	  mutation	  caused	  the	  loss	  of	  histone	  H3K4	  and	  H3K79	  
trimethylation.	  	  In	  this	  study,	  we	  have	  addressed	  a	  possible	  role	  for	  the	  Flag	  tag	  on	  histone	  H2B	  
in	   the	   regulation	   of	   H3K4	   and	   H3K79	   methylation.	   	   Our	   collective	   experiments	   have	  
demonstrated	   that	   histone	   H3K4	   and	   H3K79	   methylation	   is	   solely	   dependent	   on	   H2B	  
monoubiquitination	  and	  is	  independent	  of	  any	  other	  unknown	  factors	  or	  genetic	  backgrounds.	  
	  
Materials	  and	  Methods	  	  
Generation	  of	  histone	  mutants.	   	  Strains	  used	  in	  this	  study	  are	  listed	  in	  TABLE	  A2.1.	   	  We	  used	  a	  
plasmid	   containing	   HTA1	   and	   HTB1	   genes	   and	   a	   plasmid	   containing	   all	   four	   histones,	   HTA1,	  
HTB1,	  HHT2,	  and	  HHF2	  genes,	  as	  shown	  in	  FIGURE	  A2.1,	  panel	  B.	  	  Plasmids	  bearing	  an	  alanine	  or	  
arginine	  mutation	   in	   the	   Flag-­‐tagged	  HTB1	   gene	   and	   Flag-­‐less	  HTB1	   gene	  were	   generated	   by	  
site-­‐directed	   mutagenesis	   (QuickChange	   II	   kit;	   Agilent	   Technologies).	   	   Products	   were	  
transformed	   into	   E.	   cloni	   10G	   ELITE	   electrocompetent	   cells	   (Lucigen).	   	   Mutated	   targets	   were	  
confirmed	   by	   sequencing	   using	   the	   primers	   (HTBseqF)	   5’-­‐GGCAAATACTACCTTGGTTGG-­‐3’	   and	  
(HTBseqR)	   5’-­‐TTTCGAGAACACAATTTTACAACCGA-­‐3’.	   	   Each	   plasmid	   was	   transformed	   manually	  
into	  yeast	  shuffle	  strains	  Y131,	  FY406,	  DY20D,	  and	  JHY205	  using	  a	  standard	  yeast	  transformation	  
protocol,	  and	  strains	  were	  grown	  on	  a	  synthetic	  dropout	  (SD)	  medium	  lacking	  histidine,	  SD-­‐His	  
(for	   Y131	   and	   FY406	   strains),	   or	   a	   medium	   lacking	   leucine,	   SD-­‐Leu	   (for	   DY20D	   and	   JHY205	  
mutants).	  	  After	  2	  days	  of	  incubation,	  transformants	  were	  replica	  plated	  onto	  plates	  containing	  
either	   SD-­‐His	   plus	   5-­‐FOA	   or	   SD-­‐Leu	   plus	   5-­‐FOA	   to	   select	   single-­‐colony	   cells	   that	   had	   lost	   the	  
plasmid	  containing	   the	  wild-­‐type	  histones.	   	   Each	  colony	  was	   inoculated	   into	  YPD	  medium	   (1%	  
yeast	  extract,	  2%	  peptone,	  and	  2%	  dextrose)	  plus	  5-­‐FOA.	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Western	  blot	  analyses.	  	  Cells	  are	  grown	  in	  YPD	  or	  YPGal	  [1%	  yeast	  extract,	  2%	  peptone,	  and	  2%	  
galactose]	  to	  mid-­‐log	  phase.	  	  Whole	  cell	  extracts	  were	  prepared	  from	  the	  wild-­‐type	  and	  histone	  
mutant	  strains	  as	  previously	  described	  (WOOD	  et	  al.	  2003b)	  with	  some	  minor	  modifications.	  	  In	  
brief,	  cell	  pellets	  were	  washed	  and	  resuspended	  in	  400	  μL	  NIB	  [0.25	  M	  sucrose,	  60	  mM	  KCl,	  14	  
mM	  NaCl,	  5	  mM	  MgCl2,	  1	  mM	  CaCl2,	  and	  0.8%	  Triton	  X-­‐100].	  	  After	  the	  addition	  of	  250	  μL	  of	  0.5-­‐
mm	  glass	  beads	  to	  the	  tubes	  containing	  the	  suspension,	  the	  tubes	  were	  vortexed	  for	  20	  min	  at	  
4°C.	  	  Cell	  lysates	  were	  recovered	  by	  puncturing	  the	  bottom	  of	  the	  tube	  and	  centrifuging	  the	  con-­‐	  
tents	  at	  3,000	   rpm.	   	  After	   removal	  of	   the	   supernatant,	   the	  pellet	  was	   suspended	   in	  150	  μL	  of	  
sterile	   water	   and	   75	   μL	   of	   4×	   loading	   buffer	   and	   heated	   at	   95°C	   for	   5	   min.	   	   Extracts	   were	  
subjected	   to	   18%	   SDS-­‐PAGE	   electrophoresis,	   transferred	   to	   nitrocellulose	   membrane,	   and	  
probed	  with	  either	  anti-­‐Flag	  or	  H2B	  ubiquitin-­‐specific	  antibodies,	  as	  well	  as	  antibodies	  specific	  
for	  H3K4	  di-­‐	  and	  trimethylation	  and	  H3K79	  trimethylation,	  followed	  by	  detection	  of	  the	  bound	  
antibody	  with	  horseradish	  peroxidase-­‐conjugated	  secondary	  antibodies.	  	  An	  antibody	  to	  histone	  
H3	  was	  used	  as	  a	  loading	  control.	  
	  
Generation	   of	   H2A/H2B	   histone	   mutant	   library.	   	   The	   h2a/h2b	   histone	   mutant	   library	   was	  
generated	   in	   a	   FY406	   background	   as	   described	   previously	   (NAKANISHI	   et	   al.	   2008).	   	   In	   brief,	  
plasmids	  bearing	  alanine	  mutations	  in	  the	  HTA1	  and	  HTB1	  genes	  were	  systematically	  generated	  
by	   site-­‐directed	  mutagenesis	   in	   96-­‐well	   format.	   	   After	   transformation	   into	   E.	   cloni	   10G	   ELITE	  
electrocompetent	  cells	  using	  a	  96-­‐well	  electroporator,	  plasmids	  were	  prepared	  with	  a	  BioMekFX	  
(Beckman	   Coulter)	   using	   the	   CosMCPrep	   kit	   (Agencourt).	   	   Each	   mutation	   was	   confirmed	   by	  
sequencing	  using	   the	  aforementioned	  primers,	   and	  each	  plasmid	  was	   transformed	   into	   FY406	  
using	   a	   standard	   yeast	   transformation	   protocol.	   	   Transformants	   were	   selected	   on	   an	   SD-­‐His	  
medium	  followed	  by	  the	  second	  selection	  on	  a	  plate	  containing	  SD-­‐His	  plus	  5-­‐FOA.	   	  To	  ensure	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the	  complete	  removal	  of	  the	  plasmid	  containing	  the	  wild-­‐type	  histones,	  each	  single	  colony	  was	  
inoculated	  into	  YPD	  medium	  plus	  5-­‐FOA	  in	  96-­‐well	  plates.	  	  Finally,	  histone	  mutant	  strains	  were	  
confirmed	  by	  sequencing,	  and	  the	  glycerol	  stocks	  of	  the	  library	  were	  generated.	  
	  
Results	  and	  Discussion	  
To	   further	   investigate	   the	   role	   of	   H2BK123	   monoubiquitination	   in	   H3K4	   and	   H3K79	  
trimethylation	   and	   a	   possible	   role	   for	   the	   Flag	   epitope	   of	   H2B	   in	   this	   process,	   we	   set	   out	   to	  
analyze	   the	   role	  of	  Flag-­‐less	  H2B	  mutated	   in	  K123	   for	  H3K4	  and	  H3K79	  methylation	   in	  several	  
different	   strain	   backgrounds.	   	   We	   first	   wanted	   to	   be	   able	   to	   detect	   the	   presence	   of	  
monoubiquitinated	  H2B	  in	  a	  Flag-­‐less	  H2B	  background	  because	  the	  observation	  made	  by	  Foster	  
and	  Downs	   (2009)	   that	  H3K4	   trimethylation	   could	  be	  detected	   in	   a	   Flag-­‐less	  H2BK123R	   strain	  
could	  be	  because	  of	  the	  inadvertent	  presence	  of	  a	  wild-­‐type	  copy	  of	  H2B.	   	  To	  address	  this,	  we	  
generated	  polyclonal	  antibodies	   specific	   to	  monoubiquitinated	  H2B	   (FIGURE	  A2.1,	  panel	  A)	  and	  
then	  shuffled	  a	  plasmid	  expressing	  H2B	  lacking	  an	  N-­‐terminal	  Flag	  tag	  (FIGURE	  A2.1,	  panel	  B)	  into	  
several	   different	   backgrounds,	   including	   Y131,	   FY406,	   DY20D,	   and	   JHY205.	   	  We	   analyzed	   the	  
trimethylation	  levels	  of	  both	  H3K4	  and	  H3K79	  as	  well	  as	  the	  monoubiquitination	  of	  H2B	  in	  these	  
backgrounds	  (FIGURE	  A2.2,	  panels	  A	  and	  B).	  	  Our	  antibody	  generated	  in	  this	  study	  is	  specific	  for	  
monoubiquitinated	  H2B	  in	  yeast	  and	  is	  capable	  of	  detecting	  this	  modification	  in	  the	  presence	  or	  
absence	  of	  a	  Flag	   tag	   (FIGURE	  A2.1,	  panel	  A;	  FIGURE	  A2.2,	  panel	  A;	  FIGURE	  A2.3,	  panel	  B;	  FIGURE	  
A2.5,	  panel	  B).	  	  When	  this	  antibody	  was	  used,	  Flag-­‐less	  wild-­‐type	  H2B	  showed	  a	  band	  migrating	  
slightly	  faster	  than	  that	  of	  Flag-­‐tagged	  wild-­‐type	  H2B	  as	  a	  result	  of	  the	  deletion	  of	  the	  Flag	  tag	  
(FIGURE	  A2.2,	  panel	  A).	  	  However,	  no	  monoubiquitinated	  form	  of	  H2B	  was	  detected	  from	  K123A	  
mutants	   in	   both	   Y131	   and	   FY406	   backgrounds	   and	   K123R	   mutants	   in	   DY20D	   and	   JHY205,	  
regardless	  of	  the	  attachment	  of	  a	  Flag	  tag	  to	  H2B	  (FIGURE	  A2.2,	  panels	  A	  and	  B).	   	  Furthermore,	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we	   tested	   these	   strains	   for	   the	   methylation	   of	   histone	   H3K4	   and	   H3K79	   (FIGURE	   A2.2).	  	  
Regardless	  of	  the	  presence	  or	  absence	  of	  a	  Flag-­‐tag	  on	  H2B,	  H3K4	  methylation	  was	  detected	  in	  
strains	   bearing	  wild-­‐type	  H2B	   but	   not	   in	   strains	   in	  which	  H2B	   carries	   a	   point	  mutation	   at	   the	  
K123	  residue.	   	  Similar	  strains	  were	  generated	   independently	   in	  all	  of	  our	   laboratories,	  and	  we	  
have	  each	   confirmed	   that	   there	   is	   no	  difference	  between	   Flag-­‐tagged	  H2B	  and	  untagged	  H2B	  
and	  that	  all	  of	  the	  histone	  modifications	  are	  consistent	  among	  the	  different	  strain	  backgrounds,	  
including	  the	  FY406	  background	  used	  in	  the	  study	  performed	  by	  Foster	  and	  Downs	  ((FOSTER	  and	  
DOWNS	   2009),	   FIGURE	   A2.2).	   	   Therefore,	   we	   conclude	   that	   H3K4	   and	   H3K79	   trimethylation	   is	  
indeed	   solely	   dependent	   on	  H2B	  monoubiquitination	   regardless	   of	   an	   additional	   alteration	   to	  
the	  H2B	  sequence	  or	  strain	  backgrounds.	  
The	  Y131	  strain	  was	  originally	  generated	   for	  plasmid	   shuffling	  of	  H2A-­‐H2B	  genes,	  as	  a	  
simultaneous	  deletion	  of	  the	  HTA1-­‐HTB1	  and	  HTA2-­‐HTB2	  loci	  is	  lethal	  (ROBZYK	  et	  al.	  2000).	  	  The	  
genotype	   of	   Y131	   describes	   that	   hta1-­‐htb1	   was	   replaced	   with	   LEU2,	   whereas	   hta2-­‐htb2	   was	  
replaced	  with	  URA3	   in	  the	  presence	  of	  a	  HIS3	  HTA2-­‐HTB2	  plasmid.	   	  After	  selection	  for	  tight	  5-­‐
FOA	   resistance,	   a	  URA3	   plasmid	   carrying	  HTA1-­‐HTB1	  was	   substituted	   for	   the	  HIS3-­‐HTA2-­‐HTB2	  
plasmid,	   thus	   creating	   the	   shuffle	   strain	   that	   was	   used	   to	   introduce	   a	   HIS3-­‐marked	   plasmid	  
containing	  HTA1	   and	  Flag-­‐HTB1.	   	   The	  Y131	   strain	  expressing	   Flag-­‐tagged	  wild-­‐type	  H2B	  under	  
either	  glucose	  or	  galactose	  media	  has	  normal	  levels	  of	  H2B	  monoubiquitination	  and	  methylation	  
of	  H3K4	  and	  K79	  (FIGURE	  A2.3,	  panel	  A,	  lanes	  3–6).	  	  To	  our	  surprise,	  when	  Flag-­‐H2BK123R	  in	  the	  
Y131	  background	  was	  grown	  continuously	   in	  a	  galactose-­‐containing	  media,	   the	  methylation	  of	  
both	  of	  the	  H3	  residues	  was	  present	  at	  levels	  close	  to	  those	  in	  the	  wild-­‐type	  cells	  (FIGURE	  A2.3,	  
panel	  A,	  lanes	  7–10).	  	  Because	  the	  N-­‐terminus	  of	  H2BK123R	  was	  tagged	  with	  Flag,	  we	  tested	  for	  
the	  presence	  of	  monoubiquitination	  using	  a	  Flag	  antibody.	  	  There	  was	  no	  slower-­‐migrating	  band	  
in	  the	  histone	  H2BK123R	  bearing	  strain,	   indicating	  that	  there	   is	  no	  monoubiquitinated	  form	  of	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Flag-­‐H2B	  (FIGURE	  A2.3,	  panel	  A,	  lanes	  3–10).	  	  The	  H3K4	  and	  H3K79	  methylation	  patterns	  appear	  
to	  be	  normal.	  
	   Because	   H2B	   monoubiquitination	   is	   required	   for	   the	   methylation	   of	   these	   lysine	  
residues,	  we	   suspected	   that	  one	  of	   the	   two	  genomic	  HTB	   genes	  was	  not	  deleted	   in	  Y131	  and	  
that	   the	   genomic	   wild-­‐type	   H2B	   was	   expressed	   in	   the	   K123R	   mutant	   strain	   in	   a	   galactose-­‐
dependent	   manner.	   	   We	   tested	   this	   possibility	   by	   using	   our	   antibody	   specific	   to	  
monoubiquitinated	  histone	  H2B	  (FIGURE	  A2.3,	  panel	  B).	  	  In	  wild-­‐type	  Y131	  under	  glucose	  media,	  
the	   Flag-­‐tagged	  wild-­‐type	  H2B	  produced	  only	   an	  upper	  band	   (Flag-­‐tagged,	  monoubiquitinated	  
H2B;	   FIGURE	   A2.3,	   panel	   B,	   lane	   5,	   blue	   arrow).	   	   However,	   in	   wild-­‐type	   Y131	   under	   galactose	  
media	   there	   are	   two	   bands	   (FIGURE	   A2.3,	   panel	   B,	   lane	   6).	   	   The	   upper	   band	   is	   Flag-­‐tagged,	  
monoubiquitinated	   histone	   H2B,	   and	   the	   lower	   band	   is	   Flag-­‐less,	   monoubiquitinated	   histone	  
H2B	   (FIGURE	   A2.3,	   panel	   B,	   lane	   6).	   	   Similarly,	   the	   Flag-­‐H2BK123R	   strain	   shows	   no	   H2B	  
monoubiquitination	  under	  the	  glucose	  media	  (FIGURE	  A2.3,	  panel	  B,	  lane	  7).	  	  However,	  the	  Flag-­‐
tagged	  H2BK123R	  strain	  grown	  under	  galactose	  media	  shows	  the	  band	  corresponding	   to	  Flag-­‐
less,	  monoubiquitinated	  histone	  H2B	  (FIGURE	  A2.3,	  panel	  B,	  lane	  8).	  	  We	  have	  also	  detected	  the	  
expression	  of	  wild-­‐type	  H2B	  under	  the	  galactose	  condition	  when	  using	  H2B-­‐specific	  antibodies	  
(unpublished	  data).	  	  This	  suggests	  that	  Y131	  contains	  a	  galactose-­‐inducible	  version	  of	  wild-­‐type	  
H2B	  somewhere	  in	  the	  genome.	  
	   To	   understand	   the	   basis	   for	   these	   results	   between	   the	   two	   growth	   conditions,	   we	  
sequenced	  the	  genomic	  regions	  around	  the	  deleted	  hta1-­‐htb1	  (chromosome	  IV)	  and	  hta2-­‐htb2	  
(chromosome	   II)	   genes	   in	   strain	   Y131.	   	  We	   found	   that	   intact	  HTA2	   and	  HTB2	   genes	  were	   still	  
present	   on	   chromosome	   II	   in	   the	   Y131	   strains,	   and	   surprisingly,	   the	   bidirectional	   GAL1/10	  
promoter	  was	   inserted	  between	  the	  two	  genes	  to	  exactly	  replace	  the	  bidirectional	  HTA2-­‐HTB2	  
promoter	   (FIGURE	  A2.4).	   	  The	  GAL10	  promoter	  drives	   the	  expression	  of	  HTA2,	  and	  GAL1	  drives	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the	   expression	   of	  HTB2.	   	   The	   presence	   of	   the	  GAL1/10	   promoter	   explains	  why	  wild-­‐type	  H2B	  
was	   expressed	   only	   under	   the	   galactose	  media	   and	   not	   under	   the	   glucose	  media.	   	   It	   remains	  
somewhat	  of	  a	  mystery	  how	  GAL1/10	  was	   inserted	  exactly	  between	  the	  two	  genes	   in	  the	  first	  
place,	  although	  the	  HIS3	  plasmid	  in	  the	  original	  Y131	  strain	  carried	  a	  GAL1/10-­‐regulated	  HTA2-­‐
HTB2	   locus	  that	  may	  have	  been	   incorporated	   into	  the	  genome	  by	  a	  rare	  recombination	  event.	  	  
Because	   Y131	   is	   a	   widely	   used	   strain,	   mutants	   that	   affect	   GAL1/10	   transcription	   may	   not	  
appropriately	  repress	  wild-­‐type	  HTA2-­‐HTB2	  in	  glucose	  in	  this	  strain,	  and	  data	  obtained	  from	  its	  
usage	  under	  prolonged	  growth	   in	   galactose	   conditions	  must	  be	   interpreted	   carefully.	   	   Studies	  
using	   this	   strain	   to	   analyze	   effects	   of	   the	   H2B-­‐K123R	   mutation	   on	   GAL1	   transcription	   were	  
performed	  for	  short	  periods	  of	  galactose	   induction	  (2	  hr)	  when	  the	  expression	  of	  the	  genomic	  
HTA2-­‐HTB2	   genes	  was	   not	   detected,	   and	   the	   transcription	   results	   have	   been	   recapitulated	   in	  
other	  strain	  backgrounds	  ((XIAO	  et	  al.	  2005);	  unpublished	  data).	  
	   Finally,	  we	  have	   now	  generated	   a	   histone	  H2A	   and	  H2B	   alanine	  mutant	   library	   in	   the	  
FY406	  background	  (FIGURE	  A2.5,	  panel	  A)	   in	  addition	  to	  the	   library	  we	  reported	  earlier	   in	  Y131	  
(NAKANISHI	   et	   al.	   2008),	   as	   one	  may	  wish	   to	   use	   this	   collection	   under	   galactose	   conditions	   for	  
different	  genetic	  and	  biochemical	  screens.	  	  From	  our	  new	  library	  in	  FY406,	  we	  found	  three	  H2A	  
(Y58,	  E62,	  and	  D91)	  residues	  and	  one	  H2B	  (L109)	  residue	  that	  are	  essential	  for	  viability.	   	  These	  
data	   are	   in	   agreement	   with	   our	   previous	   published	   results	   in	   Y131	   (NAKANISHI	   et	   al.	   2008).	  	  
Furthermore,	  we	  tested	  our	  new	  library	  for	  H3K4	  methylation	  and	  H2B	  monoubiquitination	  and	  
identified	   the	   same	   residues	   in	   Y131,	   specifically	   those	   that	   regulate	   normal	   levels	   of	   H3K4	  
methylation	   in	   FY406,	   as	   well	   (FIGURE	   A2.5,	   panel	   B;	   (NAKANISHI	   et	   al.	   2008)).	   	   These	   residues	  
include	   four	   residues	  within	  H2A	   (Glu65,	   Leu66,	  Asn69,	   and	  Asp73)	   and	   three	   residues	  within	  
H2B	   (His	   112,	  Arg119,	   and	   Lys123).	   	   This	   observation	   is	   consistent	  with	  our	  previous	   findings.	  
Thus,	  strain	  differences	  did	  not	  cause	  any	  discordant	  results	  when	  grown	  under	  glucose	  media.	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In	   summary,	  our	  data	  clearly	  demonstrate	   that	  monoubiquitination	  of	  histone	  H2B	  on	  
lysine	  123	  and	  the	  machinery	  required	  for	  its	  implementation	  are	  the	  sole	  requirements	  for	  the	  
regulation	   of	   the	   trimethylation	   of	   H3K4	   and	   H3K79	   in	   yeast	   S.	   cerevisiae.	   	   Our	   collective	  
experiments	  indicate	  that	  there	  are	  no	  “unknown”	  mutations	  as	  proposed	  by	  Foster	  and	  Downs	  
(2009)	   that	   function	   with	   H2BK123R	   in	   the	   regulation	   of	   H3K4	   and	   H3K79	   trimethylation.	  	  
Furthermore,	   we	   have	   discovered	   that	   the	   widely	   used	   Y131	   strain	   background	   expresses	   a	  
previously	   undetected	   copy	   of	   the	   HTA2-­‐HTB2	   genes	   when	   this	   strain	   is	   grown	   for	   many	  
generations	  in	  the	  presence	  of	  galactose.	  	  Therefore,	  we	  generated	  the	  entire	  h2a/h2b	  mutant	  
collection	   in	  a	  background	   that	   can	  be	   readily	  used	  under	  galactose	   conditions	  and	  have	  now	  
made	  this	  collection	  available	  to	  the	  entire	  scientific	  community.	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TABLE	  A2.1	  |	  Strains	  used	  in	  this	  study	  
	  
Strain	   Genotype	   Source/Reference	  
Y131	   MATa	  (hta1-­‐htb1)Δ::LEU2,	  (hta2-­‐htb2)Δ::URA3	  and	  selected	  for	  
strong	  5-­‐FOA-­‐r,	  leu2-­‐3,-­‐112	  his3-­‐11,-­‐15	  trp1-­‐1	  ura3-­‐1	  ade2-­‐1	  can	  1-­‐
100	  [pRS426-­‐HTA1-­‐HTB1-­‐URA3]	  
	  
(ROBZYK	  ET	  AL.	  2000)	  
YSN430	   MATa	  (hta1-­‐htb1)Δ::LEU2,	  (hta2-­‐htb2)Δ::URA3	  and	  selected	  for	  
strong	  5-­‐FOA-­‐r,	  leu2-­‐3,-­‐112	  his3-­‐11,-­‐15	  trp1-­‐1	  ura3-­‐1	  ade2-­‐1	  can	  1-­‐
100	  [pZS145-­‐HTA1-­‐Flag-­‐HTB1-­‐HIS3]	  
	  
(NAKANISHI	  et	  al.	  
2008)	  
YSN536	   MATa	  (hta1-­‐htb1)Δ::LEU2,	  (hta2-­‐htb2)Δ::URA3	  and	  selected	  for	  
strong	  5-­‐FOA-­‐r,	  leu2-­‐3,-­‐112	  his3-­‐11,-­‐15	  trp1-­‐1	  ura3-­‐1	  ade2-­‐1	  can	  1-­‐
100	  [pZS145-­‐HTA1-­‐Flag-­‐htb1K123A-­‐HIS3]	  
	  
(NAKANISHI	  et	  al.	  
2008)	  
YSN66	   MATa	  (hta1-­‐htb1)Δ::LEU2,	  (hta2-­‐htb2)Δ::URA3	  and	  selected	  for	  




YSN68	   MATa	  (hta1-­‐htb1)Δ::LEU2,	  (hta2-­‐htb2)Δ::URA3	  and	  selected	  for	  




FY406	   MATa	  (hta1-­‐htb1)Δ::LEU2,	  (hta2-­‐htb2)Δ::TRP1,	  his3Δ200	  leu2Δ1	  ura3-­‐
52	  trp1Δ63	  lys2-­‐128δ	  [pSAB6	  (HTA1-­‐HTB1-­‐URA3)]	  
	  
(HIRSCHHORN	  et	  al.	  
1995)	  
YSN545	   MATa	  (hta1-­‐htb1)Δ::LEU2,	  (hta2-­‐htb2)Δ::TRP1,	  his3Δ200	  leu2Δ1	  ura3-­‐
52	  trp1Δ63	  lys2-­‐128δ	  [pZS145-­‐HTA1-­‐Flag-­‐HTB1-­‐HIS3]	  
	  
This	  study	  
YSN763	   MATa	  (hta1-­‐htb1)Δ::LEU2,	  (hta2-­‐htb2)Δ::TRP1,	  his3Δ200	  leu2Δ1	  ura3-­‐
52	  trp1Δ63	  lys2-­‐128δ	  [pZS145-­‐HTA1-­‐Flag-­‐htb1K123A-­‐HIS3]	  
	  
This	  study	  
YSN61	   MATa	  (hta1-­‐htb1)Δ::LEU2,	  (hta2-­‐htb2)Δ::TRP1,	  his3Δ200	  leu2Δ1	  ura3-­‐
52	  trp1Δ63	  lys2-­‐128δ	  [pSN888-­‐HTA1-­‐HTB1-­‐HIS3]	  
	  
This	  study	  
YSN63	   MATa	  (hta1-­‐htb1)Δ::LEU2,	  (hta2-­‐htb2)Δ::TRP1,	  his3Δ200	  leu2Δ1	  ura3-­‐
52	  trp1Δ63	  lys2-­‐128δ	  [pSN890-­‐HTA1-­‐htb1K123A-­‐HIS3]	  
	  
This	  study	  
BY4742	   MATα	  his3Δ1	  leu2Δ0	  lys2Δ0	  ura3Δ0	  
	  
Open	  Biosystems	  
JL026	   MATα	  his3Δ1	  leu2Δ0	  lys2Δ0	  ura3Δ0	  rad6Δ::kanMX	  
	  
Open	  Biosystems	  
DY20D	   MATa	  leu2-­‐3,112	  trp1-­‐1	  can1-­‐100	  ura3-­‐1	  ade2-­‐1	  his3-­‐11,15	  hhf2-­‐
hht2::NAT	  hta1-­‐htb1::HPH	  hhf2-­‐hht2::KAN	  hta2-­‐htb2::NAT	  [pJH33-­‐
HHT2-­‐HHF2-­‐HTA1-­‐HTB1-­‐URA3]	  
	  
M.	  Smitha	  &	  C.D.	  
Allisb	  
YAF120	   MATa	  leu2-­‐3,112	  trp1-­‐1	  can1-­‐100	  ura3-­‐1	  ade2-­‐1	  his3-­‐11,15	  hhf2-­‐
hht2::NAT	  hta1-­‐htb1::HPH	  hht1-­‐hht2::KAN	  hta2-­‐htb2::NAT	  [pRS315-­‐
HHT2-­‐HHF2-­‐HTA1-­‐Flag-­‐HTB1]	  
	  
(FLEMING	  et	  al.	  
2008)	  
YAF121	   MATa	  leu2-­‐3,112	  trp1-­‐1	  can1-­‐100	  ura3-­‐1	  ade2-­‐1	  his3-­‐11,15	  hhf2-­‐
hht2::NAT	  hta1-­‐htb1::HPH	  hht1-­‐hht2::KAN	  hta2-­‐htb2::NAT	  [pRS315-­‐





YJL031	   MATa	  leu2-­‐3,112	  trp1-­‐1	  can1-­‐100	  ura3-­‐1	  ade2-­‐1	  his3-­‐11,15	  hhf2-­‐




YJL032	   MATa	  leu2-­‐3,112	  trp1-­‐1	  can1-­‐100	  ura3-­‐1	  ade2-­‐1	  his3-­‐11,15	  hhf2-­‐








(AHN	  et	  al.	  2005)	  
YSF200	   MATa	  his3Δ1	  leu2Δ0	  met15Δ0	  ura3	  hhf2-­‐hht2::NAT	  hta1-­‐htb1::HPH	  









YJL033	   MATa	  his3Δ1	  leu2Δ0	  met15Δ0	  ura3	  hhf2-­‐hht2::NAT	  hta1-­‐htb1::HPH	  
hht1-­‐hht2::KAN	  hta2-­‐htb2::NAT	  [pRS315-­‐HHT2-­‐HHF2-­‐HTA1-­‐HTB1]	  
	  
This	  study	  





YKG001	   MATa	  (hta1-­‐htb1)Δ::LEU2,	  (hta2-­‐htb2)Δ::TRP1,	  his3Δ200	  leu2Δ1	  ura3-­‐
52	  trp1Δ63	  lys2-­‐128δ	  [pZS145	  HTA1-­‐FLAG-­‐HTB1-­‐HIS3]	  
	  
This	  study	  
YKG002	   MATa	  (hta1-­‐htb1)Δ::LEU2,	  (hta2-­‐htb2)Δ::TRP1,	  his3Δ200	  leu2Δ1	  ura3-­‐
52	  trp1Δ63	  lys2-­‐128δ	  [pZS146	  HTA1-­‐FLAG-­‐htb1K123R-­‐HIS3]	  
	  
This	  study	  
YKG003	   MATa	  (hta1-­‐htb1)Δ::LEU2,	  (hta2-­‐htb2)Δ::TRP1,	  his3Δ200	  leu2Δ1	  ura3-­‐
52	  trp1Δ63	  lys2-­‐128δ	  [pKG3	  HTA1	  -­‐HTB1-­‐HIS3]	  
	  
This	  study	  
YKG004	   MATa	  (hta1-­‐htb1)Δ::LEU2,	  (hta2-­‐htb2)Δ::TRP1,	  his3Δ200	  leu2Δ1	  ura3-­‐
52	  trp1Δ63	  lys2-­‐128δ	  [pKG4	  HTA1	  -­‐htb1K123R-­‐HIS3]	  
	  
This	  study	  
a	  The	  University	  of	  Virginia	  Health	  System,	  Charlottesville,	  VA	  
b	  The	  Rockefeller	  University,	  New	  York,	  NY	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TABLE	  A2.2	  |	  Key	  for	  the	  histone	  H2A	  (HTA1)	  library	  in	  FY406	  background	  
	  
	   1	   2	   3	   4	   5	   6	   7	   8	   9	   10	   11	   12	  
Plate	  1	  
A	   S1A	   S10A	   G23A	   V31A	   N39A	   P49A	   Y58A	   N69A	   I79A	   I88A	   K96A	   Q105A	  
B	   G2A	   K13A	   L24A	   H32A	   Y40A	   V50A	   L59A	   R72A	   I80A	   R89A	   L97A	   G106A	  
C	   G3A	   S15A	   T25A	   R33A	   Q42A	   Y51A	   E62A	   D73A	   P81A	   N90A	   L98A	   G107A	  
D	   K4A	   Q16A	   F26A	   L34A	   R43A	   L52A	   I63A	   N74A	   R82A	   D91A	   G99A	   V108A	  
E	   G5A	   S17A	   P27A	   L35A	   I44A	   T53A	   L64A	   K75A	   H83A	   D92A	   N100A	   L109A	  
F	   G6A	   R18A	   V28A	   R36A	   G45A	   V55A	   E65A	   K76A	   L84A	   E93A	   V101A	   P110A	  
G	   K7A	   S19A	   G29A	   R37A	   S46A	   L56A	   L66A	   T77A	   Q85A	   L94A	   T102A	   N111A	  
H	   G9A	   K21A	   R30A	   G38A	   G47A	   E57A	   G68A	   R78A	   L86A	   N95A	   I103A	   I112A	  
	  
Plate	  2	  
A	   H113A	   S121A	   WT	   	   	   	   	   	   	   	   	   	  
B	   Q114A	   K123A	   	   	   	   	   	   	   	   	   	   	  
C	   N115A	   T125A	   	   	   	   	   	   	   	   	   	   	  
D	   L116A	   K126A	   	   	   	   	   	   	   	   	   	   	  
E	   L117A	   S128A	   	   	   	   	   	   	   	   	   	   	  
F	   P118A	   Q129A	   	   	   	   	   	   	   	   	   	   	  
G	   K119A	   E130A	   	   	   	   	   	   	   	   	   	   	  




TABLE	  A2.3	  |	  Key	  for	  the	  histone	  H2B	  (HTB1)	  library	  in	  FY406	  background	  
	  
	   1	   2	   3	   4	   5	   6	   7	   8	   9	   10	   11	   12	  
Plate	  1	  
A	   S1A	   P13A	   S24A	   R32A	   S41A	   K49A	   I57A	   L65A	   F73A	   L83A	   S93A	   L103A	  
B	   K3A	   E15A	   T25A	   S33A	   S42A	   Q50A	   S58A	   N66A	   E74A	   Y86A	   R95A	   I104A	  
C	   E5A	   K16A	   S26A	   K34A	   Y43A	   T51A	   Q59A	   S67A	   R75A	   N87A	   E96A	   L105A	  
D	   K6A	   K17A	   T27A	   R36A	   I44A	   H52A	   K60A	   F68A	   I76A	   K88A	   I97A	   P106A	  
E	   K7A	   P18A	   D28A	   K37A	   Y45A	   P53A	   S61A	   V69A	   T78A	   K89A	   Q98A	   G107A	  
F	   P8A	   K21A	   G29A	   E38A	   K46A	   D54A	   M62A	   N70A	   E79A	   S90A	   T99A	   E108A	  
G	   S10A	   K22A	   K30A	   T39A	   V47A	   T55A	   S63A	   D71A	   S81A	   T91A	   V101A	   L109A	  
H	   K11A	   T23A	   K31A	   Y40A	   L48A	   G56A	   I64A	   I72A	   K82A	   I92A	   R102A	   K111A	  
	  
Plate	  2	  
A	   H112A	   T122A	   WT	   	   	   	   	   	   	   	   	   	  
B	   V114A	   K123A	   	   	   	   	   	   	   	   	   	   	  
C	   S115A	   Y124A	   	   	   	   	   	   	   	   	   	   	  
D	   E116A	   S125A	   	   	   	   	   	   	   	   	   	   	  
E	   G117A	   S126A	   	   	   	   	   	   	   	   	   	   	  
F	   T118A	   S127A	   	   	   	   	   	   	   	   	   	   	  
G	   R119A	   T128A	   	   	   	   	   	   	   	   	   	   	  






FIGURE	   A2.1	   |	   Generation	   of	   antibodies	   specific	   to	   K123-­‐monoubiquitinated	   H2B.	   	   (A)	  
Development	  of	  polyclonal	  antibodies	  specific	  to	  monoubiquitinated	  H2B.	  	  Ubiquitinated	  H2B–	  
specific	  antibodies	  generated	  in	  rabbit	  were	  affinity	  purified	  and	  characterized	  by	  Western	  blot	  
analysis	   of	   whole	   cell	   extracts	   prepared	   from	  wild	   type	   (WT),	   H2BK123A,	   ubp8Δ,	   and	   rad6Δ.	  	  
Both	  wild-­‐type	  and	  ubp8Δ	  strains	  show	  the	  presence	  of	  monoubiquitinated	  H2B	  (24	  kD	  and	  23	  
kD,	  respectively);	  however,	  an	  increased	  amount	  of	  the	  ubiquitinated	  form	  of	  H2B	  was	  observed	  
in	   the	  ubp8Δ	   strain	   as	   expected.	   	   No	   bands	  were	   detected	   in	   either	   H2BK123A	   or	   the	   rad6Δ	  
strains,	   showing	   that	   our	   H2Bub	   antibody	   is	   capable	   of	   specifically	   recognizing	   ubiquitinated	  
H2B	   in	  yeast.	   	   (B)	  Schematics	  of	   the	  plasmids	  used	   in	  this	  study.	   	  pSN888	  was	  generated	  from	  
pZS145	  by	  deletion	  of	   the	  N-­‐terminal	  Flag	  tag	   (Fg)	   from	  the	  HTB1	  gene.	   	  Similarly,	   the	  Flag	  on	  




FIGURE	   A2.2	   |	   Di-­‐	   and	   trimethylation	   of	   histone	   H3K4	   and	   trimethylation	   of	   H3K79	   are	  
dependent	   solely	   on	   monoubiquitination	   of	   H2BK123.	   	   (A)	   Western	   blotting	   of	   whole	   cell	  
extracts	   from	   strains	   transformed	   with	   a	   plasmid	   carrying	   wild-­‐type	   (WT)	   H2B	   or	   mutant	  
H2BK123	   (K123A;	   K123R)	   either	   with	   or	   without	   an	   N-­‐terminal	   Flag	   tag.	   	   Cell	   extracts	   were	  
prepared	   from	  wild-­‐type	   H2B	   or	   H2BK123	  mutants	   in	   three	   different	   strain	   backgrounds	   and	  
were	  subjected	  to	  SDS-­‐PAGE	  and	  analyzed	  by	  Western	  blot	  analysis	  with	  antibodies	  to	  dimethyl	  
H3K4,	   trimethyl	   H3K4,	   trimethyl	   H3K79	   (α-­‐H3K4me2,	   α-­‐H3K4me3,	   and	   α-­‐H3K79me3),	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monoubiquitinated	  H2BK123	  (α-­‐H2Bub),	  or	  Flag	  (α-­‐FLAG).	   	  An	  antibody	  against	  H3	  (α-­‐H3)	  was	  
used	  as	  a	  loading	  control.	  	  The	  calculated	  molecular	  masses	  of	  H2B,	  ubiquitinated	  H2B,	  and	  H3	  
are	  14	  kD,	  23	  kD,	  and	  15	  kD,	  respectively.	  	  The	  calculated	  molecular	  masses	  of	  Flag-­‐tagged	  H2B	  
and	  ubiquitinated,	  Flag-­‐tagged	  H2B	  are	  15	  kD	  and	  24	  kD,	  respectively.	  	  White	  lines	  indicate	  that	  
intervening	  lanes	  have	  been	  spliced	  out.	  	  (B)	  Western	  blotting	  of	  whole	  cell	  extracts	  from	  strains	  





FIGURE	  A2.3	  |	  The	  H2A/H2B	  shuffle	  strain	  Y131	  contains	  a	  galactose-­‐regulated	  copy	  of	  HTA2-­‐	  
HTB2	  genes	  on	  chromosome	  II.	  	  (A)	  Western	  blot	  analysis	  of	  whole	  cell	  extracts	  prepared	  from	  
Flag-­‐tagged	  wild-­‐type	  H2B	  and	  Flag-­‐H2BK123R	  grown	  under	  either	  glucose	  or	  galactose	  media.	  	  
Cell	   extracts	   were	   subjected	   to	   SDS-­‐PAGE	   and	   Western	   analysis	   with	   antibodies	   specific	   to	  
H3K4me2,	  H3K4me3,	  H3K79me3,	  and	  Flag.	  	  An	  antibody	  against	  H3	  (α-­‐H3)	  was	  used	  as	  a	  loading	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control.	   	  Triangles	  describe	  the	   increasing	  amounts	  of	  proteins	   loaded	  onto	  the	  gel.	   	  Letters	  D	  
and	  G	  denote	  glucose	  and	  galactose,	   respectively.	   	   (B)	  Western	  analysis	  of	  whole	  cell	  extracts	  
prepared	   from	   wild-­‐type	   (WT)	   BY4742	   (FM392)	   and	   its	   derivative	   rad6Δ,	   Flag-­‐H2B	   (Y131	  
background),	  and	  Flag-­‐H2BK123R	  (Y131	  background).	  	  Cell	  extracts	  were	  subjected	  to	  SDS-­‐PAGE	  
and	   Western	   analysis	   with	   antibodies	   to	   trimethyl	   H3K4	   (α-­‐H3K4me3),	   monoubiquitinated	  
H2BK123	   (α-­‐H2Bub),	   or	   Flag	   (α-­‐FLAG).	   	   An	   antibody	   against	  H3	   (α-­‐H3)	  was	   used	   as	   a	   loading	  
control.	  	  The	  H2B	  monoubiquitination-­‐specific	  antibody	  detected	  a	  faster	  migrating	  band,	  which	  
is	  indicated	  by	  red	  arrows.	  	  This	  band	  represents	  an	  untagged	  version	  of	  H2B,	  which	  is	  only	  seen	  
in	  Y131	  when	  cells	   are	  grown	   in	  galactose-­‐containing	  media.	   	  Blue	  arrows	   indicate	   the	   slower	  
migrating	  Flag-­‐tagged,	  monoubiquitinated	  H2B	  seen	  under	  both	  dextrose	  and	  galactose	  growth	  
conditions	  only	  in	  wild-­‐type	  cells	  and	  not	  H2BK123R.	  	  Black	  lines	  indicate	  that	  intervening	  lanes	  





FIGURE	  A2.4	  |	  In	  the	  Y131	  strain,	  the	  GAL1/10	  promoter	  is	  inserted	  between	  HTA2	  and	  HTB2	  on	  
chromosome	   II.	   	   Schematic	   of	   the	   regions	   containing	   HTA2-­‐HTB2	   genes	   on	   chromosome	   II.	  	  
Although	  this	  region	  was	  deleted	  and	  replaced	  with	  URA3	  in	  the	  Y131	  strain,	  a	  wild-­‐type	  copy	  of	  





FIGURE	   A2.5	   |	   Generation	   of	   the	   entire	   H2A/H2B	   alanine-­‐scanning	   collection	   in	   an	   FY406	  
background.	   	   (A)	   The	   H2A/H2B	   alanine-­‐scanning	   library	   was	   generated	   as	   described	   in	   our	  
previous	   study	   (NAKANISHI	   et	   al.	   2008).	   	   The	   complete	   removal	   of	   wild-­‐type	   (WT)	   H2B	   was	  
ensured	   by	   multiple	   rounds	   of	   5-­‐FOA	   selection	   and	   verified	   by	   sequencing.	   	   Each	   colony	  
represents	  a	  strain	  expressing	  histones	  containing	  a	  single	  alanine	  substitution	  mutation	  of	  each	  
of	  the	  residues	  of	  H2A	  and	  H2B.	  	  Red	  squares	  indicate	  the	  location	  of	  strains	  that	  are	  inviable	  in	  
177	  
SD	  media	  containing	  5-­‐FOA	  (lethal	  mutants).	   	  For	   the	  key	  to	  the	  corresponding	  mutant	  strains	  
within	  each	  plate,	  see	  TABLES	  A2.2	  and	  A2.3.	  	  (B)	  Western	  blot	  analysis	  of	  mutant	  strains	  in	  the	  
FY406	   background	   identified	   as	   defective	   for	   proper	   methylation	   of	   H3K4.	   	   Cell	   extracts	  
prepared	   from	   each	   mutant	   strain	   were	   subjected	   to	   SDS-­‐PAGE	   and	   analyzed	   by	   Western	  
analysis	   with	   antibodies	   to	   dimethyl	   H3K4,	   trimethyl	   H3K4	   (α-­‐H3K4me2	   and	   α-­‐H3K4me3,	  
respectively),	  monoubiquitinated	  H2BK123	  (α-­‐H2Bub),	  or	  Flag	  (α-­‐FLAG).	  	  An	  antibody	  against	  H3	  
(α-­‐H3)	  was	   used	   as	   a	   loading	   control.	   	  White	   lines	   indicate	   that	   intervening	   lanes	   have	   been	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